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 3 
Nowadays carbohydrates have gained a negative connotation, especially if you call them sugars. 
They are regarded as pure calories and associated with obesity, but in reality they are much more 
than just a source of energy. Certain carbohydrates can for instance stimulate the growth of 
beneficial bacteria in the colon (prebiotics), control diabetes (low-calorie sweeteners) or serve as 
building bocks for anti-cancer and anti-viral drugs, or when attached to another molecule modulate 
its stability, solubility and bioavailability. Hence, they are of great interest for the food, cosmetics 
and pharmaceutical industries, but unfortunately many interesting carbohydrates and glycosylated 
compounds are not present in nature in sufficient amounts for commercial exploitation. Efficient 
synthesis technologies that use cheap and readily available starting materials are therefore highly 
desirable.  
Linking a sugar to another molecule can be done chemically, but this is far from trivial. If the use of 
solvents, the need for often expensive or toxic catalyst and the amount of (toxic) waste generated is 
not considered for a moment, there is still another problem. Sugars namely have multiple hydroxyl 
groups that all can be used as points of attachment. Two glucose molecules, for example, can be 
linked in eleven different ways and the resulting disaccharides have distinct properties. One of 
those glucose disaccharides is kojibiose, which is highly interesting because of its prebiotic nature. 
Chemical synthesis however requires a tedious, low-yielding, multistep reaction procedure, while an 
appropriate enzyme could achieve the desired product in one single step. Sadly, there are no 
commercially appealing biocatalysts available, but existing enzymes can be modified to meet the 
demands.  
An interesting candidate is sucrose phosphorylase, which can produce kojibiose from cheap 
substrates, but currently lacks selectivity. To overcome this hurdle, enzyme engineering was applied. 
A classical approach was followed for this application-oriented research, but more fundamental 
aspects of enzyme engineering were investigated as well in this work. In the first chapter, the 
potential of sucrose phosphorylase is highlighted together with engineering techniques to improve 
it, as well as the global picture of carbohydrates, glycosides and enzymes that act on these latter 
molecules. Before sucrose phosphorylase was optimised for the selective production of kojibiose 
(Chapter 3), light was first shed on how the specificity is controlled in this enzyme (Chapter 2). The 
discovery of the novel albeit closely related sucrose 6’-phosphate phosphorylase specificity (Chapter 
4) furthermore enabled the evaluation of new engineering strategies like ancestral reconstruction 
and correlated mutations. Natural evolution of biocatalysts is believed to occur through ancestral 
enzymes with multiple functionalities, similar to a pluripotent stem cell that is still able to adopt a 
variety of specialised functions. Accordingly, in the lab they should be more easily to evolve too 
and this hypothesis was verified here for the first time in the context of enzyme engineering 
(Chapter 5). Studies on evolution of proteins also revealed that some positions in the structure do 
not mutate independently from one another. Although these coevolving positions are supposed to 
be involved in critical enzyme functions like stability and specificity, their exact role is often 
unknown, especially due to the lack of mutational data. Therefore, an attempt was made to address 
the questions how important these residues are and how they can be used to optimise biocatalysts 
Outline 
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(Chapter 6). Another task protein engineers are entrusted with is the quest for efficient ways to 
create stable enzymes. Currently emerging are in silico approaches since they can lower the often 
costly and time-consuming wet lab screening effort considerably. Some of these methods were 
assessed in this thesis (Chapter 7). In the final chapter, the results of this work are considered in a 
larger framework and future prospects in the exiting field of protein engineering are discussed. 
 
  
Chapter 1 
Literature review 
  
CHAPTER 1  Literature review 
 6 
1 GLYCOSIDIC COMPOUNDS 
Carbohydrates, glycosides and glycoconjugates are abundantly available on earth and serve a whole 
range of functions. Polysaccharides can for instance act as an energy source (e.g. amylose) or as a 
structural component (e.g. cellulose, chitin)1, while oligosaccharides can stimulate the immune system 
(e.g. human milk oligosaccharides) or function as signaling molecules in plants (e.g. oligosaccharins)2. 
Carbohydrates also mediate various recognition processes when attached to proteins or lipids3. Well-
known are the blood group determinants and the cancer epitope sialyl Lewis X. In addition, 
glycolipids like rhamnolipids or sophorolipids have excellent surfactant properties4. Glycosidic linkages 
are furthermore also present in several other glycoconjugates and glycosides. These typically display 
properties that differ from those of their non-glycosylated aglycons5. Naringin in grapefruits for 
example loses its bitter taste by removing the sugar moiety6. Attaching a carbohydrate to a 
thermolabile molecule like ascorbic acid (vitamin C) can greatly improve its stability and the long-
term storage7 and likewise the solubility of hydrophobic compounds can be increased5. Glycosides of 
flavours and fragrances, in turn, can function as controlled release compounds. The α-glucoside of L-
menthol, for example, is only slowly hydrolysed in the mouth and provides the prolonged sensation 
of freshness in chewing gum8. Linking a glycon moiety can even modulate the activity spectrum of 
antibiotics5.  
Glycosylated compounds can be synthesised chemically. Famous in that respect are the Koenigs-
Knorr reactions which make use of glycosyl halides activated with silver salts9-11. A variety of other 
reactions using different donor substrates like trichloroacetimidates or thioglycosides are available as 
well12. There are, however, two major issues connected with the outcome of these reactions, being 
the regioselectivity and the anomeric configuration of the glycosidic linkage. The former requires 
appropriate protections strategies, whereas the latter is strongly dependent on the neighbouring 
group participation of the C2 substituent, solvents and catalysts. Hence, chemical methods suffer 
from a number of drawbacks i.e. labour-intensive activation and protection procedures, multistep 
synthetic routes with low overall yields, the use of toxic catalysts and solvents and the amount of 
waste13. Therefore enzymes are an excellent alternative because they are regio- and stereospecific. 
Moreover, it has been shown that by the use of appropriate enzymes, glycosylation reactions 
generated up to five times less waste and had a fifteen times higher space-time yield, accordingly 
improving the eco-efficiency tremendously14, 15. 
2 CARBOHYDRATE-ACTIVE ENZYMES 
2.1 Types of CAZymes 
Enzymes that display activity towards glycosidic bonds are collectively known as carbohydrate 
modifying or carbohydrate-active enzymes (CAZymes). Several of them are involved in breakdown 
reactions, using different modes of action like hydrolysis (glycoside hydrolase, carbohydrate esterase), 
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phosphorolysis (glycoside phosphorylases), β-elimination (polysaccharide lyases) or redox reactions 
(lytic polysaccharide mono-oxygenases)16. In this literature review, however, focus is on the enzymes 
that can be used for synthetic purposes. Unambiguous classification of these CAZymes is far from 
trivial, but basically four types can be distinguished, i.e. the glycoside hydrolases (GH) (also termed 
glycosidases), glycoside phosphorylases (GP), transglycosidases (TG) and Leloir glycosyltransferases 
(GT)17. The former three transfer a glycosyl moiety from a carbohydrate to water, inorganic phosphate 
or another carbohydrate, respectively, while the latter can glycosylate a variety of organic molecules, 
but require a nucleotide activated sugar (e.g. UDP-glucose). Metabolically CAZymes are involved 
either in synthesis (GT and TG) or breakdown (GH and GP) of carbohydrates. 
 
 
Figure 1.1 The four different types of CAZymes il lustrated by their respective reactions with 
sucrose. Sucrose is synthesised by sucrose synthase (GT) and can be converted into amylose by 
amylosucrase (TG) or degraded by sucrose phosphorylase (GP) or sucrose hydrolase (GH) (GT: 
glycosyltransferase; TG: transglycosidase; GP: glycoside phosphorylase; GH: glycosyl hydrolase; 
adopted from 17) . 
 
In the most widely used classification (Enzyme Commission (EC) classification of the International 
Union of Biochemistry and Molecular Biology (IUBMB) based on the specific reaction being catalysed) 
CAZymes are classified as glycoside hydrolases (EC 3.2) when they use water as acceptor and as 
glycosyltransferases (EC 2.4) in any other case. This classification is very useful since it unambiguously 
defines an enzyme’s specificity. It however does not provide information on reaction mechanisms or 
evolutionary relationships. Enzymes with the same EC number thus can have a completely different 
structure or mode of action. Moreover, GPs are for instance not very different from GHs in use of 
acceptor (phosphate versus water) and they are not involved in synthesis as suggested by their EC 
number, and TGs are in essence just specialised retaining GHs17. Therefore classification into enzyme 
families based on sequence similarities (Pfam18, CAZy16, 19) or protein fold (SCOP20) is often applied. 
That way fundamental features elucidated for one member can be readily projected on another. 
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Particularly interesting for this work is the online CAZy database16, 19. Its main categories, glycoside 
hydrolases and glycosyltransferases, are the same as for the EC classification, but they differ in the 
types of CAZymes they contain. TGs here belong to the glycoside hydrolase families, reflecting their 
mechanistic resemblance with glycosidases, whereas GPs are found in both families, revealing their 
multiple evolutionary origins. 
 
2.2 Reaction mechanisms 
With a few exceptions21, 22, nearly all CAZymes discussed in this section follow one of the three main 
catalytic mechanisms, i.e. a single (SN2-like), a double (SN1-like) or a internal (SNi-like) displacement 
mechanism23, 24 (Figure 1.2). They can be either retaining (double, internal) or inverting (single), 
meaning that the respective anomeric configuration of the substrate and the product is the same or 
opposite (Table 1.1). The single displacement mechanism is used by the inverting GHs, GPs and GTs 
(Figure 1.2a). In glycosidases, two catalytic residues (typically Asp or Glu) are involved the direct 
nucleophilic attack of water on the anomeric carbon. One carboxylic acid (catalytic base) increases the 
nucleophilicity of the water molecule by abstracting a proton, while the other (catalytic acid) activates 
the leaving group by donating a proton. In GPs and GTs, in contrast, a catalytic base is not present 
because the phosphate or nucleotide group is already ionised at physiological pH and does not need 
to be deprotonated to increase its nucleophilic strength. Accordingly, these enzymes employ only 
one catalytic residue23, 25. 
Retaining GHs and GPs, and TGs follow a double displacement mechanism (Figure 1.2b). Here, also 
two carboxylic acids play a crucial role in catalysis, albeit with a slightly different function. One 
residue (catalytic nucleophile) attacks the anomeric carbon to form a covalent glycosyl-enzyme 
intermediate that subsequently can shuttle its glycosyl moiety to an appropriate acceptor substrate. 
The other residue (catalytic acid/base) protonates the leaving group in the first step and 
deprotonates the acceptor in the second step. This way the anomeric configuration is inverted twice, 
resulting in a net retention. Due to the nature of this mechanism, in GPs and TGs it can also give rise 
to a hydrolytic side reaction. Indeed, since water is abundantly available and the acid/base catalyst is 
unavoidably present in its basic form, it can activate a water molecule similarly as for GHs. GPs and 
TGs are however optimised to outcompete water, and consequently hydrolytic side activity is usually 
only a few percent of the wild-type activity17, 26. 
The internal or direct displacement mechanism is proposed for retaining GTs23, 25 and a few GPs27, 28 
as an alternative for the double displacement, since no conserved catalytic residues or a covalent 
intermediate could not be identified17. In this case a ternary complex is formed in which the 
phosphate moiety of the donor substrate deprotonates the acceptor molecule, while the latter 
performs a nucleophilic attack onto the anomeric carbon (Figure 1.2c). This front-side attack results in 
retention of the anomeric configuration. 
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Figure 1.2 Major reaction mechanisms of CAZymes (i l lustrated starting from an α-anomeric 
configuration). (a) single displacement SN2-like mechanism via a single oxocarbenium ion-like 
transition state (inversion of anomeric configuration), (b) double displacement mechanism via 
two oxocarbenium ion-like transition states with the formation of a discrete covalent glycosyl-
enzyme intermediate (retention) and (c) SNi-l ike direct front side or internal displacement 
mechanism (retention). (glycoside hydrolase: R = carbohydrate derivative and R’OH = water 
(mechanism a and b); transglycosidase: R and R’OH = carbohydrate derivative (mechanism b); 
glycosyltransferase: R = substituted phosphate (often nucleoside diphosphate), R’OH = acceptor 
group (mechanism a and c); glycoside phosphorylase: R = carbohydrate derivative and R’OH = 
phosphate (mechanism a,b and c); (adopted from 23) . 
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Each of the reaction steps of the different reaction mechanism described above passes through a 
transition state that carries a partial positive charge at the anomeric carbon. This charge is 
mesomerically stabilised by the endocyclic oxygen, giving the transition state an oxocarbenium 
character and the sugar ring a ‘distorted’ conformation (e.g. 4H3 half-chair)21, 29. Often family specific 
residues aid in the stabilisation of the transition states via hydrophobic, stacking or electrostatic 
interactions30-34, but since they do not perform the true catalysis, they are not further discussed here. 
 
Table 1.1 Classif ication and reaction mechanisms for different CAZymes (GH: glycoside 
hydrolase; TG: transglycosidase; GP: glycoside phosphorylase; GT: glycosyl transferase)  
type metabolic 
role 
EC CAZy 
family 
mechanisms example 
GH degradation 3.2 GH single (α→β / β→α) 
double (α→α / β→β) 
inverting α- / ß-glucosidase 
sucrose hydrolase / HEW lysozyme 
TG synthesis 2.4 GH double (α→α / β→β) amylosucrase / inulinsucrase 
GP degradation 2.4 GH 
 
GT 
single (α→β / β→α) 
double (α→α) 
direct (α→α) 
maltose / cellobiose phosphorylase 
sucrose phosphorylase 
trehalose phosphorylase 
GT synthesis 2.4 GT direct (α→α) 
single (α→β) 
sucrose synthase 
cellulose synthase 
 
2.3 Use of CAZymes for synthesis reactions 
In nature the vast majority of glycosylation reactions is performed by GTs. These enzymes are very 
efficient (yields >90%) and have an excellent regio- and stereocontrol, making them appealing for 
industrial applications17, 35 (Table 1.2). Unfortunately, their use is hampered by the high price of the 
nucleotide-activated donor substrates. Moreover, they are often membrane-associated and difficult to 
obtain, mainly because plants used to be the primary source36. Currently, however, quite a lot of 
different GTs have been identified in microorganisms. Since these latter are typically soluble proteins 
that can be efficiently expressed, large-scale production has been facilitated37. To counter the need of 
the expensive donor substrates on the other hand, one-pot regeneration systems have been 
developed. These usually rely on a pyruvate kinase and a pyrophosphorylase or a sucrose synthase to 
generate UDP-Glc from UDP and glucose 1-phosphate or sucrose, respectively17, 38-40. Alternatively, 
whole cell biotransformations (with engineered strains) can be applied41, 42. In addition to these 
improvements, the substrate range of transferases has also been expanded by means of enzyme 
engineering43-45. Nevertheless, GTs are still mainly located in the field therapeutic compounds like 
complex oligosaccharides46 (e.g. cell-surface carbohydrate mimicking structures) or glycoconjugates40, 
44 (e.g. antibiotics, aromatics, flavanoids). 
Glycoside hydrolases can also be exploited for synthesis purposes, despite their catabolic role in 
nature. They are readily available from natural sources, quite stable, stereospecific, use cheap 
substrates and have a broad specificity, which makes them attractive candidates for synthesis 
reactions24. GHs are however not always regio-specific, causing product mixtures and a more 
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elaborate downstream processing47. Moreover, yields are often poor since hydrolysis is 
thermodynamically more favourable. Indeed, synthesis can be achieved by so-called ‘reverse 
hydrolysis’ (thermodynamic control). By using a large excess of substrate, removing the product from 
the reaction mixture or lowering the water content (e.g. by adding organic solvents), the equilibrium 
can be pushed into the synthetic direction, according the principle of Le Châtelier15. Reactions with 
GHs following a double displacement mechanism can on the other hand also be controlled 
kinetically. In this case, yields are maximised by optimising the reaction conditions (e.g. pH, 
temperature) in such way that the transfer of the glycosyl moiety from the covalent glycosyl-enzyme 
intermediate to an acceptor molecule (transglycosylation) is favoured over the transfer to water 
(hydrolysis). The formed product can in turn also be used as donor substrate to form the glycosyl 
intermediate, potentially leading to hydrolysis (secondary hydrolysis). Therefore typically donor 
substrates are used that are preferred by the enzyme over the formed product and reactions should 
be stopped in time17. In addition to controlling the process conditions, enzyme engineering can also 
be applied. That way the hydrolytic activity can even be eliminated completely, by mutating key 
catalytic residues48-51. The resulting mutated GH’s, called glycosynthases, are hydrolytically inactive, 
but can still perform transglycosylation reactions with a suitable activated donor substrate (e.g. 
glycosylfluorides). Furthermore, thioglycosynthases and thioglycoligases have been created for the 
synthesis of glycosidic bonds that contain a sulfur instead of an oxygen as heteroatom52, 53. Despite 
the clear advantages of glycosynthases, widespread use is impeded by the limited availability and/or 
stability of the special donors51, 54. 
 
Table 1.2 Benefits and drawbacks of CAZymes for industrial use in glycosylation reactions 
type benefits drawbacks 
GT many specificities 
highly stereo- and regioselective 
high yields 
expensive nucleotide-activated donors required 
often membrane bound 
often difficult to obtain 
GH readily available from natural sources 
stereospecific + often broad specificity  
cheap substrates 
low yields 
low regioselectivity 
TG cheap donor substrates limited number of specificities 
GP cheap donor substrates 
moderate yields 
limited number of specificities 
 
Instead of forcing glycoside hydrolases to synthesise compounds, transglycosidases might offer a nice 
alternative. Indeed, this special type of retaining glycosidases has evolved to avoid hydrolysis when 
transferring one carbohydrate to another, and they use cheap donor substrates like sucrose or 
amylose35, 55. TGs have for instance been used to produce new prebiotic oligosaccharides and 
glycoconjugates56-60. Yet, their major disadvantage is the small number of available specificities 
(typically limited to the transfer of α-glucosyl or β-fructosyl groups)17, but engineered TGs60 and 
GHs61-63 (different from glycosynthases) have currently broadened the scope of available reactions. 
CHAPTER 1  Literature review 
 12 
Glycoside phosphorylases normally degrade carbohydrates, just like glycoside hydrolases. The main 
difference is that these enzymes generate an anomerically phosphorylated sugar as a high-energetic 
product, which enables the reactions to be reversed. Accordingly, synthesis with GPs resembles that 
of GTs, albeit with a shorter and much cheaper donor substrate (sugar phosphate instead of a 
nucleotide sugar)17, 64. The downside however is that yields are typically lower17. GPs can glycosylate a 
range of carbohydrate65-69 as well as non-carbohydrate acceptors70-72, but the donor specificity is 
limited to α-Glc1P, β-Glc1P, α-Man1P, α-Gal1P, α-GlcNAc1P and α-Mal1P17, 66, 73-75. Like for the other 
types of CAZymes, enzyme engineering has also been applied to alter or expand the known 
specificities70, 76-78.  
2.4 Sucrose-active enzymes in GH13 
Glycoside hydrolase family 13 (GH13), also known as the α-amylase family, is the largest family from 
the CAZy database and contains enzymes which degrade or modify starch, glycogen and related 
oligo- and polysaccharides79. More than twenty-two specificities are currently present for diverse 
types of CAZymes including hydrolases (e.g. α-amylase), transglycosidases (e.g. amylosucrase), 
phosphorylases (e.g. sucrose phosphorylase) and isomerases (e.g. isomaltulose synthase). At a higher 
level, GH13 is grouped into clan GH-H together with GH family 70 and 77, due to the close 
relatedness in three-dimensional structure and catalytic mechanism. Moreover, all members of GH-H 
require a glucose residue in the -1 subsite and reaction takes place at the anomeric carbon giving 
rise to an α-linked product80.  
Since the α-amylase family hosts several TGs and a GP, it is from an industrial point of view a very 
appealing family to find useful glycosylation catalysts. GH13 is in addition ideally suited to study 
structure-function relationships. Indeed, the enzymes are structurally very similar but have diverging 
specificities. There are for instance three different types of CAZymes that are phylogenetic neighbours 
and use sucrose as a donor substrate, but very distinct acceptor molecules. Amylosucrase (TG) 
catalyses the formation and elongation of an amylose-like polymer, whereas sucrose hydrolase (GH) 
and sucrose phosphorylase (GP) respectively use water and inorganic phosphate as acceptor. 
3 SUCROSE PHOSPHORYLASE 
3.1 Classification, sources and general properties 
Sucrose phosphorylase catalyses the reversible phosphorolysis of sucrose (α-D-glucopyranosyl-(1,2)-β-
D-fructofuranoside) into α-D-glucose 1-phosphate (Glc1P) and D-fructose81, 82. In accordance to the 
recommendations of the Enzyme Commission (EC) of the International Union of Biochemistry and 
Molecular Biology (IUBMB), SP received EC number 2.4.1.783. It thus belongs to the class of 
transferases (EC 2) and more specific to the glycosyltransferases (EC 2.4) that transfer a hexosyl group 
(EC 2.4.1). In the CAZy classification in contrast, it belongs to a Glycoside Hydrolase family, i.e. 
Glycoside Hydrolase family 13 (GH13)16, 79. Since the GH13 family is very large, it was further divided 
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in subfamilies. That way sucrose phosphorylase ended up in subfamily 18 (GH13_18) as sole 
specificity79. Among the around 400 protein sequences classified in this subfamily, only a relatively 
small number have been characterised, i.e. SP enzymes originating from Leuconostoc 
mesenteroides82, 84-88, Streptococcus mutans89-91, Lactobacillus acidophilus26, 92, Pelomonas 
saccharophila (Pseudomonas saccharophila)81, Bifidobacterium adolescentis93, Bifidobacterium 
longum94 and a metagenomes analysis of a sucrose-rich environment95 (Table 1.3).  
SP essentially catalyses an equilibrium reaction (Keq of 5.6 at 30°C, pH 7.0)96 and can therefore be 
used for the breakdown as well as synthesis of sucrose. In vivo, however, it is likely to serve a 
catabolic role, regarding the higher concentration of phosphate in the cell compared to Glc1P72. 
Moreover, the reaction products (Glc1P and fructose) can be readily converted by the bacterial cell to 
intermediates of the glycolysis, and as phosphorolysis of sucrose does not require ATP, it can be seen 
as an energy-saving cellular process97. The optimal pH (6.0-7.5) and temperature (30-37°C) for SP 
enzymes72 also reflect the optimal growth conditions of their hosts. The only exception so far is SP 
from Bifidobacterium adolescentis (BaSP), which has a remarkably optimal temperature of 58°C98.  
 
Table 1.3 Apparent kinetic parameters for the native substrates of sucrose phosphorylases from 
different sources 
enzyme sucrose  phosphate  glucose 1-P  fructose 
 KM (mM) kcat (s-1)  KM (mM) kcat (s-1)  KM (mM) kcat (s-1)  KM (mM) kcat (s-1) 
LmSP 12291# 7.3 ± 0.5 62 ± 13  n.a. n.a.  n.a. n.a.  21.9 ± 2.0 22 ± 5 
 5.7 ± 0.1 165 ± 2   9.5  ± 0.7 n.a.  17.3  ± 1.1 96 ± 0.5  21.1 ± 3.7 n.a. 
LmSP B1149 14.1 ± 0.9 28 ± 5  n.a. n.a.  n.a. n.a.  22.7 ± 1.9 14 ± 2 
LmSP B1355 3.0 ± 0.2 4 ± 1  n.a. n.a.  n.a. n.a.  17.4 ± 2.0 1 ± 0.3 
LmSP B742 3.0 n.a.  n.a. n.a.  n.a. n.a.  n.a. n.a. 
LmSP 1102 n.a. n.a.  n.a. n.a.  16 n.a.  12 n.a. 
SmSP 0.8 ± 0.1 16 ± 1  n.a. n.a.  n.a. n.a.  8.3 ± 1.0 5 ± 1 
LaSP 2.3 ± 0.2 14 ± 3  n.a. n.a.  n.a. n.a.  17.4 ± 1.3 7 ± 1 
PsSP 2.5 n.a.  1.8 n.a.  2.3 n.a.  13 n.a. 
BaSP 1.4 ± 0.1 78 ± 14  19.3 ± 1.4 n.a.  7.1 ± 0.5 n.a.  10.1 ± 0.6 16 ± 3 
BlSP 3.9 2  n.a. n.a.  n.a. n.a.  n.a. n.a. 
unSP 21.1 31.2  n.a. n.a.  n.a. n.a.  n.a. n.a. 
# values obtained from independent measurements by two different research groups; LmSP 12291: Leuconostoc 
mesenteroides ATTC 1229126, 87, 99; LmSP B1149: L. mesenteroides NRRL B114926, 84; LmSP B1355: L. 
mesenteroides NRRL B135526; LmSP B742: L. mesenteroides NRRL B74288; LmSP 1102: L. mesenteroides AKU 
110286; SmSP: Streptococcus mutans LMG 1455826; LaSP: Lactobacillus acidophilus LMG 943326; PsSP: 
Pelomonas saccharophila81, 100; BaSP: Bifidobacterium adolescentis LMG 1050226, 101; BlSP: B. longum SJ3294; 
unSP: SP from unknown species (metagenomes analysis of a sucrose-rich environment)95; n.a.: not available 
3.2 Reaction mechanism and structure-function relationships 
Sucrose phosphorylases are approximately 480-510 amino acids long and have a molecular mass of 
54-60 kDa72, 102. They are generally monomeric, but the enzymes from P. saccharophila and B. 
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adolescentis are (homo)dimeric72, 103. The crystal structure of the latter was resolved by X-ray 
crystallography some ten years ago, and it is currently still the only structure of a sucrose 
phosphorylase103, 104. It is characterised by four domains, designated as A, B, C and B’ (Figure 1.3). 
Whereas the former three are typical for GH13 enzymes, the latter is unique for the sucrose-active 
members. Domain A is a (β/α)8 barrel holding the catalytic residues, in which domains B and B’ are 
found between β-strand 3 and α-helix 3, and β-strand 7 and α-helix 7, respectively. They both 
contain loops that play a key role in defining the active site architecture and substrate specificity. 
Furthermore, the topology of the B’ domain reduces the size of the substrate access tunnel and 
disfavours oligosaccharide binding compared to other GH13 enzymes like amylosucrase or α-
amylase103. In BaSP the B domain not only is involved in specificity, it also provides the dimer 
interactions. The C domain, even though present in all GH13 enzymes, has a unique fold in sucrose 
phosphorylase and consists of a five-stranded anti-parallel β-sheet. Moreover, it has been suggested 
that in family 13 this domain stabilises the catalytic domain or aids in binding of (the often large) 
substrates80, 105, 106, but in sucrose phosphorylase its function is unknown. 
 
 
Figure 1.3 Crystal structure of sucrose phosphorylase of Bif idobacterium adolescentis (pdb entry 
2GDU; green: domain A; yellow: domain B; orange: domain B’; red: domain C; purple: sucrose). 
 
Like all GH13 enzymes, sucrose phosphorylase follows a double displacement reaction mechanism 
passing through a covalent β-glucosyl-enzyme intermediate with final retention of the anomeric 
configuration104 (Figure 1.4a). Two fully conserved catalytic residues are involved, being an aspartic 
acid (Asp192 in BaSP) performing the nucleophilic attack and a glutamic acid (Glu232) acting as the 
general acid/base catalyst16, 104 (Table 1.4). The reaction is initiated by simultaneous protonation of 
the glycosidic bond oxygen by the proton donor and nucleophilic attach on the anomeric carbon of 
the glucosyl moiety, leading to the covalently linked enzyme-substrate intermediate and the release 
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of fructose. Subsequently, after some conformational changes of the acceptor site, the intermediate 
can react with inorganic phosphate (mono or dibasic), and glucose 1-phosphate is released. Note 
that hydrolysis is always present as a minor side reaction (1-5%)26, since the covalent intermediate 
can also be intercepted by water. 
 
 
Figure 1.4 Double displacement reaction mechanism of sucrose phosphorylase (adopted from 
104) . 
 
Already over half a decade ago, studies suggested107 and experimentally confirmed100, 108 the 
progressive idea of the now well-established concept of enzymatic glycosyl transfer via a covalent 
intermediate. More recently, crystallographers have been able to capture this glycosyl-enzyme state 
and resolved its structure104. Further proof of the reaction mechanism was provided by site-directed 
mutagenesis of the catalytic nucleophile (Asp192) and the general acid/base catalyst (Glu232)99, 109 
(Table 1.4). Mutation of Asp192 to alanine yielded a variant unable to perform its wild-type reaction. 
Glycosylation of alternative acceptors (e.g. azide) from α-D-Glc1P as donor was forced to proceed via 
a ternary complex (single displacement), changing the reaction mechanism from α-retaining to 
inverting and accordingly yielding a β-glucoside (e.g. β-D-glucose 1-azide)99. Analysis of pH 
dependencies revealed a pKa of 5.6, ensuring Asp192 to be deprotonated at physiological pH and 
able to perform a nucleophilic attack109. Detailed kinetic comparison of the acid/base mutant E232Q 
and the wild-type enzyme unequivocally proved the role of Glu232109. Reactions with substrates 
requiring Brønsted catalytic assistance for glucosylation (sucrose) or deglucosylation (fructose) of the 
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enzyme were selectively slowed down at the respective step in the E232Q mutant (~105 fold). 
Moreover, the pKa of Glu232 cycles between 7.2 in the free enzyme and 5.8 in the glucosyl-enzyme 
intermediate, ensuring an optimal participation of the glutamate side chain at each step in catalysis. 
Enzyme deglucosylation to inorganic phosphate does, however, not strictly need assistance of a base, 
but in the glycosyl-enzyme intermediate Glu232 is inevitably present in its deprotonated state, like in 
other retaining glycosyl hydrolases and transglycosidases. In these enzymes it is often observed that 
anions are prevented access to the active site, presumably because of charge screening by the base 
catalyst109, 110. It thus seems that SP achieves its special transferase activity through a non-
conventional exploitation of the common catalytic machinery (see further). 
 
Table 1.4 Substrate interactions and function of residues in sucrose phosphorylase 
residuea (potential) substrate interactionb (potential) function 
Asp192 (Asp196) H-bond with OH6; 3 Å away from C1 
(anomeric carbon) 
nucleophilec, 99 
Glu232 (Glu237) H-bond with OH1 and OH1’ general acid/base catalystc, 109 
Asp290 (Asp295) H-bond with OH2 ‘transition state stabiliser’c, 34 
Phe53 (Phe52) hydrophobic/π interaction with C3, C4 and 
C6; stacking interactions with Glc-ring; cation-
π interaction with oxocarbenium ion-like 
transition state 
‘hydrophobic platform’; transition 
state stabilisationc, 111 
Phe156 (Phe160) hydrophobic/π interaction with C6 and C1’ ‘hydrophobic sandwich’ 
His88 (His87) H-bond with OH6 binding of glycosyl moiety 
Arg190 (Arg194) H-bond with OH2 binding of glycosyl moiety 
His289 (His294) H-bond with OH2 and OH3 binding of glycosyl moiety 
Asp50 (Asp49) H-bond with OH4 binding of glycosyl moietyc, 112 
Arg399 (Arg395) H-bond with OH3 and OH4 binding of glycosyl moietyc, 112 
Ala193 (Ala197) hydrophobic interaction with C6 and C1’ binding of glycosyl/fructosyl moiety 
Leu341 (Leu337) hydrophobic interaction with C6 and C6’ binding of glycosyl/fructosyl moiety 
Tyr196  (Tyr200) hydrophobic/π interaction with C1’ binding of fructosyl moiety 
Asp342 (Asp338) H-bond with OH4’ binding of fructosyl moietyc, 113 
Gln345 (Gln341) H-bond with O6’ and O3’ binding of fructosyl moiety 
Arg135  (Arg137) H-bond with phosphate O binding of phosphate groupc, 113 
Tyr344 (Tyr340) H-bond with phosphate O binding of phosphate groupc, 113 
a residue numbering according to SP from B. adolescentis; residue numbers between brackets correspond 
to the numbering of SP from L. mesenteroides ATTC 12291 
b derived from crystal structures 2GDU and 2GDV from B. adolescentis103, 104; numbered OH-groups and C-
atoms address to sucrose (apostrophe for fructosyl moiety), unless stated otherwise 
c confirmed by mutagenesis 
 
Next to the residues performing the ‘true’ catalysis, some other highly conserved GH13 residues 
contribute to the reaction course as well, by stabilising the transition states. In that respect, Asp290 is 
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referred to as the ‘transition state stabiliser’ and it is even included as a third member of the catalytic 
triad34, 80, 103, 104 (Table 1.4). Its importance is demonstrated by the ~104 fold reduction in catalytic 
activity in the D290N mutant34. Asp290 uniformly affects the formation and the breakdown of the 
covalent glycosyl-enzyme, independent of the direction of the reaction, i.e. phosphorolysis or 
synthesis. A strong hydrogen bond between the ionised aspartic acid side chain and the OH2 
hydroxyl of the glucosyl moiety stabilises the transition states (≥23 kJ/mol), and is also suggested to 
aid in substrate distortion. Asp290 is, however, not critical for the functioning of Glu232 as general 
acid/base. Besides the so-called ‘transition state stabiliser’, a highly conserved aromatic residue (here 
a Phe) is present in the -1 subsite, which is often termed ‘hydrophobic platform’17, 31, 111. Mutation of 
Phe52 in SP to Ala or Asn reduced the catalytic activity three orders of magnitude, and increased the 
KM for sucrose over a factor eighty. Positioning of the glycosyl moiety and non-polar contacts with 
the hydrophobic C4-C5-C6 glucose part (that become tightened in the transition state104) are 
believed to facilitate the reaction. In addition to this conformational stabilisation, strong electrostatic 
cation-π interactions are proposed for the stabilisation of the oxocarbenium ion-like transition state 
(≥15 kJ/mol). 
The aforementioned residues are typical for all GH13 members, but if the scope is narrowed down to 
the subgroup of sucrose-active enzymes, several other residues are highly conserved. The -1 subsite, 
also called donor site, is almost completely identical in sucrose phosphorylase, amylosucrase, sucrose 
hydrolase114, 115 (Figure 1.5). Moreover, crystal structures of these enzymes in complex with different 
ligands suggest a tight binding of the glycosyl moiety in the active site. In SP this is reflected by the 
fact that it is highly specific for transferring a glycosyl moiety and does not even tolerate 
modification like C2 and C4 epimerisation or removal of the C6OH group34, 93, 116, 117. Site-directed 
mutagenesis of Asp50 and Arg399 (side chain contact with the equatorial OH4) further support the 
finding of an optimal topology for binding of a glucosyl moiety at the -1 subsite112. A comprehensive  
 
 
 
Figure 1.5 Residues in the donor site (-1 subsite) conserved among the sucrose-active enzymes 
(green: catalytic residues; white: glucose moiety). 
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analysis of steady-state kinetics of D50A and R399L showed an increase in KM for sucrose over a 
factor of eighty and a severe lowering of the kcat. The calculated loss of transition state stabilisation 
was, in addition, large and seem to exceed by far the typical value (15-20 kJ/mol) one would 
maximally expect for the removal of a charged hydrogen bond between a side chain and a non-
reacting hydroxyl group of a substrate. The impact of the mutations was thus not strictly local, but 
introduced structural disruption of proximal parts. Loss of substrate affinity, impaired positioning of 
the substrate for catalysis and decrease in ability to stabilise the oxocarbenium ion-like transition 
states are accordingly all responsible for the dramatic lowering of catalytic efficiency in the two 
mutants112. 
In sharp contrast to the -1 subsite, the +1 subsite has an astonishing structural plasticity. Indeed, how 
can two molecules with completely different properties i.e. fructose and inorganic phosphate, be 
accommodated in the same subsite? High-resolution crystal structures of several coordinates along 
the reaction pathway revealed a large movement of two acceptor site loops, designated loop A 
(residues 336-345; domain B’) and loop B (residues 130-140; domain B), that adopt two different 
conformation suited for binding of either fructose or phosphate103, 104 (Figure 1.6). Crystal structures 
of the apo-enzyme and the complex with sucrose are perfectly superimposable, meaning that SP is 
pre-organised to bind sucrose. Conformational changes were also not observed in the covalent 
glycosyl-enzyme intermediate, contrary to the product bound state. In this structure, loops A and B 
have moved up to 16 and 4 Å, respectively, resulting in a complete reshaping of the acceptor site 
architecture. Most salient is the replacement of Asp342 by Tyr344 and Arg135, altering the net charge 
of the active site by +2. Moreover, the newly introduced residues are nearly optimally positioned for 
binding of a phosphate group. Additionally, Arg135 is expected to enable the enzyme to outcompete 
water as an acceptor through strong electrostatic interactions. Mutational data fully support these 
observations113. In the D342N mutant, catalytic efficiencies for steps involving fructose were 
decreased nearly four orders of magnitude, beside a drastic loss in binding affinity for fructose as 
well as a moderate decrease in sucrose binding. Replacement of Arg135 and Tyr344 by alanine on 
the other hand resulted in a severe lowering of the binding affinity for glucose 1-phosphate and 
phosphate, and a 50 to 2000-fold reduced catalytic efficiency for steps where these substrates are 
involved. Precise positioning of this latter group as well as hydrogen bonding are expected to 
provide selective transition state stabilisation by reducing the entropic barrier for reaction and 
reduction of electrostatic repulsion with the deprotonated side chain of the acid/base catalyst as well 
as the ability to outcompete water as an acceptor. Arg135 and Tyr344, and Asp342 clearly have a 
crucial role in the half-reaction with phosphate en fructose, respectively, but the disruptive effects of 
mutation also extend into the other half reaction. Similarly, a certain degree of synergism in catalytic 
function was suggested between the donor and the acceptor site112, highlighting the complex nature 
of the reaction mechanism. Moreover, it still remains unclear what triggers the conformational change 
of the acceptor loops and how substrates enter or leave the active site since the entrance is far too 
narrow. 
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Figure 1.6 Structural rearrangments (right) and proposed reaction course (left) of sucrose 
phosphorylase. Step (a) corresponds to the apoenzyme (pdb 1R7A), which binds the substrate 
sucrose in step (b) (pdb 2GDU). The covalent intermediate is formed in step (c) (pdb 2GDV 
chain A) and fructose has left the active site. In step (d), the glucosyl intermediate reacts with 
phosphate (gray sphere). Step (e) shows the product-bound form of the enzyme (pdb 2GDV 
chain B) (green: catalytic triad; orange; loop A; yellow: loop B; white substrate) (partly adopted 
from 104) . 
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3.3 Industrial potential and applications 
In recent years, disaccharide phosphorylases have attracted increasing attention as promising 
biocatalysts for the production of glycosides, but sucrose phosphorylase is particularly interesting 
since (i) it uses sucrose as donor substrate and (ii) it has an exceptionally broad acceptor specificity. 
Due to their single displacement mechanism, other disaccharide phosphorylases can only use Glc1P 
as donor, and not their disaccharide, to glycosylate alternative acceptors66, and moreover they are 
typically characterised by equilibrium constants of 3-5 for the synthetic direction118, 119. Hence, 
product yields higher than 65% are difficult to obtain (at least when equimolar concentrations of 
donor and acceptor are used). Sucrose phosphorylase, in contrast, uses a double displacement 
mechanism and can therefore use sucrose as (a more reactive) donor for transglycosylation. Indeed, 
the energy in the sucrose glycosidic linkage is of the same level as nucleotide-activated sugars, 
resulting in yields exceeding 90%120. Moreover, sucrose is cheap, abundantly available and 
renewable114, making it appealing from an industrial point of view. 
Sucrose phosphorylase is not only attractive because of its donor substrate, but also due to its 
acceptor promiscuity. The ability of SP to use alternative acceptors was already recognised in 1944 by 
Doudoroff and colleagues, when they were able to glycosylate L-sorbose121, 122. Over the years, several 
papers have been published reporting glycosylation of a diversity of acceptor molecules, by SP 
enzymes from different sources. These hydroxylated compounds include mono-, di- and 
trisaccharides, sugar alcohols, aminosugars, phenol derivatives, furanones, primary alcohols and even 
sugar- and fatty acids 72, 123. Glycosylation is, however, often reported qualitatively rather than 
quantitatively, and if values are given, they are most of the time represented by a (non-standardised) 
transfer ratio or yield. Moreover, this parameter reflects the thermodynamic equilibrium of the 
substrate and product, and does not provide any information about the efficiency of the enzyme 
itself. An extensive study determining the activity of six different SP enzymes on over eighty very 
diverse compounds, revealed that only a few alternative acceptors (L-sorbose and L-arabinose) are 
glycosylated efficiently26. The activity on the vast majority is in contrast very low, comparable to the 
hydrolytic side activity. In other words, transglycosylation with SP does not seem very efficient both in 
terms of substrate use and amount of enzyme needed. Thoughtful optimisation of reaction 
conditions could however offer an elegant solution. A nice example is the production of 2-O-(α-D-
glucopyranosyl)-sn-glycerol, a moisturising agent in cosmetics. Changing the concentration of sucrose 
from 50 mM to 0.5 M and glycerol from 65 mM to 2 M lowered the contaminating hydrolytic activity 
and increase the yield from 55% to 93%26, 124. That way an economically profitable process could be 
established at industrial scale, and the product is now sold under the trade name Glycoin®. 
Process engineering was also found to be very promising for the glycosylation of (poly)phenols and 
other more hydrophobic molecules. The low affinity of SP for these compounds was for instance 
countered by the addition of (co)solvents to increase their dissolved concentration. By carefully 
balancing the acceptor solubility and enzyme stability, efficiencies could be greatly improved as 
illustrated for the glycosylation of resveratrol and quercetin in ionic liquid125. The use of biphasic 
systems (e.g. water/ethyl acetate) seemed to be even more successful, and enabled the synthesis of a 
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range of α-D-glucosides such as cinnamyl α-D-glucopyranoside, geranyl α-D-glucopyranoside, 2-O-α-
D-glucopyranosyl pyrogallol, and series of alkyl gallyl 4-O-α-D-glucopyranosides126.  
Glycosylation by SP is often stereo- and regioselective as demonstrated for several glycerol 
derivatives127-129, and it can even be used for the chiral resolution of certain compounds130 (e.g. 
production of (R)-2-O-α-D-glucopyranosyl glyceric acid amide). This is however not always the case. 
Hydroxy benzyl alcohol131, epigallolcatechin gallate132 or glucose133, for instance, give rise to more 
than one product. For (poly)phenols the regioselectivity might often not be of primary importance 
since their glycosylation is often mainly to improve solubility, bioavailability and/or stability5. 
Synthesis of di- and oligosaccharides, in contrast, do require a high degree of regio- and 
stereoselectivity as properties of isomers might differ remarkably. A notable example is the 
glycosylation of D-glucose, yielding kojibose (Glc-α1,2-Glc) and maltose (Glc-α1,4-Glc) in equimolar 
amounts128, 129. While the former is a prebiotic134, the latter has little added value. A sucrose 
phosphorylase only producing kojibiose would of course be of great interest, but as selectivity is 
rather inherent to the enzyme, it is likely that altering reaction conditions will not solve the problem. 
Modifying the enzyme itself by means of protein engineering is therefore an appealing alternative.  
4 ENZYME ENGINEERING 
4.1 Classical approaches 
Enzyme engineering is altering the structure of an enzyme to improve or change its properties135. 
Initial successes were achieved by mimicking the process of natural evolution in the lab, known as 
directed evolution. Variation is created by random mutation and recombination, followed by 
screening or selection to isolate or enrich for improved variants. These steps are subsequently 
iterated until the desired level of change is reached or no further improvement can be achieved. 
Random point mutations are commonly introduced with error-prone PCR (epPRC)136 and 
(homologous) recombination by shuffling137. Currently, several variations and improvements have 
been established. The inherent bias of epPCR has been countered in SeSaM (Sequence Saturation 
Mutagenesis)138 or randomisation can be targeted to more specific regions with SRM (Segmental 
Random Mutagenesis)139. Alternatives to classical shuffling are the more straightforward PCR based 
StEP (Staggered Extension Process)140 method, RACHITT (Random Chimeragenesis on Transient 
Templates)141 for a higher crossover rate or homology-independent methods like ITCHY (Incremental 
Truncation for the Creation of Hybrid enzymes)142 and SCRATCHY143.  
Random approaches however require high-throughput screening methods which are costly and time-
consuming, and not always available. Hence, focus has shifted towards smaller libraries of higher 
quality. These so-called smart libraries reduce the screening effort and at the same time increase the 
chance of finding an improved variant. Well-known are the semi-rational approaches developed by 
the group of Manfred Reetz, which have become common practice among protein engineers 
nowadays. In Combinatorial Active Site Saturation Testing (CASTing)144, two or three positions in (or 
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close) to the active site that are close to each other, are grouped together in a small library. For an 
NNK saturated library of two positions only 3000 clones need to be screened in order to ensure 95% 
coverage145. Improved variants from different libraries can then be combined146 or used as template 
for a next round147. Since short synthetic oligonucleotides have become very cheap, the degenerate 
NNK primer can be replaced with the NDT/VHG/TGG primer trio (22c trick)148. That way all 20 amino 
acids are reached with only 22 codons and the screening effort is reduced with a factor two and 
three for two and three simultaneous positions, respectively. Alternatively, reduced alphabets like 
NDT (small set of balanced amino acids) or VRK (hydrophilic amino acids) can be used among 
others149. 
Over the years, a wealth of protein engineering strategies and techniques have emerged and these 
have been extensively reviewed135, 150-158. Some aim at finding interesting positions to mutate 
(hotspots) and what amino acids to introduce, based on structural and sequence information, while 
others entail new ways of generating diversity and finding improved variants. In the next section, a 
few recent engineering approaches that are used throughout this work will be discussed in more 
detail. 
4.2 Protein sequence-activity relationships 
Efficiency of directed evolution experiments can be improved by identifying useful mutations through 
statistical analysis159. This involves methods that try to link sequence or structure to function or 
activity. Originally these approaches were used in drug design and ecotoxicology to establish 
quantitative relationships between the structure of small molecules and their biological activity160, 
hence the name quantitative structure-activity relationships (QSAR). The QSAR methodology has been 
used for the first time in the context of protein engineering in the so-called quantitative structure-
function relationship (QSFR) analysis, and has meanwhile been applied to several enzymes like 
haloalkane dehalogenase, subtilisin, T4 lysozyme and tryptophan synthase161. In QSFR analysis, 
structural and physico-chemical properties of amino acid residues are correlated with functional data 
(e.g. activity or stability). That way, a QSFR model enables the quantification of the effect of 
mutations, and the prediction of properties of variants that have never been constructed and 
evaluated experimentally. 
Several variants for the assignment of advantageous, neutral and deleterious mutations exist162-164, 
but a notable example is the ProSAR (protein sequence-activity relationships) approach of the codexis 
group165-167. They were able to create a bacterial halohydrin dehalogenase that improved the 
volumetric productivity of a cyanation process around 4000-fold (production of the cholesterol-
lowering drug atorvastatin). The strategy consisted of an iterative process of diversity generation and 
screening, followed by statistical analysis. Each round, libraries were constructed to have 10 to 50 
mutations. The best variants and a fraction of less improved variants were sequenced and after 
ProSAR analysis individual mutations were classified as ‘beneficial’ (fixed in the template for the next 
round), ‘potentially beneficial’ (included for retesting), ‘neutral’ (discarded) or ‘deleterious’ (discarded) 
(Figure 1.7). 
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The ProSAR model in this example was established by correlating the mutations with enzyme 
function according to ! ! ! !!!! !!!!! !!! where y is the predicted response, n the number of unique 
mutations, ci the regression coefficient for mutation i, xi a binary digit indicating the presence or 
absence (1 or 0) of mutation i, and y0 the mean of the measured response. In this equation only 
linear terms are included corresponding to independent, additive effects of mutations. When needed, 
nonlinear terms can also be added to capture putatively important interactions between mutations168. 
Using the sequence-activity data of initial variants (training set), the regression coefficients are 
adjusted to minimise the difference between predicted and measured values. To do so, partial least-
squares (PLS) regression is typically used, because there are more unknowns than equations (more 
mutations than sequence-activity measurements). Mutations that have large positive regression 
coefficients after optimisation were classified as ‘beneficial’ (mutation observed a number of times) or 
‘potentially beneficial’ (observed only one or a few times). The former were enclosed in the template 
for the next round, while the latter were again included in the diversity generation. Mutations with 
small or negative coefficients were regarded as ‘neutral’ or ‘deleterious’, respectively, and discarded 
as they were less likely to contribute significantly to improved activity. 
 
 
Figure 1.7 General strategy of the ProSAR approach (adopted from 165) . 
 
ProSAR has a few advantages over traditional in vitro methods (e.g. shuffling). It does not only have 
the ability to rapidly identify beneficial mutations in hits, it can also identify such mutations in 
variants with reduced function (that would be overlooked by traditional methods)166. Moreover, it can 
also sift out deleterious mutations, in contrast to traditional methods that run a much higher risk of 
carrying over these mutations into the next round. In addition, deep screening of libraries to find the 
best mutant is not necessary166. It is sufficient to identify beneficial mutations and move them into 
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the next round. In the example above, 18 rounds of mutagenesis were performed, but in total only 
~60000 variants were screened to obtain the desired result. This once more emphasises the 
importance of library quality over quantity169. Note that the ProSAR approach is only appropriate 
when combinatorial libraries are constructed in such a way that it is expected to see each mutation a 
number of times. As a consequence, for libraries generated through traditional random mutagenesis, 
ProSAR is not applicable as the majority of mutations are only seen once. Nevertheless, new methods 
that incorporate physic-chemical properties of amino acids are being developed to cope with these 
limitations170. 
4.3 Ancestral sequence reconstruction 
4.3.1 Concept 
Ancestral sequence reconstruction (ASR) is the process in which the extinct ancestor of present-day 
sequences is reconstructed, given a certain phylogeny and model of evolution. Applications are very 
diverse ranging from inference of the palaeo-environment of prehistoric bacteria171 over resurrection 
of ancient viruses172 to characterisation of the vision of dinosaurs173 and even vaccine design174. 
Furthermore, it has also been used to elucidate the evolution of opsins175, 176, steroid receptors177-179, 
coral pigments180, 181 and neurotransmittors182. Examples of enzymes are however limited183, 184, but 
nevertheless very valuable. Worthwhile is the study on a large family of fungal glycosidases that 
underwent multiple duplication events183. Several key ancestral enzymes were reconstructed, 
kinetically fully characterised and compared with present-day glycosidases. It was shown that the first 
ancestral enzyme was primarily active on maltose-like substrates, with trace activities on isomaltose-
like sugars. Subsequent mutations shifted the activity to either one of the two, at multiple stages in 
evolution via different evolutionary routes. Interestingly, these findings support the idea of evolution 
from a multi-functional or promiscuous intermediate to a more specialised enzyme185-187. 
In addition to retracing the evolution of specificity and kinetic behaviour of enzymes, ASR was also 
applied for protein engineering purposes, i.e. to improve stability or specificity. For stabilisation of 
isocitrate dehydrogenase188 and 3-isopropylmalate dehyrogenase189, for instance, residues shared 
between archaeal sequences and the last common ancestor of Bacteria and Archaea were introduced 
in a present-day representative (as single point mutations). For β-amylase in contrary, stabilisation 
was achieved by replacing residues in a mesophilic enzyme with the counterparts found in the 
bacterial ancestor190. Specificity on the other hand was altered for sulfotransferases and paraoxonases 
by screening of libraries of existing enzymes containing ancestral mutations in or close to the active 
site191. Analogously to shuffling, the aim is to explore new combinations of substitutions that have 
already been explored by nature and proven functional. The difference however is that here diversity 
is borrowed from the evolutionary past and not from the present. As few as 300 mutants were 
screened to reach up to a 50-fold increase in activity on certain substrates. A similar approach, called 
reconstruction of evolutionary adaptive paths (REAP), yielded out of 93 mutants a Taq DNA 
polymerase variant capable of accepting a non-standard nucleotide192. 
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4.3.2 Reconstruction process 
Though the idea of resurrecting ancient genes or proteins is fairly simple, the reconstruction itself is 
far from trivial. Inferring the ancestral state is a multi-step procedure in which the result from every 
step propagates throughout the entire process and therefore it should be carefully thought through. 
A multiple sequence alignment (MSA), a phylogenetic tree and an evolutionary model (substitution 
model) are needed for the reconstruction (Figure 1.8)193 and for each step several alternatives are 
available (detailed summary of examples in Appendix). For the MSA both nucleotide and amino acid 
sequences can be used, but for proteins typically the latter are preferred because they contain less 
‘noise’ (less subjected to convergence and reversal)193. Sequences are easily retrieved from public 
databases (e.g. GenBank or UniProtKB) and tools like Clustal Omega or MUSCLE are available for the 
alignment (Table 1.5).  
 
 
Figure 1.8 Overview of the different steps in the ancestral sequence reconstruction process. 
 
In addition to a MSA, a tree is required describing the phylogenetic relationships between the 
sequences. The phylogeny can for example be derived from rRNA or whole genomes, but most often 
the MSA serves to infer the tree. Initially, the maximum parsimony (MP) principle was applied i.e. 
minimising the number of evolutionary changes194. Due to intrinsic limitations such as the ignorance 
of branch lengths and the assumption that every kind of mutation is equally probable, its accuracy 
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however rapidly declines as input sequences become less similar193, 195. To remedy the shortcomings 
of MP, neighbour-joining (NJ) and maximum-likelihood (ML) methods were developed. The former 
tries to find pairs of taxonomic neighbours that minimise the total branch length at each stage196, 197, 
while the latter identifies the tree with the highest probability of evolving the observed data198. They 
both consider the relative rates of different mutations, embraced in a so-called substitution model. 
This is a 20x20 (or 4x4) matrix containing for every amino acid (or nucleotide) the probability of 
being mutated to another amino acid (or nucleotide), if a mutation occurs during evolution.  
 
Table 1.5 Commenly used data types, models, methods, software and servers for the different 
steps in ancestral sequence reconstruction (ASR). 
ASR step data types/models/methods software/server 
multiple sequence 
alignment 
nucleotide, amino acid ClustalO/W/X199, 200, MUSCLE201, 
MAFFT202, 203, MEGA204, T-Coffee205 
substitution matrix nucleotide (e.g. HKY85), codon (e.g. F61), 
amino acid (e.g. Daydoff, JTT, WAG, LG) 
Modeltest206, ProtTest207, 208, MEGA204, 
PAUP*209, PAML210, MrBayes211, 212 
phylogenetic tree maximum parsimony (MP), neighbour-
joining (NJ), maximum likelihood (ML) 
MEGA204, FastTree, PAML210, PhyML213, 
PHYLIP214, PAUP*209, MrBayes211, 212 
ancestral 
reconstruction 
maximum parsimony (MP), maximum 
likelihood (ML), Bayesian Markov chain 
Monte Carlo (BMCMC) 
PAML210, FastML, MrBayes211, 212, 
MEGA204, PAUP*209, PHYLIP214 
 
One of the first amino acid substitution models, developed by Dayhoff and coworkers, was the point 
accepted mutation or PAM matrix215. It is derived from comparisons of existing sequences of multiple 
protein families, and it simply counted the frequency of a specific mutation. Several variants (e.g. 
JTT195, WAG216, LG217) have been developed, derived from larger data sets or taking into account 
evolutionary distances, but none of them is universally preferred218. Additionally, models can be 
further modified to fit the observed data by considering the observed amino acid frequencies in the 
input set ('+F'), invariable sites (‘+I’) and among-site rate variation (‘+G’)218-220. Consequently, different 
substitution tables and additional parameters should be evaluated, based on statistical criteria such as 
a likelihood ratio test, AIC or BIC criterion, in order to find the most adequate for a given set of 
sequence data218.  
Like for the construction of the tree, the actual ancestral reconstruction also requires a substitution 
model. If the phylogenetic relationships were derived from the input sequences (with a method using 
a substitution model), the model is the same. If it was however not the case (e.g. tree based on 
rRNA), a suitable substitution matrix for the input sequences should be selected analogous as for the 
construction of the tree. This substitution model is then used together with the MSA and the tree to 
calculate the ancestral state at every node, in a way similar to deriving the phylogenetic relationships. 
As for the tree, maximum parsimony (MP) is highly unrecommended for input sequences that are not 
very closely related. Maximum likelihood (ML) on the other hand is more accurate and therefore 
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applied in most cases. It generates every possible ancestor at each internal node and calculates the a 
posteriori probability that the input sequences actually evolved from this ancestor193. This allows the 
evaluation of the reliability of the optimal and alternative reconstructions. The Bayesian Markov chain 
Monte Carlo (BMCMC) approach deals even further with uncertainty by integrating the calculation of 
probabilities over alternative trees and substitution models with a random walk through parameter 
space221. The overall posterior probability of the ancestral state is then the average of its probability 
over all trees and models, weighted by their respective likelihoods. 
4.4 Correlated mutations and coevolution networks 
Structure and function of enzymes depend on highly complex interactions among the constituent 
residues and the net stabilisation of the folded state is often small relative to the unfolded state222. A 
mutation could thus easily result in a less fit variant and consequently some positions stay conserved 
during evolution. Others are however significantly more variable, but nevertheless these non-
conserved positions can also affect protein function. How do variable positions then change during 
evolution without compromising the activity and stability of the protein? It has been observed that 
some mutations are detrimental unless at another position a particular residue is present that 
compensates for the effect of the first222-225. This counterbalancing would logically lead to coevolution 
of these two positions. Intuitively, it would make sense that coevolution should occur between 
residues that are adjacent in the three-dimensional folded structure of a protein, since compensatory 
changes between neighbouring residues might help to maintain internal volumes, preserve salt 
bridges or retain optimal hydrogen bonding (Figure 1.9). Analysis of coevolving residues could 
accordingly serve as a tool for identifying proximal residues in the folded structure and aid in the 
prediction of structures from sequence data226. 
 
Figure 1.9 Example of coevolving positions as a result of structural constraints. Likewise, 
correlated mutation analysis can aid in inferring the structure. 
 
Residue pairs however sometimes exhibited a strong correlation, but do not have an obvious 
structural relationship222. It has therefore been proposed that some positions evolve under functional 
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rather than structural restraints227, 228. In silico analysis of several protein families suggests that 
specificity determinants indeed more often participate in coevolutionary relationships than non-
functional sites229, 230. Nevertheless, the number of studies using correlated mutation data to alter 
specificity is very limited, most likely due to the complexity of the problem. Yet, some nice examples 
are available. In the FAD-linked oxidases superfamily compensating mutations could be predicted for 
loss-of-function variants230. Similarly, the activity of homing endonucleases could be modulated over 
two orders of magnitude by mutation of residues in a coevolving network and variants with low 
activity could be rescued by compensatory mutations that restore an optimal coevolving network231. 
In the isocitrate lyase/phosphoenol-pyruvate mutase superfamily, the specificity for one of the 
substrates of a multispecific enzyme could be selectively removed, and the activity of an enzyme of 
the RmlC-like cupin superfamily could be increased by introducing two predicted well-defined 
mutations230. Mutation of two correlated positions could also improve the kcat of a transketolase 20-
fold for a non-native substrate (propionaldehyde). 
 
 
Figure 1.10 Typical output generated by correlated mutation analysis (CMA) of 3DM. (a) heat 
matrix representing the correlation strength of each position with another (green: weak 
correlation; red: strong correlation) and the relative frequency of each specif ic residue pair . (b) 
network representation of the heat matrix , visualising the interconnection of the different 
correlated positions. 
"#$!
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Coevolving positions can be detected by statistical analysis of large multiple sequence alignments. 
Different correlated mutation analysis (CMA) algorithms are available including statistical coupling232, 
233, methods that rely on Pearson’s correlation coefficient234, 235 or mutual information236 and 
variants237-239. Regardless of the approach, an accurate alignment of a large number of related 
sequences is always required for the reliable detection of correlated mutations. Worth mentioning in 
that respect is the 3DM technology which uses structurally conserved regions among related 
structures to guide a much larger multiple sequence alignment. In addition with several controls and 
iterative rounds of alignment, this results in a highly accurate alignment230. Correlated positions are 
then revealed with the Comulator tool and visualised in a heat matrix or as coevolution network 
(Figure 1.10). 
4.5 In silico methods and computational design 
4.5.1 Stability 
In computational design, the effect of mutations on stability is calculated based on the three 
dimensional structure of a protein and a certain energy function240. Two main approaches are 
currently employed i.e. computational tools to select mutations that improve the overall folding 
energy (∆GFold) or mutations that improve particular features. The latter is similar to rational design, 
but here instead mutations are suggested by bioinformatics algorithms. It includes the optimisation 
of surface charges241-243, enhancement of hydrophobic packing interactions between buried protein 
residues (filling protein voids)244-247 and rigidifying flexible regions by introducing prolines or disulfide 
bridges248-250. The other approach does not aim to improve one particular type of interaction, but 
generates all types of mutations that could be favourable for stability. Often energy functions are 
used that are specifically parameterised to predict point mutations improving ∆GFold (e.g. FoldX251, 252, 
PoPMuSiC253, 254, PreTherMut255, CUPSAT256, I-mutant2.0257 or Dmutant258). Alternatively, the Rosetta 
suite259, 260 can be used and that way the effect of not only point mutations, but also multiple 
simultaneous mutations can be evaluated.  
As discussed previously, improving stability often focuses on flexible regions. In that respect, 
molecular dynamics (MD) simulations are a powerful tool that has a few advantageous over B-factors. 
Crystallographic data is usually recorded at a temperature around 110 K and the molecules are frozen 
in a conformation that does not necessarily represent the physiological state261. Indeed, fluctuations 
tend to be larger in solution than estimated from B-factors, especially for flexible loop regions. 
Moreover, MD simulations can provide detailed information on the motional properties of atoms, 
over a period of time. By performing simulations at different temperatures or by running non-
equilibrium simulations, thermal unfolding can be analysed and unfolding regions or weak spots can 
be predicted as well262. Several software packages like Gromacs263, Amber264, NAMD265 or Charmm266 
are available to perform these simulations. Unfolding mechanism and identification of residues 
involved in critical unfolding steps can also be derived from constraint network analysis262, 267. In 
addition to these structure-based methods, some algorithms (e.g. PROFBval268, FoldUnfold269, 
PredyFlexy270 and Flexserv271) attempt to predict flexible sites from the sequence only. 
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4.5.2 Specificity 
The ultimate goal of protein engineers is to design enzymes completely from scratch for any possible 
reaction one can imagine. Computational methods are undeniably a prerequisite and these are 
currently gaining momentum in enzyme engineering272. Famous by now are the de novo design of 
enzymes catalysing a Diels-Alder reaction273 and a Kemp elimination274, new-to-nature specificities 
created by the Baker group with the ROSETTA suite275. In this approach, an active site is designed in 
a protein that lacks the desired catalytic activity. To that end, a quantum mechanical model of the 
transitions state is created together with side-chains that could effectively stabilise it. Next, the 
complete pdb database is scanned for a suitable backbone scaffold that could support the transition 
state-side chains complex, and in a last step the active site architecture is further optimised by 
introducing side chains that provide binding of the substrate272, 276. Regarding the complexity of de 
novo design, active site re-design is more frequently applied. Here, the existing catalytic machinery of 
an enzyme is employed and only the substrate-binding pocket is modified to expand the substrate 
range or change the specificity. Most (re-)designed enzymes however have low catalytic efficiencies 
(10-2-102 M-1s-1) and are often further optimised by classical directed evolution experiments to get in 
the range of natural enzymes (103-108 M-1s-1). The available algorithms are thus at present not (yet) 
accurate enough to yield the perfect enzymes, and therefore screening an ensemble of promising in 
silico candidates currently seems the best strategy. The glucose 6-oxidase activity of a galactose 
oxidase could for instance be improved 400-fold be screening only 104 top ranked variants from a 
computational design procedure277. This was four times better than the results obtained from an 
earlier site-saturation library of the same size278. 
 
 
 
Figure 1.11 General workflow for de novo enzyme design (QM: quantum mechanical) . 
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5 CONCLUSION 
Glycosidic compounds already find use in various industries and they have the potential to serve an 
even much wider range of applications. They can be synthesised chemically, but with the right 
enzymes, production processes can often be much cleaner and more efficient. Glycoside 
phosphorylases are such enzymes that can be used to synthesise glycosides, and in that respect 
sucrose phosphorylase is highly interesting. Sucrose phosphorylase is namely not restricted to its 
wild-type substrates, it can also transfer a sugar moiety to a variety of different acceptor molecules. 
In addition, it uses sucrose as a cheap, renewable and reactive donor substrate, which makes it an 
attractive biocatalyst for glycosylation reactions. Activity on alternative substrates is unfortunately 
often very low, but optimisation of process conditions can in many cases significantly improve the 
efficiency. Some properties like regioselectivity are however inherent to the enzyme. Sucrose 
phosphorylase can for instance glycosylate a glucose molecule at two different positions leading to 
either kojibiose or maltose. The former is an expensive prebiotic, while the latter has little added 
value. An enzyme variant that can selectively produce kojibiose would therefore be valuable, but this 
requires the enzyme itself to be modified. 
Several enzyme engineering strategies and techniques are available to modify enzymes, but to save 
time and money, focus is often first on the so-called ‘hotspots’. These are position in the enzyme that 
are known to be involved in specific properties like specificity or stability. Obviously, residues in the 
active site can have a profound influence on specificity, but often they are not all equally important. 
In case of sucrose phosphorylase, only the catalytic residues have been studied by mutagenesis 
together with a few residues in the acceptor site and for several others it is still unknown if they are 
involved in specificity. Sucrose phosphorylase is moreover closely related to amylosucrase 
(transglycosidase) and sucrose hydrolase and a comparison between these enzymes could not only 
yield hotspots for mutagenesis, but perhaps also valuable information on the divergence between the 
different classes of CAZymes.  
Classical engineering approaches have proved invaluable for the creation of new and improved 
biocatalyst, but there is still a need for better, faster and smarter ways to do so. One way to lower 
the screening effort, is to make use of ProSAR algorithms that link sequence to function and sift out 
beneficial and deleterious mutations. The original method required that mutations occur multiple 
times in different mutants, but improved versions try to abandon this requirement by incorporating 
physico-chemical properties of amino acids. The lack of mutational data for validation is however 
currently hampering a more widespread use. Next to filtering the best combinations out of the 
created sequence diversity, statistical algorithms can also detect hotspots for mutation from existing 
sequence diversity. Correlated mutation analysis is such a technique and can especially be helpful to 
reveal hotspots that are not located in the active site. General guidelines on how to use correlated 
mutation data for engineering specificity are unfortunately not available at present. Besides specificity, 
stability is also crucial for a biocatalyst. The explosion of sequences available from public databases 
makes it nowadays easy to search for variants from (hyper)thermophilic organisms, but the desired 
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specificities can not always be found. They accordingly need to be created by mutation of existing 
enzymes. Screening is however not always straightforward and it is therefore worth developing 
methods that can predict stability in silico.  
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ABSTRACT 
Sucrose phosphorylase (SP) is a promising biocatalyst for the production of special sugars and 
glycoconjugates, but its transglycosylation activity rarely exceeds the competing hydrolytic reaction. 
Knowing how specificity is controlled, would allow to optimise this activity in an efficient way by 
means of enzyme engineering. Therefore, in this study, a map of the acceptor site of the SP from 
Bifidobacterium adolescentis was created by substituting each residue by alanine and analysing the 
influence on the affinity for both the natural (inorganic phosphate and fructose) and alternative 
acceptors (D-arabitol and pyridoxine). All residues examined were found to contribute to the 
specificity for phosphate (Arg135, Leu343, Tyr344), fructose (Tyr132, Asp342) or both (Pro134, 
Tyr196, His234, Gln345). Alternative acceptors that are glycosylated rather efficiently (e.g. D-arabitol) 
were found to interact with the same residues as fructose, whereas poor acceptors like pyridoxine 
do not seem to make any specific interactions with the enzyme. Furthermore, it is shown here that 
SP is already optimised to outcompete water as an acceptor substrate, meaning that it will be very 
difficult to lower its hydrolytic activity any further. Consequently, increasing the transglycosylation 
activity towards alternative acceptors seems to be the best strategy, although that would probably 
require a drastic remodelling of the acceptor site in most cases. 
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1 INTRODUCTION 
Sucrose phosphorylase (SP, EC 2.4.1.7) catalyses the reversible phosphorolysis of sucrose to α-D-
glucose 1-phosphate and D-fructose, thereby contributing to an energy-efficient metabolism in 
various microorganisms97. High-resolution crystal structures are available103, 104 and its catalytic 
residues have been confirmed by mutational analysis34, 99, 109. The enzyme follows a double 
displacement mechanism that passes through a covalent β-D-glucosyl-enzyme intermediate100, 108, 
which can be attacked by either phosphate (degradation reaction) or fructose (synthetic reaction) 
(Figure 2.1). Furthermore, SP can transfer the glucosyl moiety to a wide variety of other acceptors, 
including mono-, di- and trisaccharides81, 84, 93, 279 as well as non-carbohydrate molecules like sugar 
alcohols, phenolic compounds and furanones72, 128, 131, 280. It is, therefore, an attractive biocatalyst for 
the production of special sugars and glycoconjugates, especially because a cheap, renewable and 
abundantly available substrate (sucrose) can be used as glycosyl donor. Unfortunately, the activity 
on most alternative acceptors is very low, often not even exceeding the hydrolytic side reaction26. 
This implies that the transglucosylation activity of SP will need to be optimised in order to become 
useful from an industrial point of view. In that respect, knowledge of the determinants of substrate 
specificity would be very helpful as this would allow applying semi-rational mutagenesis strategies17, 
66. 
 
 
Figure 2.1 Reactions catalysed by sucrose phosphorylase. The covalent β-glycosyl-enzyme 
intermediate can react with the natural acceptors phosphate (phosphorolysis) and fructose 
(synthesis) (green), but also with water (hydrolysis) (blue) and alternative acceptors 
(transglucosylation) (A: acceptor). 
 
Although SP was discovered more than seventy years ago82, still little is known about the structure-
function relations that govern its acceptor specificity. Some structure-activity relationships for 
acceptors have been derived by analysing their binding mode in the active site133. This top-down 
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analysis revealed what criteria an acceptor has to meet before it can be efficiently glycosylated by 
SP, and is thus helpful for selecting target molecules. A bottom-up analysis of the enzyme, on the 
other hand, would reveal what residues control specificity and consequently should be mutated to 
improve binding of alternative acceptors. Sucrose phosphorylase belongs to the glycoside hydrolase 
family 13 (GH-13), which groups several enzymes that use sucrose as donor but very distinct 
substrates as acceptor. Amylosucrase (AS, EC 2.4.1.4) for instance transfers the glycosyl moiety of 
sucrose to a linear amylose-like chain281, 282, whereas sucrose hydrolase (SH, EC 3.2.1.48) uses water 
as acceptor and thus simply hydrolyses sucrose283. As these enzymes are closely related in structure 
and mechanism, they constitute a rather unique case study to examine determinants of acceptor 
specificity. 
In this work, the acceptor site of the SP from Bifidobacterium adolescentis (BaSP) was compared 
with that of other enzymes that act on sucrose. Subsequently, several residues were mutated to 
alanine to determine their contribution to the enzyme’s specificity. Additionally, its 
transglucosylation and hydrolytic side activities were studied in more detail, and site-directed 
mutagenesis was performed to influence the latter’s relative contribution. 
2 RESULTS AND DISCUSSION 
2.1 Inspection of the acceptor site 
In order to identify possible determinants of the acceptor specificity of SP, its acceptor subsite was 
compared with that of AS and SH. These three enzymes are all active on sucrose as substrate but 
recruit very distinct acceptors, i.e. phosphate (SP), amylose (AS) or water (SH). A structural 
superposition (Figure 2.2) and sequence alignment (Table 2.1) might thus reveal crucial differences 
that are responsible for their deviating specificities. All BaSP residues within 5 Å from the fructose 
or phosphate moiety that are not the nucleophile (Asp192), general acid/base catalyst (Glu232) or 
transition state stabiliser (Asp290), were regarded as the acceptor subsite and accordingly were 
selected as candidate residues. For the superposition, crystal structures were selected that contain 
sucrose as ligand to allow a direct comparison of the enzyme-substrate interactions. For the 
sequence alignment, the 3DM-database of family GH-13 was employed, which makes use of a 
structure-based alignment for maximal accuracy230, 284. 
It has been suggested that the flexible loops A (residues 336-345) and B (residues 130-140) are 
crucial for the specificity of SP104. These loops can adopt two very different conformations that are 
believed to be ideal for the binding of either fructose or phosphate (Figure 2.2a,b). The most 
striking difference hereby is that upon switching from ‘fructose binding mode’ to ‘phosphate 
binding mode’, Asp342 (loop A) is moved out of the active site, while Arg135 (loop B) and Tyr344 
(loop A) are moved in. For loop A, it has already been proven in the SP from Leuconostoc 
mesenteroides (LmSP) that the residues equivalent to Asp342 and Tyr344 strongly contribute to the 
affinity for fructose and phosphate, respectively113. These two residues are conserved in all SP which 
Mapping the acceptor site of sucrose phosphorylase by alanine scanning  CHAPTER 2 
 37 
Table 2.1 Comparison of amino acid residues in the acceptor subsite of various sucrose-
converting enzymes 
BaSP other SP AS SH remarks 
Tyr132b Tyr Arg (Pro)c Gly (Val)c at the entrance of active site; hydrophobic surroundings  
Pro134b Pro/Arg Ile Val in vicinity of C4-OH of fructose 
Arg135b Arg/Lys - - involved in phosphate binding 
Tyr196 Tyr Phe Tyr CE2-atom close to C1 of fructose  
Val233 Val/Ile Ala Ala next to the acic/base catalyst Glu232; side chain turned 
away from active site 
His234 His Ile Ile in vicinity of C3 and C3-OH of fructose 
Asp342a Asp - - involved in fructose binding 
Leu343a Leu/Ile - - in between important residues Asp342 and Tyr344 
Tyr344a Tyr - - involved in phosphate binding 
Gln345a Gln - - potential hydrogen bond with O3 and O6 of fructose 
a residue from loop A; b residue from loop B; c residue present an a small fraction of the sequences 
 
is also the case for Gln345 (Figure 2.2c). Although not yet investigated by mutational analysis, this 
residue is probably involved in fructose binding114, 133. On the other hand, Leu343 is not fully 
conserved in SP, but might have a profound influence on acceptor binding, as it located in between 
Asp342 and Tyr344 (Table 1.1). Unfortunately, a structural comparison with AS and SH is not 
possible as the conformation and length of their loop A is totally different from that in SP (Figure 
2.2d). 
In loop B, only Pro134 and Arg135 are part of the acceptor site. Most likely, the latter is involved in 
phosphate binding as has already been shown for a similar Arg residue in LmSP113. In contrast, the 
role of Pro134 is less clear. The only residue in loop B which is fully conserved among all known 
sucrose phosphorylases is Tyr132, located at the entrance of the active site. Since Arg and Gly are 
present at the corresponding position in AS an SH, Tyr132 might be involved in determining the 
acceptor specificity. 
The remaining part of the acceptor subsite is composed of Tyr196, Val233 and His234 (Figure 2.2c). 
The first seems to be involved in a hydrophobic interaction with the C1-atom of fructose. It is 
completely conserved in SP enzymes and a similar residue is also present in AS and SH (Phe and 
Tyr, respectively). In contrast, His234 is conserved in SP, but replaced by Ile in AS and SH, which 
might indicate that a His is important for sucrose phosphorylase activity. At position 233, in turn, 
various hydrophobic residues can be found, such as Ala, Val and Ile (Table 2.1). 
Inspection of the acceptor site thus showed that at each of the five positions where the backbone 
is conserved among the sucrose-active enzymes (position 132, 134, 196, 233 and 234), a different 
amino acid is present in SP compared to AS or SH. The remainder of the acceptor site consists of 
loop segments that are highly conserved in SP enzymes but display a divergent composition and 
conformation in the other enzymes. Hence, every residue discussed above could potentially be a 
determinant of the enzyme’s specificity and accordingly all were individually mutated to alanine. 
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Figure 2.2 Acceptor site loops in BaSP and structural comparison with AS and SH. (a) location 
of loop A (orange) and B (yellow) in the ‘fructose binding mode’ (pdb entry: 2GDU chain A) 
and (b) in the ‘phosphate binding mode’ (pdb entry: 2GDV chain A), (c) close-up of the active 
site of BaSP and (d) structural superposition of the active site of BaSP (white, yellow, orange), 
NpAS (green) (pdb entry: 1ZS2) and XaSH (blue) (pdb entry: 3CZK) (glucose moiety is not 
shown for clarity) . 
 
2.2 Analysis of wild-type reactions 
The importance of the residues in the acceptor site of SP was examined by means of alanine 
scanning. Replacing an amino acid with alanine amounts to the removal of its side chain without 
affecting the main chain conformation285. To evaluate their contribution to the substrate specificity, 
the variants’ affinity for the natural acceptors fructose (synthetic reaction) and inorganic phosphate 
(degradation reaction) was estimated. To that end, their activity was measured at two substrate 
concentrations i.e. one that equals the KM of the wild-type enzyme (10.1 ± 0.6 mM for fructose and 
19.3 ± 1.4 mM for phosphate, respectively) and one that is ten times higher. The activity was thus 
measured at a fructose concentration of 10 and 100 mM, and a phosphate concentration of 20 and 
200 mM. The resulting activity ratio is a good measure of the affinity for the acceptor, independent 
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of changes in kcat or affinity for the donor substrate. The ratio is by definition 0.5 for the wild-type 
enzyme, since it follows normal Michaelis-Menten kinetics (Figure S2.1), and lower values indicate a 
decrease in affinity. 
The activity ratio’s for the wild-type enzyme and the alanine mutants are summarised in Figure 2.3, 
while the acceptor-enzyme interactions described in the next paragraphs are visualised in Figure 
2.4. For the binding of phosphate in the acceptor site of BaSP, it is clear that Arg135 and Tyr344 
are by far the most important residues, as their mutation to Ala dramatically decreased their activity 
ratio. In fact, their ratio even drops below the theoretical lower limit of 0.1, meaning that their 
behaviour deviates from the Michaelis-Menten equation (Figure S2.2). Nevertheless, these 
measurements still point to a crucial role in phosphate binding, and are in good agreement with a 
detailed kinetic analysis of the equivalent mutations in LmSP113. A decreased affinity for phosphate 
is also observed for mutant L343A. As the side chain of Leu343 does not point toward the acceptor 
substrates (Figure 2.4), it can be assumed that this residue is necessary for the correct positioning 
of the neighbouring phosphate binding residue Tyr344. When loop A switches from the ‘fructose 
binding’ to the ‘phosphate binding’ conformation, Leu343 is moved from the protein surface to a 
hydrophobic pocket consisting of the side chains of Val319, Thr334, Ala337 and Val346 (Figure 
S2.3). As a result, Tyr344 might be pushed into the active site, enabling its interaction with 
phosphate. 
 
 
Figure 2.3 Activity ratios for wild-type SP and various alanine mutants for fructose or 
inorganic phosphate as acceptor substrate. Dotted lines indicate ratio’s corresponding to an 
unchanged KM or a two-, f ive- and twentyfold increased KM value compared to the wild-type 
enzyme (variant H234A is not included as its activity was too low for accurate measurements). 
 
Changing Asp342 to Ala results in a strongly reduced affinity for fructose, as has also been 
reported for LmSP113. A similar pattern is observed here for Y132A and Y196A, which are both 
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totally conserved in SP enzymes. Removal of their side chains reduces the affinity for fructose more 
than tenfold. By mutating Tyr196 to Ala, the hydrophobic interaction between the Tyr side chain 
and the C1-atom of fructose is lost. In contrast, Tyr132 is too far away to directly interact with 
fructose. However, the behaviour of Y132A could be explained by the loss of interaction with 
Tyr196. Indeed, the latter’s side chain is normally kept in a tight conformation due to hydrophobic 
interactions with Tyr132 and Phe206 (Figure S2.4). The hydroxyl group of Tyr196 is in the 
phosphate binding conformation also within hydrogen bonding distance of the hydroxyl group of 
Tyr344, which might explain the reduced affinity of the Y196A mutant for phosphate (Figure 2.4d). 
 
 
 
Figure 2.4 Overview of all mutated residues during the alanine scanning, coloured according 
to the influence on affinity for the different substrates. (a) ‘fructose binding mode’ (pdb 
entry: 2GDU chain A) coloured by affinity for fructose and (b) coloured by affinity for 
phosphate, (c) ‘phosphate binding mode’ (pdb entry: 2GDV chain A) coloured by affinity for 
fructose and (d) coloured by affinity for phosphate (red: very important for activity; orange: 
strong affinity for fructose; yellow: moderate affinity for fructose; green: strong affinity for 
phosphate; blue: moderate affinity for phosphate; white: no/litt le affinity for acceptor; red 
dashed lines: potential hydrogen bonds)(glucose part is not shown for clarity) . 
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Although the side chain of Pro134 is part of the acceptor site, it is located too far away to directly 
interact with either fructose or phosphate. Consequently, the affinity for these acceptors is only 
moderately lowered in the Ala mutant. The binding of phosphate could perhaps be influenced 
indirectly via Arg135, while the binding of fructose could be influenced through the surrounding 
residues Tyr132, Tyr196 and Asp342 (Figure 2.4). Similarly, mutation of Val233 has very little effect 
on the binding of either acceptor. Although this residue is located next to the general acid/base 
catalyst Glu232, the mutation also did not affect the catalytic activity (Table S2.2). The observation 
that a Val side chain is not crucial at position 233 is supported by the fact that Leu can be found in 
other SP enzymes and that Ala is even naturally present in AS and SH (Table 2.1). 
Gln345 has been suggested to be important for fructose binding in LmSP133. Indeed, this residue is 
assumed to be responsible for the enzyme’s preference for fructose over L-sorbose, because of a 
predicted hydrogen bond with the former’s C6-OH (Figure 2.4a). Our findings, however, show that 
mutating Gln345 only moderately reduces the affinity for fructose. Furthermore, fructose still is a 
much better acceptor than L-sorbose for the Q345A mutant, with a kinetic partition coefficient (see 
materials and methods for definition and determination) of 210 and 13, respectively. In contrast to 
the moderate decrease in fructose affinity, a more profound influence on the affinity for phosphate 
was observed. Interestingly, docking of glucose 1-phosphate revealed that the side chain of Gln345 
is within hydrogen bonding distance of the phosphate moiety (Figure 2.4b,d). In addition, Gln345 is 
located next to the important ‘phosphate’ residue Tyr344 and could thus also have an indirect 
effect.  
Removal of the side chain of His234 had the most drastic effect of all mutations, as the activity was 
almost completely lost. Moreover, because of this low activity, the experimental error became too 
large and the affinity ratios for fructose and phosphate could not be calculated accurately. His234 is 
positioned close to the C3-OH of fructose and the O--group of phosphate (Figure 2.4), but it does 
not seem to make polar contact or direct interactions with either of these molecules. Therefore, this 
remarkable result will be examined in more detail in one of the next sections. In conclusion, all 
residues that shape the acceptor site strongly contribute to the affinity for either phosphate or 
fructose, or both. Sucrose phosphorylase thus seems to be highly optimised to perform its wild-
type reaction. 
 
2.3 Analysis of transglycosylation reactions 
In the previous section, all acceptor site residues were assigned a role in recognition of the native 
acceptors. In order to further investigate their role in substrate specificity, the activity on alternative 
acceptors was measured as well. For that purpose, D-arabitol and pyridoxine were selected as they 
represent compounds that are glycosylated fairly well and rather poorly by SP, respectively26. Their 
transfer products were verified with HPAEC and LC-MS (data not shown), but the rate of 
transglycosylation is in the same range as the rate of hydrolysis. Accordingly, the ratio of phosphate 
release and concurrent glucose release from α-D-glucose 1-phosphate as donor was used as a 
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measure of the transglycosylation efficiency. Based on this ratio, residues His234, Asp342 and 
Glu345 are clearly involved in binding of D-arabitol (Table 2.2). Specific activities of the mutants are 
all lower compared to the wild-type enzyme, except for L343A. For this mutant, the activity on D-
arabitol is around 40% higher than the wild-type enzyme and the activity is about the same as on 
fructose. Also for pyridoxine, L343A was the only mutant with a higher activity compared to the 
wild-type enzyme, although its ratio was not improved. In general for pyridoxine the ratios were 
very similar for all mutants, and also much lower than for D-arabitol. This means that none of the 
acceptor site residues is crucial for binding of pyridoxine. It thus appears to be that good acceptors 
exploit the same interactions as the natural substrates, whereas poor acceptors make no specific 
interactions with the enzyme, explaining the lower activities. Moreover, this conclusion is consistent 
with results obtained from docking of D-arabitol and pyridoxine (Figure S2.5). 
 
Table 2.2 Phosphate release (total activity) and concurrent glucose release (hydrolysis) upon 
glycosylation of D-arabitol and pyridoxine by BaSP and alanine mutants (U/mg). 
mutant D-arabitol  pyridoxine 
 vPia vGlcb ratio  vPia vGlcb ratio 
WT 7.2 ± 0.4 1.14 ± 0.01 6.3 ± 0.3  2.7 ± 0.3 2.00 ± 0.11 1.4 ± 0.2 
Y132A 1.1 ± 0.1 0.17 ± 0.01 6.7 ± 0.6  0.4 ± 0.1 0.27 ± 0.01 1.6 ± 0.3 
P134A 5.8 ± 1.2 0.86 ± 0.15 6.7 ± 0.2  1.4 ± 0.3 1.00 ± 0.01 1.4 ± 0.3 
R135A 1.1 ± 0.1 0.20 ± 0.01 5.8 ± 0.1  0.6 ± 0.1 0.47 ± 0.03 1.2 ± 0.1 
Y196A 2.5 ± 0.3 0.38 ± 0.05 6.5 ± 0.1  0.8 ± 0.1 0.58 ± 0.09 1.3 ± 0.2 
H234A 0.1 ± 0.1 0.06 ± 0.01 2.6 ± 0.8  0.1 ± 0.1 0.09 ± 0.01 1.3 ± 0.3 
D342A 0.2 ± 0.1 0.11 ± 0.01 2.3 ± 0.2  0.1 ± 0.1 0.08 ± 0.01 1.0 ± 0.2 
L343A 10.0 ± 0.8 1.66 ± 0.15 6.0 ± 0.1  3.5 ± 0.4 2.72 ± 0.06 1.3 ± 0.1 
Y344A 0.5 ± 0.1 0.09 ± 0.02 5.7 ± 0.4  0.1 ± 0.1 0.08 ± 0.01 1.3 ± 0.1 
Q345A 1.3 ± 0.1 0.55 ± 0.04 2.4 ± 0.3  1.0 ± 0.1 0.85 ± 0.13 1.2 ± 0.2 
a total activity = transglucosylation and hydrolytic side activity; b hydrolytic side activity 
 
2.4 Investigation of His234 
In the three-dimensional structure, His234 is not only close to the substrate, but it is also in the 
vicinity of the acid/base catalyst Glu232, as well Tyr344 and Gln345. Removal of the His side chain 
decreased the activity 3000-fold and 25000-fold in the phosphorolytic and synthetic direction, 
respectively (Table S2.2). The hydrolytic side activity, however, was only decreased 5 to 25 times, 
essentially turning SP into a (slow) SH. This seems to indicate that the enzyme’s intrinsic acid/base 
catalysis is not affected, but rather that interactions with both acceptors and/or with neighbouring 
residues are destroyed. As hydrolytic activity was not severally affected, it is not very likely that 
His234 influences the acid/base catalyst, unless subtle displacements in the Ala mutant ensure that 
water is more easily (de)protonated than an acceptor molecule. To support this hypothesis, the 
arsenolysis of α-D-Glc-1-P was compared with the hydrolysis, like in the study on the general 
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acid/base catalyst109. That way, a discrimination can be made between a reaction that needs 
acid/base assistance and one that does not. The fact that the arsenolysis was only three times 
faster than the hydrolysis indicates that the decreased activity is indeed not caused by disturbed 
(de)protonation (if this was the case than the difference would be much larger). To further 
investigate the importance of this conserved His residue, a saturation library was screened for wild-
type activity. Only H234V and H234L were found to retain significant activity, with specific activities 
of 38 and 80 U/mg, respectively, compared to 120 U/mg for the wild-type enzyme. Surprisingly, 
introducing an Ile, the residue that is at the exact same position in the crystal structure of AS and 
SH, makes the activity drop to 0.05 U/mg. The reason for this position’s crucial role is unclear, but 
apparently a His creates the ideal active site architecture for sucrose phosphorylase activity.  
 
2.5 Determinants of hydrolysis 
As discussed before, the rate of transglycosylation is often in the same range as the rate of 
hydrolysis when SP is used to glycosylate acceptor molecules26. For production purposes this means 
an inefficient use of substrate, as hydrolysis leads to pure loss of donor substrate. Optimisation of 
the reaction conditions can in some cases greatly favour glycosylation over hydrolysis, allowing the 
development of an economically feasible process. A nice example is the production of glucosyl 
glycerol, which is commercially available under the trade name Glycoin®124. Nevertheless, it would 
be valuable to have an enzyme that inherently has little or no hydrolytic activity. Analysis of the 
alanine mutants, however, showed that mutation of residues in the acceptor pocket does not have 
a profound influence on the rate of hydrolysis (Table S2.2, Table 2.2). Consequently, other residues 
might be responsible for this side activity. 
The hydrolytic activity of cyclomaltodextrin glucanotransferase (CGTase, EC 2.4.1.19), another 
member of family GH-13, has already been examined. After applying random and site-directed 
mutagenesis, three ‘hotspots’ could be identified that have a major influence on the ratio of 
cyclisation over hydrolysis286, 287. Two of them, equivalent to Ala193 and His234 in BaSP, were 
located in the active site whereas the third, equivalent to Leu40, is further away. At the position of 
Ala193, all enzymes in family GH-13 that catalyse transfer reactions have an Ala, while in the 
hydrolytic members other residues can occur, such as a Ser in SH. Introduction of this residue in 
BaSP almost doubled its hydrolytic activity and decreased its wild-type activity twenty-fold. It is, 
therefore, very unlikely that the hydrolytic side reaction can be lowered by mutagenesis of position 
193. For position 234, the only two mutants that could retain significant phosphorolytic activity are 
H234V and H234L (see previous section). Both have a hydrolytic activity of 0.2 U/mg (0.2-0.4% of 
their wild-type activity), which is almost identical to the wild-type enzyme. Saturation mutagenesis 
of Leu40 in BaSP also did not yield any mutants with a decreased hydrolysis over transglycosylation 
ratio. In contrast, several mutants had an increased ratio, without significant decrease in hydrolytic 
activity (not further characterised). Hence, although not exclusive, these findings suggest that SP is 
already optimised to outcompete water as an acceptor substrate. 
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3 CONCLUSION 
Sucrose phosphorylase is an interesting biocatalyst for the glycosylation of various hydroxylated 
compounds. Its transglycosylation activity is, however, often so low that the hydrolytic side reaction 
takes the upper hand. One way to tilt this balance is to engineer the enzyme towards increased 
transglycosylation activity and/or decreased hydrolytic activity. Knowing how the specificity is 
related to the protein structure would hereby allow for a more focussed mutagenesis approach. In 
this study, we have explored the acceptor site of BaSP and identified determinants of affinity and 
activity. In addition, the hydrolytic side reaction was studied in detail, although it could not be 
lowered by means of site-specific mutagenesis. Consequently, the most convenient way to 
outcompete water seems to be increasing the transglycosylation activity towards other acceptors. 
However, since most acceptors were found to make no specific interactions with the enzyme, 
optimising its specificity will most likely require a drastic remodelling of the acceptor site. 
4 METHODS AND MATERIALS 
4.1 Materials 
Unless noted otherwise, all chemicals were obtained from Sigma-Aldrich or Merck and were of the highest 
purity. Sucrose and D-fructose were purchased at Sigma-Aldrich and were ≥99.5% pure (GC), while α-D-glucose 
1-phosphate was produced in-house and contained less than 0.5% inorganic phosphate and glucose as 
contaminants288. 
4.2 Structural analysis and multiple sequence alignment 
All structural analyses were performed with the molecular modelling program YASARA and the 
YASARA/WHATIF twinset289, 290. For comparison of the acceptor subsite, crystal structures from sucrose 
phosphorylase from B. adolescentis (pdb entry: 2GDU)104, amylosucrase from Neisseria polysaccharea (pdb 
entry: 1ZS2)114 and sucrose hydrolase from Xanthomonas axonopodis (pdb entry: 3CZK)115, all in complex with 
sucrose, were structurally aligned using the MOTIF algorithm291. The interactions of SP with fructose were 
derived from the complex with sucrose (pdb entry: 2GDU), while those with phosphate were analyzed by 
docking α-D-glucose 1-phosphate in the complex with glucose (PDB entry: 2GDV) from which the ligand was 
manually removed. Docking was performed with the AutoDock 4.2292 module implemented in YASARA, using 
the AMBER03 force field293. The default parameters provided by the standard docking macro in YASARA 
v12.11.19 were used, except for the number of runs which was increased to 50. Figures were created with 
PyMol v1.3294. The multiple sequence alignment of sucrose-converting enzymes was extracted from the 3DM 
database of the α-amylase family GH-13230, 284. Note: all residues are numbered according to the numbering 
scheme of BaSP. 
4.3 Site-directed mutagenesis, enzyme production and purification 
The sucrose phosphorylase gene from B. adolescentis (sucP), cloned in the constitutive expression plasmid 
pCXP34h92, was used as template for mutagenesis. Mutations were introduced with a modified two-stage 
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megaprimer based whole plasmid PCR method295, using the primers described in Table S2.1. The PCR program 
starts with a hot start, followed by megaprimer formation and whole plasmid amplification by means of 
extension of the megaprimer. The PCR mix contained 0.05 U/μl PfuUltraTM High-Fidelity DNA Polymerase 
(Stratagene), 0.2 mM dNTP mix, 1-2 ng/μl template plasmid DNA (pCXP34h BaSP), 0.1 pmol/μl forward (Fw) 
and reverse (Rv) primer, and 5 % DMSO in a total volume of 50 μl PfuUltraTM HF reaction buffer. The 
amplification program started with an initial denaturation (3 min at 94°C), followed by 5 cycles of denaturation 
30 s at 94°C, annealing 1 min at 55°C and extension 1 min (1 min/kb) at 72°C. The second stage consisted of 
20 cycles of 30 s at 94°C and extension 10 min (2 min/kb) at 68°C and one final extension of 10 min (2 
min/kb) of template at 72°C. After digestion of the template DNA by DpnI (Westburg), mutagenised plasmids 
were transformed in E. coli BL21 (DE3) (Novagen). All constructs were subjected to nucleotide sequencing 
(AGOWA sequence service, Berlin) to confirm that the correct mutations had been introduced, and to exclude 
the presence of undesirable mutations. Wild-type and variant enzymes were produced and purified as 
previously reported26 and checked by SDS-PAGE for purity (Figure S2.6). 
4.4 Analysis of alanine mutants 
In the synthesis direction, the release of inorganic phosphate from α-D-Glc-1-P as glycosyl donor was 
measured with the method of Gawronski, while in the phosphorolytic direction the release of fructose from 
sucrose was measured with the BCA reducing sugars assay, as previously reported26. Note that no hydrolysis of 
the formed α-D-Glc-1-P is detected with the latter assay under the conditions used here. The hydrolytic side 
reaction was quantified by concurrently monitoring the release of glucose by the glucose oxidase-peroxidase 
coupled enzymatic assay, as previously reported26. All reactions were performed with His-tag purified enzyme 
in 50 mM MOPS buffer at pH 7.0 and 37°C. One unit of SP activity was defined as the amount of enzyme that 
released 1 µmol inorganic phosphate or reducing sugar per minute from 100 mM donor and acceptor 
substrate, unless stated otherwise.  
The KM of the wild-type enzyme for fructose and inorganic phosphate was determined using 100 mM α-D-Glc-
1-P and 100 mM sucrose, respectively, as donor substrate. The KM values were calculated by non-linear 
regression of the Michaelis-Menten equation using Sigma Plot 11.0, and found to be 10.1 ± 0.6 mM (fructose) 
and 19.3 ± 1.4 mM (phosphate), respectively. The affinity of the variants for these acceptors was estimated by 
comparing the transglucosylation rate at a concentration that equals the KM of the wild-type enzyme and at 
one that is ten times higher. The activity was thus measured at a fructose concentration of 10 and 100 mM, 
and a phosphate concentration of 20 and 200 mM. All measurements were conducted in triplicate. 
The reaction mixture for the determination of the kinetic partition coefficient contained 100 mM α-D-glucose 
1-phosphate, and four concentrations in the range 0-150 mM for sorbitol or 0-50 mM for fructose as acceptor. 
The kinetic partition coefficient is the slope of the linear regression between the ratio of phosphate and 
glucose release rates (vPi/vGlc) and the acceptor concentration, and reflects the reactivity of an acceptor 
molecule compared to water acting as an acceptor133. Phosphate and glucose release rates were measured as 
described above. Kinetic partition coefficients (kacceptor/kwater) were determined from plots of the rate ratio 
vPi/vGlc in function of the acceptor concentration according to the following equation: vPi/vGlc = 1 + 
(kacceptor/kwater) x [acceptor]26, 133. Note: vPi is the total reaction rate whereas vGlc measures the hydrolysis rate. 
The arsenolysis was performed with 100 mM α-D-glucose 1-phosphate and 100 mM arsenate, and the glucose 
release was measured. For the glycosylation of the non-native acceptors D-arabitol and pyridoxine, 100 mM α-
D-glucose 1-phosphate and 250 mM acceptor was used. 
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4.5 Saturation mutagenesis and screening 
Creation of saturation libraries of position 40 and 234 was performed as described above, using the respective 
primer pairs ATGACGGTGTCCACATTNNKCCGTTTTTCACCC (Fw) ATCCAACGCGTTGGGAGCTCTC (Rv) and 
ATTCTGATCGAAGTCNNKAGCTATTACAAAAAACAGG (Fw) and ATCCAACGCGTTGGGAGCTCTC (Rv). Libraries 
were transformed in E. coli CGSC8974 acid glucose-1-phosphatase (agp) negative strain (Coli Genetic Stock 
Center, New Haven, USA), and plated out on solid LB medium containing ampicillin (100 µg/ml). Individual 
colonies were picked with an automated colony-picker (QPix2, Genetix) and inoculated into sterile 96-well flat-
bottomed microtiter plates (Nunc) containing 175 μl LB medium per well, supplemented with 100 μg/ml 
ampicillin. Inoculated MTP’s were incubated for 24h at 37°C and 250 rpm (50 mm shaking amplitude), and 
subsequently replicated into new sterile 96-well flat-bottomed microtiter plates (Nunc) to constitutively express 
the enzyme variants. After overnight incubation (16h) at 37°C and 250 rpm (50 mm shaking amplitude), MTP’s 
were centrifuged at 5000 g for 20 min, the supernatant was discarded and the pellets were frozen at -20°C for 
at least one hour. After thawing, cells were lysed according to the procedure described by De Groeve et al76. 
The mutant libraries were screened for phosphorolysis (100 mM sucrose and 200 mM inorganic phosphate), 
synthesis (100 mM α-D-glucose 1-phosphate and 100 mM fructose), and hydrolysis activity (100 mM sucrose 
or 100 mM α-D-glucose 1-phosphate). 
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5 SUPPLEMENTARY DATA 
 
Figure S2.1 Michaelis-Menten curves for fructose and inorganic phosphate for the wild-type 
sucrose phosphorylase from Bifidobacterium adolescentis. 
 
 
Figure S2.2 Activity curve of mutant Y344A. Activity in function of increasing concentration of 
inorganic phosphate. Although the curve suggests a potential cooperative effect (which could 
in some way be related to the out-of-sync action of the subunits of the dimer104) , this was 
beyond the scope of this work and was accordingly not further investigated. 
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Figure S2.3 Hydrophobic interactions of Leu343. (red dashed line: distance between two 
carbon atoms marked in Angstrom). 
 
 
 
 
Figure S2.4 Hydrophobic interactions of Tyr196. (red dashed line: distance between two 
carbon atoms marked in Angstrom 
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Figure S2.5 Docking of alternative acceptors in the active site of BaSP. The crystal structure of 
the β-glycosyl-enzyme intermediate (pdb entry: 2GDV chain B) was used as receptor (Asp192: 
catalytic nucleophile, Glu232: catalytic acid/base). (a) D-arabitol is nicely positioned for a 
nucleophil ic attack, guided by the substrate-enzyme interactions described in the manuscript. 
(b) Although pyridoxine can be docked in the active site, none of the resulting binding modes 
are productive (glycosylation does not occur at the aromatic hydroxyl group, unpublished 
results) . Most l ikely, the correct orientation is never observed because it is not mediated by 
specif ic interactions, which is consistent with our mutational data. 
 
 
 
Figure S2.6 SDS-PAGE of the his-tag purif ied mutants 
 
 
Table S2.1 Primers used for site directed mutagenesis 
mutant primers sequence (5'→ 3') 
Y132A BaSP Fcl01a 
BaSP_Rv_Y132Ab 
ATGAAAAACAAGGTGCAGCTCATC 
CGCGGACGTGCGATGCCGGCCAGGTCCTCTTC 
P134A BaSP Fcl01a 
BaSP_Rv_P134Ab 
ATGAAAAACAAGGTGCAGCTCATC 
GAACGGCAGGCCCGGACGCGCACGGTAGATG 
R135A FwpTRChis fraga GAATTCGGAGGAAACAAAGATGGGGGGTTCTCATCATC 
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BaSP_Rv_R135Ab GAACGGCAGGCCCGGAGCCGGACGGTAGATG 
A193S BaSP Fcl01a 
BaSP_Rv_A193Sb 
ATGAAAAACAAGGTGCAGCTCATC 
CCATAGCCGACGGAGTCGAGGCGGATGTAG 
Y196A BaSP Fcl01a 
BaSP_Rv_Y196Ab 
ATGAAAAACAAGGTGCAGCTCATC 
TTCCTTGGCGCCAGCGCCGACGGCGTCGAG 
V233A BaSP Fcl01 a 
BaSP_Rv_V233Ab 
ATGAAAAACAAGGTGCAGCTCATC 
AGTAGGAGTGCGCTTCGATGAGGATTTCCAGAC 
H234A BaSP Fcl01a 
BaSP_Rv_H234Ab 
ATGAAAAACAAGGTGCAGCTCATC 
CTGCTTCTTGTAGTAGGAGGCCACTTCGATGAG 
D342A BaSP_Fw_D342Aa 
BaSP Rcl01b 
CGCATCCAATCTCGCCCTCTACCAGGTCAACAG 
TCAGGCGACGACAGGCGGATT 
L343A BaSP_Fw_L343a 
BaSP Rcl01b 
ATCCAATCTCGACGCCTACCAGGTCAACAG 
TCAGGCGACGACAGGCGGATT 
Y344A BaSP_Fw_Y344Aa 
BaSP Rcl01b 
AATCTCGACCTCGCCCAGGTCAACAGCACCTAC 
TCAGGCGACGACAGGCGGATT 
Q345A BaSP_Fw_Q345Aa 
BaSP Rcl01b 
AATCTCGACCTCTACGCGGTCAACAGCACCTAC 
TCAGGCGACGACAGGCGGATT 
a forward primer; b reverse primer; underlined: mismatched bp 
 
 
Table S2.2 Transglucosylation activity on the wild-type acceptors fructose and phosphate  and 
hydrolytic side acitivity of BaSP and alanine mutants 
mutant transglucosylationa (U/mg)  hydrolysisb (U/mg) 
 [acc] = 10 x KM [acc] = KM ratio  [acc] = 10 x KM [acc] = KM 
activity on phosphate 
 WT 118.3 ± 2.7 65.6 ± 0.6 0.55 ± 0.01  0.50 ± 0.02 (0.4 %)c 0.60 ± 0.01 (0.9 %) 
 Y132A 77.6 ± 2.0 32.2 ± 0.7 0.42 ± 0.01  0.10 ± 0.01 (0.1 %) 0.19 ± 0.02 (0.6 %) 
 P134A 107.3 ± 2.6 38.3 ± 1.0 0.36 ± 0.01  0.56 ± 0.04 (0.5 %) 0.59 ± 0.04 (1.5 %) 
 R135A 20.7 ± 0.3 0.5 ± 0.1 0.03 ± 0.01  0.61 ± 0.01 (2.9 %) 0.94 ± 0.04 (175 %) 
 Y196A 35.7 ± 0.7 8.7 ± 0.7 0.24 ± 0.02  0.13 ± 0.02 (0.4 %) 0.29 ± 0.01 (4.6 %) 
 V233A 92.4 ± 5.6 41.4 ± 0.9 0.45 ± 0.03  0.32 ± 0.02 (0.3 %) 0.29 ± 0.02 (0.7 %) 
 H234A <0.1 - -  0.11 ± 0.01 (250 %) - 
 D342A 0.2 ± 0.1 0.1 ± 0.1 0.47 ± 0.06  0.03 ± 0.01 (18.2 %) 0.04 ± 0.01 (52.3 %) 
 L343A 83.3 ± 9.1 11.6 ± 0.7 0.14 ± 0.02  1.10 ± 0.04 (1.3 %) 1.70 ± 0.07 (14.7 %) 
 Y344A 5.9 ± 0.1 0.1 ± 0.1 0.01 ± 0.01  0.26 ± 0.03 (4.5 %) 0.48 ± 0.01 (812.5 %) 
 Q345A 30.8 ± 0.9 5.4 ± 0.1 0.18 ± 0.01  0.05 ± 0.01 (0.2 %) 0.16 ± 0.01 (2.9 %) 
activity on fructose 
 WT 51.6 ± 0.5 26.1 ± 1.2 0.51 ± 0.02  0.21 ± 0.01 (0.4 %) 0.66 ± 0.01 (2.5 %) 
 Y132A 27.4 ± 1.8 3.1 ± 0.1 0.11 ± 0.01  0.12 ± 0.01 (0.5 %) 0.25 ± 0.01 (8.1 %) 
 P134A 54.3 ± 2.1 14.1 ± 1.6 0.26 ± 0.03  0.64 ± 0.03 (1.2 %) 1.41 ± 0.06 (10 %) 
 R135A 2.3 ± 0.1 0.8 ± 0.1 0.37 ± 0.02  0.25 ± 0.02 (11.3 %) 0.53 ± 0.02 (62.9 %) 
 Y196A 6.0 ± 0.1 1.1 ± 0.1 0.18 ± 0.01  0.16 ± 0.01 (2.7 %) 0.25 ± 0.01 (16.8 %) 
 V233A 50.2 ± 2.2 15.8 ± 0.2 0.32 ± 0.01  0.31 ± 0.04 (0.6 %) 0.27 ± 0.02 (1.7 %) 
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 H234A <0.1 - -  0.01 ± 0.01 (420 %) - 
 D342A 0.1 ± 0.1 <0.1 0.16 ± 0.08  0.20 ± 0.01 (250 %) 0.21 ± 0.01 (1747 %) 
 L343A 9.4 ± 0.3 6.1 ± 0.4 0.65 ± 0.05  0.76 ± 0.13 (8.1 %) 1.99 ± 0.08 (32.8 %) 
 Y344A 0.7 ± 0.1 0.3 ± 0.1 0.51 ± 0.02  0.03 ± 0.01 (4.5 %) 0.20 ± 0.01 (57.7 %) 
 Q345A 7.1 ± 0.1 2.4 ± 0.1 0.33 ± 0.01  0.04 ± 0.01 (0.5 %) 0.06 ± 0.01 (2.5 %) 
a activity on phosphate: 100 mM sucrose as donor substrate, and 20 and 200 mM inorganic phosphate as 
acceptor; activity on fructose: 100 mM Glc-1-P as donor, and 10 and 100 mM fructose as acceptor; b hydrolytic 
side activity measured in the presence of acceptor; c relative to transglucosylation 
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ABSTRACT 
Regarding its bioactive properties, kojibiose (2-O-α-D-glucopyranosyl-α-D-glucose) could have a 
number of potential applications, but these are so far limited due to its high price and low 
availability. In this work a sucrose phosphorylase was therefore engineered to enable the selective 
production of kojibiose starting from sucrose and glucose. To that end, ten positions in the 
acceptor site were randomised individually and screened with a high performance anion exchange 
chromatography (HPAEC) based screening procedure. Several improved mutants were obtained 
from this first round of mutagenesis and the best mutant L341I displayed a selectivity of 79%. 
Rational combination as well as combinations predicted by a statistical ProSAR model could further 
improve the selectivity, although the former approach yielded the best mutants. Two double 
(L341I_Q345S and L341I_Q345N) and one triple mutant (L341I_Y344A_Q345N) were obtained with 
selectivities of 93 to 95%. Activities were only slightly lower than the wild-type enzyme and 
therefore, the variants created in this work will allow the development of a cost-effective and 
scalable process for the enzymatic synthesis of kojibiose from the readily available and low-cost 
substrates sucrose and glucose. 
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1 INTRODUCTION 
Kojibiose (2-O-α-D-glucopyranosyl-D-glucopyranose) is a promising prebiotic for the stimulation of 
beneficial bacterial populations in the human gut134, 296. The α-1,2 bond can indeed be handled by 
specific micro-organisms such as Bifidobacteria, but it is largely resistant to the action of enzymes 
in the digestive tract297, 298. Moreover, kojibiose and derivatives have the ability to inhibit α-
glucosidase I in different tissues and organisms299-302. Accordingly, these are appealing molecules 
because inhibitors that act upon α-glucosidase I are suggested to be interesting candidate drugs 
for the treatment of human immunodeficiency virus type 1 (HIV-1) infections303. Given their α-
glucosidases inhibitory action, they can also limit the digestion of dietary carbohydrates and could 
therefore be useful to counter diabetes, obesity and cardiovascular diseases304, 305. Studies on the 
health-promoting properties of kojibiose are however hampered by the limited availability of this 
disaccharide134. Kojibiose is naturally present in honey306, beer307, sweet potato starch hydrolysate308, 
sake and koji309 (hence the name), but the amounts are too low for extraction on larger scale. 
According to some authors, the isolation from the partial acetolysis of dextran from Leuconostoc 
mesenteroides NRRL B-1299 is currently the best method298, 310, 311. Yet, it is a multi-step process 
involving several chemical reagents like glacial acetic acid, acetic anhydride, concentrated sulphuric 
acid, chloroform and methanol. Chemical synthesis via modified Koenigs-Knorr reactions is still 
applied as well (e.g. by companies like Carbosynth), despite the need for multiple (de)protection 
steps, silver or mercury catalysts and solvents like acetonitrile, and low yields312-314. Alternatively, 
enzymes like α-glucosidase315, 316, α-glucoamylase316, 317, glucansucrase318, dextransucrase319 and 
kojibiose phosphorylase (concerted action with maltose phosphorylase)298 can be used, but 
unfortunately these suffer from product mixtures and/or low productivities. Sucrose phosphorylase 
(SP) is another enzyme that is capable of producing kojibiose129, 320, starting from sucrose 
(renewable, cheap and readily available114) and D-glucose. It naturally catalyses the reversible 
phosphorolysis of sucrose into α-D-glucose 1-phosphate and D-fructose, but it can also glycosylate 
alternative acceptors with yields exceeding 90%24, 66. In case of D-glucose as acceptor, the overall 
kojibiose yield is however lowered by the side-formation of maltose (4-O-α-D-glucopyranosyl-D-
glucopyranose) in about equimolar amounts129. Therefore, in this work semi-rational mutagenesis 
was applied in order to enhance the selectivity of sucrose phosphorylase from Bifidobacterium 
adolescentis towards the production of kojibiose. To that end, all positions in the acceptor site were 
randomised one by one and the improved variants were combined either rationally or based on a 
statistical model. 
2 RESULTS & DISCUSSION 
2.1 Quantifying activity and selectivity 
Due to its double displacement mechanism, sucrose phosphorylase can glycosylate glucose 
(acceptor) starting from either sucrose or glucose 1-phosphate (donor) (Figure 3.1). Regarding its 
interesting properties for production (reactive, cheap, abundantly available, renewable), sucrose is 
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the preferred substrate, but libraries will be screened with glucose 1-phosphate as well (see further). 
Classical colorimetric assays for the quantification of the transglycosylation reaction rely on the 
detection of the released fructose92, 321, 322 or inorganic phosphate26, 323. These accordingly measure 
the (total) activity indirectly and cannot distinguish the formation of kojibiose from maltose nor 
from the hydrolytic side activity (which can be prominent if transglycosylation activity is low). As a 
consequence, high performance anion exchange chromatography (HPAEC) was applied to follow 
the reactions. 
 
 
Figure 3.1 Reactions of sucrose phosphorylase with (a) sucrose or (b) glucose 1-phosphate as 
donor substrate and glucose as acceptor. Formation of kojibiose (α-1,2) and maltose (α-1,4) 
by the wild-type enzyme, and other glucose disaccharides potential ly produced by mutant 
enzymes (trehalose (α-1,1), nigerose (α-1,3) and isomaltose (α-1,6)) . Note that water can also 
act as acceptor leading to hydrolysis of the donor substrate (formation of glucose and 
fructose, or glucose and inorganic phosphate from sucrose or glucose 1-phosphate, 
respectively; hydrolytic side reaction not depicted on the figure). 
 
The wild-type enzyme produces kojibiose (α-1,2) and maltose (α-1,4), but introducing mutations 
could shift the regioselectivity (partly) towards the formation of trehalose (α-1,1), nigerose (α-1,3) or 
isomaltose (α-1,6) as well. Hence, HPAEC methods were optimised that were able to quantify each 
O
OH
OH
OH
OH
O
O
OH
OH
OH
OHsucrose
 Glc-1,2-Fru)
O
OH
OH
OH
OH
O O
-
P
O
OH
glucose 1-phosphate
(Glc1P)
O
OH
OH
OH
OH
OH
O
OH
OH
OH
OH
O O
OH
OH
OH
OH
O
OH
OH
OH
OH
O
O
OH
OH
OH
OH
glucose
 Glc)
maltose
 Glc-α1,4-Glc)
kojibiose
 Glc-α1,2-Glc)
+
O
OH
OH
OH
OH
OH
nigerose
 Glc-α1,3-Glc)
isomaltose
 Glc-α1,6-Glc)
trehalose
 Glc-α1,1-Glc)
+ +
+
fructose
 Fru)
...
OH O
-
P
O
OH
inorganic phosphate
(Pi)
O
OH
OH
OH
OH
OH
O
OH
OH
OH
OH
O O
OH
OH
OH
OH
O
OH
OH
OH
OH
O
O
OH
OH
OH
OH
glucose
 Glc)
maltose
 Glc-α1,4-Glc)
kojibiose
 Glc-α1,2-Glc)
+
nigerose
 Glc-α1,3-Glc)
isomaltose
 Glc-α1,6-Glc)
trehalose
 Glc-α1,1-Glc)
+ +
+
...
(a)
(b)
Engineering of sucrose phosphorylase for the selective production of kojibiose  CHAPTER 3 
 57 
possible product and substrate in one run, even in the presence of an excess of the others (Figure 
3.2). That way, not only the transglycosylation (formation of disaccharides), but also the hydrolysis 
can be (indirectly) quantified by comparing the rate of product formation to the rate of donor 
substrate depletion. Alternatively, for sucrose as donor, comparison between product formation and 
fructose release can be used for the same purpose. A shorter method was developed as well, which 
is more convenient for screening. The analysis time was shortened to 12 min per sample, while 
maintaining the ability to detect all reaction products unequivocally. Reactions using purified 
enzyme as well as crude cell extract were followed over a broad time interval and the method was 
found to be fairly robust. Especially the proportion of kojibiose formation in the total product 
formation (kojibiose + maltose) showed little deviation for repeated measurements (cv <10%). This 
parameter, representing the selectivity, was found to be around 35% for the wild-type enzyme. The 
value for the enzyme in this study (from Bifidobacterium adolescentis) thus slightly deviates from 
that reported in literature for SP from Leuconostoc mesenteroides (50%, under different 
conditions)129, 324. 
 
Figure 3.2 High performance anion exchange chromatography (HPAEC) profi les for (a) detailed 
characterisation and (b) init ial screening with sucrose as donor substrate (top: standard 
series; below: reaction at different time points for wild-type enzyme incubated with 100 mM 
sucrose and 200 mM glucose). 
 
2.2 Alanine scanning 
It was previously shown that all residues in the acceptor site of sucrose phosphorylase contribute to 
the binding of the wild-type substrates and that the enzyme is highly optimised to perform its wild-
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type reaction (Chapter 2). As a consequence, the acceptor site might need drastic changes to 
completely shift the specificity. In contrast, to alter the preference for one of two existing but 
competing reactions, small modifications could already be enough. To verify this hypothesis, the 
activity and selectivity of the previously created alanine mutants was assayed with glucose as 
acceptor and either sucrose or glucose 1-phosphate as donor. In short, in these mutants all 
residues in the acceptor site i.e. all residues within 5 Å from the fructose or phosphate moiety that 
are not the nucleophile (Asp192), general acid/base catalyst (Glu232) or transition state stabiliser 
(Asp290), were individually substituted to alanine (single mutants; see Chapter 2 for details). Initial 
velocities of kojibiose and maltose formation were determined (activity) as well as the ratio of both 
activities, expressed as the share of kojibiose formation in the total product formation (selectivity) 
(Figure 3.3 and Table S3.1). The results show that the ratio can indeed be altered by small changes. 
In some cases the preference of maltose formation was enhanced (like for Tyr196), but for several 
other alanine mutants the opposite was observed (e.g. Pro134, Asp342, Tyr344 and Gln345). 
Moreover, not only selectivity, but also activity was affected, although it comprised most often a 
decrease. In addition, whereas the selectivity was in general very similar for sucrose or glucose 1-
phosphate as donor, the change in activity sometimes differed remarkably. For example for mutant 
Y344A, the activity was increased around 1.5 times for sucrose, while it was decreased around 3.5 
times for glucose 1-phosphate. Since the selectivity was the same and Tyr344 is known to be 
important for binding of phosphate (and accordingly glucose 1-phosphate), the difference in 
activity can most likely be accounted to a hampered use of glucose 1-phosphate as donor. The 
donor substrate can thus influence the outcome to a large extent, and therefore mutant libraries 
were screened with both donors. Furthermore, since all alanine mutants had an influence on activity 
 
Figure 3.3 Specif ic activity and selectivity of kojibiose formation for all acceptor site alanine 
mutants. Reactions performed with 200 mM glucose as acceptor and (a) 100 mM sucrose or 
(b) glucose 1-phosphate as donor substrate (58°C, pH 7) (selectivity: share of kojibiose 
formation in total product formation (kojibiose + maltose); variant H234A is not included as 
its activity was too low for accurate measurements). 
Y196A Y196A 
Y132A Y132A 
L341A 
L341A 
D342A 
D342A 
Q345A Q345A Y344A 
Y344A 
P134A P134A 
L343A 
L343A 
R135A 
R135A 
V233A wt 
wt 
V233A 
(a) (b) 
Engineering of sucrose phosphorylase for the selective production of kojibiose  CHAPTER 3 
 59 
and/or selectivity (similar as in Chapter 2), all positions were targeted for mutagenesis. Single site-
saturation libraries were created in order to minimise the screening effort (no high-throughput 
screening method available) while not impeding the odds of finding improved mutants (point 
mutations already had a profound influence on selectivity and activity). 
2.3 Generation of single site-saturation libraries 
Mutant libraries are typically generated with whole plasmid amplification methods such as the 
widely used QuikChangeTM protocols from Stratagene. In these procedures, the complete plasmid is 
amplified using two complementary degenerate primers (Figure 3.4a). Initial attempts did not result 
in libraries of sufficient quality, i.e. incomplete randomisation and/or overrepresentation of the wild-
type codon. Therefore, the standard protocol was optimised by altering the primer (0.20-0.75 µM) 
and template (20-50 ng) concentrations, the annealing temperature (45-60°C), the number of cycles 
(20-30), the elongation time (1-3 min/kb) and the concentration of DMSO (0-5%). For libraries 
R135X, L343X and Y344X, the quality of the library was acceptable, but for other positions this was 
not the case.  
 
Figure 3.4 Overview of whole plasmid amplif ication methods for the creation of saturation 
libraries. (a) Stratagene’s QuikchangeTM method, (b) Sanchis method and (c) three-step 
megaprimer whole-plasmid method. 
(a) (c) 
(b) step 2  degenerate fragment amplification 
step 1   fragment amplification 
step 3   whole plasmid amplification 
 whole plasmid amplification 
megaprimer + whole plasmid amplification 
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The phenomenon that QuikChangeTM procedures sometimes fail, is also known from literature295. In 
order to counter this drawback, Sanchis and colleagues have devised an alternative two-stage PCR 
method (Figure 3.4b). In the first five cycles (first stage), a fragment is amplified with a degenerated 
and a non-mutagenic primer, in a normal PCR reaction. In the next 20 cycles (second stage), 
conditions are adjusted in such way that the primers cannot bind anymore. Only the fragment can 
anneal and now serves as a megaprimer for the amplification of the whole plasmid. Using this 
protocol, libraries H234X, D342X and Q345X could be created successfully (after optimising 
annealing temperatures (50-60°C) and length of the megaprimer (200-3000 bp)). However, for the 
remaining positions randomisation was again insufficient. The wild-type codon was overrepresented 
and some bases were sometimes absent, most likely due to preferential binding of codons that are 
most similar to the wild-type codon. To tackle this problem, a method was used consisting of three 
separate PCR reactions (Figure 3.4c). First, a fragment adjacent to the codon to be randomised is 
amplified with a non-mutagenic primer pair. The degenerate megaprimer is subsequently created 
by amplifying this fragment with a degenerate primer having NNK degeneracy in its overhang. In a 
final step, the megaprimer is used for the whole plasmid PCR, similar to the last stage of the 
original Sanchis protocol. Since the degenerated codon is situated in the overhang region, there is 
no preferential binding to the template, which should result in a better library. Degeneracy of 
megaprimers of different lengths was indeed found to be close to the theoretical values, but could 
only be successfully incorporated in the final library for position Leu341. Varying denaturation (30-
60 sec) and elongation (2-4 min/kb) times, number of cycles (20-30), concentrations of template 
(10-100 ng) and megaprimer (50-500 ng), length of the megaprimer (200-200) and concentration of 
DMSO added to the whole plasmid reaction (0-5%) did not lead to the desired library quality. 
Moreover, the number of colonies after transformation was in some cases too low to statistically 
cover a sufficient number for screening. Accordingly, other approaches that do no rely on whole 
plasmid amplification were evaluated. 
Successful randomisation of libraries Y132X and P134X could be achieved with the method 
described by Coussement and colleagues325 (Figure 3.5a). Herein, a short fragment (50-60 bp) 
containing the degenerated codon is ligated into a backbone fragment (based on Gibson 
assembly326) (Figure 3.5a). The latter fragment is amplified from the template plasmid while the 
former consists of two synthetic oligonucleotides that share 20 base pairs overlap with one another 
at one end and with the backbone fragment at the other. Note that the randomised part does not 
anneal to the backbone nor to the other oligonucleotide, and accordingly preferential binding 
cannot occur in contrast to whole plasmid amplification methods. For library Y196X, however, 
library quality was still insufficient. The formation of secondary structures in or dimers between the 
oligonucleotides was attributed as the main cause of failure. Indeed, it is known that secondary 
structures decrease the efficiency of homologous recombination based assemblies326. Therefore, two 
variants of the standard Gibson assembly were applied, namely a first in which the temperature was 
raised from the usual 50°C to 60°C and a second in which 5% of DMSO was added to the reaction 
mixture. The oligonucleotides were in addition preheated for 5 min at 95°C. Unfortunately, it did 
not yield any improvements. As a consequence, an extra step was introduced which creates a larger 
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fragment containing the degeneracy (Figure 3.5). First, a fragment was generated in exact the same 
way as the backbone fragment described in the method above (step 1). In the second step, two 
parts of similar length (2000-2500 bp) were amplified in a separate PCR, one of them containing 
the degenerated codon. To that end, the same oligonucleotides designed for the method of 
Coussement could be used as primers, together with two additional, complementary primers (step 
2). Both fragments were constructed to have 20 base pair homology at each end, which enables the 
fusion of both pieces in a regular Gibson assembly (step 3). That way the desired NNK degeneracy 
could be achieved for library Y196X. 
 
 
Figure 3.5 Overview of assembly based methods for the creation of saturation libraries. (a) 
method of Coussement and (b) large fragments assembly. 
 
None of the methods described above thus seems to be universally applicable. Especially the whole 
plasmid protocols could often not deliver the desired degeneracy, even not after elaborate 
optimisation of the reaction conditions. Therefore, assembly based methods might be a more 
interesting alternative. They do not suffer from preferential binding of wild-type and closely related 
codons, yield more colonies and required less optimisation compared to whole plasmid methods, 
and can be readily used for longer stretches of randomisation. 
(a) (b) step 1   backbone amplification 
step 2   Gibson assembly step 2   fragments amplification 
step 1   backbone amplification 
step 3   Gibson assembly 
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2.4 Screening of libraries 
As discussed above, sucrose is the preferred donor substrate, but libraries were also screened with 
glucose 1-phosphate as donor. Indeed, certain residues are essential for the binding of the fructose 
moiety (and thus sucrose), and accordingly if upon mutation sucrose cannot bind anymore, the 
 
 
Figure 3.6 Specif ic activity and selectivity of kojibiose formation of all hits obtained from the 
initial screening. Reactions performed with purif ied enzyme, 200 mM acceptor (glucose) and 
100 mM donor (sucrose or glucose 1-phosphate) at 58°C, pH 7. 
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glycosyl intermediate cannot be formed and obviously no kojibiose will be produced, even though 
the mutation is the key for changing the selectivity. This same mutation could on the other hand 
have no influence on the binding of the phosphate group (and thus glucose 1-phosphate). 
Initial screening was performed in microtiter plates with crude cell extract, and afterwards hits were 
expressed on a larger scale and purified for further characterisation (Figure 3.6, Table S3.1). The 
selectivities were in general very similar for both donors, which agreed with the data obtained from 
the alanine mutants. Activities on the other hand were much higher for sucrose, and therefore 
discussion of the mutants will be based on the data obtained from this donor. The best mutant was 
L341I since it had the highest selectivity (79%) and activity (0.37 U/mg). Moreover, both values were 
more than twice as high compared to the wild-type enzyme (35% and 0.15 U/mg, respectively). 
High selectivities (62-73%) were also observed for P134R, P134W, Y344I, Q345N, Q345S and P134V. 
These latter two had an activity comparable to the wild-type enzyme, whereas the others had 
significantly lower activities. Y344A had a higher activity as well, but its improvement in selectivity 
was less profound. Beside the formation of kojibiose and maltose, none of the hits produced 
another glucose disaccharide, and neither did the other screened variants. 
In total, screening of the ten single site-saturation libraries yielded 18 variants with improved, two 
with a similar (P134T and R135V) and six with a worse selectivity (R135P and all Y132 mutants). 
These latter all had activities that are twenty to hundred times lower than the wild-type enzyme. In 
the initial screening, the product peaks were therefore very small, making the accurate 
quantification of the total product formation and fraction of kojibiose very difficult. Consequently, it 
may have been wise to not consider these results as hits in the first place. Additionally, the initial 
screening tended to overestimate the fraction of kojibiose in the total product formation (Figure 
S3.1). Nonetheless, the majority of the hits indeed displayed an improved selectivity, and the overall 
screening procedure can thus be considered reliable and valuable for discovering improved 
variants. 
2.5 Rational combination of point mutations 
Several point mutations already had a pronounced positive effect on the selectivity, and 
combinations might therefore further improve the enzyme. To that end, the best single mutant 
L341I was combined with the next best mutations in terms of selectivity, i.e. P134V, Q345S and 
Q345N. Combination of Q345N or Q345S together with L341I gave rise to an increase in selectivity 
from 79% for L341I to 93-94% for both double mutants. The activity was unfortunately decreased 
to a value below that of the wild-type enzyme. P134V_L341 in contrast had a higher activity, but 
the selectivity was worse than both single mutants. A similar pattern was observed for the triple 
mutants having a valine at position 134, namely an improved activity compared to the double 
mutants, albeit at the cost of selectivity. 
The selectivity of L341I_Q345N, the best mutant so far, was further optimised by introducing an 
alanine or isoleucine at position 344. That way, a selectivity of 95.7% could be achieved for 
L341I_Y344A_Q345N, together with a slight increase in activity compared to the double mutant 
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lacking the Y344A mutation. Introducing a leucine also resulted in an improvement, although less 
prominent. In general, combining mutations resulted in significant better selectivities, but could 
never surpass the activity of the best single mutant. In the end, compared to the wild-type enzyme 
the best mutant L341I_Y344A_Q345N displayed an impressive increase in selectivity from 35% to 
95%, while maintaining 40% of the activity. 
 
 
Figure 3.7 Specif ic activity and selectivity of kojibiose formation of rationally combined 
mutants (single: alanine and single mutants from initial screening; rational: rationally 
combined mutants; dotted lines: wild-type reference). 
 
2.6 Combinations predicted by a statistical model 
In the previous section, the mutations selected for combination were to some extent arbitrarily 
chosen. Indeed, focus was only on combining the ‘best’ mutations, while it is known that sometimes 
less favourable mutations can have a profound positive influence in combination with others. 
Unfortunately, it is nearly impossible to predict this effect on a rational basis. In addition, a large 
number of possibilities further complicates the decision making process. To address these 
problems, statistical approaches can offer a solution by trying to relate sequence or structural 
information to a certain function or activity of a protein, in order to predict improved mutants. 
Moreover, all possible mutants can be evaluated instead of only a small fraction.  
Several variants of such statistical approaches have been established by the group of professor 
Bernard Offmann from the Université de Nantes. In this work, three of these prediction models 
(AFSAR, SipSAR and AFSipSAR) were evaluated. In brief, the AFSAR (Amino Acid Features in 
Sequence-Activity Relationships) model takes into account physico- and biochemical properties of 
amino acids for the encoding of the mutated positions, in contrast to the original ProSAR approach. 
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Incorporation of these amino acid properties is also included in the SipSAR (Signal-Processing in 
Sequence-Activity Relationships) method. Here, however, the focus is not only on the mutated 
positions, but the complete sequence is taken into account (by means of Fourier transformation). 
Finally, in AFSipSAR, the characteristics of both methods are combined (detailed information170). 
This way, predictions for selectivity and activity can be made, based on both numerical and spectral 
information.  
Twenty-six single mutants present at that time were used as input data (training set) (Table S3.1). 
These included alanine as well as other single mutants for nine different positions and covered 
deleterious, neutral and beneficial mutations, both in terms of selectivity and activity. The 
parameters of the three models were optimised to maximise the correlation between the predicted 
and the measured values (work done at Université de Nantes), and the model that fitted the input 
data best was chosen (AFSAR). The selected prediction model can be considered quite accurate, 
since the coefficients of determination between the measured and predicted values were 0.64 and 
0.60 for selectivity and activity, respectively (leave one out cross validation) (Figure 3.8). Using this 
model, values were predicted for the ~60 500 possible combinations, ranging from all double 
mutants to those containing up to nine simultaneous mutations. All mutants with a predicted 
activity lower than the wild-type enzyme were discarded and the remaining were ranked according 
to their selectivity (i.e. as high as possible). The top ten were subsequently selected for in vitro 
evaluation. 
 
 
Figure 3.8 Predicted values for the training set. Predicted versus measured (a) selectivity and 
(b) specif ic activity (data obtained from leave one out cross validation). 
 
All ten SAR mutants were all successfully expressed and purified, and their selectivity and specific 
activity was determined (Figure 3.9). Unfortunately, mutants SAR_3, SAR_6 and SAR_9 did not show  
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Figure 3.9 Mutations (a) and specif ic activity and selectivity of kojibiose formation (b) of the 
predicted top 10 performing enzyme variants. SAR_3, SAR_6 and SAR_9 did not show any 
measurable activity (single: alanine and single mutants from initial screening; rational: 
rationally combined mutants; SAR: mutants predicted by the statistical model; dotted lines: 
wild-type reference). 
 
any measurable activity, in contrast to the others. These latter had selectivities between 81 and 
90%, which is better than the best single mutant L341I (79%), but lower than several rationally 
combined mutants (selectivities up to 95%). Moreover, the activities were very low, i.e. 1-10% 
compared to the wild-type enzyme. The only exception was mutant SAR_4, which had an activity 
similar to the least active rationally designed mutant (but a lower selectivity). Accordingly, the 
rationally designed mutants overall performed better. 
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Considering the SAR mutants, incorporation of as few mutations as possible yielded the most active 
mutant (SAR_4). The mutant that only contained the three mutations present in all ten SAR mutants 
(P134V, L341I and Q345N) would even have been better (Figure 3.9). The three SAR mutants that 
did not show activity, all contained the H234T mutation. The activity of the single mutant was 
already fifty times lower than the wild-type enzyme (and likewise predicted by the model), and 
apparently combination with other mutations was detrimental for activity. Also incorporation of an 
Ala on the position of Asp342, an important residue for binding of sucrose, decreased the activity 
severely (SAR_1 and SAR 4 compared to SAR_2 and SAR_5, respectively). Consequently, no positive 
synergistic effects between less favourable mutations were observed (which the model might have 
assumed), and mutations one would not introduce on a rational basis, were indeed found to have a 
negative impact. The activity was thus largely overestimated, especially for the SAR mutants (Figure 
3.10b). The selectivity in contrast was predicted quite accurately (Figure 3.10a). Note that most of 
the rationally designed mutants had predicted activities that were higher than the SAR mutants, but 
they were not part of the top ten mutants due to the selection criteria used (first ranked on 
selectivity, then on activity). 
 
 
Figure 3.10 Evaluation of the prediction model. Predicted versus measured (a) selectivity and 
(b) specif ic activity for the rationally combined mutants (rational) and the mutants predicted 
by the statistical model (SAR). 
 
2.7 Characterisation of best mutants 
The best single, double and triple mutants were kinetically characterised and compared to the wild-
type enzyme (Table 3.1). The latter had a KM of around 300 mM for both the Glckoji and Glcmalt state 
(glucose in the orientation and conformation that leads to production of kojiobose and maltose, 
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respectively). The selectivity (33%) is thus due to the difference in kcat, which is double as high for 
Glcmalt. In mutant L341I, this relationship is completely inverted and the kcat for Glckoji has become 
five times higher than Glcmalt. In addition, the KM for Glcmalt slightly increased, while the value for 
Glckoji was lowered to 191 mM. Further improvement of the KM to a value below 100 mM was 
observed when mutation Q345S or Q345N was introduced in the L341I mutant. The kcat 
unfortunately decreased for L341I_Q345S to half the value of the wild-type enzyme, and for 
L341_Q345N even to one fifth. Moreover, both enzymes suffered from substrate inhibition at higher 
concentrations of glucose (Figure S3.2). This latter problem could however be eliminated in the 
L341I_Y344A_Q345N mutant without affecting the apparent kinetic parameters.  
 
Table 3.1 Apparent kinetic parameters of the wild-type enzyme and improved single, double 
and triple mutants (Glckoji:  glucose state leading to formation of kojibiose; Glcmalt: glucose 
state leading to formation of maltose). 
enzyme Glckoji Glcmalt 
 KM (mM) kcat (s-1) 
kcat/KM 
(s-1M-1) 
KM (mM) kcat (s-1) 
kcat/KM 
(s-1M-1) 
wild-type 305 ± 48 0.70 ± 0.03 2.3 312 ± 57 1.35 ± 0.08 4.3 
L341I 191 ± 25 2.49 ± 0.10 13.1 347 ± 133 0.55 ± 0.07 1.6 
L341I_Q345Sa 83 ± 13 0.39 ± 0.02 4.7 n.p. n.p. n.p. 
L341I_Q345Sb 236 ± 66 0.75 ± 0.13 3.2 n.p. n.p. n.p. 
L341I_Q345Na 79 ± 7 0.14 ± 0.01 1.8 n.p. n.p. n.p. 
L341I_Q345Nb 155 ± 35 0.21 ± 0.02 1.3 n.p. n.p. n.p. 
L341I_Y344A_Q345N 81 ± 8 0.14 ± 0.01 1.7 n.p. n.p. n.p. 
a from classical Michaelis-Menten curve fitted to activity values obtained from glucose concentrations up to 
500 mM; b from substrate inhibition curve fitted to activity values obtained from glucose concentrations up to 
1500 mM (see methods and materials for equation), Ki,L341I_Q345S = 542 ± 161 mM and Ki, L341I_Q345N = 1342 ± 
367 mM; n.p. not possible to accurately measure the initial reaction velocity 
 
Up till now, focus has been on finding an enzyme that can produce kojibiose as fast and as 
selective as possible. For production purposes, however, efficient use of the donor substrate should 
be considered too. Indeed, sucrose phosphorylase displays next to transglycosylation activity, 
hydrolytic activity as well. Hydrolysis of sucrose not only lowers the overall atom economy, it also 
prevents reaching high kojibiose titers. Therefore, the hydrolytic activity of the mutants was assayed 
in parallel with the transglycosylation. For the wild-type enzyme, one third of the sucrose is lost due 
to hydrolysis. Taken into account that for this enzyme maltose formation is double as fast as 
kojibiose formation, only 20-25% of the donor glucose ends up in kojibiose. For the single mutant 
L341I, the hydrolytic activity was lowered to around 10% (and its selectivity is ~80%), entailing 
~70% of the donor glucose is incorporated in kojibiose. Values of above 90% could even be 
reached for the remaining mutants, since all of them hardly showed any hydrolysis.  
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It is however very difficult to conclude which mutant is the best, or which one will perform best 
under industrial conditions. Indeed, all values for activity, selectivity and share of hydrolysis were 
obtained from measurements of initial reaction velocities, using 100 mM sucrose and 200 mM 
glucose. The improved selectivity of some mutants was for instance (partly) due to an improved KM, 
which is less relevant at high glucose concentrations. Elevated concentrations of sucrose could also 
influence the overall activity or hydrolytic side activity differently in different mutants. Moreover, it 
is possible that some mutants start to use kojibiose as donor substrate or produce side products 
like sucrose isomers near the end of the reaction. It is therefore wise to evaluate and optimise 
process conditions for all four mutants. 
3 CONCLUSION 
This chapter describes the first example of a successfully engineered sucrose phosphorylase with an 
altered substrate preference. The HPAEC screening method developed here was able to detect 
improved variants and the number of false positives was limited. Due to the universal applicability 
for other CAZyme reactions and the ease of adapting the analysis conditions, it could generally be 
a useful screening method, if throughput is not of highest priority. Here it was used to screen for 
sucrose phosphorylase variants that can selectively produce kojibiose. Preliminary analysis of several 
active site alanine mutants showed that point mutations could have a profound effect on selectivity 
and subsequent screening of single site-saturation libraries indeed yielded several improved 
variants. From the most promising combinations predicted by a statistical ProSAR model, a few 
displayed an increased selectivity. Activities were however fairly low and largely overestimated by 
the model. Rational combination of the best single mutants resulted on the other hand in two 
double and one triple mutant that produce kojibiose in selectivities up to 93-95%. This would 
enables the development of an industrial process and it can furthermore be expected that the 
proof-of-concept study in this work can be extended to other substrates or other enzymes. 
4 METHODS AND MATERIALS 
4.1 HPAEC-PAD analysis 
All reactions were monitored by High Performance Anion Excange Chromatography (HPAEC) (Dionex ICS-3000, 
Thermo Scientific), using a CarboPac PA20 pH-stable column and Pulsed Amperometric Detection (PAD) and 
all samples (10 µl) were analysed at a constant flow rate of 0.5 ml/min at 30°C. The method used for screening 
with sucrose as donor consisted of an isocratic elution with 35 mM NaOH and 15 mM acetate for 12 min. That 
way trehalose, kojibiose, nigerose, maltose and isomaltose (products) could be separated from one another 
and from sucrose, glucose and fructose (which are not separated from each other). When glucose 1-phosphate 
was used as donor the same eluens composition was applied for 8 min, after which the acetate concentration 
was raised to 400 mM in 2 min and brought back to the initial conditions in 2 min, followed by an 
equilibration of another 2 min (resulting in a total analysis time of 14 min). This enabled the separation of 
trehalose, kojibiose, nigerose, maltose, isomaltose, glucose and glucose 1-phosphate. Note that for the 
screening with crude cell extract, retention times of the peaks sometimes tend to shift to higher values (for 
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unknown reasons), and it can therefore be wise to elongate the methods with 2 minutes. For the detailed 
characterisation with sucrose as donor, separation of all possible substrate and (potential) product peaks 
(sucrose, glucose, fructose, trehalose, kojibiose, nigerose, maltose, isomaltose) was achieved with a 30 min long 
method. After 13 min of isocratic elution with 30 mM NaOH, the concentration was gradually increased to 100 
mM in 5 min, kept constant for 3 min and decreased again to 30 mM within 1 min, followed by an 
equilibration period of 8 min. 
4.2 Library generation and site-directed mutagenesis 
All libraries were generated from the constitutive expression plasmid pCXP34h containing the sucrose 
phosphorylase gene from Bifidobacterium adolescentis92 as (initial) template and the primers described in 
Table S3.2. Libraries R135X, L343X and Y344X were produced with (adjusted) QuikChange protocols. The PCR 
mastermix contained 50 ng of template, 0.35 μM of each primer, 0.2 mM of dNTP mix and 2.5 U of PfuUltra 
High Fidelity polymerase AD in a 50 μl reaction. The PCR program consisted of 1 initial denaturation cycle of 3 
min at 95°C, followed by 25 cycles of denaturation for 1 min at 95°C, 1 min of annealing at 55°C and 2 min/kb 
of elongation at 68°C, concluding with a final elongation cycle for 10 min at 72°C. These initial conditions were 
adjusted if library quality was not sufficient (see results and discussion for the optimisation of the conditions 
and end of this section for the library quality control). 
The Sanchis protocol295 was applied to make libraries H234X, D342X and Q345X, as described in Chapter 2, 
and optimised if necessary (see results and discussion). Inspired by this technique, library L341X was produced 
in three subsequent PCR reactions, in which the megaprimer was amplified from a fragment of the entire 
plasmid, followed by a whole plasmid PCR. The PCR mastermix for the initial fragment contained 100 ng of 
plasmid template, 0.1 μM of each primer, 0.2 mM of dNTP mix and 2.5 U of PfuUltra High Fidelity polymerase 
AD in a 50 μl reaction. The PCR program consisted of 1 initial denaturation cycle of 3 min at 95°C, followed by 
30 cycles of denaturation for 1 min at 95°C, 1 min of annealing at 55°C and 2 min/kb min of elongation at 
68°C, concluding with a final elongation cycle for 10 min at 72°C. The megaprimer was amplified in exact the 
same way, albeit with the fragment as a template. The whole plasmid PCR was subsequently performed with 
500 ng megaprimer and 50 ng plasmid template, according to the last step of the Sanchis protocol. 
Libraries Y132X and P134X were generated according to the method described by Coussement et al325. In 
brief, a backbone fragment is amplified in which a short fragment (50-60 bp) containing the degenerated 
codon is ligated by means of a Gibson assembly procedure326. The backbone fragment was amplified from the 
constitutive expression plasmid pCXP34h containing the sucrose phosphorylase gene from Bifidobacterium 
adolescentis92. The mastermix contained 0.02U/μL Phusion DNA polymerase, 1x Phusion HF buffer, 0.2 mM 
dNTP mix, 10 ng plasmid template and 0.25 μM of both primers in a 50 μL reaction. The PCR cycling program 
consisted of 1 cycle of 30 sec at 98°C, 30 cycles of 10 sec at 98°C, 20 sec at 55°C and 30 sec/kb at 72°C, 
followed by a final elongation cycle of 5 min at 72°C. Amplified products were treated with 20 U of DpnI for at 
least two hours at 37°C and were then purified using the QIAQuick PCR Purification Kit Protocol (Qiagen). 
Fragment length and purity was checked using agarose gel electrophoresis. For the assembly, 100 ng 
backbone framgent was added to the Gibson mastermix (0.004 U/ml T5 exonuclease, 0.025 U/mL Phusion 
polymerase and 4 U/mL Taq ligase in 1x ISO buffer) together with 400 nM of ssDNA oligos in a total volume 
of 20 μl, and incubated for 60 min at 50°C. 
For library Y196X, first a fragment was amplified in the same way as described for libraries Y132X and P134X. 
Subsequently, this fragment served as a template to generate two fragments of similar size, one of them 
containing the degenerate codon. To that end, the same PCR conditions, DpnI treatment and purification were 
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used. Both pieces (100 ng) having 20 bp homology islands at both ends were then fused together in a Gibson 
assembly, as described above. 
In all cases, the generated library DNA was transformed in E. coli CGSC 8974 (Coli Genetic Stock Center, New 
Haven, CT, USA). For each library, the constructs were subjected to nucleotide sequencing (AGOWA Sequence 
Service, Berlin, Germany) as a mixture, in order to confirm that the whole plasmid amplification or ligation was 
correct, to exclude the presence of undesirable mutations and to evaluate the degeneracy. The latter was 
obtained by comparing the relative peak height of each base at the NNK position with the theoretical 
values295. In addition, it was taken care that the number of transformants was >103 cfu/ml. 
Site-directed mutations were introduced according to the protocol reported by Sanchis et al.295 as described in 
Chapter 2, using the primers listed in Table S3.3. Note that the alanine mutants were created previously (see 
Chapter 2). 
4.3 Screening 
Individual colonies were picked, grown and lysed as described in Chapter 2, with the difference that the lysis 
buffer composition was different. Since chloride destroys the detector of the Dionex device, NaCl, MgCl and 
Tris.HCl were replaced with Na2SO4, MgSO4 and MOPS, respectively (1 mg/ml lysozyme, 0.1 mM PMSF, 50 mM 
Na2SO4, 4 mM MgSO4 and 1 mM EDTA in 50 mM MOPS buffer pH 7.0). 
Reaction were initiated by adding 50 µl of crude cell extract to 50 µl substrate solution in low well microtiter 
plates (Nunc) (final concentration of 100 mM donor (sucrose or α-D-glucose 1-phosphate) and 200 mM 
acceptor). Reactions were incubated for 16 hours at 37°C, after which 200 µl of 0.01 N NaOH was added to 
stop the reaction. Subsequently, microtiter plates were spun down for 30 min at 4500 rpm. Supernatant (12 µl 
or 7.5 µl with sucrose or glucose 1-phosphate as donor, respectively) was transferred to deep well plates (total 
volume of 2 ml/well) and diluted with mQ to a final dilution of 500x or 800x. Samples were analysed with the 
short HPAEC-PAD methods described above. For each library, two hundred clones were screened for each 
donor substrate. 
4.4 Characterisation of wild-type enzyme and mutants 
Enzyme production and purification was performed as previously described26. All reactions were performed at 
58°C in 50 mM MOPS buffer pH 7.0. Specific activity, selectivity and share of donor substrate hydrolysis were 
calculated from initial reaction rates obtained from reactions of 0.25-2 mg/ml enzyme in the presence of 100 
mM donor substrate (sucrose or α-D-glucose 1-phosphate) and 200 mM acceptor (D-glucose).  
Michaelis-Menten profiles were obtained from reactions with 200 mM sucrose and glucose concentrations 
ranging from 0-1500 mM. For the wild-type enzyme and mutants L341I and L341I_Y344A_Q345N the classical 
Michaelis-Menten equation was fitted to activity values from the entire glucose concentration range, whereas 
for mutants L341I_Q345S and L341I_Q345N only values below 500 mM glucose were used. Alternatively, a 
substrate inhibition curve was fitted to activity values from the entire range: ! ! !"!# ! !!!!! ! !!! ! ! !!!!!  
with Vmax maximum enzyme velocity if the substrate did not inhibit enzyme activity, KM Michaelis-Menten 
constant and Ki inhibition constant. 
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For every reaction, samples (10 µl) were taken at regular time intervals, inactivated with 0.01 N NaOH (25 µl in 
case of sucrose as donor and 50 µl in case of glucose 1-phosphate) and spun down for 10 min at 14 000 rpm. 
Supernatant (10 µl) was subsequently diluted in 1500 µl mQ to a final dilution of 525x and 900x for sucrose 
and glucose 1-phosphate as donor, respectively, and samples were analysed with the appropriate HPAEC 
methods described above. 
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SUPPLEMENTARY DATA 
 
 
Figure S3.1 Selectivity (% kojibiose) obtained from the initial screening with crude cell extract 
compared to the values obtained from the subsequent characterisation with purif ied enzyme 
for (a) sucrose and (b) glucose 1-phosphate as donor. 
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Figure S3.2 Michaelis-Menten profi les of the wild-type enzyme and improved mutants 
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Table S3.1 Specif ic activit ies and selectivity of all single mutants (cv <20% for activity and 
<10% for selectivity, from three replicates; al l reactions performed with 100 mM donor and 
200 mM acceptor, pH 7.0 and 58°C) 
l ibrary mutant donor sucrose donor glucose 1-phosphate 
  activity (U/mg) selectivity (%) activity (U/mg) selectivity (%) 
- wild-typec 0,150 (100%) 35 0,044 (100%) 34 
Y132X Y132Ga,c 0,005 (3%) 23 0,004 (8%) 20 
 Y132Ia,c 0,002 (1%) 27 0,001 (3%) 28 
 Y132La,c 0,005 (5%) 29 0,006 (14%) 33 
 Y132Ra,c 0,005 (3%) 26 0,003 (7%) 33 
 Y132Sa,c 0,007 (4%) 29 0,004 (9%) 30 
P134X P134Aa,b,c 0,112 (101%) 44 0,052 (118%) 45 
 P134Ra,b,c 0,016 (11%) 62 0,012 (27%) 68 
 P134Sb 0,072 (48%) 51 0,012 (27%) 48 
 P134Tb 0,113 (75%) 36 0,014 (32%) 28 
 P134Va,b,c 0,136 (90%) 68 0,050 (114%) 78 
 P134Wb 0,028 (19%) 74 0,004 (9%) 68 
R135X R135Ea,c 0,018 (12%) 44 0,015 (33%) 42 
 R135Pa,c 0,010 (6%) 15 0,004 (8%) 16 
 R135Va,c 0,038 (26%) 38 0,035 (79%) 39 
H234X H234Ta,c 0,003 (2%) 51 0,001 (1%) 43 
L341X L341Ia,b,c 0,372 (248%) 79 0,055 (125%) 78 
D342X D342Aa,c 0,050 (33%) 47 0,020 (46%) 57 
L343X L343Pa,c 0,023 (15%) 53 0,006 (13%) 48 
Y344X Y344Aa,c 0,210 (140%) 49 0,013 (29%) 51 
 Y344Da,c 0,051 (34%) 40 0,005 (11%) 37 
 Y344Fa,c 0,123 (82%) 38 0,036 (82%) 37 
 Y344Ia,c 0,038 (26%) 61 0,004 (10%) 56 
 Y344Ra,c 0,069 (46%) 44 0,031 (71%) 43 
 Y344Va,c 0,074 (49%) 54 0,027 (61%) 55 
Q345X Q345Na,b,c 0,010 (7%) 72 0,004 (10%) 73 
 Q345Sa,b,c 0,138 (92%) 68 0,032 (74%) 66 
a obtained from screening with sucrose as donor; b obtained from screening with glucose 1-phosphate as 
donor; c used as input for the statistical model 
 
Table S3.2 Primers used for l ibrary generation 
template primer name 5’→3’ sequence 
Y132X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_P136_frag CCGGGTCTGCCGTTTACCCAC 
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 BaSP_CO3_Rv_BBloopB_gib CCGTGGCACCGTTCGGGAAC 
- BaSP_CO3_Fw_Y132NNK GAAGAAGACCTGGCAGGCATTNNKCGTCCGCGTCCGGGTC
TGCCGTTTACCCAC 
 BaSP_CO3_Rv_loopB_gib AATGCCTGCCAGGTCTTCTTCCGTGGCACCGTTCGGGAAC 
P134X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_P136_frag CCGGGTCTGCCGTTTACCCAC 
 BaSP_CO3_Rv_BBloopB_gib CCGTGGCACCGTTCGGGAAC 
- BaSP_CO3_Fw_P134NNK GAAGAAGACCTGGCAGGCATTTATCGTNNKCGTCCGGGTC
TGCCGTTTACCCAC 
 BaSP_CO3_Rv_loopB_gib AATGCCTGCCAGGTCTTCTTCCGTGGCACCGTTCGG GAAC 
R135X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_R135NNK_long GCAGGCATTTATCGTCCGNNKCCGGGTCTGCCGTTTACC 
 BaSP_CO3_Rv_R135NNM_long GGTAAACGGCAGACCCGGMNNCGGACGATAAATGCCTGC 
Y196X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_Y196frag CAAAGAAGCAGGCACCAGTTG 
 BaSP_CO3_Rv_BB196_gib ACATGGCTGGCCGCCATTTGG 
fragment BaSP_CO3_Fw_Y196NNK GTCTTATATCCGCCTGGATGCGGTTGGCNNKGGTGCCAAA
GAAGCAGGCACCAGTTG 
 BaSP_CO3_Rv_lib CTACGATACGGGAGGGCTTACC 
fragment BaSP_CO3_Fw_lib GGTAAGCCCTCCCGTATCGTAG 
 BaSP_CO3_Rv_196_gib ATCCAGGCGGATATAAGACACATGGCTGGCCGCCATTTGG 
H234X   
pCXP34h_BaSP_CO3 BaSP_NLFI_Fw_H234I ATTCTGATCGAAGTCNNKAGCTATTACAAAAAACAGG 
 oMEMO073_Rv TACGATACGGGAGGGCTTAC 
L341X   
pCXP34h_BaSP_CO3 oMEMO074_Fw TCCGTGTCGCCCTTATTCCC 
 BaSP_NLFI_Rv_N340frag CCGGGTCTGCCGTTTACCCAC 
fragment oMEMO018_Fw GAGAAAGGCGGACAGGTATC 
 BaSP_NLFI_Rv_L341NNM TAACTTGGTACAGATCMNNGTTCGATGCCG 
D342X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_D342NNK TGCGGCGGCATCGAACCTGNNKCTGTACCAAGTTAATAGTA
CC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
L343X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_L343NNK_long  TGCGGCGGCATCGAACCTGGATNNKTACCAAGTTAATAGT
ACC 
 BaSP_CO3_Rv_L343NNM_long
2 
TAGGTACTATTAACTTGGTAMNNATCCAGGTTCGATGCCGC
CGC 
Y344X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_Y344NNK_long GCGGCATCGAACCTGGATCTGNNKCAAGTTAATAGTACCTA
CTAC 
 BaSP_CO3_Rv_Y344NNM_long GTAGTAGGTACTATTAACTTGMNNCAGATCCAGGTTCGAT
GCCG 
Q345X   
pCXP34h_BaSP_CO3 BaSP_CO3_Fw_Q345NNK AACCTGGATCTGTACNNKGTTAATAGTACCTACTACTC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
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Table S3.3 Primers used for site-directed mutagenesis 
mutant template primer name 5’→3’ sequence 
L341IP134V L341I BaSP_CO3_Fw_P134V GGCATTTATCGTGTGCGTCCGGGTCTGCCGTTTAC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
L341I_Q345S L341I BaSP_CO3_Fw_Q345S GGCGGCATCGAACATTGATCTGTACTCGGTTAATAGTA
CCTAC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
L341I_Q345N L341I BaSP_CO3_Fw_Q345N ATTGATCTGTACAACGTTAATAGTACCTACTACTC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
P134V_Q345S Q345S BaSP_CO3_Fw_P134V GGCATTTATCGTGTGCGTCCGGGTCTGCCGTTTAC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
P134V_Q345N Q345N BaSP_CO3_Fw_P134V GGCATTTATCGTGTGCGTCCGGGTCTGCCGTTTAC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
P134V_L341I_Q345S L341I_Q345S BaSP_CO3_Fw_P134V GGCATTTATCGTGTGCGTCCGGGTCTGCCGTTTAC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
P134V_L341I_Q345N L341I_P134V BaSP_CO3_Fw_Q345N ATTGATCTGTACAACGTTAATAGTACCTACTACTC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
L341I_Y344A_Q345N L341I_Q345N BaSP_CO3_Fw_Y344A CGAACATTGATCTGGCCAACGTTAATAGTACC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
L341I_Y344I_Q345N L341I_Q345N BaSP_CO3_Fw_Y344I CGAACATTGATCTGATCAACGTTAATAGTACC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
SAR_1 P134V_L341I_Q345N shuf pCXP 01 Fw GAATTCGGAGGAAACAAAGATGGG 
  BaSP_CO3_Rv_LY344PI GGTACTATTAACGTTGATCGGATCAATGTTCGATGCC 
SAR_2 P134V_L341I_Q345N BaSP_CO3_Fw_DLY342A
PI 
GGCGGCATCGAACATTGCTCCGATCAACGTTAATAGTA
CC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
SAR_3 P134V_L341I_Q345N BaSP_CO3_Fw_H234T GGAAATTCTGATCGAAGTCACCAGCTATTACAAAAAAC 
  BaSP_CO3_Rv_Y344I CGAACATTGATCTGATCAACGTTAATAGTACC 
SAR_4 P134V_L341I_Q345N shuf pCXP 01 Fw GAATTCGGAGGAAACAAAGATGGG 
  BaSP_CO3_Rv_Y344I CGAACATTGATCTGATCAACGTTAATAGTACC 
SAR_5 P134V_L341I_Q345N BaSP_CO3_Fw_DY342AI CGGCATCGAACATTGCTCTGATCAACGTTAATAGTACC 
  shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
SAR_6 P134V_L341I_Q345N BaSP_CO3_Fw_H234T GGAAATTCTGATCGAAGTCACCAGCTATTACAAAAAAC 
  BaSP_CO3_Rv_LY344PV GGTACTATTAACGTTGATCAGATCAATGTTCG 
SAR_7 P134V_L341I_Q345N shuf pCXP 01 Fw GAATTCGGAGGAAACAAAGATGGG 
  BaSP_CO3_Rv_LY344PV GGTACTATTAACGTTGATCAGATCAATGTTCG 
SAR_8 P134V_L341I_Q345N BaSP_CO3_Fw_R135E GGCATTTATCGTGTGGAACCGGGTCTGCCGTTTAC 
  BaSP_CO3_Rv_Y344I CGAACATTGATCTGATCAACGTTAATAGTACC 
SAR_9 P134V_L341I_Q345N BaSP_CO3_Rv_VH233AT GGAAATTCTGATCGAAGCCACCAGCTATTACAAAAAAC 
  BaSP_CO3_Rv_LY344PV GGTACTATTAACGTTGATCAGATCAATGTTCG 
SAR_10 P134V_L341I_Q345N BaSP_CO3_Fw_R135V GGCATTTATCGTGTGGTGCCGGGTCTGCCGTTTAC 
  BaSP_CO3_Rv_LY344PV GGTACTATTAACGTTCACCGGATCAATGTTCGATGCC 
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ABSTRACT 
Sucrose phosphorylase is a promising biocatalyst for the glycosylation of a wide range of 
compounds, but its industrial application has been hampered by the low thermostability of known 
representatives. Hence, in this study, the putative sucrose phosphorylase from the thermophile 
Thermoanaerobacterium thermosaccharolyticum was recombinantly expressed and fully 
characterised. The enzyme showed significant activity on sucrose (optimum at 55°C), and with a 
melting temperature of 79°C and a half-life of 60 hours at the industrially relevant temperature of 
60°C, it is far more stable than known sucrose phosphorylases. Substrate screening and detailed 
kinetic characterisation revealed however a preference for sucrose 6’-phosphate over sucrose. The 
enzyme can thus be considered as a sucrose 6’-phosphate phosphorylase, a specificity not yet 
reported to date. Homology modelling and mutagenesis pointed out particular residues (Arg134 
and His344) accounting for the difference in specificity. Moreover, phylogenetic and sequence 
analysis suggest that glycoside hydrolase 13 subfamily 18 might harbour even more specificities. In 
addition, the second gene residing in the same operon as sucrose 6’-phosphate phosphorylase was 
identified as well, and found to be a phosphofructokinase. The concerted action of these both 
enzymes implies a new pathway for the breakdown of sucrose, in which the reaction products end 
up at different stages of the glycolysis. 
  
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 81 
1 INTRODUCTION 
Sucrose phosphorylase (SP, EC 2.4.1.7) is classified in glycoside hydrolase family 13, and the sole 
specificity in subfamily 18 (GH13_18)79. Its closest phylogenetic neighbours are amylosucrase (EC 
2.4.1.4) and sucrose hydrolase (EC 3.2.1.-), both found in subfamily 4 (GH13_4). Sucrose 
phosphorylase catalyses the reversible phosphorolysis of sucrose into α-D-glucose 1-phosphate 
(Glc1P) and D-fructose17, 19, 81, but due to its promiscuous nature, SP can also be used to glycosylate 
a variety of monosaccharides, sugar alcohols, phenolic compounds and even carboxylic acids24, 26, 72. 
Moreover it uses a cheap, renewable and abundantly available donor substrate i.e. sucrose, which 
makes SP a very interesting biocatalyst for the production of α-glycosides as industrial fine 
chemicals72, 114. A commercial production process is already available for 2-O-(α-D-glucopyranosyl)-
sn-glycerol (trade name Glycoin®)124, and recently glycosylation efficiencies for phenolic 
compounds (e.g. resveratrol) have been greatly improved125. 
Industrial carbohydrate conversions are preferably performed at 60°C, mainly to avoid microbial 
contamination327-329. Sucrose phosphorylases however have currently only been isolated from 
mesophilic sources such as Leuconostoc mesenteroides, Lactobacillus acidophilus and 
Bifidobacterium adolescentis26, 72. Among these, the SP from B. adolescentis is the most 
thermostable, with a half-life of 12 hours at 60°C98. Since the limited thermostability of mesophilic 
isolates could hamper the commercial exploitation, efforts have been made to improve their 
stability by means of immobilization87, 98, 330 and mutagenesis102, 331, 332. Nevertheless, the isolation of 
SP enzymes from thermophilic sources could still yield enzymes that are considerable more stable 
than the best variants available today.  
A rich source of thermostable disaccharide phosphorylases are Thermoanaerobacter species, 
thermophilic bacteria able to grow on a wide range of carbohydrates. Several phosphorolytic 
enzymes have already been identified in these organisms, but a sucrose phosphorylase is notably 
missing333-335. Therefore, we have explored additional sequence information in public databases to 
identify SP enzymes from thermophilic organisms, and recombinantly expressed a suitable 
candidate to determine its properties. 
2 RESULTS 
2.1 Selection of a target sequence 
To gain more insight in the genetic diversity of SP enzymes, a phylogenetic tree was constructed 
for all sequences (~400) classified in family GH13_18 (Figure 4.1). These originate from a diverse 
group of bacteria, such as lactic acid bacteria, soil and marine bacteria, inhabitants of the gastro-
intestinal tract and even cyanobacteria (Table S4.3). In Archaea or Eukaryota, in contrast, no SP 
genes have been identified yet. Interestingly, the phylogenetic tree was found to fall apart in two 
major branches, of which only one contains known SP enzymes 26, 72. From the around 150 species  
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 82 
 
harbouring a (putative) SP gene, twelve can be designated as thermophilic (Table 4.1). Only the 
sequences from the Thermoanaerobacterales Family III (>90% identical) were found in the clade 
with proven activity. Therefore, in this study, the gene from Thermoanaerobacterium 
thermosaccharolyticum was selected as a candidate thermostable sucrose phosphorylase. 
 
 
Table 4.1 Thermophil ic sources of GH13_18 sequences 
organism UniProt 
ID 
growth 
rangea (°C) 
reference 
Caldilinea aerophila (strain DSM 14535 / JCM 11387 / 
NBRC 104270 / STL-6-O1) 
I0I189 50-60 (55) (Sekiguchi et al. 
2003)336 
Deferribacter desulfuricans (strain DSM 14783 / JCM 
11476 / NBRC 101012 / SSM1) 
D3PAG7 40-70 (60-65) (Takai et al. 
2003)337 
Geobacillus thermodenitrificans (strain NG80-2) A4ITA6 45-73 (65) (Feng et al. 
2007)338 
Marinithermus hydrothermalis (strain DSM 14884 / JCM 
11576 / T1) 
F2NL32 50-72.5 (67.5) (Sako et al. 
2003)339 
Marinitoga piezophila (strain DSM 14283 / JCM 11233 / 
KA3) 
H2J6Y9 45-70 (65) (Alain et al. 
2002)340 
Meiothermus ruber (strain ATCC 35948 / DSM 1279 / 
VKM B-1258 / 21) (Thermus ruber) 
D3PQE0 35-70 (60) (Tindall et al. 
2010)341 
Meiothermus silvanus (strain ATCC 700542 / DSM 9946 
/ VI-R2) (Thermus silvanus) 
D7BAR0 40-65 (55) (Sikorski et al. 
2010)342 
Oceanithermus profundus (strain DSM 14977 / NBRC 
100410 / VKM B-2274 / 506) 
E4U9R0 40-68 (60) (Miroshnichenko 
et al. 2003)343 
Spirochaeta thermophila (strain ATCC 49972 / DSM 
6192 / RI 19.B1) 
E0RTJ0 40-73 (66) (Aksenova et al. 
1992)344 
Spirochaeta thermophila (strain ATCC 700085 / DSM 
6578 / Z-1203) 
G0GBS4 40-73 (66) (Aksenova et al. 
1992)344 
Thermoanaerobacterium thermosaccharolyticum (strain 
ATCC 7956 / DSM 571 / NCIB 9385 / NCA 3814) 
(Clostridium thermosaccharolyticum) 
D9TT09 45-70 (60)  (Lee et al. 1993)345 
Thermoanaerobacterium thermosaccharolyticum M0795 L0IL15 45-70 (60)  (Lee et al. 1993)345 
Thermoanaerobacterium xylanolyticum (strain ATCC 
49914 / DSM 7097 / LX-11) 
F6BJS0 45-70 (60) (Lee et al. 1993)345 
a optimal growth temperature between brackets 
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Figure 4.1 Phylogenetic tree of all protein sequences classif ied in glycoside hydrolase family 
GH13_18 ((○ ) known sucrose phosphorylases, (( ) thermophil ic sources) 
 
2.2 Substrate specificity and kinetic properties 
The purified (putative) SP from T. thermosaccharolyticum displayed a single protein band on SDS-
PAGE with an estimated molecular weight of 56 kDa (theoretical value: 56.7 kDa; 488 amino acids), 
a typical value for SP enzymes72, 346. Activity measurements showed that the (putative) SP from T. 
thermosaccharolyticum is indeed able to catalyse the reversible phosphorolysis of sucrose. Its 
optimal temperature for activity was found to be 55°C (Figure S4.1), which is significantly higher 
than SP enzymes from Leuconostoc mesenteroides and Streptococcus mutans (30-37°C)72. It is, 
however, comparable with the optimum of SP from B. adolescentis (58°C), which is remarkably 
stable for a mesophilic isolate98. The pH optimum was 6 and 6.5 for the synthetic and 
phosphorolytic reaction, respectively, and is in good agreement with that of other SP enzymes72 
(Figure S4.1). Furthermore, the apparent kinetic parameters have been determined for the donor as 
well as for the acceptor substrate, in both directions of the reversible reaction (Table 4.2). The KM 
values for inorganic phosphate and α-D-glucose 1-phosphate are comparable with those of SP from 
L. mesenteroides87, 99. For sucrose (77 mM) and D-fructose (42 mM) in contrast, KM values are 
significantly higher than for other known sucrose phosphorylases (1-15 mM and 8-22 mM, 
respectively)26 (see also Table 1.3). Hence, this low affinity might imply that sucrose and fructose are 
not the natural substrates and accordingly other substrates were evaluated (Table 4.3). Relative 
activities on monosaccharides like D-glucose, D-mannose and D-galactose were however far below 
that of fructose as acceptor. Maltose and maltodextrins in addition, which are acceptors for SP’s 
closest phylogenetic neighbour amylosucrase347, also did not act as acceptors. 
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Table 4.2 Apparent kinetic parameters for sucrose 6'-phosphate phosphorylase from 
T.thermosaccharolyticum. 
reaction substrate KM (mM) kcat (s-1) kcat/KM (mM-1s-1) 
phosphorolysis sucrosea 76.5 ± 10.3 66.2 ± 4.5 0.9 
 sucrose 6’-phosphatea 12.7 ± 1.9 82.6 ± 3.1 6.5 
 phosphateb 6.9 ± 0.6 59.3 ± 3.1 8.6 
synthesis α-D-glucose 1-phosphatec 15.6 ± 1.8 14.4 ± 0.7 0.9 
 D-fructosed 41.6 ± 5.3 16.9 ± 1.3 0.4 
 D-fructose 6-phosphated 15.1 ± 2.3 24.2 ± 1.8 1.6 
initial rates were determined at 55°C in 50 mM MES buffer pH 6.5 in the presence of a 100 mM of inorganic 
phosphate or b 350 mM sucrose (phosphorolysis), and in 50 mM MES buffer pH 6.0 in the presence of c 200 
mM D-fructose or d 100 mM α-D-glucose 1-phosphate (synthesis) 
 
Alternatively, to guide the choice of substrate, the gene landscape around the sp gene from T. 
thermosaccharolyticum was evaluated and compared with other organisms expressing a sucrose 
phosphorylase (Figure 4.2). For the latter, sp genes often reside in an operon together with major 
facilitator superfamily (MFS) permeases (e.g. L. mesenteroides) or are accompanied by multiple 
sugar metabolism (msm) transporter proteins and glycosidases (e.g. L. acidophilus and S. mutans). 
In T. thermosaccharolyticum, in contrast, a distinct gene landscape was  
 
Table 4.3 Substrate specif icity for sucrose 6'-phosphate phosphorylase from T. 
thermosaccharolyticum. 
reaction substrate relative activity (%) 
phosphorolysisa sucrose 6’-phosphate 100 
sucrose 51 
trehalose 6-phosphate 0 
synthesisb D-fructose 6-phosphate 100 
D-fructose 62 
D-psicose n.s. 
D-tagatose 8 
L-sorbose 31 
α-D-glucose 1-phosphate n.s. 
D-glucose 6-phosphate n.s. 
D-glucose n.s. 
D-mannose n.s. 
D-galactose n.s. 
D-maltose n.s. 
maltodextrin DE-15 n.s. 
n.s. not significantly higher than the hydrolytic side activity (4% compared to wild-type activity); all reactions 
were performed at 55°C in 50 mM MES buffer pH 6.5 and a 100 mM donor and 100 mM acceptor (inorganic 
phosphate) or b 100 mM donor (α-D-glucose 1-phosphate) and 200 mM acceptor 
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observed. The ttsp gene is located in an operon with a putative (phospho)fructokinase, near genes 
that encode a phosphoenolpyruvate dependent transport system (PTS). Unlike MFS permeases 
(passive transport) and msm transport systems (active transport) that both bring in a sugar in its 
native form, the PTS system phosphorylates it during transport. Hence, the enzyme of T. 
thermosaccharolyticum might be active on phosphorylated sugars. Therefore, its ability to use 
sucrose 6’-phosphate (Suc6’P) and D-fructose 6-phosphate (Fru6P) as donor and acceptor substrate 
respectively, was investigated. It was found that the enzyme was indeed capable to perform these 
reactions, and kinetic characterisation revealed the preference for Fru6P over fructose and Suc6’P 
over sucrose (Table 4.2). KM values for Suc6’P and Fru6P were six and three times lower, 
respectively, compared to their non-phosphorylated counterparts and kcat values were slightly 
higher. The enzyme of T. thermosaccharolyticum can thus be designated as a sucrose 6’-phosphate 
phosphorylase (SPP) (Figure 4.3). 
 
 
Figure 4.2 Gene landscape of different organisms expressing a sucrose phosphorylase (MFS: 
major facil itator superfamily permease; msm: multiple sugar metabolism; PTS: 
phosphoenolpyruvate-dependent sugar phosphotransferase system; pfkB: 
(phospho)fructokinase; SP: sucrose phosphorylase; gene names and identif iers were retrieved 
from the ncbi genome database) 
 
As mentioned above, the spp gene is present in an operon together with an enzyme annotated as 
a putative (phospho)fructokinase. In order to investigate the true specificity of this enzyme, it was 
also recombinantly expressed, and activity measurements disclosed the preference of Fru6P over 
fructose as substrate (Figure S4.2), proving this enzyme to be a phosphofructokinase (Figure 4.3). 
Indeed, for the same concentration of Fru6P and fructose (1 mM), the former quickly gave rise to 
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the formation of fructose-1,6-bisphosphate, whereas the latter did not result in product formation, 
even not upon prolonged incubation. 
 
 
Figure 4.3 Reactions catalysed by sucrose 6'-phosphate phosphorylase (SPP) and 
phosphofructokinase (pfk) from T. thermosaccharolyticum. 
 
2.3 Thermostability 
To evaluate the thermostability of sucrose 6’-phosphate phosphorylase from T. 
thermosaccharolyticum (TtSPP), it was compared with SP from B. adolescentis (BaSP), the most 
stable SP representative known to date98. Differential scanning fluorimetry (DSF) was used to 
determine the melting temperature (Tm), i.e. a parameter representing a protein’s tendency to 
unfold as a function of temperature348. Melting temperatures were found to be nearly identical for 
both enzymes, with a value of 78 °C (Figure S4.3). Kinetic stability, reflecting the time a protein 
remains active before undergoing irreversible denaturation, was examined as well348. To that end, 
the half-life (t50) was determined at the industrially relevant temperature of 60°C (Figure S4.3). For 
TtSPP, it was found to be almost three times higher than for BaSP (60h compared to 21h, 
respectively). The enzyme from T. thermosaccharolyticum thus has comparable melting 
characteristics as its most stable SP counterpart, but it is remarkably more stable over time. 
This characteristic is particularly interesting for industrial processes, such as the production of α-D-
glucose 1-phosphate or α-glucosyl glycerol. For that purpose, the enzyme’s lower affinity for 
sucrose as glycosyl donor is not a problem, since high substrate concentrations are typically 
applied. For example, one molar of sucrose and inorganic phosphate could be readily converted to 
0.7 M of α-D-glucose 1-phosphate (Figure S4.4), which is the theoretical maximal yield288. 
Furthermore, a five-fold excess of sucrose is preferentially used for convenient downstream 
processing, in which case the sucrose concentration remains saturating throughout the reaction 
(Figure S4.4). In turn, 0.6 M of α-glucosyl glycerol could be produced from 0.8 M of sucrose and 2 
M of glycerol, which are the optimal concentrations according to Goedl et al124 (Figure S4.5). At a 
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temperature of 60°C, a glycosyl transfer yield of 75% was achieved, comparable to the 85% 
reported for SP at 30°C. 
2.4 Structure-function relationships 
In the phylogenetic tree, the enzyme of T. thermosaccharolyticum can be found in between SP 
enzymes from lactic acid bacteria (LAB) and Bifidobacteria (Figure 4.1), but nevertheless its 
specificity differs. To gain more insight in which residues account for this difference, a multiple 
sequence alignment (MSA) was performed of several SP representatives together with TtSPP (Figure 
4.4a and Figure S4.6). The acceptor site of the former mainly constitutes of loop A and B, and a 
number of residues are highly conserved and involved in specificity101, 113. The MSA shows that in 
TtSPP a His is present at position 344 (loop A) whereas all SP enzymes have a  
 
 
Figure 4.4 Multiple sequence alignment (MSA) of the acceptor site loops of several 
representative sucrose phosphorylases (SP) and sucrose 6'-phosphate phosphorylase (SPP) 
(loop A and B, starting at position 340 and 132, respectively (TtSPP numbering)) and docking 
of sucrose 6’-phosphate into the homology model of Thermoanaerobacterium 
thermosaccharolyticum SPP (BaSP: Bif idobacterium adolescentis SP; BlSP: Bif idobacterium 
longum SP; LmSP: Leuconostoc mesenteroides SP; SmSP: Streptococcus mutans SP; LaSP: 
Lactobacil lus acidophilus SP; TtSPP: T. thermosaccharolyticum SPP; residue with gray 
background: conserved in SP enzymes; boxed residue: conserved within subgroup of SP 
enzymes (lactic acid bacteria or Bif idobacteria) ; bold residues: involved in specif icity, 
confirmed by mutagenesis) . 
 
Tyr, a residue involved in phosphate binding. Furthermore, the NL motif at the beginning of the 
loop is replaced by GF. In loop B two conserved motifs can be found in SP enzymes, i.e. YRPRP 
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(Bifidobacteria) and YKRKD (lactic acid bacteria). In TtSPP however this loop is one residue shorter 
and it has a distinct motif, i.e. FLRR. 
Docking of sucrose 6’-phosphate in the homology model of TtSPP suggested that Arg134 is 
important for binding of the phosphate group (Figure 4.4b). As Lys301 and Arg135 are also in close 
proximity and therefore could fulfil this function as well, mutagenesis was performed to indentify 
the role of these residues (Figure 4.4b). Alanine mutants were created and the specific activities on 
fructose and fructose 6-phosphate were compared (Table 4.4). Additionally, His344 was mutated to 
Tyr, the residue present in SP enzymes. 
 
Table 4.4 Specif ic activity of wild-type sucrose 6’-phosphate phosphorylase from T. 
thermosaccharolyticum and alanine mutants (55°C, 50 mM MES pH 6.5, 100 mM donor (α-D-
glucose 1-phosphate) and 50 mM acceptor (D-fructose or D-fructose 6-phosphate)) . 
Enzyme ActFru6P (U/mg) ActFru (U/mg) Ratio ActFru6P/ActFru 
WT 20.7 10.1 2.0 
R134A 0.5 0.7 0.7 
R135A 15.5 7.8 2.0 
K301A 21.2 8.6 2.5 
H344Y 4.4 4.3 1.0 
 
R135A and K301A displayed similar activities as the wild-type enzyme. R134A and H344Y, on the 
other hand, showed a decreased ratio of activity on phosphorylated fructose over fructose, proving 
their role in binding of the phosphate group. Their lower activity on fructose might indicate that 
they are also involved in binding of the donor substrate (Glc1P) or that they are simply necessary 
for the overall activity. 
3 DISCUSSION 
3.1 Specificities in GH13 subfamily 18 
The gene from Thermoanaerobacterium thermosaccharolyticum was predicted to encode a sucrose 
phosphorylase, and the enzyme was indeed active on sucrose. Kinetic analysis however revealed its 
preference for phosphorylated sucrose and more specifically sucrose 6’-phosphate (β-D-Fru6P-
(2→1)-α-D-Glc). The enzyme thus represents a novel specificity, i.e. sucrose 6’-phosphate 
phosphorylase, for which no EC number is yet available. Furthermore, it was shown that TtSPP is 
able to accommodate the extra phosphate group due to some differences in the acceptor site 
loops compared to SP enzymes. Several residues in these loops are highly conserved in SP enzymes 
and their importance in substrate recognition has already been demonstrated 101, 113. Hence, the 
presence of different residues might be indicative for diverging specificities. Multiple sequence 
alignment of all GH13_18 sequences disclosed some distinct motifs for different branches of the 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 89 
phylogenetic tree (Figure 4.5). Sequences from Thermoanaerobacterium xylanolyticum and 
Clostridium saccharoperbutylacetonicum (SPP branch) share the same motifs as TtSPP and are most 
likely also sucrose 6’-phosphate phosphorylases. The closely related sequences from Marinobacter 
adhaerens and Thalassolituus oleivorans (unknown branch n=3) on the other hand differ from both 
SP and SPP enzymes, and particularly the aspartate in loop A which is replaced by an alanine. In SP 
enzymes this residue is very important for binding of the fructose moiety and substitution to 
alanine led to a tremendous loss of activity101, 113. Therefore it is likely that these enzymes are not 
sucrose phosphorylases. For the branch that does not contain any characterised representatives 
(unknown n=222), major differences are observed compared to the remainder of the tree. In SP 
enzymes the histidine near the general acid/base catalyst is crucial for sucrose phosphorylase 
activity101, but here an asparagine is present. In addition, loop A is two residues shorter and only 
shares its tyrosine with sucrose phosphorylases. From all these findings, it can be concluded that 
the GH13 subfamily 18 might be more diverse than expected. Although it cannot be excluded that 
the different acceptor site architectures yield the same specificity, it is very likely that next to 
sucrose phosphorylases and sucrose 6’-phosphate phosphorylases still other specificities are 
present. 
 
 
Figure 4.5 Sequence logos of the acceptor site representing the frequency of each residue in 
a multiple sequence alignment of all sequences classif ied in family GH13_18, for different 
branches of the phylogenetic tree (LAB: lactic acid bacteria; A/B: loop containing the general 
acid/base catalyst; * residues involved in specif icity, confirmed by mutagenesis) . 
 
3.2 Physiological role of sucrose 6’-phosphorylase 
Sucrose 6’-phosphate phosphorylase not only represents a new functionality, it also implies a new 
pathway for the degradation of sucrose (Figure 4.6a). The higher in vivo concentrations of the 
substrates compared to the products, especially inorganic phosphate72, indeed favour 
phosphorolysis (breakdown) over synthesis. Note that, analogues to sucrose phosphorylase (Figure 
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4.6b), this is an energy-saving step as no ATP is required97. The catabolic role is further supported 
by the presence of a phosphofructokinase gene in the same operon. The pfk enzyme can namely 
directly process the Fru6P produced by SPP. Accordingly, a complete pathway is established in 
which sucrose 6’-phosphate is first phosphorolytically split by SPP into Glc1P and Fru6P, where after 
the latter is phosphorylated by pfk yielding Fru1,6PP (Figure 4.6a). The Glc1P on the other hand can 
be readily converted to Glc6P by the action of phosphoglucomutase present in bacteria. Finally, 
both reaction products end up as intermediates in the glycolytic pathway. 
 
 
Figure 4.6 Different pathways for uptake and catabolism of sucrose via (a) sucrose 6’-
phosphate phosphorylase, (b) sucrose phosphorylase and (c) sucrose 6-phosphate hydrolase 
(PTS: phosphoenolpyruvate-dependent sugar phosphotransferase system; SPH: sucrose 6-
phosphate hydrolase; SP: sucrose phosphorylase; SPP: sucrose 6’-phosphate phosphorylase; fk: 
fructokinase; pfk: phosphofructokinase; Suc6P: sucrose 6-phosphate (β-D-Fru-(2→1)-α-D-Glc 6-
P); Suc6’P: sucrose 6’-phosphate (β-D-Fru 6-P-(2→1)-α-D-Glc)) . 
 
Although the pathway itself is straightforward, it remains unclear where the sucrose 6’-phosphate 
originates from. Currently, the only known way in bacteria to obtain Suc6’P is by the action of 
sucrose 6’-phosphate synthase, which belongs to glycosyltransferase family 4 (GT4) and uses UDP-
Glc and Fru6P as substrates349. T. thermosaccharolyticum has a few gene products classified in this 
family (Table 4.4) and since these enzymes are not characterised yet, they might entail sucrose 6’-
phosphate synthase activity. However, as T. thermosaccharolyticum is known for the degradation 
rather than synthesis of sugars350, another possibility would be that Suc6’P is generated during 
uptake of sucrose. Phosphorylation of sucrose during translocation is normally performed by a 
sucrose specific PTS system, which attaches a phosphate to the 6 position of the glucose moiety97. 
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Thereafter it is further degraded via sucrose 6-phosphate hydrolase (Figure 4.6c). Here in contrast, 
sucrose is phosphorylated on the fructose moiety. Among the T. thermosaccharolyticum genes 
annotated as PTS components, none of them seem to be sucrose specific (Table T4). In contrary, 
complete PTS systems are predicted from the mannose/fructose/sorbose family (Transporter 
Classification Database; www.tcdb.org). This family is known for its wide range of specificities, and 
its members often accept a wide range of sugars351. It is therefore possible that sucrose enters via 
one of these PTS systems and becomes phosphorylated on its fructose moiety. Future research 
however should provide further prove for this new route for breakdown of sucrose. 
3.3 Potential applications 
Next to its interesting in vivo role, TtSPP also has some potential advantages in terms of practical 
applications. Although sucrose 6’-phosphate is its natural substrate, sucrose can be readily used as 
alternative glycosyl donor. This allows α-D-glucose 1-phosphate to be produced in an identical way 
as reported for SP, albeit with a biocatalyst that is more stable. Additionally, the production of α-
glucosyl glycerol can now be performed at 60°C, whereas 30°C was previously used with SP. Of 
course, TtSPP also offers the possibility to convert sucrose 6’-phosphate to D-fructose 6-phosphate 
and vice versa, although the market of these compounds probably is rather small. Nevertheless, 
none of these applications require protein immobilisation, thanks to the enzyme’s excellent stability 
4 MATERIALS AND METHODS 
4.1 Sequence analysis 
All full-length protein sequences classified in subfamily GH13_18 were extracted from the CAZy database 
(http://www.cazy.org/)19 and aligned with ClustalO199 using default parameters. Next, a phylogenetic tree was 
generated with MEGA5352 using the neighbour-joining algorithm196 and default parameters. For the evaluation 
of the gene landscape and the organisation of operons containing a (putative) sp gene, the complete 
genomes of Leuconostoc mesenteroides ATCC 8293, Lactobacillus acidophilus NCFM, Bifidobacterium 
adolescentis ATCC 15703, Streptococcus mutans UA159 and Thermoanaerobacterium thermosaccharolyticum 
DSM 571 were retrieved from the ncbi genome database (http://www.ncbi.nlm.nih.gov/) and analysed, aided by 
data from the Prokaryotic Operon DataBase 353. 
4.2 Cloning and site-directed mutagenesis 
The protein sequences of the sucrose 6’-phosphate phosphorylase (UniProt ID D9TT09) and 
phosphofructokinase (UniProt ID D9TT10) from Thermoanaerobacterium thermosaccharolyticum were back-
translated to DNA sequences, codon optimised for E. coli and chemically synthesised by GenScript (Piscataway, 
NJ, USA) (full sequences are given in supplementary material). They were cloned into the constitutive 
expression vector pCXP34h92 by means of a Gibson assembly procedure326. First, the genes and the vector 
backbone were amplified in a separate high fidelity PCR (PfuUltra™ High-Fidelity, according to the protocol of 
Roche) with the respective primers listed in Table S4.1. PCR products were treated with DpnI (Westburg) to 
remove template DNA, and were subsequently purified using the Qiagen purification kit, checked on a 1% 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 92 
agarose gel and the DNA concentration was measured with a Nanodrop ND-1000 (Thermo Scientific). For the 
ligation of the two fragments, the Gibson assembly mix (20 µl) containing 100 ng backbone and an equimolar 
amount of gene product was incubated for 1 hour at 50°C. Finally, the resulting expression plasmids were 
transformed in E. coli CGSC 8974 (Coli Genetic Stock Center, New Haven, USA). All constructs were subjected 
to nucleotide sequencing (AGOWA sequence service, Berlin) to confirm that the ligation was correct, and to 
exclude the presence of undesirable mutations. 
Site-directed mutations were introduced with a modified two-stage megaprimer based whole plasmid PCR 
method295 as previously reported101, using the primers described in Table S4.2. 
4.3 Characterisation of sucrose 6’-phosphate phosphorylase 
For enzyme production, 2% of an overnight culture was inoculated in 500 ml LB medium containing 100 μg/ml 
ampicillin in a 2 L shake flask, and incubated at 37 °C with continuous shaking at 200 rpm for 8 hours. The 
produced biomass was harvested by centrifugation for 10 minutes at 10000 rpm and 4 °C, and the obtained 
cell pellets were frozen at -20°C for at least 4 hours. For enzyme extraction and purification, cell pellets were 
thawed and dissolved in 20 ml lysis buffer (300 mM NaCl, 10 mM imidazole, 0.1 mM PMSF and 50 mM 
sodium phosphate buffer pH 7.4) supplemented with lysozyme at a final concentration of 1 mg/ml. This cell 
suspension was incubated on ice for 30 minutes and sonicated 3 times for 2.5 minutes (Branson sonifier 250, 
level 3, 50% duty cycle). The His6-tagged proteins were purified by Ni-NTA chromatography as described by 
the supplier (Qiagen), after which the buffer was exchanged to 50 mM MOPS pH 7.0 in a Centricon YM-30 
(Millipore). The protein content was analysed by measuring the absorbance at 280 nm. The extinction 
coefficients for the His6-tagged proteins were calculated using the ProtParam tool on the ExPASy server 
(http://web.expasy.org/protparam/), as well as the theoretical molecular weight. Approximately 10 mg of 
protein was obtained from 500 ml of culture medium. Purity and molecular weight were verified by SDS-PAGE 
(10% gel). 
Phosphorylase activity was measured in both directions of the equilibrium reaction, using discontinuous assays, 
as previously described26, 98. The phosphorolytic and the synthetic reaction were monitored by measuring the 
production of α-D-glucose 1-phosphate with an enzymatic coupled assay85, 100 and the release of inorganic 
phosphate with the phosphomolybdate assay323, respectively. Hydrolytic activity was quantified with a 
discontinuous coupled assay using glucose oxidase and peroxidase (GOD-POD)354. Inactivation of the samples 
was achieved by either the acidic conditions of the assay solution (phosphomolybdate assay) or heating for 5 
minutes at 95°C (other assays). 
The specificity toward different monosaccharides (synthesis) was analysed using 100 mM Glc1P as donor and 
200 mM acceptor, i.e. D-fructose 6-phosphate, D-fructose, D-psicose, D-tagatose, l-sorbose, D-glucose 6-
phosphate, D-glucose, D-mannose, D-galactose, D-maltose, maltodextrin DE-15 (50 g/l), while phosphorolysis 
was assayed with 100 mM inorganic phosphate and 100 mM donor, i.e. sucrose 6’-phosphate, sucrose and 
trehalose 6-phosphate. 
All reactions were monitored in 50 mM MES pH 6.5 at 55°C, for 15 min with sampling at regular intervals. 
The temperature optimum was determined in the phosphorolytic direction using 350 mM sucrose and 350 mM 
sodium phosphate buffer at pH 6.5. The pH optimum was determined with acetate (pH 4.5), MES (pH 5 - 6.5) 
and MOPS (pH 7 - 8) buffer at a concentration of 50 mM and a temperature of 55°C. Reactions were again 
monitored for 15 min with sampling at regular intervals. Inactivation of the samples was achieved by either the 
acidic conditions of the assay solution or heating for 5 minutes at 95°C. 
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The apparent kinetic parameters for sucrose and Glc1P as donor substrates and for inorganic phosphate and 
D-fructose as acceptor substrates were determined at the optimal pH and temperature. Michaelis Menten 
curves were obtained using 350 mM or 100 mM of co-substrate in the phosphorolytic direction (sucrose or 
inorganic phosphate, respectively) and 100 mM or 200 mM of co-substrate in the synthetic direction (Glc1P or 
fructose, respectively). The parameters were calculated by non-linear regression of the Michaelis-Menten 
equation using Sigma Plot 11.0. 
The enzyme’s kinetic stability was examined by incubating purified protein (8.5 µg/mL) at 60°C. At regular time 
intervals, the residual activity was measured and compared to the activity of the untreated enzyme. The t50 
value was calculated from the equation obtained by fitting the experimental data to the following equation: 
f=a.exp(-b.x) assuming first-order inactivation kinetics. The enzyme’s melting temperature was measured using 
differential scanning fluorimetry (DSF)355 in a Rotor-Gene Q cycler with HRM channel (Qiagen). For optimal 
results, 10 µg purified protein was used with 1.25 µl SYPRO Orange (400x diluted) (Sigma-Aldrich) in 25 µL. 
The gain was optimised before the temperature increase was started. The temperature increased from 35°C to 
95°C, rising 1°C/min. The fluorescent signal was detected at 510 nm with the green detection filter and the 
excitation occurred at 460 nm with a HRM lamp. The melting temperature (Tm) was calculated from the 
maximum of the first derivative of the melt curve using the Rotor-Gene Q software (Qiagen). 
Production of α-D-glucose 1-phosphate was achieved starting from 1 M of sucrose in 1 or 0.2 M of phosphate 
buffer pH 7.0 and 0.5 mg/ml enzyme at 60°C. Formation of α-D-glucose 1-phosphate and decrease of 
phosphate were measured with the assays described above, as reported by De Winter et al288. Production of 
α-glucosyl glycerol was performed by adding sucrose, glycerol and enzyme in a final concentration of 0.8 M, 2 
M and 0.5 mg/ml, respectively, in 50 mM MOPS pH 7.0 at 60°C. The reaction was monitored with the BCA 
reducing sugars assay and GOD-POD, as well as HPLC, as described by Goedl et al124 and De Winter et al356. 
The specific activity of the mutants was determined using 100 mM donor (Glc1P) and 50 mM acceptor 
(fructose or fructose 6-phosphate). Reaction conditions, sampling and sample treatment were the same as for 
the substrate specificity determination. 
4.4 Characterisation of phosphofructokinase 
The (phospho)fructokinase activity was analysed by high performance anion exchange with pulsed 
amperometric detection (HPAEC-PAD)(Dionex ICS-3000 Ion Chromatography System (Thermo Scientific),  
CarboPac PA20 column). All samples were properly diluted and analysed at 30°C, with a fixed flow rate of 0.5 
ml/min. Separation of D-fructose, D-fructose 6-phosphate and D-fructose 1,6-bisphosphate was achieved by a 5 
min isocratic elution with 40 mM NaOH, followed by a linear increase of sodium acetate from 0 to 500 mM 
over 9 min after which initial conditions were restore in one minute and were maintained for four more 
minutes. The phosphorylation reaction was performed with 1 mM ATP and 1 mM fructose or fructose 6-
phosphate supplemented with 0.1 mM MgCl, in 5 mM MES buffer pH 6.5 at 55°C. Samples were taken at 
regular time intervals over one hour, and inactivated at 95°C for 5 min. 
4.5 Homology modelling and docking 
A homology model of sucrose 6’-phosphate phosphorylase from Thermoanaerobacterium 
thermosaccharolyticum was generated with the molecular modelling program YASARA289, 357, using default 
parameters. Crystal structures from the closely related sucrose phosphorylase from Bifidobacterium 
adolescentis (40% sequence identity, 61% similarity) served as templates (pdb entries 1R7A, 2GDU and 2GDV). 
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Sucrose 6’-phosphate was created with YASARA as well, and docked in the generated model using the 
implemented VINA module358 (default parameters, except for the number of runs which was increased to fifty). 
Figures were created with PyMol v1.3294.  
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SUPPLEMENTARY DATA 
Codon optimised genes 
>sucrose 6’-phosphate phosphorylase from Thermoanaerobacterium thermosaccharolyticum 
ATGGCACTGAAAAACAAAGTCCAACTGATTACCTATCCGGACAGCCTGGGCGGTAACCTGAAAACCCTGAATGACG
TTCTGGAAAAATATTTCAGCGATGTGTTTGGCGGTGTTCATATCCTGCCGCCGTTCCCGAGCTCTGGTGACCGTGG
TTTTGCACCGATTACCTACTCTGAAATCGAACCGAAATTCGGCACGTGGTACGATATTAAGAAAATGGCTGAAAAC
TTCGACATCCTGCTGGATCTGATGGTTAATCACGTCAGTCGTCGCTCCATTTACTTTCAGGACTTCCTGAAAAAAG
GCCGCAAAAGTGAATATGCGGATATGTTTATTACCCTGGACAAACTGTGGAAAGATGGCAAACCGGTTAAAGGTGA
TATCGAAAAAATGTTCCTGCGTCGCACCCTGCCGTACTCCACGTTTAAAATTGAAGAAACCGGTGAAGAAGAAAAA
GTCTGGACCACGTTCGGCAAAACGGATCCGTCAGAACAGATCGACCTGGATGTCAACTCGCATCTGGTGCGTGAAT
TTCTGCTGGAAGTGTTCAAAACCTTCTCAAACTTCGGTGTGAAAATTGTTCGCCTGGATGCGGTCGGCTATGTGAT
TAAGAAAATTGGCACGTCGTGCTTTTTCGTTGAACCGGAAATCTACGAATTTCTGGATTGGGCCAAAGGCCAGGCG
GCCAGTTATGGTATTGAACTGCTGCTGGAAGTTCACTCCCAGTTCGAAGTCCAATATAAACTGGCAGAACGTGGCT
TTCTGATTTACGATTTCATCCTGCCGTTTACCGTGCTGTATACGCTGATCAACAAAAGTAACGAAATGCTGTACCA
TTACCTGAAAAACCGCCCGATTAATCAATTTACCATGCTGGACTGCCACGATGGTATTCCGGTCAAACCGGACCTG
GATGGCCTGATCGACACGAAAAAAGCGAAAGAAGTGGTTGATATTTGTGTGCAGCGTGGCGCCAACCTGAGCCTGA
TCTATGGTGATAAATACAAATCTGAAGACGGCTTCGATGTTCATCAAATTAACTGCACCTATTACAGCGCTCTGAA
TTGTGATGACGATGCGTATCTGGCAGCTCGCGCCATTCAGTTTTTCACGCCGGGTATCCCGCAAGTTTATTACGTC
GGCCTGCTGGCAGGTGTGAACGATTTTGAAGCTGTGAAGAAAACCAAAGAAGGTCGTGAAATTAACCGCCACAATT
ACGGCCTGAAAGAAATCGAAGAATCTGTGCAGAAAAATGTCGTGCAACGTCTGCTGAAACTGATCCGTTTCCGCAA
CGAATATGAAGCCTTTAATGGCGAATTTTTCATTGAAGACTGCCGTAAAGATGAAATCCGCCTGACCTGGAAAAAA
GACGATAAACGCTGTAGCCTGTTTATTGATCTGAAAACCTACAAAACGACGATTGATTACATTAACGAAAACGGTG
AAGAAGTGAAATACCTGGTTTAA 
>phosphofructokinase from Thermoanaerobacterium thermosaccharolyticum 
ATGTTCAACTTTAATGATAAGATTGTTTTTGATGATAAGAAATACGATGTGCTGACGGTCGGCGAAATGCTGGTCG
ATATGATTAGCACCGACTATGGTGATGACTTTGAATGCGATACGTATAAAAAGTACTTCGGCGGTAGCCCGGCGAA
CATTGCCATCAATAGCAAAATGCTGGGTATTAACTCTATTATCGTGAGCAGCGTGGGCAATGACGGCCTGGGTAAA
TTTCTGCTGAAAAAGCTGCAGGAACATCACATTGAAATCAAATATGTCCGTCAAGTGGATTACAGCACCTCTATGG
TCCTGGTGACGAAAAGCAAGAGTTCCCCGACCCCGATCTTTTATCGCGATGCGGACTATCATATCGAATACTCTGA
TGAACTGAAGTACCTGATTGAAAACACCAAAATCGTCCACTTCTCATCGTGGCCGATTAGTCGTAATCCGAGTCGC
TCCACGGTTGAAATTCTGATCGATGAATGCAAAAAGTATGACGTTCTGGTCTGTTATGATCCGAACTACCATTCTA
TGATCTGGGAACGTGGCCACGACGGTCGCGAATATATTAAATCACTGATCGCAAAGGTGGATATTATCAAACCGTC
GGAAGATGACGCTGAACGTATTTTTGGTAAAGACACCCCGGAAAATCAGCTGAAAAAGTTCCTGGATCTGGGCGCG
AAGCTGGTGATCCTGACGCTGGGCAAAGATGGTGCCATTGTTTCCAACGGCGAAGAAACCATCCGCTTTAATACGC
TGGCAGATGAAGTGGTTGACACCACGGGCGCAGGTGATGCTTTTTGGTCAGGCTTCTATTCGGGTCTGATTAAAGG
CTACACCCTGAAAAAGAGTCTGGAACTGGGTTTCGCGGTTTCCGCCTATAAACTGCGTTACGTCGGCGCGATTGTT
GACCTGCCGGATATTGACACCATTAAGTCTATGTATGACCTGAAGAAACTGCGTTAA 
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Figure S4.1 Temperature (a) and pH (b) profi le for sucrose 6’-phosphate phosphorylase from 
Thermoanaerobacterium thermosaccharolyticum. 
 
 
Figure S4.2 HPAEC profi les of phosphofructokinase reaction with fructose 6-phosphate (a) and 
fructose (b), and corresponding blancs (b,d) (substrate, no enzyme) (note that Fru6P contains 
a small amount of Fru1,6P as contaminant). 
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Figure S4.3 Differential scanning fluorimetry profi le (a) and kinetic stabil ity at 60°C (b) for 
sucrose phosphorylase from Bifidobacterium adolescentis and sucrose 6’-phosphate 
phosphorylase from Thermoanaerobacterium thermosaccharolyticum. 
 
 
 
 
 
Figure S4.4 Production of α-D-glucose 1-phosphate from 1 M of sucrose and 1 M (a) or 0.2 M 
(b) of inorganic phosphate. Reaction performed with 0.5 mg/ml enzyme, pH 7.0 at 60°C. 
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Figure S4.5 Production of α-glucosyl glycerol from 0.8 M of sucrose and 2 M of glycerol. 
Reaction performed with 0.5 mg/ml enzyme, pH 7.0 at 60°C. 
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Figure S4.6 Multiple sequence alignment (MSA) of several sucrose phosphorylases (SP) and 
sucrose 6'-phosphate phosphorylase (SPP) (BaSP: Bif idobacterium adolescentis SP (UniProt ID 
Q84HQ2); BlSP: Bif idobacterium longum SP (UniProt ID Q84BY1); LmSP: Leuconostoc 
mesenteroides SP (UniProt ID Q59495); SmSP: Streptococcus mutans SP (UniProt ID P10249); 
LaSP: Lactobacil lus acidophilus SP (UniProt ID Q7WWP8); TtSPP: Thermoanaerobacterium 
thermosaccharolyticum SPP (UniProt ID D9TT09); group 1: Bif idobacteria (BaSP and BlSP); 
group 2: lactic acid bacteria (LmSP, SmSP and LaSP); group 3: TtSP) (red box/white character: 
conserved across all sequences (strict identity) ; bold character: similarity within group; blue 
frame/yellow background: similarity across groups; green background: conserved within 
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group, but different between groups; BLOSUM62 similarity score matrix was used for similarity 
determination; ! :  catalytic residue; " :  donor site residue; ! :  acceptor site residue). 
Sequences were extracted from the full MSA of all GH13_18 sequences (~400), used for the 
construction of the phylogenetic tree. Numbering is according to BaSP, and the secondary 
structure depicted above the sequences is derived from the crystal structure of BaSP (PDB 
entry: 2GDU chain A). Residues 132-139 and 340-346 comprise loop B and A, respectively. 
Figure was created with ESPript (http://espript. ibcp.fr) (Gouet, P. , Robert, X. and Courcelle E. 
(2003) "ESPript/ENDscript: extracting and rendering sequence and 3D information from atomic 
structures of proteins". Nucl. Acids Res. 31(13), 3320-3323). 
 
 
Table S4.1 Primers used for cloning of sucrose 6’-phosphate phosphorylase and 
phosphofructokinase genes from Thermoanaerobacterium thermosaccharolyticum. 
fragment Primer name 5’→3’ sequence 
TtSPP_Nhis_backbone TtSPP_Fw_BB GAAGTGAAATACCTGGTTTAATCTGCAGGTCGACCATATG 
 TtSPP_Rv_BB GTGGTGGTGCGAACCGCCCATCTTTGTTTCCTCCGAATTC 
TtSPP_Nhis_gene TtSPP_Fw_gene AATTCGGAGGAAACAAAGATGGGCGGTTCGCACCACCAC 
 TtSPP_Rv_gene CATATGGTCGACCTGCAGATTAAACCAGGTATTTCACTTC 
pfkB_Chis_backbone TtpfKB_Fw_BB2 GCGTGGAGGTCACCACCACCACCACCACTAACTGCAGGTC
GACCATATGGG 
 TtpfKB_Rv_BB2 CTTATCATTAAAGTTGAACATCTTTGTTTCCTCCGAATTCG 
pfkB_Chis_gene TtpfKB_Fw_gene2 CGAATTCGGAGGAAACAAAGATGTTCAACTTTAATGATAAG 
 TtpfKB_Rv_gene2 GTTAGTGGTGGTGGTGGTGGTGACCTCCACGCAGTTTCTTC
AGGTC 
 
Table S4.2 Primers used for site-directed mutagenesis of sucrose 6’-phosphate phosphorylase 
from Thermoanaerobacterium thermosaccharolyticum. 
mutant Primer name 5’→3’ sequence 
TtSPP_R134A TtSPP_Fw_R134A AAAATGTTCCTGGCTCGCACCCTGCCGTAC 
 TtSPP_Rv_mp1 ATCCAACGCGTTGGGAGCTCTC 
TtSPP_R135A TtSPP_ Fw_R135A AAAATGTTCCTGCGTGCCACCCTGCCGTAC 
 TtSPP_Rv_mp1 ATCCAACGCGTTGGGAGCTCTC 
TtSPP_K159A TtSPP_ Fw_K159A GCCGTACTCCACGTTTGCAATTGAAGAAACCGGTG 
 TtSPP_Rv_mp1 ATCCAACGCGTTGGGAGCTCTC 
TtSPP_K301A TtSPP_ Fw_K301A GATGGTATTCCGGTCGCACCGGACCTGGATGG 
 TtSPP_Rv_mp2 GTCGACGTATACGAATAAGG 
TtSPP_H344Y TtSPP_ Fw_H344Y GACGGCTTCGATGTTTATCAAATTAACTGC 
 TtSPP_Rv_mp2 GTCGACGTATACGAATAAGG 
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Table S4.3 UniProt ID, organism and lineage for all (putative) sucrose phosphorylases. 
 U
n
iP
ro
t I
D
 
o
rg
an
is
m
 
lin
ea
ge
 
A0
AF
62
 
Li
st
e
ria
 w
e
lsh
im
e
ri 
se
ro
va
r 6
b 
(s
tra
in
 A
TC
C
 
35
89
7 
/ D
SM
 2
06
50
 / 
SL
C
C
53
34
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
w
e
ls
hi
m
er
i 
A0
AM
F6
 
Li
st
e
ria
 w
e
lsh
im
e
ri 
se
ro
va
r 6
b 
(s
tra
in
 A
TC
C
 
35
89
7 
/ D
SM
 2
06
50
 / 
SL
C
C
53
34
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
w
e
ls
hi
m
er
i 
A0
KR
92
 
Sh
ew
a
n
e
lla
 s
p.
 (s
tra
in
 A
N
A-
3)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
sp
. 
A0
ZZ
H
6 
Bi
fid
o
ba
ct
e
riu
m
 
a
do
le
sc
e
nt
is
 (s
tra
in
 A
TC
C
 
15
70
3 
/ D
SM
 2
00
83
 / 
N
C
TC
 1
18
14
 / 
E1
94
a)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
do
le
sc
e
nt
is 
A1
AA
S1
 
Es
ch
er
ich
ia
 
co
li O
1:
K1
 / 
AP
EC
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
A1
SX
V4
 
Ps
yc
hr
om
on
as
 
in
gr
ah
a
m
ii (
st
ra
in
 3
7)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Ps
yc
hr
om
on
a
da
ce
a
e 
Ps
yc
hr
om
on
as
 
in
gr
ah
am
ii 
A1
U
3S
2 
M
a
rin
o
ba
ct
e
r 
a
qu
a
e
o
le
i (
st
ra
in
 A
TC
C
 7
00
49
1 
/ D
SM
 1
18
45
 / 
VT
8)
 (M
a
rin
ob
ac
te
r 
hy
dr
o
ca
rb
on
oc
la
st
icu
s 
(s
tra
in
 D
SM
 1
18
45
)) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
a
qu
ae
ol
ei
 
A1
VI
S9
 
Po
la
ro
m
on
as
 
n
a
ph
th
al
en
ivo
ra
ns
 (s
tra
in
 C
J2
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Be
ta
pr
ot
e
o
ba
ct
e
ria
 
Bu
rk
ho
ld
e
ria
le
s 
Co
m
a
m
o
n
a
da
ce
a
e 
Po
la
ro
m
on
as
 
n
a
ph
th
al
en
ivo
ra
n
s 
A2
BQ
X0
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 A
S9
60
1)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A2
BW
U
0 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 M
IT
 9
51
5)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A2
C
1W
2 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 N
AT
L1
A)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A3
C
M
L7
 
St
re
pt
oc
oc
cu
s 
sa
n
gu
in
is 
(s
tra
in
 S
K3
6)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
sa
n
gu
in
is 
A3
D
AJ
0 
Sh
ew
a
n
e
lla
 b
al
tic
a
 (s
tra
in
 O
S1
55
 / 
AT
C
C
 
BA
A-
10
91
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
A3
PC
P3
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 M
IT
 9
30
1)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A4
IT
A6
 
G
eo
ba
ci
llu
s 
th
er
m
o
de
ni
tri
fic
a
ns
 (s
tra
in
 N
G
80
-
2)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Ba
cil
la
ce
a
e 
G
eo
ba
ci
llu
s 
th
er
m
od
en
itr
ific
a
n
s 
A4
VW
N
2 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 0
5Z
YH
33
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
A4
W
2Y
2 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 9
8H
AH
33
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
A4
W
AW
0 
En
te
ro
ba
ct
e
r s
p.
 (s
tra
in
 6
38
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
En
te
ro
ba
ct
e
r 
sp
.
 
A5
A8
M
5 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
A5
G
PN
5 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 W
H
78
03
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
A5
G
VJ
6 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 R
C
C
30
7)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
A5
VL
R
3 
La
ct
o
ba
cil
lu
s 
re
ut
e
ri 
(s
tra
in
 D
SM
 2
00
16
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
re
u
te
ri 
A6
VW
68
 
M
a
rin
o
m
o
na
s 
sp
. (
st
ra
in
 M
W
YL
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
M
a
rin
o
m
o
na
s 
sp
. 
A6
W
H
E5
 
Sh
ew
a
n
e
lla
 b
al
tic
a
 (s
tra
in
 O
S1
85
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
A7
M
G
M
2 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i (
st
ra
in
 A
TC
C
 B
AA
-8
94
) 
(E
nt
er
ob
ac
te
r s
ak
az
ak
ii)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i 
A7
ZL
D
7 
Es
ch
er
ich
ia
 
co
li O
13
9:
H
28
 (s
tra
in
 E
24
37
7A
 / 
ET
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
A7
ZZ
Q
1 
Es
ch
er
ich
ia
 
co
li O
9:
H
4 
(s
tra
in
 H
S)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
A8
AM
E4
 
Ci
tro
ba
ct
e
r 
ko
se
ri 
(s
tra
in
 A
TC
C
 B
AA
-8
95
 / 
C
D
C
 4
22
5-
83
 / 
SG
SC
46
96
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ci
tro
ba
ct
e
r 
ko
se
ri 
A8
G
4L
1 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 M
IT
 9
21
5)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A8
LM
M
1 
Di
no
ro
se
o
ba
ct
e
r 
sh
ib
a
e
 (s
tra
in
 D
FL
 1
2)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
od
ob
ac
te
ra
le
s 
Rh
od
ob
ac
te
ra
ce
a
e 
Di
no
ro
se
o
ba
ct
e
r 
sh
ib
a
e 
A8
ZU
P8
 
De
su
lfo
co
cc
u
s 
ol
eo
vo
ra
n
s 
(s
tra
in
 D
SM
 6
20
0 
/ 
H
xd
3)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
De
lta
pr
o
te
o
ba
ct
e
ria
 
De
su
lfo
ba
ct
e
ra
le
s 
De
su
lfo
ba
ct
e
ra
ce
a
e 
De
su
lfo
co
cc
u
s 
o
le
ov
o
ra
n
s 
A8
ZY
47
 
De
su
lfo
co
cc
u
s 
ol
eo
vo
ra
n
s 
(s
tra
in
 D
SM
 6
20
0 
/ 
H
xd
3)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
De
lta
pr
o
te
o
ba
ct
e
ria
 
De
su
lfo
ba
ct
e
ra
le
s 
De
su
lfo
ba
ct
e
ra
ce
a
e 
De
su
lfo
co
cc
u
s 
o
le
ov
o
ra
n
s 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 102 
 A
9B
9U
4 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 M
IT
 9
21
1)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
A9
KV
44
 
Sh
ew
a
n
e
lla
 b
al
tic
a
 (s
tra
in
 O
S1
95
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
A9
M
Q
42
 
Sa
lm
o
n
e
lla
 a
riz
o
n
a
e
 (s
tra
in
 A
TC
C
 B
AA
-7
31
 / 
C
D
C
34
6-
86
 / 
R
SK
29
80
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Sa
lm
o
n
e
lla
 
a
riz
o
n
a
e
 
B0
C
3E
0 
Ac
a
ry
oc
hl
or
is 
m
a
rin
a 
(s
tra
in
 M
BI
C
 1
10
17
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Ac
a
ry
oc
hl
or
is 
m
a
rin
a 
B0
F4
11
 
Le
u
co
n
os
to
c 
m
es
en
te
ro
id
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
B1
I8
A2
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 
H
un
ga
ry
19
A-
6)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
B1
IS
V1
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 A
TC
C
 8
73
9 
/ D
SM
 
15
76
 / 
C
ro
ok
s)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B1
LG
B9
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 S
M
S-
3-
5 
/ S
EC
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B1
M
XD
7 
Le
uc
o
n
os
to
c 
cit
re
u
m
 (s
tra
in
 K
M
20
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
uc
o
n
os
to
c 
ci
tre
u
m
 
B1
M
ZX
1 
Le
uc
o
n
os
to
c 
cit
re
u
m
 (s
tra
in
 K
M
20
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
uc
o
n
os
to
c 
ci
tre
u
m
 
B1
V9
C
4 
Ph
yt
o
pl
as
m
a
 a
us
tra
lie
ns
e 
Ba
ct
e
ria
 
Te
n
e
ric
u
te
s 
M
o
llic
u
te
s 
Ac
ho
le
pl
as
m
at
a
le
s 
Ac
ho
le
pl
as
m
at
ac
e
ae
 
Ca
n
di
da
tu
s 
Ph
yt
o
pl
as
m
a 
16
Sr
XI
I (
St
ol
bu
r 
gr
ou
p)
 
B1
W
Y0
2 
Cy
a
n
ot
he
ce
 s
p.
 (s
tra
in
 A
TC
C
 5
11
42
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Cy
a
n
ot
he
ce
 
sp
. 
B1
XC
D
8 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 K
12
 / 
D
H
10
B)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B1
XH
U
0 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 A
TC
C
 2
72
64
 / 
PC
C
 7
00
2 
/ P
R
-6
) (
Ag
m
en
el
lu
m
 
qu
ad
ru
pl
ic
at
um
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
B2
BS
85
 
Le
u
co
n
os
to
c 
m
es
en
te
ro
id
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
B2
G
93
6 
La
ct
o
ba
cil
lu
s 
re
ut
e
ri 
(s
tra
in
 J
C
M
 1
11
2)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
re
u
te
ri 
B2
IS
Z2
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 C
G
SP
14
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
B2
TL
M
7 
Cl
os
tri
di
um
 
bo
tu
lin
um
 (s
tra
in
 E
kl
un
d 
17
B 
/ 
Ty
pe
 B
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
Cl
os
tri
di
ac
ea
e 
Cl
os
tri
di
um
 
bo
tu
lin
um
 
B2
VJ
V7
 
Er
wi
ni
a 
ta
sm
an
ie
ns
is 
(s
tra
in
 D
SM
 1
79
50
 / 
Et
1/
99
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
wi
ni
a 
ta
sm
a
n
ie
n
sis
 
B3
D
N
R
7 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 (s
tra
in
 D
JO
10
A)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
B5
E2
08
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
19
F 
(s
tra
in
 G
54
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
B6
IA
24
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 S
E1
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
G
T3
4|
E8
M
N
B8
 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. i
nf
a
nt
is
 (s
tra
in
 
AT
C
C
 1
56
97
 / 
D
SM
 2
00
88
 / 
JC
M
 1
22
2 
/ 
N
C
TC
 1
18
17
 / 
S1
2)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
B7
L5
73
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 5
59
89
 / 
EA
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
LY
70
 
Es
ch
er
ich
ia
 
co
li O
8 
(s
tra
in
 IA
I1
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
M
LY
4 
Es
ch
er
ich
ia
 
co
li O
45
:K
1 
(s
tra
in
 S
88
 / 
Ex
PE
C
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
M
U
E9
 
Es
ch
er
ich
ia
 
co
li O
81
 (s
tra
in
 E
D
1a
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
N
H
L1
 
Es
ch
er
ich
ia
 
co
li O
7:
K1
 (s
tra
in
 IA
I3
9 
/ E
xP
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B7
U
R
B7
 
Es
ch
er
ich
ia
 
co
li O
12
7:
H
6 
(s
tra
in
 E
23
48
/6
9 
/ 
EP
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
B8
D
C
X0
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
H
C
C
23
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
B8
D
D
85
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
H
C
C
23
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
B8
D
EZ
0 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
H
C
C
23
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
B8
D
VD
1 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 (s
tra
in
 
AD
01
1)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
B8
E3
H
2 
Sh
ew
a
n
e
lla
 b
al
tic
a
 (s
tra
in
 O
S2
23
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
B8
FI
23
 
De
su
lfa
tib
ac
illu
m
 
al
ke
n
ivo
ra
n
s 
(s
tra
in
 A
K-
01
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
De
lta
pr
o
te
o
ba
ct
e
ria
 
De
su
lfo
ba
ct
e
ra
le
s 
De
su
lfo
ba
ct
e
ra
ce
a
e 
De
su
lfa
tib
ac
illu
m
 
a
lk
en
ivo
ra
n
s 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 103 
 B
8Y
3Y
0 
un
cu
ltu
re
d 
ba
ct
er
iu
m
 
Ba
ct
e
ria
 
en
vi
ro
nm
en
ta
l 
sa
m
pl
es
 
ba
ct
e
riu
m
 
 
 
 
 
B8
ZN
J9
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 A
TC
C
 
70
06
69
 / 
Sp
ai
n 
23
F-
1)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
C
1C
9G
2 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 7
05
85
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
C
1C
G
C
1 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 J
JA
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
C
1C
M
K5
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 P
10
31
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
C
1C
TC
2 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 
Ta
iw
an
19
F-
14
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
C
1K
YJ
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
C
LI
P8
04
59
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
C
1K
ZU
0 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
C
LI
P8
04
59
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
C
1L
0H
4 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
C
LI
P8
04
59
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
C
4Z
V5
8 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 K
12
 / 
M
C
41
00
 / 
BW
29
52
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
C
5B
PR
7 
Te
re
di
ni
ba
ct
e
r 
tu
rn
e
ra
e 
(s
tra
in
 A
TC
C
 3
98
67
 / 
T7
90
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
al
es
 
ge
n
e
ra
 
in
ce
rta
e
 s
e
di
s 
Te
re
di
ni
ba
ct
e
r 
tu
rn
e
ra
e 
C
5B
Q
K7
 
Te
re
di
ni
ba
ct
e
r 
tu
rn
e
ra
e 
(s
tra
in
 A
TC
C
 3
98
67
 / 
T7
90
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
al
es
 
ge
n
e
ra
 
in
ce
rta
e
 s
e
di
s 
Te
re
di
ni
ba
ct
e
r 
tu
rn
e
ra
e 
C
5V
YP
4 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 P
1/
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
C
6A
5Y
4 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 (s
tra
in
 
Bl
-0
4 
/ D
G
C
C
29
08
 / 
R
B 
48
25
 / 
SD
52
19
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
C
6A
G
J2
 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 (s
tra
in
 
D
SM
 1
01
40
 / 
JC
M
 1
06
02
 / 
LM
G
 1
83
14
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
C
6E
FS
3 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 B
 / 
BL
21
-D
E3
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
C
6G
M
P5
 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 S
C
84
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
C
6G
V6
9 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 B
M
40
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
C
6S
R
17
 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 s
er
ot
yp
e 
c 
(s
tra
in
 
N
N
20
25
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 
C
6U
G
V7
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 B
 / 
R
EL
60
6)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
C
6X
KJ
1 
Hi
rs
ch
ia
 
ba
ltic
a 
(s
tra
in
 A
TC
C
 4
98
14
 / 
D
SM
 
58
38
 / 
IF
AM
 1
41
8)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
od
ob
ac
te
ra
le
s 
Hy
ph
om
on
a
da
ce
a
e 
Hi
rs
ch
ia
 
ba
ltic
a 
C
7R
FN
2 
An
ae
ro
co
cc
u
s 
pr
ev
ot
ii (
st
ra
in
 A
TC
C
 9
32
1 
/ 
D
SM
 2
05
48
 / 
JC
M
 6
50
8 
/ P
C
1)
 
(P
ep
to
st
re
pt
oc
o
cc
u
s 
pr
e
vo
tii
) (
Pe
pt
oc
oc
cu
s 
pr
ev
o
tii)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
Cl
os
tri
di
al
es
 F
am
ily
 
XI
. I
n
ce
rta
e 
Se
di
s 
An
ae
ro
co
cc
u
s 
pr
ev
o
tii 
C
8U
7C
8 
Es
ch
er
ich
ia
 
co
li O
10
3:
H
2 
(s
tra
in
 1
20
09
 / 
EH
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
C
9Q
X4
3 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 A
TC
C
 3
38
49
 / 
D
SM
 
42
35
 / 
N
C
IB
 1
20
45
 / 
K1
2 
/ D
H
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
C
9Y
58
8 
Cr
o
n
o
ba
ct
e
r 
tu
ric
e
ns
is
 (s
tra
in
 D
SM
 1
87
03
 / 
LM
G
 2
38
27
 / 
z3
03
2)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Cr
o
n
o
ba
ct
e
r 
tu
ric
e
ns
is 
D
1A
H
Z8
 
Se
ba
ld
e
lla
 
te
rm
itid
is 
(s
tra
in
 A
TC
C
 3
33
86
 / 
N
C
TC
 1
13
00
) 
Ba
ct
e
ria
 
Fu
so
ba
ct
e
ria
 
Fu
so
ba
ct
e
ria
le
s 
Le
pt
o
tri
ch
ia
ce
a
e 
Se
ba
ld
e
lla
 
te
rm
itid
is 
D
2B
M
B7
 
La
ct
oc
oc
cu
s 
la
ct
is 
su
bs
p.
 la
ct
is 
(s
tra
in
 K
F1
47
) B
a
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
La
ct
oc
oc
cu
s 
la
ct
is 
D
2N
I5
6 
Es
ch
er
ich
ia
 
co
li O
15
0:
H
5 
(s
tra
in
 S
E1
5)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
D
2N
V1
7 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
08
-5
57
8)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
D
2N
VR
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 104 
 
08
-5
57
8)
 
D
2N
W
L6
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
08
-5
57
8)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
D
2P
6I
5 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
08
-5
92
3)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
D
2P
77
9 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
08
-5
92
3)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
D
2P
83
5 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
08
-5
92
3)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
D
2Q
74
8 
Bi
fid
o
ba
ct
e
riu
m
 
de
n
tiu
m
 (s
tra
in
 A
TC
C
 2
75
34
 / 
D
SM
 2
04
36
 / 
JC
M
 1
19
5 
/ B
d1
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
a
e 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
de
n
tiu
m
 
D
2T
KB
5 
Ci
tro
ba
ct
e
r 
ro
de
nt
iu
m
 (s
tra
in
 IC
C
16
8)
 
(C
itr
o
ba
ct
e
r 
fre
un
di
i b
io
ty
pe
 4
28
0)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ci
tro
ba
ct
e
r 
ro
de
nt
iu
m
 
D
3H
G
T9
 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
(s
tra
in
 U
C
N
34
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
D
3P
AG
7 
De
fe
rr
ib
ac
te
r 
de
su
lfu
ric
a
ns
 (s
tra
in
 D
SM
 1
47
83
 
/ J
C
M
 1
14
76
 / 
N
BR
C
 1
01
01
2 
/ S
SM
1)
 
Ba
ct
e
ria
 
De
fe
rr
ib
ac
te
re
s 
De
fe
rr
ib
ac
te
ra
le
s 
De
fe
rr
ib
ac
te
ra
ce
a
e 
De
fe
rr
ib
ac
te
r 
de
su
lfu
ric
a
ns
 
D
3P
Q
E0
 
M
e
io
th
e
rm
u
s 
ru
be
r (
st
ra
in
 A
TC
C
 3
59
48
 / 
D
SM
 
12
79
 / 
VK
M
 B
-1
25
8 
/ 2
1)
 (T
he
rm
us
 ru
be
r) 
Ba
ct
e
ria
 
De
in
oc
o
cc
u
s-
Th
er
m
u
s 
De
in
oc
o
cc
i 
Th
er
m
a
le
s 
Th
er
m
a
ce
a
e 
M
e
io
th
e
rm
u
s 
ru
be
r 
D
3R
7S
5 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 (s
tra
in
 
BB
-1
2)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
D
4G
D
28
 
Pa
nt
o
e
a 
a
n
an
at
is 
(s
tra
in
 L
M
G
 2
01
03
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
n
to
e
a 
a
n
a
n
at
is 
D
4I
34
2 
Er
wi
ni
a 
a
m
ylo
vo
ra
 (s
tra
in
 C
FB
P1
43
0)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
wi
ni
a 
a
m
ylo
vo
ra
 
D
4I
D
V9
 
Er
wi
ni
a 
a
m
ylo
vo
ra
 (s
tra
in
 A
TC
C
 4
99
46
 / 
C
C
PP
B 
02
73
 / 
Ea
27
3 
/ 2
7-
3)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
wi
ni
a 
a
m
ylo
vo
ra
 
D
4J
1P
7 
Bu
ty
riv
ib
rio
 
fib
ris
o
lve
ns
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
o
st
rid
ia
 
Cl
o
st
rid
ia
le
s 
La
ch
n
os
pi
ra
ce
a
e 
Bu
ty
riv
ib
rio
 
fib
ris
o
lve
n
s 
D
4L
1H
2 
Ro
se
bu
ria
 
in
te
st
in
a
lis
 X
B6
B4
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
o
st
rid
ia
 
Cl
o
st
rid
ia
le
s 
La
ch
n
os
pi
ra
ce
a
e 
Ro
se
bu
ria
 
in
te
st
in
a
lis
 
D
4Z
P5
7 
Ar
th
ro
sp
ira
 
pl
a
te
n
sis
 N
IE
S-
39
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
O
sc
illa
to
ria
le
s 
Ar
th
ro
sp
ira
 
pl
at
en
sis
 
 
D
5A
J2
7 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 G
Z1
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
D
5C
7V
7 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e 
su
bs
p.
 c
lo
ac
ae
 (s
tra
in
 
AT
C
C
 1
30
47
 / 
D
SM
 3
00
54
 / 
N
BR
C
 1
35
35
 / 
N
C
D
C
 2
79
-5
6)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
En
te
ro
ba
ct
er
 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e
 c
om
pl
ex
 
D
5D
1W
3 
Es
ch
er
ich
ia
 
co
li O
18
:K
1:
H
7 
(s
tra
in
 IH
E3
03
4 
/ 
Ex
PE
C
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
D
5E
PQ
6 
Co
ra
lio
m
a
rg
ar
ita
 
ak
a
jim
e
ns
is 
(s
tra
in
 D
SM
 
45
22
1 
/ I
AM
 1
54
11
 / 
JC
M
 2
31
93
 / 
KC
TC
 
12
86
5)
 
Ba
ct
e
ria
 
Ve
rru
co
m
icr
ob
ia
 
O
pi
tu
ta
e 
Pu
ni
ce
ico
cc
a
le
s 
Pu
ni
ce
ico
cc
a
ce
a
e 
Co
ra
lio
m
a
rg
ar
ita
 
a
ka
jim
e
ns
is
 
D
5G
YJ
0 
La
ct
o
ba
cil
lu
s 
cr
isp
a
tu
s 
(s
tra
in
 S
T1
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
cr
isp
at
u
s 
D
5H
1R
5 
La
ct
o
ba
cil
lu
s 
cr
isp
a
tu
s 
(s
tra
in
 S
T1
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
cr
isp
at
u
s 
D
5T
56
1 
Le
uc
o
n
os
to
c 
ki
m
ch
ii (
st
ra
in
 IM
SN
U
 1
11
54
 / 
KC
TC
 2
38
6 
/ I
H
25
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
ki
m
ch
ii 
 
D
5T
F4
6 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 (s
tra
in
 
V9
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
D
5U
C
81
 
Ce
llu
lo
m
o
na
s 
fla
vi
ge
n
a
 (s
tra
in
 A
TC
C
 4
82
 / 
D
SM
 2
01
09
 / 
N
C
IB
 8
07
3 
/ N
R
S 
13
4)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Ac
tin
om
yc
et
a
le
s 
M
icr
oc
oc
ci
ne
a
e 
Ce
llu
lo
m
o
na
da
ce
a
e 
Ce
llu
lo
m
o
na
s 
D
5V
4E
5 
Ar
co
ba
ct
e
r 
n
itr
o
fig
ilis
 (s
tra
in
 A
TC
C
 3
33
09
 / 
D
SM
 7
29
9 
/ L
M
G
 7
60
4 
/ N
C
TC
 1
22
51
 / 
C
I) 
(C
a
m
py
lo
ba
ct
e
r 
n
itr
of
ig
ilis
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
Ep
sil
o
n
pr
o
te
o
ba
ct
e
ria
 
Ca
m
py
lo
ba
ct
er
a
le
s 
Ca
m
py
lo
ba
ct
er
ac
e
a
e 
Ar
co
ba
ct
e
r 
n
itr
of
ig
ilis
 
D
6D
AR
0 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. l
on
gu
m
 F
8 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
D
6X
VK
0 
Ba
cil
lu
s 
se
le
n
itir
ed
u
ce
ns
 (s
tra
in
 A
TC
C
 7
00
61
5 
/ D
SM
 1
53
26
 / 
M
LS
10
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Ba
cil
la
ce
a
e 
Ba
cil
lu
s 
se
le
n
itir
e
du
ce
n
s 
D
6Z
N
M
8 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
A1
9 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 105 
 
(s
tra
in
 T
C
H
84
31
) 
D
6Z
XE
7 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. l
on
gu
m
 (s
tra
in
 
JD
M
30
1)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
D
7B
AR
0 
M
e
io
th
e
rm
u
s 
si
lva
n
u
s 
(s
tra
in
 A
TC
C
 7
00
54
2 
/ 
D
SM
 9
94
6 
/ V
I-R
2)
 (T
he
rm
u
s 
si
lva
nu
s)
 
Ba
ct
e
ria
 
De
in
oc
o
cc
u
s-
Th
er
m
u
s 
De
in
o
co
cc
i 
Th
e
rm
a
le
s 
Th
e
rm
a
ce
a
e 
M
e
io
th
e
rm
u
s 
si
lva
n
u
s 
D
8M
EP
5 
Le
uc
o
n
os
to
c 
ga
sic
o
m
ita
tu
m
 (s
tra
in
 D
SM
 
15
94
7 
/ C
EC
T 
57
67
 / 
JC
M
 1
25
35
 / 
LM
G
 
18
81
1 
/ T
B1
-1
0)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
ga
sic
o
m
ita
tu
m
 
D
8M
Y3
2 
Er
wi
ni
a 
bi
llin
gi
ae
 (s
tra
in
 E
b6
61
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
w
in
ia
 
bi
llin
gi
a
e 
D
9T
T0
9 
Th
er
m
o
a
n
ae
ro
ba
ct
e
riu
m
 
th
er
m
os
ac
ch
ar
o
lyt
icu
m
 (s
tra
in
 A
TC
C
 7
95
6 
/ 
D
SM
 5
71
 / 
N
C
IB
 9
38
5 
/ N
C
A 
38
14
) 
(C
lo
st
rid
iu
m
 th
er
m
os
ac
ch
ar
ol
yt
ic
um
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Fa
m
ily
 II
I. 
In
ce
rta
e 
Se
di
s 
Th
er
m
o
a
n
ae
ro
ba
ct
e
riu
m
 
th
er
m
os
ac
ch
ar
o
l
yt
icu
m
 
E0
IU
U
9 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 A
TC
C
 9
63
7 
/ C
C
M
 
20
24
 / 
D
SM
 1
11
6 
/ N
C
IM
B 
86
66
 / 
N
R
R
L 
B-
76
6 
/ W
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E0
R
TJ
0 
Sp
iro
ch
ae
ta
 
th
er
m
o
ph
ila
 (s
tra
in
 A
TC
C
 4
99
72
 / 
D
SM
 6
19
2 
/ R
I 1
9.
B1
) 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
iro
ch
ae
ta
 
th
er
m
op
hi
la
 
E0
SX
F5
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 A
P2
00
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
E0
TT
F2
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 6
70
-6
B)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
E1
P7
P3
 
Es
ch
er
ich
ia
 
co
li O
R
:K
5:
H
- (
st
ra
in
 A
BU
 8
39
72
) B
ac
te
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E1
R
BP
8 
Sp
iro
ch
ae
ta
 
sm
a
ra
gd
in
ae
 (s
tra
in
 D
SM
 1
12
93
 / 
JC
M
 1
53
92
 / 
SE
BR
 4
22
8)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
iro
ch
ae
ta
 
sm
a
ra
gd
in
ae
 
E1
R
C
G
5 
Sp
iro
ch
ae
ta
 
sm
a
ra
gd
in
ae
 (s
tra
in
 D
SM
 1
12
93
 / 
JC
M
 1
53
92
 / 
SE
BR
 4
22
8)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
iro
ch
ae
ta
 
sm
a
ra
gd
in
ae
 
E1
S3
Y7
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 U
M
14
6)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E1
SG
V6
 
Pa
nt
o
e
a 
va
ga
ns
 (s
tra
in
 C
9-
1)
 (P
an
to
e
a
 
a
gg
lo
m
e
ra
ns
 
(s
tra
in
 C
9-
1)
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
nt
o
e
a 
va
ga
n
s 
E1
SV
56
 
Fe
rr
im
o
n
as
 
ba
le
a
ric
a 
(s
tra
in
 D
SM
 9
79
9 
/ C
C
M
 
45
81
 / 
PA
T)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Fe
rr
im
o
n
a
da
ce
a
e 
Fe
rr
im
o
n
as
 
ba
le
ar
ica
 
E1
U
BW
7 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
L9
9)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
E1
U
C
75
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
L9
9)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
E1
U
C
Y1
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
L9
9)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
E1
XC
V6
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
3 
(s
tra
in
 
O
XC
14
1)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
E1
XL
U
3 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
14
 
(s
tra
in
 IN
V2
00
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
E1
XM
V5
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
1 
(s
tra
in
 
IN
V1
04
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
E2
IH
A5
 
Le
u
co
n
os
to
c 
m
es
en
te
ro
id
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
E2
Q
LR
8 
Es
ch
er
ich
ia
 
co
li 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E3
D
IR
0 
Er
wi
ni
a 
sp
. (
st
ra
in
 E
jp
61
7)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
wi
ni
a 
sp
. 
E3
PL
69
 
Es
ch
er
ich
ia
 
co
li O
78
:H
11
 (s
tra
in
 H
10
40
7 
/ 
ET
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E3
VS
06
 
Ar
th
ro
sp
ira
 
pl
a
te
n
sis
 A
V 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
O
sc
illa
to
ria
le
s 
Ar
th
ro
sp
ira
 
pl
at
en
sis
 
 
E4
P4
60
 
Es
ch
er
ich
ia
 
co
li O
83
:H
1 
(s
tra
in
 N
R
G
 8
57
C
 / 
AI
EC
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
E4
PG
X6
 
M
a
rin
o
ba
ct
e
r 
a
dh
ae
re
n
s 
(s
tra
in
 H
P1
5)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
a
le
s 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
a
dh
a
e
re
n
s 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 106 
 E
4P
M
A5
 
M
a
rin
o
ba
ct
e
r 
a
dh
ae
re
n
s 
(s
tra
in
 H
P1
5)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
a
le
s 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
a
dh
a
e
re
n
s 
E4
R
15
3 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. l
on
gu
m
 (s
tra
in
 
BB
M
N
68
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
E4
SL
99
 
La
ct
o
ba
cil
lu
s 
a
m
ylo
vo
ru
s 
(s
tra
in
 G
R
L 
11
12
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
m
ylo
vo
ru
s 
E4
U
9R
0 
O
ce
a
n
ith
er
m
u
s 
pr
of
u
n
du
s 
(s
tra
in
 D
SM
 1
49
77
 
/ N
BR
C
 1
00
41
0 
/ V
KM
 B
-2
27
4 
/ 5
06
) 
Ba
ct
e
ria
 
De
in
oc
o
cc
u
s-
Th
er
m
u
s 
De
in
o
co
cc
i 
Th
e
rm
a
le
s 
Th
e
rm
a
ce
a
e 
O
ce
a
n
ith
e
rm
u
s 
pr
o
fu
n
du
s 
E5
BA
43
 
Er
wi
ni
a 
a
m
ylo
vo
ra
 A
TC
C
 B
AA
-2
15
8 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Er
wi
ni
a 
a
m
ylo
vo
ra
 
E6
R
Q
V0
 
Ps
eu
do
al
te
ro
m
o
n
as
 s
p.
 (s
tra
in
 S
M
99
13
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Ps
eu
do
al
te
ro
m
o
n
ad
a
ce
a
e 
Ps
eu
do
al
te
ro
m
o
n
as
 
sp
. 
E6
R
R
E7
 
Ps
eu
do
al
te
ro
m
o
n
as
 s
p.
 (s
tra
in
 S
M
99
13
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Ps
eu
do
al
te
ro
m
o
n
ad
a
ce
a
e 
Ps
eu
do
al
te
ro
m
o
n
as
 
sp
. 
E6
SY
M
0 
Sh
ew
a
n
e
lla
 b
al
tic
a
 (s
tra
in
 O
S6
78
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
E6
U
9M
7 
Et
ha
n
o
lig
e
n
e
ns
 
ha
rb
in
en
se
 (s
tra
in
 D
SM
 
18
48
5 
/ J
C
M
 1
29
61
 / 
C
G
M
C
C
 1
.5
03
3 
/ Y
U
AN
-
3)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
Ru
m
in
oc
o
cc
ac
ea
e 
Et
ha
n
o
lig
e
n
e
ns
 
ha
rb
in
en
se
 
E6
W
H
09
 
Pa
nt
o
e
a 
sp
. (
st
ra
in
 A
t-9
b)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
nt
o
e
a 
sp
. 
E8
M
G
73
 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. l
on
gu
m
 (s
tra
in
 
AT
C
C
 1
57
07
 / 
D
SM
 2
02
19
 / 
JC
M
 1
21
7 
/ 
N
C
TC
 1
18
18
 / 
E1
94
b)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
E8
M
W
U
0 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. i
nf
a
nt
is
 (s
tra
in
 
15
7F
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
E8
U
N
V6
 
St
re
pt
oc
oc
cu
s 
su
is
 (s
tra
in
 J
S1
4)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
E8
XV
N
6 
Ra
hn
el
la
 s
p.
 (s
tra
in
 Y
96
02
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
el
la
 
sp
. 
E8
XV
S1
 
Ra
hn
el
la
 s
p.
 (s
tra
in
 Y
96
02
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
el
la
 
sp
. 
E8
YB
L6
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 A
TC
C
 5
51
24
 / 
KO
11
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
F0
R
R
L2
 
Sp
ha
er
o
ch
ae
ta
 
gl
ob
o
sa
 (s
tra
in
 A
TC
C
 B
AA
-
18
86
 / 
D
SM
 2
27
77
 / 
Bu
dd
y)
 (S
pi
ro
ch
a
e
ta
 s
p.
 
(s
tra
in
 B
ud
dy
)) 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
ha
er
o
ch
ae
ta
 
gl
ob
os
a 
 
F0
TG
61
 
La
ct
o
ba
cil
lu
s 
a
cid
op
hi
lu
s 
(s
tra
in
 3
0S
C
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
ci
do
ph
ilu
s 
F0
VV
88
 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
(s
tra
in
 A
TC
C
 B
AA
-
20
69
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
F2
EW
K1
 
Pa
nt
o
e
a 
a
n
an
at
is 
(s
tra
in
 A
J1
33
55
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
n
to
e
a 
a
n
a
n
at
is 
F2
JI
21
 
Ce
llu
lo
si
lyt
icu
m
 
le
n
to
ce
llu
m
 (s
tra
in
 A
TC
C
 
49
06
6 
/ D
SM
 5
42
7 
/ N
C
IM
B 
11
75
6 
/ R
H
M
5)
 
(C
lo
st
rid
iu
m
 
le
n
to
ce
llu
m
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
La
ch
n
os
pi
ra
ce
a
e 
Ce
llu
lo
si
lyt
icu
m
 
le
nt
oc
el
lu
m
 
F2
JV
S9
 
M
a
rin
o
m
o
na
s 
m
e
di
te
rr
a
n
ea
 (s
tra
in
 A
TC
C
 
70
04
92
 / 
JC
M
 2
14
26
 / 
N
BR
C
 1
03
02
8 
/ M
M
B-
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
M
a
rin
o
m
o
na
s 
m
e
di
te
rr
a
n
ea
 
F2
M
1C
4 
La
ct
o
ba
cil
lu
s 
a
m
ylo
vo
ru
s 
(s
tra
in
 G
R
L 
11
18
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
m
ylo
vo
ru
s 
F2
N
L3
2 
M
a
rin
ith
er
m
u
s 
hy
dr
ot
he
rm
a
lis
 (s
tra
in
 D
SM
 
14
88
4 
/ J
C
M
 1
15
76
 / 
T1
) 
Ba
ct
e
ria
 
De
in
oc
o
cc
u
s-
Th
er
m
u
s 
De
in
o
co
cc
i 
Th
e
rm
a
le
s 
Th
e
rm
a
ce
a
e 
M
a
rin
ith
e
rm
u
s 
hy
dr
o
th
e
rm
a
lis
 
F2
Q
BT
3 
St
re
pt
oc
oc
cu
s 
o
ra
lis
 (s
tra
in
 U
o5
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
o
ra
lis
 
F4
AE
80
 
La
ct
o
ba
cil
lu
s 
joh
ns
o
n
ii 
D
PC
 6
02
6 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
joh
ns
o
n
ii 
F4
AQ
R
0 
G
la
cie
co
la
 s
p.
 (s
tra
in
 4
H
-3
-7
+Y
E-
5)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
G
la
cie
co
la
 
sp
. 
F4
EG
W
9 
St
re
pt
oc
oc
cu
s 
su
is
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
 
su
is 
F4
FT
G
0 
La
ct
o
ba
cil
lu
s 
bu
ch
ne
ri 
(s
tra
in
 N
R
R
L 
B-
30
92
9)
 B
a
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
bu
ch
n
e
ri 
F4
G
J8
5 
Sp
iro
ch
ae
ta
 
co
cc
o
id
es
 (s
tra
in
 A
TC
C
 B
AA
-
12
37
 / 
D
SM
 1
73
74
 / 
SP
N
1)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
ha
er
o
ch
ae
ta
 
co
cc
o
id
es
 
F4
H
3A
0 
Ce
llu
lo
m
o
na
s 
fim
i (
st
ra
in
 A
TC
C
 4
84
 / 
D
SM
 
20
11
3 
/ J
C
M
 1
34
1 
/ N
BR
C
 1
55
13
 / 
N
C
IM
B 
89
80
 / 
N
C
TC
 7
54
7)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Ac
tin
om
yc
et
a
le
s 
M
icr
oc
oc
ci
ne
a
e 
C
el
lu
lo
m
on
ad
ac
ea
e C
e
llu
lo
m
o
na
s 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 107 
 F
4M
4T
5 
Es
ch
er
ich
ia
 
co
li 
U
M
N
K8
8 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
F5
W
YM
5 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
(s
tra
in
 A
TC
C
 4
31
43
 
/ F
-1
86
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
ga
llo
lyt
icu
s 
F5
X4
H
8 
St
re
pt
oc
oc
cu
s 
pa
st
e
u
ria
n
u
s 
(s
tra
in
 A
TC
C
 
43
14
4 
/ J
C
M
 5
34
6 
/ C
D
C
 1
72
3-
81
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pa
st
e
ur
ia
n
u
s 
F5
XH
R
0 
M
icr
o
lu
n
at
u
s 
ph
os
ph
ov
or
u
s 
(s
tra
in
 A
TC
C
 
70
00
54
 / 
D
SM
 1
05
55
 / 
JC
M
 9
37
9 
/ N
BR
C
 
10
17
84
 / 
N
C
IM
B 
13
41
4 
/ V
KM
 A
c-
19
90
 / 
N
M
-
1)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Ac
tin
om
yc
et
a
le
s 
Pr
op
io
n
ib
ac
te
rin
e
a
e 
Pr
op
io
n
ib
ac
te
ria
ce
a
e
 
M
icr
o
lu
n
at
us
 
F5
YL
Y9
 
Tr
e
po
ne
m
a 
pr
im
itia
 (s
tra
in
 A
TC
C
 B
AA
-8
87
 / 
D
SM
 1
24
27
 / 
ZA
S-
2)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Tr
e
po
ne
m
a 
pr
im
itia
 
 
F5
Z8
C
6 
Al
te
ro
m
o
n
as
 s
p.
 (s
tra
in
 S
N
2)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
sp
. 
F5
ZA
N
0 
Al
te
ro
m
o
n
as
 s
p.
 (s
tra
in
 S
N
2)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
sp
. 
F6
BJ
S0
 
Th
er
m
o
a
n
ae
ro
ba
ct
e
riu
m
 
xy
la
no
lyt
icu
m
 (s
tra
in
 
AT
C
C
 4
99
14
 / 
D
SM
 7
09
7 
/ L
X-
11
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Fa
m
ily
 II
I. 
In
ce
rta
e 
Se
di
s 
Th
er
m
o
a
n
ae
ro
ba
ct
e
riu
m
 
xy
la
no
lyt
icu
m
 
F6
C
60
9 
Bi
fid
o
ba
ct
e
riu
m
 
br
e
ve
 (s
tra
in
 A
C
S-
07
1-
V-
Sc
h8
b)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
br
ev
e 
F6
C
T3
5 
M
a
rin
o
m
o
na
s 
po
sid
on
ica
 (s
tra
in
 C
EC
T 
73
76
 / 
N
C
IM
B 
14
43
3 
/ I
VI
A-
Po
-1
81
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
M
a
rin
o
m
o
na
s 
po
sid
on
ica
 
F6
D
B0
0 
Th
io
al
ka
lim
icr
o
bi
um
 
cy
cl
icu
m
 (s
tra
in
 D
SM
 
14
47
7 
/ J
C
M
 1
13
71
 / 
AL
M
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Th
io
tri
ch
a
le
s 
Pi
sc
iri
ck
et
ts
ia
ce
a
e 
Th
io
al
ka
lim
icr
o
bi
um
 
cy
cl
icu
m
 
F7
ZK
S6
 
Ro
se
ob
ac
te
r 
lito
ra
lis
 (s
tra
in
 A
TC
C
 4
95
66
 / 
D
SM
 6
99
6 
/ J
C
M
 2
12
68
 / 
N
BR
C
 1
52
78
 / 
O
C
h 
14
9)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
Al
ph
a
pr
o
te
o
ba
ct
e
ria
 
Rh
o
do
ba
ct
e
ra
le
s 
Rh
o
do
ba
ct
e
ra
ce
a
e 
Ro
se
ob
ac
te
r 
lit
o
ra
lis
 
F8
AU
H
7 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 s
ub
sp
. l
on
gu
m
 K
AC
C
 
91
56
3 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
F8
BA
95
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
M
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
F8
BB
A2
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
M
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
F8
BC
29
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4a
 (s
tra
in
 
M
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
F8
D
I6
1 
St
re
pt
oc
oc
cu
s 
pa
ra
sa
n
gu
in
is
 (s
tra
in
 A
TC
C
 
15
91
2 
/ D
SM
 6
77
8 
/ C
IP
 1
04
37
2 
/ L
M
G
 
14
53
7)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pa
ra
sa
n
gu
in
is 
F8
D
N
P1
 
La
ct
o
ba
cil
lu
s 
re
ut
e
ri 
(s
tra
in
 A
TC
C
 5
57
30
 / 
SD
21
12
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
re
u
te
ri 
F8
E9
G
3 
Fl
ex
ist
ip
es
 
si
nu
sa
ra
bi
ci
 (s
tra
in
 D
SM
 4
94
7 
/ 
M
AS
 1
0)
 
Ba
ct
e
ria
 
De
fe
rr
ib
ac
te
re
s 
De
fe
rr
ib
ac
te
ra
le
s 
De
fe
rr
ib
ac
te
ra
ce
a
e 
Fl
ex
ist
ip
es
 
si
nu
sa
ra
bi
ci 
F8
H
XF
5 
Le
uc
o
n
os
to
c 
sp
. (
st
ra
in
 C
2)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
sp
. 
 
F8
VJ
I4
 
Sa
lm
o
n
e
lla
 b
on
go
ri 
(s
tra
in
 A
TC
C
 4
39
75
 / 
D
SM
 1
37
72
 / 
N
C
TC
 1
24
19
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Sa
lm
o
n
e
lla
 
bo
ng
or
i 
F9
V7
J6
 
La
ct
oc
oc
cu
s 
ga
rv
ie
ae
 (s
tra
in
 A
TC
C
 4
91
56
 / 
D
SM
 6
78
3 
/ N
C
IM
B 
13
20
8 
/ Y
T-
3)
 
(E
nt
e
ro
co
cc
u
s 
se
rio
lic
id
a)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
La
ct
oc
oc
cu
s 
ga
rv
ie
a
e 
F9
VC
K2
 
La
ct
oc
oc
cu
s 
ga
rv
ie
ae
 (s
tra
in
 L
g2
) 
(E
nt
e
ro
co
cc
u
s 
se
rio
lic
id
a)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
La
ct
oc
oc
cu
s 
ga
rv
ie
a
e 
F9
Y0
18
 
Bi
fid
o
ba
ct
e
riu
m
 
br
e
ve
 (s
tra
in
 N
C
IM
B 
88
07
 / 
U
C
C
20
03
) 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
br
ev
e 
F9
ZZ
84
 
M
et
hy
lo
m
on
as
 
m
et
ha
n
ica
 (s
tra
in
 M
C
09
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
M
et
hy
lo
co
cc
a
le
s 
M
et
hy
lo
co
cc
ac
e
a
e 
M
et
hy
lo
m
on
as
 
m
e
th
an
ica
 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 108 
 G
0A
PU
4 
Sh
ew
a
n
e
lla
 b
al
tic
a
 B
A1
75
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
G
0D
AB
0 
Es
ch
er
ich
ia
 
co
li 
N
A1
14
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
G
0D
H
74
 
Sh
ew
a
n
e
lla
 b
al
tic
a
 O
S1
17
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
ba
ltic
a 
G
0G
BS
4 
Sp
iro
ch
ae
ta
 
th
er
m
o
ph
ila
 (s
tra
in
 A
TC
C
 7
00
08
5 
/ D
SM
 6
57
8 
/ Z
-1
20
3)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
iro
ch
ae
ta
 
th
er
m
op
hi
la
 
G
0H
7C
4 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 C
N
C
M
 
I-2
49
4 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
G
1U
B4
1 
La
ct
o
ba
cil
lu
s 
a
cid
op
hi
lu
s 
(s
tra
in
 A
TC
C
 
70
03
96
 / 
N
C
K5
6 
/ N
2 
/ N
C
FM
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
ci
do
ph
ilu
s 
G
1U
B4
2 
La
ct
o
ba
cil
lu
s 
a
cid
op
hi
lu
s 
(s
tra
in
 A
TC
C
 
70
03
96
 / 
N
C
K5
6 
/ N
2 
/ N
C
FM
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
ci
do
ph
ilu
s 
G
2J
R
77
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 J
01
61
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2J
VK
6 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 J
01
61
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2J
W
C
2 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 J
01
61
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2J
YM
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
10
40
3S
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
0V
8 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
1/
2a
 (s
tra
in
 
10
40
3S
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
BR
6 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 F
SL
 R
2-
56
1 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
C
Z5
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 F
SL
 R
2-
56
1 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
F7
0 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 F
in
la
nd
 1
99
8 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
FW
7 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 F
in
la
nd
 1
99
8 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2K
G
02
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 F
in
la
nd
 1
99
8 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
G
2S
TA
5 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 B
LC
1 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
G
2Z
9X
6 
Li
st
e
ria
 iv
a
no
vii
 (s
tra
in
 A
TC
C
 B
AA
-6
78
 / 
PA
M
 
55
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
iv
a
no
vii
 
G
2Z
A4
2 
Li
st
e
ria
 iv
a
no
vii
 (s
tra
in
 A
TC
C
 B
AA
-6
78
 / 
PA
M
 
55
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
iv
a
no
vii
 
G
4P
VK
1 
Es
ch
er
ich
ia
 
co
li O
7:
K1
 s
tr.
 C
E1
0 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
G
4Q
G
R
4 
G
la
cie
co
la
 
n
itr
at
ire
du
ce
ns
 (s
tra
in
 J
C
M
 1
24
85
 / 
KC
TC
 1
22
76
 / 
FR
10
64
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
G
la
cie
co
la
 
n
itr
at
ire
du
ce
ns
 
G
4T
0D
2 
M
et
hy
lo
m
icr
ob
iu
m
 
a
lca
lip
hi
lu
m
 (s
tra
in
 D
SM
 
19
30
4 
/ N
C
IM
B 
14
12
4 
/ V
KM
 B
-2
13
3 
/ 2
0Z
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
M
et
hy
lo
co
cc
a
le
s 
M
et
hy
lo
co
cc
ac
e
a
e 
M
et
hy
lo
m
icr
ob
iu
m
 
a
lc
a
lip
hi
lu
m
 
G
7R
3V
4 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 'c
lo
ne
 D
 i2
') 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
G
7R
R
E7
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 'c
lo
ne
 D
 i1
4'
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
G
7R
W
82
 
St
re
pt
oc
oc
cu
s 
su
is 
A7
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
G
7S
3C
7 
St
re
pt
oc
oc
cu
s 
su
is
 S
S1
2 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
G
7S
99
1 
St
re
pt
oc
oc
cu
s 
su
is
 D
9 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
G
7S
I5
8 
St
re
pt
oc
oc
cu
s 
su
is
 D
12
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
G
7U
BE
3 
Pa
nt
o
e
a 
a
n
an
at
is 
PA
13
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
n
to
e
a 
a
n
a
n
at
is 
G
7V
KE
7 
Le
uc
o
n
os
to
c 
m
es
en
te
ro
id
es
 s
ub
sp
. 
m
e
se
nt
e
ro
id
es
 J
18
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
 
G
7W
1M
5 
Pa
en
ib
a
cil
lu
s 
te
rr
a
e 
(s
tra
in
 H
PL
-0
03
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Pa
en
ib
a
cil
la
ce
a
e 
Pa
en
ib
a
cil
lu
s 
te
rr
ae
 
G
8L
D
P7
 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e 
Ec
W
SU
1 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
En
te
ro
ba
ct
e
r 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e
 c
om
pl
ex
 
G
8Q
Y6
6 
Sp
ha
er
o
ch
ae
ta
 
pl
eo
m
o
rp
ha
 (s
tra
in
 A
TC
C
 
BA
A-
18
85
 / 
D
SM
 2
27
78
 / 
G
ra
pe
s)
 
Ba
ct
e
ria
 
Sp
iro
ch
ae
te
s 
Sp
iro
ch
ae
ta
le
s 
Sp
iro
ch
ae
ta
ce
a
e 
Sp
ha
er
o
ch
ae
ta
 
pl
eo
m
o
rp
ha
 
 
G
9A
VJ
5 
Pa
nt
o
e
a 
a
n
an
at
is 
LM
G
 5
34
2 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Pa
n
to
e
a 
a
n
a
n
at
is 
H
0Q
C
J7
 
Es
ch
er
ich
ia
 
co
li s
tr.
 K
-1
2 
su
bs
tr.
 M
D
S4
2 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
H
2A
49
9 
St
re
pt
oc
oc
cu
s 
m
a
ce
do
ni
cu
s 
(s
tra
in
 A
C
A-
D
C
 
19
8)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
m
a
ce
do
n
icu
s 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 109 
 H
2I
SR
7 
Ra
hn
el
la
 
a
qu
a
tili
s 
(s
tra
in
 A
TC
C
 3
30
71
 / 
D
SM
 
45
94
 / 
JC
M
 1
68
3 
/ N
BR
C
 1
05
70
1 
/ N
C
IM
B 
13
36
5 
/ C
IP
 7
8.
65
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
e
lla
 
a
qu
at
ilis
 
H
2I
TG
3 
Ra
hn
el
la
 
a
qu
a
tili
s 
(s
tra
in
 A
TC
C
 3
30
71
 / 
D
SM
 
45
94
 / 
JC
M
 1
68
3 
/ N
BR
C
 1
05
70
1 
/ N
C
IM
B 
13
36
5 
/ C
IP
 7
8.
65
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
e
lla
 
a
qu
at
ilis
 
H
2J
6Y
9 
M
a
rin
ito
ga
 
pi
ez
o
ph
ila
 (s
tra
in
 D
SM
 1
42
83
 / 
JC
M
 1
12
33
 / 
KA
3)
 
Ba
ct
e
ria
 
Th
er
m
o
to
ga
e 
Th
er
m
o
to
ga
le
s 
Th
er
m
o
to
ga
ce
a
e 
M
a
rin
ito
ga
 
pi
ez
o
ph
ila
 
H
6N
44
7 
G
or
do
n
ia
 
po
lyi
so
pr
e
n
ivo
ra
n
s 
(s
tra
in
 D
SM
 
44
26
6 
/ V
H
2)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Ac
tin
om
yc
et
a
le
s 
Co
ry
n
e
ba
ct
e
rin
ea
e 
G
or
do
ni
ac
ea
e 
G
or
do
n
ia
 
H
6P
D
67
 
St
re
pt
oc
oc
cu
s 
in
fa
nt
a
riu
s 
(s
tra
in
 C
J1
8)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
in
fa
n
ta
riu
s 
H
8L
C
H
9 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 (s
tra
in
 A
us
00
04
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
En
te
ro
co
cc
a
ce
a
e 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 
H
8L
JZ
7 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 S
T5
56
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
H
8N
0X
1 
Co
ra
llo
co
cc
u
s 
co
ra
llo
id
e
s 
(s
tra
in
 A
TC
C
 2
52
02
 
/ D
SM
 2
25
9 
/ N
BR
C
 1
00
08
6 
/ M
2)
 
(M
yx
oc
oc
cu
s 
co
ra
llo
id
es
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
De
lta
pr
o
te
o
ba
ct
e
ria
 
M
yx
o
co
cc
a
le
s 
Cy
st
o
ba
ct
er
in
e
ae
 
M
yx
o
co
cc
ac
ea
e 
Co
ra
llo
co
cc
u
s 
H
8N
W
T1
 
Ra
hn
el
la
 
a
qu
a
tili
s 
H
X2
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
e
lla
 
a
qu
at
ilis
 
H
8N
Y9
1 
Ra
hn
el
la
 
a
qu
a
tili
s 
H
X2
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Ra
hn
e
lla
 
a
qu
at
ilis
 
H
8W
9V
6 
M
a
rin
o
ba
ct
e
r 
hy
dr
o
ca
rb
on
o
cla
st
icu
s 
AT
C
C
 
49
84
0 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
hy
dr
o
ca
rb
on
oc
la
s t
ic
u
s 
H
9U
SZ
3 
Es
ch
er
ich
ia
 
co
li P
12
b 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
I0
C
N
C
2 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 0
7P
F0
77
6 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
I0
C
V8
2 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 0
7P
F0
77
6 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
I0
C
VI
9 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 0
7P
F0
77
6 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
I0
I1
89
 
Ca
ld
ilin
ea
 a
e
ro
ph
ila
 (s
tra
in
 D
SM
 1
45
35
 / 
JC
M
 
11
38
7 
/ N
BR
C
 1
04
27
0 
/ S
TL
-6
-O
1)
 
Ba
ct
e
ria
 
Ch
lo
ro
fle
xi 
Ca
ld
ilin
ea
e 
Ca
ld
ilin
ea
le
s 
Ca
ld
ilin
ea
ce
a
e 
Ca
ld
ilin
ea
 
a
e
ro
ph
ila
 
I1
W
7Y
4 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. a
n
im
a
lis
 
(s
tra
in
 A
TC
C
 2
55
27
 / 
D
SM
 2
01
04
 / 
JC
M
 1
19
0 
/ R
10
1-
8)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
I1
YF
86
 
M
et
hy
lo
ph
ag
a 
sp
. (
st
ra
in
 J
AM
7)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Th
io
tri
ch
a
le
s 
Pi
sc
iri
ck
et
ts
ia
ce
a
e 
M
et
hy
lo
ph
ag
a 
sp
. 
I1
ZM
M
4 
St
re
pt
oc
oc
cu
s 
pa
ra
sa
n
gu
in
is
 F
W
21
3 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pa
ra
sa
n
gu
in
is 
I2
EI
A0
 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i E
S1
5 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i 
I6
PK
82
 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 B
i-0
7 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
I6
PV
X5
 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 s
ub
sp
. l
ac
tis
 B
42
0 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
I6
SE
Y2
 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e 
su
bs
p.
 d
iss
o
lve
n
s 
SD
M
 B
ac
te
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
En
te
ro
ba
ct
e
r 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e
 c
om
pl
ex
 
I6
T6
Q
7 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 G
S-
5 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 
J7
G
G
L8
 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e 
su
bs
p.
 c
lo
ac
ae
 
EN
H
KU
01
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
En
te
ro
ba
ct
e
r 
En
te
ro
ba
ct
e
r 
cl
oa
ca
e
 c
om
pl
ex
 
J7
KN
M
4 
St
re
pt
oc
oc
cu
s 
su
is 
S7
35
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
J7
M
I8
3 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
7 
st
r. 
SL
C
C
24
82
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
M
J8
4 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
27
55
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
M
KX
5 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
7 
st
r. 
SL
C
C
24
82
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
M
M
89
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
27
55
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
M
VQ
2 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
27
55
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
M
YV
0 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
7 
st
r. 
SL
C
C
24
82
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
C
77
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
72
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
ER
2 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
58
50
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 110 
 J
7N
FP
6 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
71
79
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
G
P4
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
58
50
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
KH
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
24
79
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
LJ
0 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
71
79
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
PM
3 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
72
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
U
96
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
76
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
U
K3
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
76
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
X0
7 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 L
31
2 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
XK
7 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
24
79
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
N
Y6
3 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 A
TC
C
 1
91
17
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
P3
08
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 L
31
2 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
P4
Z5
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 A
TC
C
 1
91
17
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
P5
77
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 A
TC
C
 1
91
17
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PC
B6
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
78
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PD
E2
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 L
31
2 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PD
H
4 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
78
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PE
64
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
25
40
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PQ
E7
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
23
78
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
PW
71
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
25
40
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
Q
0R
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 S
LC
C
25
40
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
J7
SD
00
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 S
PN
A4
5 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
J9
W
A2
8 
La
ct
o
ba
cil
lu
s 
bu
ch
ne
ri 
C
D
03
4 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
bu
ch
n
e
ri 
J9
Y6
F2
 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii A
TC
C
 2
71
26
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
J9
Y9
L2
 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii A
TC
C
 2
71
26
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
J9
YF
F9
 
Le
uc
o
n
os
to
c 
ge
lid
um
 (s
tra
in
 J
B7
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
ge
lid
u
m
 
J9
Z1
17
 
al
ph
a 
pr
ot
eo
ba
ct
er
iu
m
 H
IM
B5
9 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
SA
R
11
 c
lu
st
er
 
pr
ot
e
o
ba
ct
e
riu
m
 
J9
ZP
62
 
Es
ch
er
ich
ia
 
co
li O
10
4:
H
4 
(s
tra
in
 2
00
9E
L-
20
50
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
K0
AP
26
 
Es
ch
er
ich
ia
 
co
li O
10
4:
H
4 
(s
tra
in
 2
01
1C
-3
49
3)
 B
ac
te
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
K0
BI
B3
 
Es
ch
er
ich
ia
 
co
li O
10
4:
H
4 
(s
tra
in
 2
00
9E
L-
20
71
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
K0
C
Q
35
 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 E
ng
lis
h 
C
ha
nn
el
 6
73
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K0
C
TL
5 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 E
ng
lis
h 
C
ha
nn
el
 6
73
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K0
D
3Q
1 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 B
la
ck
 S
ea
 1
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K0
D
58
1 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 B
la
ck
 S
ea
 1
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K0
D
BR
9 
Le
uc
o
n
os
to
c 
ca
rn
os
u
m
 (s
tra
in
 J
B1
6)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
ca
rn
o
su
m
 
K0
EA
Q
8 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 B
al
ea
ric
 S
ea
 
AD
45
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K0
EB
K3
 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii (
st
ra
in
 B
al
ea
ric
 S
ea
 
AD
45
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K4
J3
B4
 
Bi
fid
o
ba
ct
e
riu
m
 
as
te
ro
id
e
s 
(s
tra
in
 P
R
L2
01
1)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
st
e
ro
id
es
 
K4
KJ
61
 
Si
m
id
ui
a 
a
ga
riv
o
ra
n
s 
(s
tra
in
 D
SM
 2
16
79
 / 
JC
M
 1
38
81
 / 
BC
R
C
 1
75
97
 / 
SA
1)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Si
m
id
ui
a 
a
ga
riv
o
ra
n
s 
K6
Z1
13
 
G
la
cie
co
la
 
ps
yc
hr
op
hi
la
 1
70
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
G
la
cie
co
la
 
ps
yc
hr
op
hi
la
 
K7
R
U
78
 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii A
ltD
E1
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K7
S9
N
4 
Al
te
ro
m
o
n
as
 
m
ac
le
od
ii A
ltD
E1
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Al
te
ro
m
o
n
as
 
m
a
cl
eo
di
i 
K8
F0
Z5
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 s
tr.
 
LL
19
5 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
K8
F1
G
3 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 s
tr.
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 111 
 
 
LL
19
5 
K8
FE
I8
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 s
tr.
 
LL
19
5 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
K9
PU
M
6 
Le
pt
o
lyn
gb
ya
 s
p.
 P
C
C
 7
37
6 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
O
sc
illa
to
ria
le
s 
Le
pt
o
lyn
gb
ya
 
sp
. 
 
K9
T2
S9
 
Pl
eu
ro
ca
ps
a
 s
p.
 P
C
C
 7
32
7 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pl
eu
ro
ca
ps
a
le
s 
Pl
eu
ro
ca
ps
a 
sp
. 
 
 
K9
T8
M
8 
Pl
eu
ro
ca
ps
a
 s
p.
 P
C
C
 7
32
7 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pl
eu
ro
ca
ps
a
le
s 
Pl
eu
ro
ca
ps
a 
sp
. 
 
 
K9
XU
32
 
St
a
ni
er
ia
 
cy
a
n
os
ph
a
e
ra
 (s
tra
in
 A
TC
C
 2
93
71
 / 
PC
C
 7
43
7)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pl
eu
ro
ca
ps
a
le
s 
St
a
ni
er
ia
 
cy
a
n
os
ph
a
e
ra
 
 
 
K9
Z5
J0
 
Cy
a
n
ob
ac
te
riu
m
 
a
po
ni
nu
m
 (s
tra
in
 P
C
C
 
10
60
5)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Cy
a
n
ob
ac
te
riu
m
 
a
po
ni
nu
m
 
 
L0
IL
15
 
Th
er
m
o
a
n
ae
ro
ba
ct
e
riu
m
 
th
er
m
os
ac
ch
ar
o
lyt
icu
m
 M
07
95
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Th
er
m
o
a
n
ae
ro
ba
ct
e
r
a
le
s 
Fa
m
ily
 II
I. 
In
ce
rta
e 
Se
di
s 
Th
er
m
o
a
n
ae
ro
ba
c
te
riu
m
 
th
er
m
os
ac
ch
ar
o
lyt
ic
u
m
 
L0
S8
90
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 S
PN
99
40
38
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
L0
SD
94
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 S
PN
03
41
83
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
L0
SM
N
1 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 S
PN
99
40
39
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
L8
A9
R
6 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 N
R
R
L 
B-
23
54
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
En
te
ro
co
cc
a
ce
a
e 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 
L8
D
XC
9 
Li
st
e
ria
 
m
on
oc
yt
o
ge
n
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
L8
E4
71
 
Li
st
e
ria
 
m
on
oc
yt
o
ge
n
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
L8
E5
Z4
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 N
53
-1
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
M
1F
B8
0 
M
a
rin
o
ba
ct
e
r s
p.
 B
Ss
20
14
8 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
sp
. 
M
1F
HW
7 
M
a
rin
o
ba
ct
e
r s
p.
 B
Ss
20
14
8 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Al
te
ro
m
o
n
ad
ac
e
a
e 
M
a
rin
o
ba
ct
e
r 
sp
. 
M
1J
EC
7 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i S
P2
91
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Cr
o
n
o
ba
ct
e
r 
sa
ka
za
ki
i 
M
1M
L4
9 
Cl
os
tri
di
um
 
sa
cc
ha
ro
pe
rb
u
ty
la
ce
to
ni
cu
m
 N
1-
4(
H
M
T)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
Cl
os
tri
di
ac
ea
e 
Cl
os
tri
di
um
 
sa
cc
ha
ro
pe
rb
u
ty
la
ce
to
n
icu
m
 
M
1M
YA
0 
Cl
os
tri
di
um
 
sa
cc
ha
ro
pe
rb
u
ty
la
ce
to
ni
cu
m
 N
1-
4(
H
M
T)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Cl
os
tri
di
a 
Cl
os
tri
di
al
es
 
Cl
os
tri
di
ac
ea
e 
Cl
os
tri
di
um
 
sa
cc
ha
ro
pe
rb
u
ty
la
ce
to
n
icu
m
 
M
1U
Q
12
 
St
re
pt
oc
oc
cu
s 
su
is
 S
C
07
07
31
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
su
is 
M
4H
U
K5
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 g
am
PN
I0
37
3 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
M
4J
JY
4 
Es
ch
er
ich
ia
 
co
li A
PE
C
 O
78
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
M
4R
C
Y8
 
Bi
fid
o
ba
ct
e
riu
m
 
th
er
m
op
hi
lu
m
 R
BL
67
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
th
er
m
op
hi
lu
m
 
M
5A
56
6 
Ilu
m
at
o
ba
ct
e
r 
co
cc
in
eu
m
 Y
M
16
-3
04
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
id
im
icr
o
bi
da
e 
Ac
id
im
icr
o
bi
al
e
s 
Ac
id
im
icr
o
bi
ne
a
e 
Ac
id
im
icr
o
bi
ac
ea
e 
Ilu
m
at
o
ba
ct
e
r 
M
5D
P0
7 
Th
al
as
so
litu
u
s 
o
le
ivo
ra
ns
 M
IL
-1
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
Th
al
as
so
litu
u
s 
o
le
ivo
ra
ns
 
 
M
5D
R
I3
 
Th
al
as
so
litu
u
s 
o
le
ivo
ra
ns
 M
IL
-1
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
Th
al
as
so
litu
u
s 
o
le
ivo
ra
ns
 
 
M
9Z
S9
3 
La
ct
o
ba
cil
lu
s 
re
ut
e
ri 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
re
u
te
ri 
P1
02
49
|Q
99
06
4 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 s
er
ot
yp
e 
c 
(s
tra
in
 
AT
C
C
 7
00
61
0 
/ U
A1
59
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
m
u
ta
ns
 
P3
39
10
 
Ag
ro
ba
ct
e
riu
m
 
vit
is 
(R
hi
zo
bi
um
 v
iti
s)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
izo
bi
al
es
 
Rh
izo
bi
ac
e
a
e 
R
hi
zo
bi
um
/A
gr
ob
a
ct
er
iu
m
 g
ro
up
 
Ag
ro
ba
ct
e
riu
m
 
P7
60
41
|P
78
14
9|
P7
81
51
 E
sc
he
ric
hi
a 
co
li (
st
ra
in
 K
12
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
Q
02
6K
9 
So
lib
ac
te
r 
u
si
ta
tu
s 
(s
tra
in
 E
llin
60
76
) 
Ba
ct
e
ria
 
Ac
id
o
ba
ct
e
ria
 
So
lib
ac
te
re
s 
So
lib
ac
te
ra
le
s 
So
lib
ac
te
ra
ce
a
e 
C
an
di
da
tu
s 
So
lib
ac
te
r 
u
sit
at
u
s 
Q
03
Z6
6 
Le
uc
o
n
os
to
c 
m
es
en
te
ro
id
es
 s
ub
sp
. 
m
e
se
nt
e
ro
id
es
 (s
tra
in
 A
TC
C
 8
29
3 
/ N
C
D
O
 
52
3)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
 
Q
04
D
54
 
O
en
oc
oc
cu
s 
oe
n
i (
st
ra
in
 A
TC
C
 B
AA
-3
31
 / 
PS
U
-1
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
O
e
n
oc
oc
cu
s 
o
e
n
i 
 
Q
04
IR
6 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
2 
(s
tra
in
 
D
39
 / 
N
C
TC
 7
46
6)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
Q
07
VZ
9 
Sh
ew
a
n
e
lla
 fr
ig
id
im
a
rin
a 
(s
tra
in
 N
C
IM
B 
40
0)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
fri
gi
di
m
a
rin
a 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 112 
 Q
07
Z7
9 
Sh
ew
a
n
e
lla
 fr
ig
id
im
a
rin
a 
(s
tra
in
 N
C
IM
B 
40
0)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
fri
gi
di
m
a
rin
a 
Q
0H
P7
2 
Sh
ew
a
n
e
lla
 s
p.
 (s
tra
in
 M
R
-4
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
sp
. 
Q
0I
0N
7 
Sh
ew
a
n
e
lla
 s
p.
 (s
tra
in
 M
R
-7
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Sh
ew
a
n
e
lla
ce
a
e 
Sh
ew
a
n
e
lla
 
sp
. 
Q
0I
D
79
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 C
C
93
11
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
 
Q
0T
I5
7 
Es
ch
er
ich
ia
 
co
li O
6:
K1
5:
H
31
 (s
tra
in
 5
36
 / 
U
PE
C
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
Q
14
EH
6 
Le
u
co
n
os
to
c 
m
es
en
te
ro
id
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
 
Q
15
TV
6 
Ps
eu
do
al
te
ro
m
o
n
as
 
at
la
nt
ica
 (s
tra
in
 T
6c
 / 
AT
C
C
 B
AA
-1
08
7)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Ps
eu
do
al
te
ro
m
o
n
ad
a
ce
a
e 
Ps
eu
do
al
te
ro
m
o
n
a
s 
a
tla
nt
ica
 
Q
16
2A
6 
Ro
se
ob
ac
te
r 
de
n
itr
ific
a
ns
 (s
tra
in
 A
TC
C
 3
39
42
 
/ O
C
h 
11
4)
 (E
ry
th
ro
ba
ct
e
r s
p.
 (s
tra
in
 O
C
h 
11
4)
) (
Ro
se
o
ba
ct
er
 d
e
n
itr
ific
a
ns
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
Al
ph
a
pr
o
te
o
ba
ct
e
ria
 
Rh
o
do
ba
ct
e
ra
le
s 
Rh
o
do
ba
ct
e
ra
ce
a
e 
Ro
se
ob
ac
te
r 
de
n
itr
ific
an
s 
Q
1G
JL
5 
Ru
e
ge
ria
 s
p.
 (s
tra
in
 T
M
10
40
) (
Si
lic
ib
a
ct
e
r s
p.
) B
ac
te
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
od
ob
ac
te
ra
le
s 
Rh
od
ob
ac
te
ra
ce
a
e 
Ru
e
ge
ria
 
sp
. 
Q
1Q
U
C
3 
Ch
ro
m
o
ha
lo
ba
ct
e
r 
sa
le
xi
ge
ns
 (s
tra
in
 D
SM
 
30
43
 / 
AT
C
C
 B
AA
-1
38
 / 
N
C
IM
B 
13
76
8)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
Ha
lo
m
o
n
a
da
ce
a
e 
Ch
ro
m
o
ha
lo
ba
ct
e
r s
a
le
xi
ge
ns
 
Q
1R
C
57
 
Es
ch
er
ich
ia
 
co
li (
st
ra
in
 U
TI
89
 / 
U
PE
C
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
Q
21
FR
2 
Sa
cc
ha
ro
ph
a
gu
s 
de
gr
a
da
ns
 (s
tra
in
 2
-4
0 
/ 
AT
C
C
 4
39
61
 / 
D
SM
 1
70
24
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
a
le
s 
Al
te
ro
m
o
n
ad
ac
e
a
e 
Sa
cc
ha
ro
ph
a
gu
s 
de
gr
a
da
n
s 
Q
2L
X8
0 
Sy
n
tro
ph
us
 
a
cid
itr
o
ph
icu
s 
(s
tra
in
 S
B)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
De
lta
pr
o
te
o
ba
ct
e
ria
 
Sy
n
tro
ph
o
ba
ct
e
ra
le
s 
Sy
n
tro
ph
ac
e
ae
 
Sy
n
tro
ph
u
s 
a
ci
di
tro
ph
icu
s 
Q
2N
Q
H
7 
So
da
lis
 
gl
os
si
ni
di
us
 (s
tra
in
 m
or
si
ta
ns
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
So
da
lis
 
gl
o
ss
in
id
iu
s 
Q
2S
Q
92
 
Ha
he
lla
 
ch
eju
en
sis
 
(s
tra
in
 K
C
TC
 2
39
6)
 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
O
ce
a
n
os
pi
ril
la
le
s 
Ha
he
lla
ce
a
e 
Ha
he
lla
 
ch
e
jue
n
sis
 
Q
31
B4
7 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 M
IT
 9
31
2)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
 
Q
31
H
K3
 
Th
io
m
ic
ro
sp
ira
 
cr
u
n
og
en
a 
(s
tra
in
 X
C
L-
2)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Th
io
tri
ch
a
le
s 
Pi
sc
iri
ck
et
ts
ia
ce
a
e 
Th
io
m
ic
ro
sp
ira
 
cr
u
n
o
ge
na
 
Q
3A
G
E9
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 C
C
96
05
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
 
Q
3A
VS
5 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 C
C
99
02
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
 
Q
3X
ZR
1 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 D
O
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
En
te
ro
co
cc
a
ce
a
e 
En
te
ro
co
cc
u
s 
fa
ec
iu
m
 
Q
46
L9
0 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 N
AT
L2
A)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
 
Q
48
9K
0 
Co
lw
e
llia
 
ps
yc
hr
e
ry
th
ra
e
a 
(s
tra
in
 3
4H
 / 
AT
C
C
 
BA
A-
68
1)
 (V
ib
rio
 
ps
yc
hr
o
e
ry
th
us
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
Al
te
ro
m
o
n
ad
al
es
 
Co
lw
e
llia
ce
a
e 
Co
lw
e
llia
 
ps
yc
hr
er
yt
hr
ae
a 
Q
59
49
5 
Le
u
co
n
os
to
c 
m
es
en
te
ro
id
es
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
Le
u
co
n
os
to
c 
m
e
se
nt
e
ro
id
es
 
 
Q
71
VS
1 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
F2
36
5)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
Q
71
W
29
 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
F2
36
5)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
Q
72
4F
3 
Li
st
e
ria
 m
on
oc
yt
o
ge
n
es
 s
er
ot
yp
e 
4b
 (s
tra
in
 
F2
36
5)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
m
o
n
o
cy
to
ge
n
es
 
Q
74
LC
2 
La
ct
o
ba
cil
lu
s 
joh
ns
o
n
ii (
st
ra
in
 C
N
C
M
 I-
12
25
0 
/ 
La
1 
/ N
C
C
 5
33
) 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
joh
ns
o
n
ii 
Q
7M
C
J3
 
Vi
br
io
 
vu
ln
ific
u
s 
(s
tra
in
 Y
J0
16
) 
Ba
ct
e
ria
 
Pr
o
te
o
ba
ct
e
ria
 
G
a
m
m
a
pr
ot
e
ob
ac
te
ria
 
Vi
br
io
n
a
le
s 
Vi
br
io
n
a
ce
a
e 
Vi
br
io
 
vu
ln
ific
u
s 
Q
7U
3J
7 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. (
st
ra
in
 W
H
81
02
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
O
sc
illa
to
rio
ph
yc
id
ea
e 
Ch
ro
oc
o
cc
al
es
 
Sy
n
e
ch
oc
o
cc
u
s 
sp
. 
 
Q
7U
IS
9 
Rh
od
op
ire
llu
la
 
ba
ltic
a 
(s
tra
in
 S
H
1)
 
Ba
ct
e
ria
 
Pl
an
ct
o
m
yc
et
es
 
Pl
an
ct
o
m
yc
et
ia
 
Pl
an
ct
o
m
yc
et
a
le
s 
Pl
an
ct
o
m
yc
et
ac
e
ae
 
Rh
od
op
ire
llu
la
 
ba
ltic
a 
Q
7V
1B
8 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
su
bs
p.
 p
as
to
ris
 
(s
tra
in
 C
C
M
P1
98
6 
/ M
ED
4)
 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
 
Q
7V
C
L2
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
u
s 
(s
tra
in
 S
AR
G
 / 
C
C
M
P1
37
5 
/ S
S1
20
) 
Ba
ct
e
ria
 
Cy
a
n
ob
ac
te
ria
 
Pr
oc
hl
or
al
es
 
Pr
oc
hl
or
oc
oc
ca
ce
ae
 
Pr
oc
hl
or
oc
oc
cu
s 
m
a
rin
us
 
 
Q
7W
W
P8
|F
1S
VF
2|
Q
5F
J
62
 
La
ct
o
ba
cil
lu
s 
a
cid
o
ph
ilu
s 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
ci
do
ph
ilu
s 
Q
7W
W
Q
5|
F
1S
VJ
9|
Q
5F
L
N
4 
La
ct
o
ba
cil
lu
s 
a
cid
o
ph
ilu
s 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
La
ct
o
ba
cil
la
ce
a
e 
La
ct
o
ba
cil
lu
s 
a
ci
do
ph
ilu
s 
Sucrose 6'-phosphate phosphorylase as a novel specificity  CHAPTER 4 
 113 
 
  
Q
84
BY
1 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
Q
84
H
Q
2 
Bi
fid
o
ba
ct
e
riu
m
 
a
do
le
sc
e
nt
is
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
a
e 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
do
le
sc
e
nt
is 
Q
8C
W
P4
 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 (s
tra
in
 A
TC
C
 
BA
A-
25
5 
/ R
6)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
Q
8F
H
S2
 
Es
ch
er
ich
ia
 
co
li O
6:
H
1 
(s
tra
in
 C
FT
07
3 
/ A
TC
C
 
70
09
28
 / 
U
PE
C
) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
G
am
m
a
pr
ot
e
ob
ac
te
ria
 
En
te
ro
ba
ct
e
ria
le
s 
En
te
ro
ba
ct
e
ria
ce
a
e 
Es
ch
er
ich
ia
 
co
li 
Q
8G
6U
7 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 (s
tra
in
 N
C
C
 2
70
5)
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
lo
ng
um
 
Q
8K
U
X6
 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
Ba
ct
e
ria
 
Ac
tin
ob
ac
te
ria
 
Ac
tin
ob
ac
te
rid
ae
 
Bi
fid
o
ba
ct
e
ria
le
s 
Bi
fid
o
ba
ct
e
ria
ce
a
e 
Bi
fid
o
ba
ct
e
riu
m
 
a
n
im
a
lis
 
Q
92
6R
8 
Li
st
e
ria
 in
n
oc
u
a 
se
ro
va
r 6
a 
(s
tra
in
 C
LI
P 
11
26
2)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
Ba
cil
la
le
s 
Li
st
e
ria
ce
a
e 
Li
st
e
ria
 
in
no
cu
a 
Q
97
NW
5 
St
re
pt
oc
oc
cu
s 
pn
eu
m
o
n
ia
e
 s
er
ot
yp
e 
4 
(s
tra
in
 
AT
C
C
 B
AA
-3
34
 / 
TI
G
R
4)
 
Ba
ct
e
ria
 
Fi
rm
ic
u
te
s 
Ba
cil
li 
La
ct
o
ba
cil
la
le
s 
St
re
pt
oc
oc
ca
ce
ae
 
St
re
pt
oc
oc
cu
s 
pn
e
u
m
o
n
ia
e 
Q
9R
6E
2 
Rh
izo
bi
um
 
ra
di
ob
ac
te
r (
Ag
ro
ba
ct
e
riu
m
 
tu
m
ef
ac
ie
ns
) (
Ag
ro
ba
ct
e
riu
m
 
ra
di
ob
a
ct
e
r) 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
izo
bi
al
es
 
Rh
izo
bi
ac
e
a
e 
Rh
izo
bi
um
/A
gr
ob
a
ct
e
riu
m
 g
ro
up
 
Ag
ro
ba
ct
e
riu
m
 
Q
9W
W
B0
 
Ag
ro
ba
ct
e
riu
m
 
ra
di
ob
a
ct
e
r (
st
ra
in
 K
84
 / 
AT
C
C
 
BA
A-
86
8)
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Al
ph
ap
ro
te
o
ba
ct
e
ria
 
Rh
izo
bi
al
es
 
Rh
izo
bi
ac
e
a
e 
Rh
izo
bi
um
/A
gr
ob
a
ct
e
riu
m
 g
ro
up
 
Ag
ro
ba
ct
e
riu
m
 
Q
9X
BR
0 
Ps
eu
do
m
o
na
s 
sa
cc
ha
ro
ph
ila
 
Ba
ct
e
ria
 
Pr
ot
e
o
ba
ct
e
ria
 
Be
ta
pr
ot
e
o
ba
ct
e
ria
 
Bu
rk
ho
ld
e
ria
le
s 
Co
m
a
m
o
n
a
da
ce
a
e 
Pe
lo
m
o
na
s 
sa
cc
ha
ro
ph
ila
 
CHAPTER 4  Sucrose 6'-phosphate phosphorylase as a novel specificity 
 114 
Table S4.4 Relevant genes in Thermoanaerobacterium thermosaccharolyticum DSM571. 
locus tag annotation 
sucrose-active enzymes 
Tthe_1921 sucrose 6’-phosphate phosphorylase (incorrectly annotated as sucrose phosphorylase) 
Tthe_1924 sucrose-6-phosphate hydrolase 
  
phosphoglucomutases 
Tthe_0493 phosphoglucosamine mutase/ phosphoglucomutase/phosphomannomutase 
Tthe_1016 phosphoglucomutase/phosphomannomutase 
Tthe_1054 beta-phosphoglucomutase 
  
(phospho)fructokinases 
The_0770 6-phosphofructokinase (ATP + Fru 6-P " Fru 1,6-PP) 
(Tthe_1699) (PfkB domain containing protein) 
(Tthe_1726) (PfkB domain containing protein) 
Tthe_1922 6-phosphofructokinase 
(Tthe_2482) (PfkB domain containing protein) 
Tthe_2552 1-phosphofructokinase (ATP + Fru 1-P " Fru 1,6-PP) 
  
GT4 family synthases (family of sucrose 6’-phosphate synthase) 
Tthe_0063 group 1 glycosyl transferase 
Tthe_0911 group 1 glycosyl transferase 
Tthe_0917 group 1 glycosyl transferase 
Tthe_1078 group 1 glycosyl transferase 
Tthe_1179 group 1 glycosyl transferase 
Tthe_1788 group 1 glycosyl transferase 
Tthe_2187 family 2 glycosyl transferase 
Tthe_2417 glycogen synthase 
  
PTS components 
Tthe_0393 phosphoenolpyruvate-protein phosphotransferase 
Tthe_0634 PTS system beta-glucoside-specific subunit IIABC 
Tthe_0646 PTS system transcriptional activator 
Tthe_0647 PTS system lactose/cellobiose-specific subunit IIA 
Tthe_0649 PTS system lactose/cellobiose-specific subunit IIB 
Tthe_0650 PTS system cellobiose-specific subunit IIC 
Tthe_0766 PTS system phosphocarrier protein HPr 
Tthe_1733 PTS system mannose/fructose/sorbose family component IID 
Tthe_1734 PTS system sorbose-specific IIC subunit 
Tthe_1735 protein-N(pi)-phosphohistidine--sugar phosphotransferase 
Tthe_1736 PTS system fructose subfamily component IIA 
Tthe_1737 PTS system transcriptional activator 
Tthe_1829 PTS system mannose/fructose/sorbose family subunit IID 
Tthe_1830 PTS system mannose/fructose/sorbose family subunit IIC 
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Tthe_1831 PTS system mannose/fructose/sorbose family subunit IIB 
Tthe_1832 PTS system mannose/fructose/sorbose family subunit IIA 
Tthe_1833 PTS system transcriptional activator 
Tthe_1911 PTS system galactitol-specific subunit IIC 
Tthe_1912 PTS system lactose/cellobiose-specific subunit IIB 
Tthe_1913 PTS IIA-like protein nitrogen-regulatory protein PtsN 
Tthe_2093 PTS system lactose/cellobiose-specific subunit IIA 
Tthe_2094 PTS system lactose/cellobiose family subunit IIC 
Tthe_2095 PTS system lactose/cellobiose-specific subunit IIB 
Tthe_2097 PTS modulated transcriptional regulator 
Tthe_2348 protein-N(pi)-phosphohistidine--sugar phosphotransferase 
Tthe_2349 PTS system glucose subfamily subunit IIA 
Tthe_2355 PTS system lactose/cellobiose-specific subunit IIA 
Tthe_2357 PTS system lactose/cellobiose family subunit IIC 
Tthe_2358 PTS system lactose/cellobiose -specific subunit IIB 
Tthe_2359 PTS system transcriptional activator 
Tthe_2469 PTS system sorbose subfamily component IIB 
Tthe_2470 PTS system mannose/fructose/sorbose family component IID 
Tthe_2471 PTS system sorbose-specific subunit IIC 
Tthe_2472 PTS system fructose subfamily component IIA 
Tthe_2473 PTS system transcriptional activator 
Tthe_2550 PTS system fructose subfamily subunit IIC 
Tthe_2551 PTS IIA-like protein nitrogen-regulatory protein PtsN 
  
not present 
- sucrose 6’-phosphate synthase (UDP-Glc + Fru 6-P " Suc 6’-P) 
- sucrose 6’-phosphate phosphatase (Suc 6’-P " Suc + Pi) 
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ABSTRACT 
Present-day enzymes have evolved from a common ancestor that is believed to be promiscuous or 
to have an appropriate mutational background to evolve. Ancestral enzymes would accordingly be 
ideally suited to create new (related) specificities by directed evolution. To investigate whether an 
ancestral enzyme could be a good starting point for mutagenesis and what the role of promiscuity 
is, a full-length ancestor of sucrose phosphorylase (SP) and sucrose 6’-phosphate phosphorylase 
(SPP) enzymes was reconstructed. The ancestor behaved like a sucrose phosphorylase, but its 
activity was one to three orders of magnitude lower than present-day SP’s. This was mainly due to 
a low kcat (<1 s-1) and a high KM for sucrose and fructose (>200 mM). In addition, promiscuity was 
very similar in qualitative terms, but activities were in general lower. Swapping SP specific residues 
with their SPP counterpart could furthermore not introduce SPP activity in the ancestor. However, 
the same mutations could enable a specificity switch in a thermostable present-day SP, suggesting 
that for directed evolution a stable template might be more appropriate than an ancestral. 
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1 INTRODUCTION 
An important difference between natural and directed evolution is the starting point. Indeed, 
directed evolution is applied to present-day enzymes, whereas natural evolution of enzyme families 
started from a common ancestor. It is believed that this latter exhibited a broad substrate 
specificity, although the activity towards the various substrates was probably relatively low185, 186. 
Through the acquisition of various mutations, one of these activities could be stimulated or new 
(related) activities be introduced. The enzymes that exist at present are thus much more specialised 
and might not always offer the required flexibility to modify their specificity by directed evolution. 
Indeed, careful analysis of mutational pathways in enzyme evolution experiments has revealed that 
sequences first tend to drift towards their progenitor before a switch to a new activity is achieved. 
The reduced flexibility of present-day enzymes (and proteins in general) does however not 
necessarily have to be because they are too specialised. It can just simply be that they house 
certain mutations that are neutral to the current specificity, but make it impossible to switch to 
another. This phenomenon was for instance observed in steroid receptors177-179, 359. These nuclear 
transcription factors directly regulate gene expression in a ligand-dependent fashion. Swapping key 
residues responsible for specificity yielded receptors that could not activate at all. Introducing the 
same residues in a common ancestor, in contrast, did result in the desired ligand preference. 
Resurrecting successive ancestors revealed that some mutations allow a function switch (permissive 
mutations) while others block the return to the ancestral function (restrictive mutations). Similar 
conclusions were found for turning green opsins into red, and vice versa175, 176. 
Clearly, the ancestral sequence plays a crucial role in the evolution of new specificities. Yet, only a 
few examples are known where ancestral information is used for enzyme engineering purposes191, 
192. There, small libraries of ancestral mutations, introduced in present-day enzymes, were screened 
for altered specificity, but the use of a full-length ancestor as a template for mutagenesis has not 
yet been reported. Therefore, in this work we investigated whether an ancestral enzyme is a better 
starting point for mutagenesis, and if so, whether it is due to promiscuity or a more favourable 
evolutionary background. To that end, the common ancestor of sucrose phosphorylase (SP) and 
sucrose 6’-phosphate phosphorylase (SPP) was reconstructed, and determinants of SPP specificity 
were introduced in the ancestral enzyme as well as in two present-day sucrose phosphorylases.  
2 RESULTS 
2.1 Reconstruction of the ancestral sequence 
According to the CAZy database16, around 400 sequences are classified in the α-amylase subfamily 
18 (GH13_18). Until recently sucrose phosphorylase was the only known specificity, but it has been 
shown that this subfamily also harbours sucrose 6’-phosphate phosphorylases and most likely other 
specificities (Chapter 4). These latter are grouped into a distinct branch of the phylogenetic tree 
and in order to reduce the complexity of the reconstruction process, these sequences were 
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discarded (except for a few, to ensure sufficient diversity in the outgroup). The remaining protein 
sequences (~250) were used to construct a maximum likelihood tree in MEGA, based on the 
WAG+I+G model (best scoring model for the input sequences) (Figure 5.1). The tree nicely 
branched into genera and species, with related organism close to each other. Moreover, the 
topology of a bootstrap consensus tree and a tree using the LG+I+G model (second best model) 
largely agreed, with the exception of a few recent splits, and therefore increased our confidence in 
the constructed tree. The reconstruction process however is more challenging, since SP enzymes 
have several loops that vary in length. Accordingly, the alignment has several gaps, often spanning 
multiple sites. Therefore the FastML package was used, since it particularly pays attention to indel 
events (indels are treated as complete entities instead of single characters at one position)360. In 
addition, it returns the posterior probability (see methods and materials for definition) for each 
character and indel at each sequence position, providing information on the confidence of the 
reconstruction process. Moreover, posterior probabilities of alternative states at a given position are 
provided as well, allowing for positions with low probabilities to be studied in more detail.  
 
 
Figure 5.1 Maximum likelihood tree of sucrose phosphorylases and sucrose 6’-phosphorylases 
(#  characterised SP; " characterised SPP; ! reconstructed ancestor). 
 
After reconstruction of the ancestral sequence, positions with low probabilities were carefully 
examined for anomalies that could hamper proper folding (Table S5.1). They were compared with 
the variation in the input sequences (Figure S5.1 and Figure S5.2), and a homology model was 
Streptococcus 
species 
Lactobacillus 
species 
Leuconostoc 
species 
Bifidobacterium 
species 
Altero- 
monadales  
(Lacto)bacillales 
Clostridiales  
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constructed to examine (potentially) interacting residues. The structure was visually inspected for 
unsatisfied buried hydrogen bonds, (clusters of) solvent exposed hydrophobic residues, steric 
clashes and polar mismatches. Special attention was paid to positions within 10 Å from the active 
site, since some mutations can easily result in an impaired enzyme (Figure 5.2). Around two-thirds 
of the positions had a posterior probability of more than 0.80, which is quite a high number 
regarding the low sequence identity of the input sequences (~30%) (Figure S5.3).  
 
 
Figure 5.2 Positions with low posterior probabil it ies (< 0.80) within 10 Å of the active site, 
depicted on the homology model of the ancestral sequence (residue label: AA1n (AA2) with 
AA1 amino acid with highest probabil ity, n residue number and AA2 amino acid with second 
highest probabil ity (prob AA1 + AA2 > 0.80); green: region within 10 Å from sucrose (yellow 
sticks); green sticks: all residues with low posterior probabil it ies) . 
 
The lower probabilities of the remainder of the positions arise from the high variability in the input 
sequences. Often mutations at these positions are very conservative (e.g. Leu-Ile or Glu-Gln) or 
appear in pairs (e.g Glu-Arg, Lys-Asp) (Figure S5.4). They are however not always maintained in one 
lineage of the tree, and they show the same variability for different clades. This of course hampers 
the accurate prediction of the ancestral sequence. Yet, the joint posterior probabilities of the most 
likely and second most likely residue are nearly always > 0.80. Some mutations thus could have a 
minor effect on stability or activity, but since the same alternatives are present in modern-day SP 
enzymes, no obvious conflicts were observed that could hamper the proper folding of the ancestral 
enzyme. 
Ile335 (Val) 
Ile294 (Val) 
Val295 (Ile) 
Ile332 (Leu) 
Thr156 (Ser) 
Glu158 (Gln) 
Arg131 (Lys) 
Ala51 (Ser) 
Met82 (Ile) 
His55 (Tyr) 
Glu235 (Gln) 
Phe206 (Leu) 
Val83 (Ile) 
Ile211 (Val) 
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2.2 Specificity and kinetic properties 
The reconstructed enzyme is the ancestor of sucrose and sucrose 6’-phosphate phosphorylases and 
could accordingly display either one of both, or a mixed specificity. Therefore both specificities were 
assayed. These are very similar and the respective enzymes use inorganic phosphate to convert 
sucrose or sucrose 6’-phosphate into α-D-glucose 1-phosphate and D-fructose or D-fructose 6-
phosphate in a reversible way. The specific SP activity of the ancestor was found to be 0.09 and 
0.06 U/mg for the phosphorolysis and synthesis of sucrose, respectively. SPP activity in contrast 
hardly exceeded the detection limit (~0.0001 U/mg for both directions). The ancestral enzyme can 
thus be considered a sucrose phosphorylase and will therefore be referred to as AncSP. It should 
be noted that SP enzymes typically show only a minor hydrolytic side activity (1-5%). Here however, 
hydrolysis rates appeared to be quite substantial, i.e. the same and three times higher compared to 
the phosphorolysis and synthesis reaction, respectively. 
In order to further assess the properties of the ancestral enzyme, the Michaelis-Menten profiles for 
all substrates and their corresponding apparent kinetic parameters were determined (Table 5.1). 
Interestingly, the KM values for inorganic phosphate and glucose 1-phosphate appear to lie within 
the typical range for sucrose phosphorylases (2-20 mM), which is in sharp contrast with the values 
for sucrose and fructose. For the latter, it was even impossible to experimentally obtain a 
characteristic Michaelis-Menten profile. Indeed, a linear dependency on the substrate concentration 
up to a very high level of 1000 mM was observed, suggesting a KM for fructose at least 50-fold 
higher compared to present-day SP enzymes. Moreover, the turnover numbers and catalytic 
efficiencies for all substrates were very low (one to three orders of magnitude lower than known 
SPs). Hence, despite the preference of sucrose over sucrose 6’-phosphate as a substrate, AncSP is 
not very efficient in performing its sucrose phosphorylase activity. 
 
Table 5.1 Apparent kinetic parameters of the ancestral sucrose phosphorylase (AncSP) for 
sucrose, inorganic phosphate, glucose 1-phosphate and fructose (pH 7.0 and 37°C). 
reaction substrate KM (mM) kcat (s-1) kcat/KM (s-1mM-1) 
phosphorolysis sucrose 236 ± 55 0.17 ± 0.02 0.001 
 inorganic phosphatea 6.4 ± 0.9 0.06 ± 0.01 0.009 
synthesis glucose 1-phosphateb 7.2 ± 3.7 0.02 ± 0.01 0.003 
 fructosec n.a. n.a. 0.0006 
a 100 mM sucrose as co-substrate (non-saturating); b 100 mM fructose as co-substrate (non-saturating); c calculated from 
v = vmax.[S]/KM (simplified Michaelis equation, assuming [S] << KM); n.a. not available 
 
In order to find a cause for the strikingly low affinity and catalytic efficiency for fructose, the active 
site of AncSP was compared to that of other SP enzymes, based on sequence and structure. 
Residues in the -1 subsite (donor site) are the same for AncSP and other SP (Figure S5.5), which is 
in accordance with the observed results. The acceptor site is however nearly identical as well (Figure 
5.3). The crucial residues Tyr196 and His234 are present, and the flanking amino acids in AncSP are 
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those commonly observed in SP. The same is true for loop A. Only a minor difference can be found 
in loop B, which resembles that of lactic acid bacteria (LAB) SP enzymes. An Arg is present instead 
of a Lys, at a position that is not crucial for specificity. Moreover, the Pro at the tail of the loop is 
naturally present in one fourth of the LAB, and even in all Bifidobacteria-like sucrose 
phosphorylases. Accordingly, a clear reason for the low affinity cannot be indicated, and it is 
therefore likely that more distant residues cause subtle changes to the active site architecture, 
which might hamper optimal substrate-enzyme interactions. In addition, the movement of loop A 
en B, that are known to undergo structural rearrangements during sucrose conversion, might be 
obstructed as well, similarly resulting in reduced affinity and activity. 
 
 
Figure 5.3 Comparison of the acceptor site of present-day sucrose phosphorylases (sequence 
logos) and the ancestral enzymes (sequence above logos) (crystal structure from B. 
adolescentis SP (PDB entry 2GDU chain A); sequence logo: height of character represents the 
frequency of occurrence of a residue among all (al l SP), lactic acid bacteria-l ike (LAB SP) or 
Bif idobacteria-l ike sequences (Bif ido SP); ball : fructose; asterisk: residues involved in acceptor 
specif icity, confirmed by mutagenesis) . 
 
2.3 Promiscuity 
Extant sucrose phosphorylases have already a rather broad acceptor promiscuity26, 72. They are able 
to transglycosylate a wide range of acceptor molecules, but the activities are often lower than the 
competing hydrolytic side activity. Moreover, it was shown that SP enzymes are really optimised to 
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accommodate fructose (and inorganic phosphate) in their acceptor site (Chapter 2). This is however 
not the case for AncSP, and the reduced affinity for fructose might be in favour of the overall 
promiscuity. Therefore, to evaluate whether the ancestral enzyme behaves differently on alternative 
substrates, the activity of AncSP on a range of carbohydrate donors and acceptors was compared 
to that of SP from Bifidobacterium adolescentis (BaSP) and Leuconostoc mesenteroides (LmSP) (two 
widely used SP enzymes, representative for the two major SP branches in the phylogenetic tree) 
(Table 5.2). AncSP shows activity towards all considered substrates, but it is consistently far less 
active than the other enzymes. Activities relative to the respective wild-type reaction might suggest 
that AncSP is slightly more promiscuous, but the higher values for AncSP are mainly caused by a 
much lower wild-type activity. 
 
Table 5.2 Specif ic activity (U/mg) on different donor and acceptor substrates of the ancestral 
enzyme (AncSP) and present-day representatives from L. mesenteroides (LmSP) and B. 
adolescentis (BaSP) (al l reactions were performed with 100 mM donor and acceptor at 37°C, 
pH 7.0). 
substrate AncSP BaSP LmSP 
acceptor a D-fructose 0.0620 (100%) 49.2 (100%) 22.7 (100%) 
 D-glucose 0.0013 (2%) 0.0281 (<1%) 0.0037 (<1%) 
 D-galactose 0.0006 (1%) 0.0288 (<1%) 0.0222(<1%) 
 L-sorbose 0.0033 (5%) 12.0 (24%) 4.5 (20%) 
donorb sucrose 0.0900 (100%) 120.0 (100%) 37.2 (100%) 
 kojibiose 0.0010 (1%) 0.0155 (<1%) 0.0035(<1%) 
 maltose  0.0010 (1%) 0.0404 (<1%) 0.0047(<1%) 
a with glucose 1-phosphate as donor; b with inorganic phosphate as acceptor 
 
Table 5.3 Activity on non-carbohydrate acceptors of the ancestral enzyme (AncSP) and SP 
from B. adolescentis (BaSP) (present-day representative) (activity was rated as no activity (-) 
over poor (+) to very good (++++), based on the intensity of product spots on TLC; see 
methods and materials for further details) . 
compound AncSP BaSP compound AncSP BaSP 
pyrogallol ++ ++++ (S)-1-phenylethanol - - 
4-methylcatechol - +++ p-hydroxypyridine - - 
2-hydroxybenzylalcohol - + cinnamyl alcohol - - 
methylgallate ++ +++ curcumin - - 
ethylgallate ++ ++ quercetin - - 
propylgallate ++ ++ hydroquinone - - 
laurylgallate - - resveratrol - - 
2-nitrophenol - - gallic acid - - 
4-nitrophenol - - salicylic acid - - 
vanillin - - L-ascorbic acid - - 
vanillyl alcohol - - methyl 4-
hydoxybenzoate 
- - 
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Not only carbohydrates, but also phenolic molecules can be glycosylated by SP, and therefore the 
activity on these compounds was evaluated as well (Table 5.3). AncSP is able to produce glycosides 
from pyrogallol and short-chain esters of gallic acid, but never significantly better than its 
descendant BaSP. In addition, AncSP can also not glycosylate any compound that BaSP cannot, but 
the contrary is true for a few (e.g. methylcatechol and hydroxybenzylalcohol). In conclusion, in 
terms of substrate range the ancestor has in general a similar promiscuity as present-day sucrose 
phosphorylases, but an overall lower activity. 
2.4 Ancestor as a starting point for mutagenesis 
Even though AncSP is not more promiscuous, it could still be an interesting starting point for 
mutagenesis. Ancestral enzymes could have residues that do not structurally restrict function-
changing mutations, and should accordingly be more appropriate to evolve to a new specificity185. 
In that respect, AncSP is ideal to simulate this process in vitro, since AncSP is a sucrose 
phosphorylase that intrinsically has the ability to evolve to a new specificity (sucrose 6’-phosphate 
phosphorylase). Hence, the hypothesis that a function-switch is more successful in the case of an 
ancestor compared to present-day enzymes, was verified by introducing function-switching 
mutations in AncSP, and BaSP and LmSP, respectively. 
For both SP and SPP the determinants of acceptor specificity have been elucidated (Chapter 2 and 
4). The residues near the nucleophile, general/acid base catalyst and the transition state stabiliser, 
whose side chains point into the acceptor site, are the same for SP and SPP (Figure S5.5). The 
important differences can be found in loop A en B (Figure 5.4). Mutagenesis experiments on 
Thermoanaerobacterium thermosaccharolyticum SPP (TtSPP) showed that Arg134 and His344 are 
involved in the binding of the fructose-bound phosphate group. Therefore, these residues were  
 
 
Figure 5.4 Position of loop A en B in the structure of sucrose phosphorylase and alignment of 
these regions for the ancestral enzyme (AncSP) and characterised sucrose/sucrose 6’-
phosphate phosphorylases (SP/SPP) (LmSP: L. mesenteroides SP; BaSP: B. adolescentis SP; 
TtSPP: T. thermosaccharolyticum SPP; crystal structure from BaSP: pdb entry 2GDU chain A; 
balls : fructose; asterisk: residue involved in acceptor specif icity, confirmed by mutagenesis; 
dark background: residue mutated to its SPP counterpart) . 
Tyr132 
Gln345 
Gly137 Pro136 
Arg135 
Arg133 
Pro134 
Tyr344 
Asn340 
Leu343 
Leu341 
Asp342 
TtSPP 132 F L R* R T - 
AncSP 130 Y R R K P G 
BaSP 132 Y* R P* R* P G 
LmSP 135 Y K R* K D K 
TtSPP 340 G F D V H* Q 
AncSP 329 N L D I Y Q 
BaSP 340 N L D* L Y* Q* 
LmSP 336 N L D* I Y* Q 
loop A 
loop B 
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introduced at the equivalent positions in the SP enzymes (if not already present). In addition, the SP 
conserved Asn-Leu motif in loop A was replaced with Gly-Phe. In the crystal structure of BaSP, the 
leucine makes a hydrophobic contact with the C6 of the fructosyl moiety, and accordingly the 
presence of a different residue in SPP is most likely related to the difference in specificity. The 
asparagine was mutated at the same time, since it was believed that the backbone flexibility 
introduced by Gly helps to accommodate the larger Phe side chain in loop A. Finally, Leu133 in 
loop B of TtSPP was introduced as well, as this residue contributes to the conformation of the loop 
(and hence the shape of the acceptor site), and because in SP enzymes a positively charged residue 
(Arg or Lys) is present. The wild-type AncSP is able to glycosylate fructose 6-phosphate, albeit at a 
very slow rate (Table 5.4). Introduction of SPP specific mutations, however, abolished this ability 
entirely. The SP activity in contrast remained the same. Similarly, SPP activity was completely lost in 
LmSP upon mutation, and a severe drop in SP activity was observed as well. The only mutant that 
did show SPP activity, was that from BaSP, but a complete switch could not be achieved and the 
activity was also very poor. Accordingly, these finding clearly show that in this case the ancestor is 
not a better starting point for mutagenesis compared to present-day enzymes.  
 
Table 5.4 Specif ic activity on fructose 6’-phosphate and fructose for wild-type enzymes and 
SP/SPP switch mutants (TtSPP: T. thermosaccharolyticum SPP; AncSP: ancestror SP; LmSP: L. 
mesenteroides SP; BaSP: B. adolescentis SP) (al l reactions were performed with 100 mM donor 
and acceptor at 37°C, pH 7.0) 
enzyme/mutant activityFru6P (U/mg) activityFru (U/mg) ratioFru6P/Fru 
wild-type TtSPP 17.1 9.1 1.9 
 AncSP 0.0001 0.06 0.001 
 LmSP 0.0003 22.7 0.0001 
 BaSP - 49.2 - 
mutant AncSP_loopAB - 0.06 - 
 LmSP_loopAB - 0.02 - 
 BaSP_loopAB 0.03 0.10 0.3 
 
3 DISCUSSION 
The ancestral enzyme shows trace activity on sucrose 6’-phosphate, but performs much better as a 
sucrose phosphorylase. It can thus be concluded that SPP evolved from SP and not the other way 
around. This is perhaps not very surprising, because AncSP is not the ancestor of all SP enzymes. 
Indeed, SP and SPP activity do not split at the root. Bifidobacteria-like SP enzymes branch off 
earlier, and AncSP is the ancestor of the lactic acid bacteria-like SP and the SPP enzymes (Figure 
5.1). Yet, AncSP is not very efficient in carrying out the SP activity. It is however not uncommon for 
ancestral enzymes to lose much of their activity185, 186, and besides it has also been observed that 
an activity is temporary reduced during evolution, in order to allow a new specificity to originate, 
but is restored afterwards183. Still, the similar promiscuity as present-day enzymes in terms of 
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substrate range, but lower absolute activities, might indicate that the catalytic machinery is not 
optimally tuned. Careful inspection of the active site revealed that it is highly similar to that of 
known SP enzymes, and accordingly the discrepancy in activity should be the result of subtle 
differences. These could be caused by the reconstruction process, since inference of ancestral 
sequences is never statistically unambiguous193, 359. Some positions have indeed a rather low 
probability, and it is therefore not unlikely that a site might have been occupied by an amino acid 
other than the most likely. Although second most likely residues almost always comprised highly 
conservative mutations, it is possible that these are better for the overall performance of the 
enzyme. Ideally, these alternative sequences were also created in the lab and their activities 
investigated together with other properties like soluble expression and stability. That way, fitter 
ancestors could have been found or if different ancestors would display similar patterns of activity 
and promiscuity, it would provide stronger evidence for the observations from the single ancestor 
created here. Nevertheless, it is remarkable that a full-length ancestor like AncSP shows activity. In 
this work, around 250 input sequences with an approximate length of 500 amino acids and only 
30% sequence identity were used, in contrast to literature examples that reported reconstruction 
from less than 60 sequences with sequence identities over 80% and lengths below 350 (Table S5.2). 
Moreover, N and C-termini are often discarded (due to their high variability), and replaced by parts 
of extant enzymes. The C-terminal domain of sucrose phosphorylases is also highly variable, but 
nevertheless we included it in the reconstruction. Strikingly, it did not hamper the soluble 
expression like in the consensus design102. There, sequences were designed that contained at every 
position the residue that was most frequently occurring in a multiple sequence alignment. Different 
sets of input sequences were used, but the resulting proteins failed to express in soluble form. This 
problem could only be solved by swapping the C-terminus with that of the closest homologue. 
Hence, to be sure that the low activity of the ancestor is not caused by errors in the C-domain, 
variants were constructed in which the C-terminus was swapped with that of present-day enzymes 
(in the same way as for the consensus enzymes) (data not shown). The original ancestor however 
performed better, strengthening our confidence in the reconstruction. 
As discussed above, AncSP is not very active nor very promiscuous. Yet, this does not exclude that 
some particular mutations might increase the activity or switch the specificity. AncSP is supposed to 
have a more appropriate mutational background than present-day enzymes and therefore should 
be easier to evolve to a SPP. In other words, it would require fewer mutations or the same 
mutations would result in a more pronounced influence. This was however clearly not the case. 
Introduction of SPP specific residues in AncSP eliminated all SPP activity, in contrast to BaSP where 
the complete opposite was observed. The wild-type BaSP did not show any SPP activity, but after 
mutation it did. One could speculate that BaSP might have had an advantage over the others, 
because it has some residues (near the active site) in common with SPP, that other SP enzymes do 
not have. LmSP and AncSP have for instance a Phe and a Ile close to the catalytic nucleophile and 
general acid/base catalyst, respectively, whereas TtSPP and BaSP two times have a Val (Figure S4). 
On the other hand, loop B of BaSP is less similar to TtSPP, which should hence be a disadvantage. 
Moreover, using the criteria of similarity to TtSPP, AncSP should be in favour. Indeed, the sequence 
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of AncSP concurs more with TtSPP (~50% identical and ~60% similar), than the sequences of BaSP 
and LmSP do (~40% identity and ~45% similarity for both). What perhaps is of higher (or even 
only) relevance, is the exceptional stability of BaSP361. It is generally known that stable enzymes can 
tolerate a larger number of mutations and give better results when used as a starting point in 
protein engineering223, 224, 240, 362. The results presented here concur with these findings and suggest 
that a stable template might be more valuable than an ancestral template. They are however rather 
preliminary and should be interpreted with caution. The newly introduced activity was for instance 
very low and it is possible that upon further mutation (e.g. introducing the gap from loop B) the 
activity in BaSP can not be increased anymore, while this might be the case for the ancestor. Hence, 
creating alternative ancestral sequences and more elaborate mutagenesis are necessary to provide 
stronger evidence for the proposed hypothesis. 
4 METHODS AND MATERIALS 
4.1 Reconstruction of the ancestral sequence 
All full-length protein sequences classified in subfamily GH13_18 were extracted from the CAZy database16 
(www.cazy.org/). In order to reduce the number of sequences that can be handled for the actual 
reconstruction, sequences most distantly related to known SP enzymes (Chapter 4) were discarded (except for 
the sequences from Meiothermus silvanus DSM 9946 (UniProt D7BAR0), Spirochaeta thermophila DSM 6192 
(UniProt E0RTJ0) and E. coli K12 DH10B (UniProt B1XCD8) to root the tree and provide additional sequence 
diversity). The remaining sequences were aligned with ClustalO199 (default parameters) and thereafter the 
alignment was manually cured to improve its reliability at gap positions. Subsequently, the best-fitting 
evolutionary model for the alignment was predicted with ProtTest 3.2.1208 and was found to be the WAG+I+G 
substitution matrix (on the basis of the Bayesian information criterium (BIC)). Using this model a maximum 
likelihood (ML) phylogenetic tree was constructed in MEGA5352, with eight discrete categories for the gamma 
distribution, a nearest-neighbor-interchange heuristic ML method and a strong branch swap filter. It was 
checked manually to assess its validity (clustering of genera, species, related organisms, … ) and compared to a 
bootstrap consensus tree (1000 replicates) and a tree based on the LG+I+G model (second best model). As 
Alcolombri and colleagues191 also noted, most of the above steps (removing sequences that might be 
irrelevant, refining the alignment, and assessing the tree's quality) are manual and family specific. A precise 
methodology cannot be described, and the only general rule is to run several iterative rounds of alignment 
and tree making until the tree has converged to its most convincing format. After aligning the sequences and 
building the tree, the most likely state at each position at each node was calculated with the FastML 
webserver360, together with the posterior probability (in Bayesian statistics, the posterior probability is the 
probability that a hypothesis is true after the data have been analysed; in the context of ancestral 
reconstruction this is the probability that the residue present in the reconstructed sequence is the correct 
residue; likewise the probability of alternative states can be calculated). The probability cutoff to prefer an 
ancestral indel over a character was set to 0.9 (lower values resulted in an incomplete TIM barrel (=structural 
core of the enzyme)). Branch lengths and the alpha value for the gamma distribution were already optimised 
in MEGA5. The ancestral (protein) sequence of interest was back translated, codon optimised for E. coli and 
chemically synthesised by GeneArt® (Life Sciences, Invitrogen), including a sequence coding for a N-terminal 
His6-tag (full sequence in Supplementary data).  
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4.2 Cloning, site-directed mutagenesis, enzyme expression and purification 
The gene coding for the ancestral protein sequence (AncSP) was cloned into the constitutive expression vector 
pCXP34h92 by means of a Gibson assembly procedure326 (as described in Chapter 4), using the primers in 
Table S5.3. Site-directed mutations on the other hand were introduced with a modified two-stage 
megaprimer-based whole-plasmid PCR method295 (as described in Chapter 2), using the primers listed in Table 
S5.4 and the plasmids (templates) reported by Aerts and co-workers92. Enzymes were produced and purified 
as described previously26, and checked on SDS-PAGE for purity (Figure S5.6). 
4.3 Substrate specificity and kinetic parameters 
For enzyme production, 2% of an overnight culture was inoculated in 500 ml LB medium containing 100 μg/ml 
ampicillin in a 2 liter shake flask. First, cells were grown for 5 hours at 37°C and thereafter incubated overnight 
at 25°C (always continuous shaking at 200 rpm). Incubation at 37°C ensured sufficient biomass, while better 
expression is observed at 25°C for the ancestral enzyme (and mutant). For the sucrose phosphorylases from L. 
mesenteroides and B. adolescentis this is not necessary, but nevertheless applied for conformity. Harvesting, 
cell lysis and purification were preformed as described in Chapter 2 and 4, except for the imidazole 
concentration in the lysis buffer which was increased from 10 mM to 20 mM.  
All reactions were performed in 50 mM MOPS buffer pH 7.0 at 37°C. Specific activity was determined with 100 
mM donor and acceptor. Michaelis-Menten profiles for sucrose and inorganic phosphate were obtained by 
varying the substrate concentration in a range of 5-750 mM and 0.5-200 mM, respectively, in the presence of 
100 mM co-substrate. For α-D-glucose 1-phosphate and D-fructose, a range of 1-500 mM and 0-200 mM was 
used, respectively, with 400 mM fructose or 100 mM Glc1P as co-substrate. The apparent kinetic parameters 
were calculated by non-linear regression of the Michaelis–Menten equation using Sigma Plot 11, except for 
fructose (saturating conditions could not be reached). There, a simplified Michaelis equation (V=Vmax.[S]/KM, 
assuming KM >> [S]) was applied to derive the catalytic efficiency (kcat/KM). Reactions with alternative sugar 
acceptors were done with 100 mM donor (glucose 1-phosphate) and 100 mM acceptor (D-fructose 6-
phosphate, D-glucose, L-sorbose, D-galactose), whereas alternative donors (kojibiose, maltose) (100 mM) were 
assayed in the presence of 100 mM inorganic phosphate. Reactions with phenolic compounds contained 1 M 
sucrose and 10 mM acceptor.  
Samples from reactions with sugar acceptors were analysed by High Performance Anion Exchange 
Chromatography (HPAEC) (Dionex ICS-3000, Thermo Scientific), using a CarboPac PA20 pH-stable column and 
Pulsed Amperometric Detection (PAD). Sample (10 μL) is separated at 30°C at a constant flow rate of 0.5 
ml/min. To monitor sucrose phosphorylase activity (separation of glucose, fructose, sucrose and glucose 1-
phosphate) both in the phosphorolysis and synthesis direction, isocratic elution with 30 mM NaOH for 8 min, 
followed by a linear increase of acetate from 0 to 500 mM over 1.5 min (NaOH meanwhile decreased to 0 
mM), after which initial conditions were restored within 1.5 min and maintained for 6 min (to equilibrate the 
column). For separation of glucose, Suc6’P, Glc1P and Fru6P (sucrose 6’-phosphate phosphorylase activity), 
isocratic elution with 40 mM NaOH was applied for 5 min, after which NaOH was gradually decreased to 0 
mM while the concentration of acetate was increased 500 mM over a period of 9 min. Thereafter initial 
conditions were restored in 1 min and the column was equilibrated for 5 min. For galactose and sorbose as 
acceptor, an isocratic elution of 60 mM NaOH for 10 minutes and 80 mM NaOH for 5 min, respectively, was 
used, while for glucose icocratic elution with 35 mM NaOH and 15 mM acetate was applied. Elution of glucose 
1-phosphate was for these latter analyses achieved by adding the same acetate peak as for sucrose activity to 
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the method. In all cases 20 μL sample was inactivated with 15 μL 0.01M NaOH and centrifuged at 14000 rpm 
for 5 minutes. Thereafter, 10 μL supernatant was taken and diluted with ddH2O up to a final dilution of 525x. 
Reactions with a substrate concentration exceeding 500 mM were diluted 700x. Reactions of non-carbohydrate 
acceptors were analysed by thin layer chromatography (TLC). Properly diluted samples (1.5 μL) were spotted 
on TLC silica gel 60 F254 plates (Merck), dried and run with an eluent consisting of EtOAc, methanol and 
ddH2O at a 30/5/4 ratio. After drying, spots were visualised by oxidation with 10% H2SO4. Reactions were first 
set up for 24 hours and if no product spot appeared reactions were classified as ‘no activity’. Reactions where 
a spot was visible were characterised in more detail. Samples were taken at several time intervals and the 
intensity of the spots was quantified with ImageJ. The slope of the product spot intensity in function of time 
from the reaction of BaSP with pyrogallol was taken as a reference and compared with slopes from the other 
reactions (products spots have the same intrinsic intensity which makes the comparison possible). Reaction 
rates were categorised as 0-25% (+), 25-50% (++), 50-75% (+++) or 75-100% (++++) compared to the 
reference activity.  
4.4 Homology modelling 
A homology model of the ancestor sucrose phosphorylase was generated with the molecular modelling 
program YASARA182, 289, using default parameters. Crystal structures from the closely related sucrose 
phosphorylase from B. adolescentis (48% sequence identity and 57% similarity) served as templates (pdb 
entries 1R7A, 2GDU and 2GDV). Figures were created with PyMol v1.3294. 
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Figure S5.1 Sequence logo representing the posterior probabil it ies of every residue in the 
ancestral sequence (height of each character is proportional to the posterior probabil ity that 
the corresponding residue occurs at that position in the ancestor; note that the probabil it ies 
are given for all positions from the multiple sequence alignment including gap positions; 
Table S5.1 can be used to relate the residue number in the ancestral sequence to the position 
in the MSA) 
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Figure S5.2 Sequence logo representing the frequency of occurrence of a residue for every 
position in the multiple sequence alignment used as input for the ancestral reconstruction 
(height of each character is proportional to the frequency; width is proportional to the 
presence of a character over a gap (the smaller the width, the more a gap is present in the 
MSA); Table S5.1 can be used to relate the residue number in the ancestral sequence to the 
position in the MSA) 
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Figure S5.3 Histogram of the posterior probabil it ies 
 
 
 
 
Figure S5.4 Examples of specif ic residue pairs. (a) Asp74 and Lys30 most l ikely residues, Glu74 
and Gln30, second most l ikely and (b) Glu165 and Arg217 most l ikely, Lys165 and Glu217 
second most l ikely 
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Figure S5.5 Multiple sequence alignment (MSA) of the ancestral sequence (AncSP), several 
known sucrose phosphorylases (SP) and sucrose 6'-phosphate phosphorylase (SPP) (BaSP: 
Bif idobacterium adolescentis SP (UniProt ID Q84HQ2); BlSP: Bif idobacterium longum SP 
                                                    TT                     BaSP 
  1       10        20        30        40        50        60        70   
1 BaSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   MK KVQ  T A RL DGT SM DILRTRFDGVYD V I  F T FDGA A  D IDHTKVDERL S D VAE.. IK T
BlSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   MK KVQ  T A RL DGT SM DILRTRFDGVYD V I  F T FDGA A  D IDHTKVDERL S D VAE.. LS A
2 LmSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   M I  K M  T  SL KNLKD Q L AIG V L  F  STG  R  A Y VD F D  VEE Q A A . VH V KEDIGD . . AD TR AA A A
SmSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   M I  K M  T  SL KNLKE E I AVG V L  F  STG  R  A Y VD F D  VKP I T A . LN N ENYFGD . . ID HE SA D C
LaSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   M I  K M  T  SL KNLKE E L AVG I L  F  STG  R  A Y VD F D  IEP E V P . LD I SEDLKG . . TG TE PK S K
3 TtSPP     N   LI Y D  G                    G H LP F P    D GF P          G W D   MALK KVQ  T P SL .GNLKTLNDVLEKYFSDVFG V I  P . SSG. R  A ITYSEIEPKF T Y IKK
4 AncSP     N   LI Y D  G                    G H LP F P    D GF P          G W D   ..MK AVQ  C P RI .NNLKDLYTVLDTYLKGVFG V I  F . SSA. G  A ITHTEVDPRF T D IEA
                                                                           BaSP 
     80        90       100       110       120           130       140    
1 BaSP          D   NH S  S    D       S Y   F                  D           P     LSKTHNIMV AIV  M WE KQFQ VL KGEE E YPM LTMSSVFP NG ATEE LAGIYRPRPGL FTHYKA ... .
BlSP          D   NH S  S    D       S Y   F                  D           P     LSKTHNIMV AIV  M WE KQFQ VL KGEE E YPM LTMSSVFP NG ATEE LAGIYRPRPGL FTHYKE ... .
2 LmSP          D   NH S  S    D       S Y   F                  D           P     LGEEYYLMF FMI  I RE YQ FK D   D  I WEKFW E RPTQ  VDLIYKRKDKA QEIVM KNH D K K F R AKAG N A T T
SmSP          D   NH S  S    D       S Y   F                  D           P     LGEKYYLMF FMI  I RQ YK YQ E   D  L WDKFW K RPTQ  VDLIYKRKDRA QEIKY EKH A A K L N P... N E K Q
LaSP          D   NH S  S    D       S Y   F                  D           P     IGKKYYLMF FMI  I RQ YK FK D   D  L WDKFW E RPTR  IDLIYKRKDRA QEIKF QKK K K A L S P... G K Y T
3 TtSPP          D   NH S  S    D       S Y   F                  D           P     MAENFDILL LMV  V RR IYFQ FLKKGRK E ADM ITLDKLWK...DGKPVKG IEKMFLRRTL. YSTFK
4 AncSP          D   NH S  S    D       S Y   F                  D           P     LAEDYDLMV LMV  I SQ PQFQ FLAKGDA E ADM ITFDKFWP...NGEPTEE LAKIYRRKPGA FTEVT
 T..T          T....T                                         TT           BaSP 
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1 BaSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   FA  KTRLV VS TP Q V I TDSDKGWEYLMSIFDQMAASHVSYI    VG GA EAG SC MT  KTF.. .... .
BlSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   FA  KTRLV VS TP Q V I TDSDKGWEYLMSIFDQMAASHVSYI    VG GA EAG SC MT  KTF.. .... .
2 LmSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   F D  E L NT GE E I  V I FIK TL M HG NLI    FA AV K D ND FVE EIWD . TT N .... I NSA AKE T ED VK A V
SmSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   F D  E L NT GE E I  V V FIR TI L NG DLI    FA AV K D ND FVE EIWA . SV H .... L TKE TMD S EN AA C L
LaSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   F D  E L NT GE E I  V V FIK TL L HG DII    FA AV K D ND FVE EIWT . SK K .... M RKE TQK D RA ID A L
3 TtSPP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   IEET EEEKV TT GKTDPSE I L VNSHLVREFLLEVFKTFSNFGVKIV    VG VI KIG SC FVE EIY
4 AncSP     G     W  F       Q D D                         RLDA  Y  K   T  F   P   LAD. TKRKV CT TE....E I L VESEQARQFLEDTLRFLASKGVSMI    FG AT KLG SC FVE EIY
                                                                           BaSP 
     220       230       240       250       260       270       280       
1 BaSP                  L E H                YDF LP   L  L               P    T LDKLISRLREEGVKRGLEI I V SYYKKQVEIASKVDRV   A  PLL H  TGHVEPVAHWT IR NNAV V  A S D
BlSP                  L E H                YDF LP   L  L               P    T LDKLISRLREEGVKRGLEI I V SYYKKQVEIASKVDRV   A  PLL H  TGHVEPVAHWT IR NNAV V  S F E
2 LmSP                  L E H                YDF LP   L  L               P    T LDL VRE A I P I EHY KI H YF    A  M T Y  YS K NQLA WLK  MKQF T  DT NE ILTPLK E SIPK ND G T T T G T K MS
SmSP                  L E H                YDF LP   L  L               P    T LDL VRD A I P I EHY KI H YY    A  M T Y  YS K DRLA WLK  MKQF T  TL DK IAAVSG E TIQF AD D V V S S V K MS
LaSP                  L E H                YDF LP   L  L               P    T LDL VQD A I P I EHY KI H YY    A  M T Y  YS K NRLA WLK  MKQF T  DL KQ DISDKG M SMPF SK G I V S G S D KC
3 TtSPP                  L E H                YDF LP   L  L               P    T LDEFLDWAKGQAASYGIEL L V SQFEVQYKLAERGFLI   I  FTV YT INKSNEMLYHYLKNR INQF M  
4 AncSP                  L E H                YDF LP   L  L               P    T LDEILERIQQIAKEYGVEL P I EHYSTQIAIAKRGYWV   A  PLV HA YSGNSKYLKHWLKIC RNQI V  
             TT TT                              ..                         BaSP 
290       300       310       320       330         340       350       360
1 BaSP  HDGI                                                   D  Q N TYY AL   D  T    GVIDIGSDQLDRSLKGLVPDEDVDNLVNTIHANTHGESQAATG AAASNL LY V S   S  GCN QH..
BlSP  HDGI                                                   D  Q N TYY AL   D  T    GVIDIGSDQLDRSLKGLVPDEDVDNLVNTIHANTHGESQAATG AAASNL LY V S   S  GCN QH..
2 LmSP  HDGI                                                   D  Q N TYY AL   D  T    GVVD RDILT DEI Y S QLYKVGANV K YS A YNNL IY I    S  GND A......... D D A E K T S.. S S AA
SmSP  HDGI                                                   D  Q N TYY AL   D  T    GVVD KDILT EEI Y S ELYKVGANV R YS A YNNL IY I    S  GDD V......... D T T N N K T.. E S QK
LaSP  HDGI                                                   D  Q N TYY AL   D  T    GVVD RDILS DEI Y S ELYKVGANV K YS A YHNL IY I    S  GND A......... P K T N K K S.. E T KK
3 TtSPP  HDGI                                                   D  Q N TYY AL   D  C    PVKPD........LDGLIDTKKAKEVVDICVQRGANLSLIYGDKYKSEDGF VH I C   S  NCD DA
4 AncSP  HDGI                                                   D  Q N TYY AL   D  T    GIVDV.........EGLLPDEEIEALVETIHARSANVKRKYSG....ASNL IY I C   D  GQN DA
                                                                           BaSP 
       370       380       390       400       410       420       430     
1 BaSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A AA AV F L  V  V    A     MELLR  NN  D    Y STA IDENL RPV KA NA AKF  EL  I K K K D
BlSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A AA AV F L  V  V    A     MELLR  NN  D    Y STA IDENL RPV KA NA AKF  EL  L R R E P
2 LmSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A L    A  I  I       E  I LLE  KE  N    Y E V E KRP   L     L S VF V L A S TR KS V V AN K LSW ESP
SmSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A L    A  I  V       K  L LLE  KE  N    Y E I E KRP   L     F A LI A F E S SS AK V V KA N FTY QSA
LaSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A I    A  I  V       K  I LLE  KE  N    Y E V E KRP   L     F A LI M M E K GR AE T L AA K FNF NEA
3 TtSPP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A LAA AI F T  I  V    L   V  FEAVKK KE  E    N GLK IEESVQKNV QR LK IRF  EYE 
4 AncSP Y   R  Q F PG PQ YYVG LAG ND      T  GR INRH Y   E         V  L  L   RN   A LLA AI F T  I  V    L   E  HELLER GE  D    Y TLE IEEEVERPV QR LK MRF  TYP 
                                         TT            TT       TTT        BaSP 
    440       450         460       470       480       490       500      
1 BaSP F   G                                                                       D  FSY D DTSI F W S A LTFEP RGLG DN TPVA L W D AGDH DL ANPPV.. T TT D S T RGET.. Q T K V T M E E S RSD I VA..
BlSP F   G                                                                       D  FSY D DTSI F W S A LTFEP RGLG DN TPVA L W D AGDH DL ANPPI.. E EV G T R TAADGT T A G T A S A S A ETR L ADID
2 LmSP F   G                                                                       DL  I V TP D I V R DEN A D N TF I N Q VA S T D T TT V T Q GQNK VLT........A AA K E VE G T MSSDNLTQN........
SmSP F   G                                                                       DL  I V TP E I I R NKD A N D TY V N Q ID R E E N AT V E Q GSHI KAE........I LQ M R TE D T SFE..............
LaSP F   G                                                                       DL  I I TP E I I R NKD A N N TY V N E ID S E T N NV Q T M KTRK RAV........I LK L Q TV N V NF...............
3 TtSPP F   G                                                                       N.. EFFIEDCRKDEIRLTWKKDD..KRCSLF........IDLKTYKTTIDYINENGEEVKYLV..........
4 AncSP F   G                                                                       N.. EFTVESSTNSSLVITWKHGD..HYATLF........VDLKSKTFTITYTDEGEGE...............
β1 α1 β2 β3 β4 α2 
β5 β6 α3 η1 η2 α4 α5 β7 
β8 β9 α6 β10 η3 
α7 β11 α8 β12 α9 α10 β13 
α11 α12 η4 α13 
α14 β14 α15 α16 η5 α17 α18 η6 
β15 β16 β17 η7 β18 β19 
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(UniProt ID Q84BY1); LmSP: Leuconostoc mesenteroides SP (UniProt ID Q59495); SmSP: 
Streptococcus mutans SP (UniProt ID P10249); LaSP: Lactobacil lus acidophilus SP (UniProt ID 
Q7WWP8); TtSPP: Thermoanaerobacterium thermosaccharolyticum SPP (UniProt ID D9TT09); 
group 1: Bif idobacteria (BaSP and BlSP); group 2: lactic acid bacteria (LmSP, SmSP and LaSP); 
group 3: TtSP) (red box/white character: conserved across all sequences (strict identity) ; bold 
character: similarity within group; blue frame/yellow background: similarity across groups; 
green background: conserved within group, but different between groups; BLOSUM62 
similarity score matrix was used for similarity determination; ★ :  catalytic residue; ( :  donor 
site residue; ▲ :  acceptor site residue). Sequences were extracted from the full MSA of all 
GH13_18 sequences (~400), used for the construction of the phylogenetic tree. Numbering is 
according to BaSP, and the secondary structure depicted above the sequences is derived from 
the crystal structure of BaSP (PDB entry: 2GDU chain A). Residues 132-139 and 340-346 
comprise loop B and A, respectively. Figure was created with ESPript (http://espript. ibcp.fr) 
(Gouet, P. , Robert, X. and Courcelle E. (2003) "ESPript/ENDscript: extracting and rendering 
sequence and 3D information from atomic structures of proteins". Nucl. Acids Res. 31(13), 
3320-3323) 
 
 
 
Figure S5.6 SDS-PAGE analysis of the different steps during the purif ication process of the 
ancestor (CCE: crude cell extract; FT: f low through; W1, W2 and W3: wash 1, 2 and 3; P: 
purif ied protein) 
 
 
Table S5.1 Posterior probabil ity of all residues from the derived ancestral sequence 
residuea prb residuea prb residuea prb residuea prb residuea prb 
M1 (58) 1.00 F96 (172) 0.98 D191 (353) 0.97 L286 (459) 0.98 L381 (585) 0.63 
K2 (59) 1.00 L97 (173) 0.89 A192 (354) 0.94 D287 (460) 0.97 E382 (586) 0.89 
N3 (60) 1.00 A98 (174) 0.55 F193 (355) 0.95 T288 (461) 0.94 R383 (587) 0.83 
A4 (61) 1.00 K99 (175) 0.56 G194 (356) 0.98 H289 (462) 0.99 T384 (588) 0.90 
V5 (62) 1.00 G100 (176) 1.00 Y195 (357) 0.99 D290 (463) 0.97 G385 (589) 0.97 
Q6 (63) 1.00 D101 (177) 0.82 A196 (358) 0.88 G291 (464) 1.00 E386 (590) 0.82 
L7 (64) 1.00 A102 (178) 0.42 T197 (359) 0.86 I292 (465) 0.92 G387 (591) 0.96 
I8 (65) 1.00 S103 (179) 0.91 K198 (360) 0.94 G293 (466) 0.98 R388 (594) 0.98 
C9 (66) 1.00 E104 (180) 0.84 K199 (361) 0.75 I294 (467) 0.69 D389 (595) 0.94 
Y10 (67) 1.00 Y105 (181) 0.99 L200 (362) 0.40 V295 (469) 0.72 I390 (596) 0.93 
P11 (68) 1.00 A106 (182) 0.89 G201 (363) 1.00 D296 (470) 0.97 N391 (597) 0.92 
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residuea prb residuea prb residuea prb residuea prb residuea prb 
D12 (69) 0.96 D107 (183) 0.93 T202 (364) 0.95 V297 (482) 0.82 R392 (598) 0.98 
R13 (70) 1.00 M108 (184) 0.77 S203 (365) 0.83 E298 (483) 0.34 H393 (599) 0.99 
I14 (71) 0.76 F109 (185) 0.99 C204 (366) 1.00 G299 (484) 0.99 Y394 (600) 0.92 
G15 (72) 1.00 I110 (186) 0.76 F205 (367) 0.99 L300 (485) 0.95 Y395 (601) 0.96 
N16 (73) 1.00 T111 (187) 0.42 F206 (368) 0.53 L301 (486) 0.97 T396 (602) 0.82 
N17 (74) 0.91 F112 (188) 0.28 V207 (369) 0.87 P302 (487) 0.74 L397 (603) 0.92 
L18 (75) 1.00 D113 (189) 0.83 E208 (370) 0.87 D303 (488) 0.91 E398 (604) 0.86 
K19 (81) 1.00 K114 (190) 0.88 P209 (371) 1.00 E304 (489) 0.91 E399 (605) 0.91 
D20 (82) 1.00 F115 (191) 0.96 E210 (372) 0.86 E305 (490) 0.74 I400 (606) 0.86 
L21 (83) 1.00 W116 (192) 0.76 I211 (373) 0.45 I306 (491) 0.90 E401 (607) 0.88 
Y22 (84) 1.00 P117 (193) 0.97 Y212 (374) 0.45 E307 (492) 0.74 E402 (608) 0.77 
T23 (85) 1.00 N118 (194) 0.67 E213 (375) 0.79 A308 (496) 0.69 E403 (609) 0.59 
V24 (89) 1.00 G119 (195) 0.99 I214 (376) 0.48 L309 (497) 0.87 V404 (610) 0.45 
L25 (90) 0.92 E120 (205) 0.81 L215 (377) 0.91 V310 (498) 0.86 E405 (611) 0.47 
D26 (91) 0.86 P121 (206) 0.57 E216 (378) 0.62 E311 (499) 0.67 R406 (612) 0.76 
T27 (92) 0.50 T122 (207) 0.87 R217 (379) 0.30 T312 (500) 0.46 P407 (613) 1.00 
Y28 (93) 0.62 E123 (208) 0.65 I218 (380) 0.57 I313 (501) 0.75 V408 (620) 0.92 
L29 (94) 0.83 E124 (209) 0.85 Q219 (381) 0.47 H314 (502) 0.51 V409 (621) 0.93 
K30 (95) 0.59 D125 (210) 0.96 Q220 (382) 0.58 A315 (503) 0.60 Q410 (622) 0.81 
G31 (96) 0.74 L126 (211) 0.89 I221 (383) 0.62 R316 (504) 0.92 R411 (623) 0.93 
V32 (98) 0.85 A127 (212) 0.67 A222 (384) 0.85 S317 (505) 0.54 L412 (624) 0.98 
F33 (99) 0.95 K128 (213) 0.76 K223 (385) 0.47 A318 (506) 0.84 L413 (625) 0.85 
G34 (101) 1.00 I129 (214) 0.90 E224 (386) 0.37 N319 (507) 0.68 K414 (626) 0.27 
G35 (102) 1.00 Y130 (215) 0.96 Y225 (387) 0.65 V320 (508) 0.58 L415 (627) 0.98 
V36 (103) 0.50 R131 (216) 0.66 G226 (388) 1.00 K321 (509) 0.54 M416 (628) 0.82 
H37 (104) 0.99 R132 (217) 0.92 V227 (389) 0.35 R322 (510) 0.84 R417 (629) 0.94 
I38 (105) 0.88 K133 (218) 0.81 E228 (392) 0.91 K323 (511) 0.47 F418 (630) 0.99 
L39 (106) 0.98 P134 (219) 0.97 L229 (393) 0.48 Y324 (512) 0.46 R419 (631) 0.98 
P40 (107) 1.00 G135 (220) 0.63 L230 (394) 0.98 S325 (513) 0.82 N420 (632) 0.89 
F41 (108) 0.98 A136 (221) 0.33 P231 (395) 0.95 G326 (514) 0.51 T421 (633) 0.84 
F42 (109) 0.97 P137 (222) 1.00 E232 (396) 0.93 A327 (515) 0.83 Y422 (634) 0.64 
P43 (110) 0.98 F138 (223) 0.89 I233 (397) 0.81 S328 (523) 0.64 P423 (635) 1.00 
S44 (111) 0.85 T139 (224) 0.52 H234 (398) 0.99 N329 (524) 0.76 A424 (636) 0.94 
S45 (114) 0.73 E140 (225) 0.53 E235 (399) 0.63 L330 (525) 0.77 F425 (637) 0.99 
A46 (115) 0.65 V141 (226) 0.81 H236 (400) 0.99 D331 (526) 0.91 N426 (638) 0.65 
D47 (116) 0.97 T142 (227) 0.90 Y237 (401) 0.97 I332 (527) 0.75 G427 (640) 1.00 
G48 (117) 0.68 L143 (228) 0.83 S238 (402) 0.79 Y333 (528) 0.99 E428 (641) 0.65 
G49 (118) 1.00 A144 (229) 0.60 T239 (403) 0.46 Q334 (529) 0.93 F429 (642) 0.98 
F50 (119) 0.99 D145 (234) 0.96 Q240 (404) 0.93 I335 (530) 0.68 T430 (643) 0.34 
A51 (120) 0.47 G146 (235) 1.00 I241 (405) 0.61 N336 (531) 0.89 V431 (644) 0.75 
P52 (121) 1.00 T147 (236) 0.44 A242 (410) 0.37 C337 (532) 1.00 E432 (645) 0.53 
I53 (122) 0.70 K148 (237) 0.52 I243 (411) 0.89 T338 (533) 0.95 S433 (653) 0.31 
T54 (123) 0.50 R149 (238) 0.55 A244 (412) 0.90 Y339 (534) 0.84 S434 (654) 0.83 
H55 (124) 0.54 K150 (239) 0.59 K245 (413) 0.30 Y340 (535) 0.98 T435 (655) 0.29 
T56 (125) 0.36 V151 (240) 0.78 R246 (414) 0.51 D341 (536) 0.77 N436 (680) 0.39 
E57 (131) 0.71 W152 (241) 1.00 G247 (415) 0.70 A342 (537) 0.94 S437 (681) 0.49 
V58 (132) 0.92 C153 (242) 0.94 Y248 (416) 0.75 L343 (538) 0.97 S438 (682) 0.35 
D59 (133) 0.97 T154 (243) 0.95 W249 (417) 0.60 G344 (539) 0.96 L439 (683) 0.92 
P60 (134) 1.00 F155 (244) 0.99 V250 (418) 0.89 Q345 (540) 0.38 V440 (684) 0.41 
R61 (135) 0.62 T156 (245) 0.59 Y251 (419) 0.99 N346 (541) 0.64 I441 (685) 0.42 
F62 (137) 0.87 E157 (319) 0.51 D252 (420) 0.94 D347 (551) 0.96 T442 (686) 0.42 
G63 (138) 1.00 E158 (320) 0.68 F253 (421) 0.99 D348 (552) 0.89 W443 (687) 1.00 
T64 (139) 0.69 Q159 (321) 0.93 A254 (422) 0.92 A349 (553) 0.85 K444 (688) 0.60 
W65 (140) 1.00 I160 (322) 0.92 L255 (423) 0.98 Y350 (554) 0.99 H445 (689) 0.69 
D66 (141) 0.77 D161 (323) 0.97 P256 (424) 1.00 L351 (555) 0.95 G446 (690) 0.99 
D67 (142) 0.97 L162 (324) 0.81 P257 (425) 0.89 L352 (556) 0.90 D447 (691) 0.91 
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residuea prb residuea prb residuea prb residuea prb residuea prb 
I68 (143) 0.80 D163 (325) 0.79 L258 (426) 0.98 A353 (557) 0.93 H448 (692) 0.49 
E69 (144) 0.83 V164 (326) 0.79 V259 (427) 0.80 R354 (558) 0.98 Y449 (693) 0.40 
A70 (145) 0.85 E165 (327) 0.40 L260 (428) 0.98 A355 (559) 0.94 A450 (710) 0.86 
L71 (146) 0.93 S166 (328) 0.89 H261 (429) 0.97 I356 (560) 0.92 T451 (711) 0.36 
A72 (147) 0.82 E167 (329) 0.58 A262 (430) 0.65 Q357 (561) 0.93 L452 (712) 0.98 
E73 (148) 0.82 Q168 (330) 0.67 L263 (431) 0.97 F358 (562) 0.99 F453 (713) 0.41 
D74 (150) 0.48 A169 (331) 0.62 Y264 (432) 0.56 F359 (563) 0.99 V454 (714) 0.86 
Y75 (151) 0.97 R170 (332) 0.90 S265 (433) 0.59 T360 (564) 0.58 D455 (715) 0.97 
D76 (152) 0.90 Q171 (333) 0.72 G266 (434) 0.94 P361 (565) 1.00 L456 (716) 0.92 
L77 (153) 0.91 F172 (334) 0.86 N267 (435) 0.44 G362 (566) 1.00 K457 (717) 0.52 
M78 (154) 0.91 L173 (335) 0.64 S268 (436) 0.74 I363 (567) 0.92 S458 (718) 0.72 
V79 (155) 0.43 E174 (336) 0.84 K269 (437) 0.35 P364 (568) 1.00 K459 (719) 0.64 
D80 (156) 0.97 D175 (337) 0.44 Y270 (438) 0.81 Q365 (569) 0.93 T460 (720) 0.53 
L81 (157) 0.85 T176 (338) 0.37 L271 (439) 0.98 V366 (570) 0.91 F461 (721) 0.33 
M82 (158) 0.61 L177 (339) 0.95 K272 (440) 0.70 Y367 (571) 0.99 T462 (722) 0.83 
V83 (159) 0.69 R178 (340) 0.36 H273 (441) 0.95 Y368 (572) 0.99 I463 (723) 0.90 
N84 (160) 0.92 F179 (341) 0.74 W274 (442) 1.00 V369 (573) 0.92 T464 (724) 0.92 
H85 (161) 0.99 L180 (342) 0.91 L275 (443) 0.98 G370 (574) 1.00 Y465 (725) 0.96 
I86 (162) 0.86 A181 (343) 0.68 K276 (444) 0.60 L371 (575) 0.98 T466 (726) 0.88 
S87 (163) 0.91 S182 (344) 0.63 I277 (445) 0.88 L372 (576) 0.97 D467 (727) 0.87 
S88 (164) 0.57 K183 (345) 0.40 C278 (446) 0.99 A373 (577) 0.94 E468 (728) 0.69 
Q89 (165) 0.58 G184 (346) 1.00 P279 (452) 1.00 G374 (578) 1.00 G469 (729) 0.82 
S90 (166) 0.91 V185 (347) 0.74 R280 (453) 0.97 E375 (579) 0.67 E470 (730) 0.72 
P91 (167) 1.00 S186 (348) 0.37 N281 (454) 0.69 N376 (580) 0.92 G471 (731) 0.75 
Q92 (168) 0.76 M187 (349) 0.76 Q282 (455) 0.56 D377 (581) 0.97 E472 (732) 0.58 
F93 (169) 0.99 I188 (350) 0.86 I283 (456) 0.51 H378 (582) 0.62   
Q94 (170) 0.85 R189 (351) 0.98 T284 (457) 0.95 E379 (583) 0.91   
D95 (171) 0.97 L190 (352) 0.98 V285 (458) 0.81 L380 (584) 0.96   
a position in multiple sequence alignment between brackets (same numbering as sequence logos) 
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Table S5.2 Detailed summary of l iterature examples where ASR has been applied 
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Table S5.3 Primers used for cloning of the ancestral sequence 
fragment primer 5’→3’ sequence 
AncSP_ pCXPgene AncSP_Fw_pCXPgene1 CGAATTCGGAGGAAACAAAGATGGGTGGTAGCCATCATCATC  
 AncSP_Rv_pCXPgene2 CCCATATGGTCGACCTGCAGTTATTCGCCTTCACCTTCATC 
AncSP_pCXPBB AncSP_Fw_pCXPBB1 ATGAAGGTGAAGGCGAATAACTGCAGGTCGACCATATGGG 
 AncSP_Rv_pCXPBB2 TGATGATGGCTACCACCCATCTTTGTTTCCTCCGAATTC 
1 forward primer; 2 reverse primer 
 
Table S5.4 Primers used for site-directed mutagenesis 
mutant primer 5’→3’ sequence 
AncSP_LoopAB AncSP_Fw_R131L1 TCTGGCCAAAATCTATCTGCGTAAACCGGGTGC 
 AncSP_Rv_NLY329GFH2 GGTGCAGTTAATCTGATGAATATCGAAGCCGCTTGCACCGCTATATTTAC 
BaSP_LoopAB BaSP_CO3_Fw_RP133LR1 GACCTGGCAGGCATTTATCTGCGTCGTCCGGGTCTGCCGTTTAC 
 BaSP_CO3_Rv_NLY340GFH2 GGTACTATTAACTTGGTGCAGATCAAAGCCCGATGCCGCCGCACCG 
LmSP_LoopAB LmSP_12291_Fw_K136L1 GTTGACTTAATTTACCTGCGTAAAGATAAGGCACC 
 LmSP_12291_Rv_NLY336GFH2 GACCTGGCAGGCATTTATCTGCGTCGTCCGGGTCTGCCGTTTAC 
1 forward primer; 2 reverse primer 
 
E. coli codon optimised gene coding for the ancestral sequence (His-tag in italics) 
ATGGGTGGTAGCCATCATCATCACCATCATGGTATGGCAAGCATGAAAAATGCAGTTCAGCTGATTTGTTATCCGG
ATCGCATTGGCAATAATCTGAAAGATCTGTATACCGTGCTGGACACCTATCTGAAAGGTGTTTTTGGTGGTGTTCA
TATCCTGCCGTTTTTTCCGAGCAGCGCAGATGGTGGTTTTGCACCGATTACCCATACCGAAGTTGATCCGCGTTTT
GGCACCTGGGATGATATTGAAGCACTGGCCGAAGATTATGATCTGATGGTTGACCTGATGGTGAATCATATTAGCA
GCCAGAGTCCGCAGTTTCAGGATTTTCTGGCAAAAGGTGATGCAAGCGAATATGCCGATATGTTTATCACCTTCGA
TAAATTCTGGCCGAATGGTGAACCGACCGAAGAAGATCTGGCCAAAATCTATCGTCGTAAACCGGGTGCACCGTTT
ACCGAAGTGACCCTGGCAGATGGCACCAAACGTAAAGTTTGGTGTACCTTTACGGAAGAACAAATCGATCTGGATG
TTGAAAGCGAACAGGCACGTCAGTTTCTGGAAGATACCCTGCGTTTTCTGGCCAGCAAAGGTGTTAGCATGATTCG
TCTGGATGCATTTGGTTATGCAACCAAAAAACTGGGCACCAGCTGTTTTTTTGTTGAGCCGGAAATTTATGAAATC
CTGGAACGTATTCAGCAGATCGCCAAAGAATATGGTGTTGAACTGCTGCCGGAAATCCATGAACATTATAGCACCC
AGATTGCAATTGCCAAACGTGGTTATTGGGTTTATGATTTTGCACTGCCTCCGCTGGTTCTGCATGCACTGTATAG
CGGTAATAGCAAATATCTGAAACATTGGCTGAAAATCTGTCCGCGTAATCAGATTACCGTTCTGGATACCCATGAT
GGCATTGGTATTGTTGATGTTGAAGGTCTGCTGCCTGATGAAGAAATTGAAGCCCTGGTTGAAACCATTCATGCAC
GTAGCGCAAATGTGAAACGTAAATATAGCGGTGCAAGCAACCTGGATATTTATCAGATTAACTGCACCTATTATGA
TGCCCTGGGTCAGAATGATGATGCATATCTGCTGGCACGTGCAATTCAGTTTTTTACACCGGGTATTCCGCAGGTT
TATTACGTTGGCCTGCTGGCAGGCGAAAATGATCACGAACTGCTGGAACGCACCGGTGAAGGTCGTGATATTAATC
GTCACTATTATACCCTGGAAGAGATCGAAGAAGAAGTTGAACGTCCGGTTGTTCAGCGTCTGCTGAAACTGATGCG
TTTTCGTAATACCTATCCGGCATTTAATGGTGAGTTTACCGTTGAAAGCAGCACCAATAGCAGCCTGGTTATTACC
TGGAAACATGGTGATCATTATGCCACCCTGTTTGTTGATCTGAAAAGCAAAACCTTTACCATCACCTATACCGATG
AAGGTGAAGGCGT 
 
 
  
Chapter 6 
The role of correlated positions in the  
sucrose-active enzymes of the GH13 family 
  
CHAPTER 6  The role of correlated positions in the sucrose-active enzymes of the GH13 family 
 148 
ABSTRACT 
Statistical analysis of large multiple sequence alignments reveals positions that are correlated with 
each other, i.e. positions that house specific combinations of residues more prevalent than expected 
from random distribution. These positions often form complex networks and they are likely to be 
involved in activity, specificity and stability. Their exact role is however currently still obscure. 
Therefore, in this work we compared correlated mutations in two related specificities (sucrose and 
sucrose 6’-phosphate phosphorylase) and experimentally evaluated hypotheses on different aspects 
of the correlation network. Distribution across the structure suggests that correlated positions 
might be involved in supporting the different active site topologies, rather than directly being 
involved in substrate contact. Retracing the evolution showed that correlated positions that are 
close to each other in the structure or that are strongly correlated often not evolve simultaneously. 
Introduction of the active site of sucrose 6’-phosphate phosphorylase in sucrose phosphorylase 
enable this latter enzyme to catalyse the former reactions. The activity was however very low en 
therefore correlated positions were mutated as well. This caused a decrease in activity (up to fifty-
fold) in most cases, but in one double mutant the activity could selectively be increased by a factor 
of two. Mutation of correlated positions can thus alter the specificity, but general guidelines on 
which positions to mutate and which residues to introduce could unfortunately not be derived and 
will need further research. 
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1 INTRODUCTION 
The structure as well as the function of a protein can put restraints to the evolution of certain 
residues. Indeed, the number of possible mutations at a certain position is sometimes limited by 
the presence of a residue at another position and they can accordingly not evolve independently 
from one another. This phenomenon is known as coevolution. Detection of coevolving or correlated 
positions might be interesting for protein engineers since these positions are more likely to be 
involved in stability, activity and specificity than others230. They are consequently hotspots for 
improving stability or specificity through mutagenesis. 
Although correlated positions can be traced by statistical analysis of large multiple sequence 
alignments (MSA), it is often very hard to define the exact role of the different mutations229. 
Correlation networks can in addition be very complex and the reason why residues are connected is 
not always understood. Wet lab data on the influence of correlated mutations on the specificity is 
moreover very scarce225, 230, 284, 363. Therefore, this work focuses on how correlated position can be 
used to alter the specificity of an enzyme and which characteristics of the coevolution network are 
most important to achieve this goal. This includes the strength of correlation between positions, the 
number of correlations one position has with others, the spatial proximity in the structure and the 
moment of mutation during evolution. In addition, it was investigated if point mutations are 
tolerated within a densely connected network or if multiple mutations are required. To that end, the 
correlated positions of sucrose phosphorylase from Bifidobacterium adolescentis (BaSP) and sucrose 
6’-phosphate phosphorylase from Thermoanaerobacterium thermosaccharolyticum (TtSPP) were 
compared. Both specificities are closely related and that way the complexity of the problem can be 
limited to some extend. The number of differences at correlated positions is lower and the close 
phylogenetic relationship allows to retrace the evolution by ancestral sequence reconstruction. 
Determinants of specificity are furthermore known for both enzymes (Chapter 2 and 4), and the 
crystal structure of BaSP is available103, 104 which allows for structural interpretation. After in silico 
analysis of the coevolution network itself, its distribution across the crystal structure and its 
evolution, residues were mutated in BaSP to their TtSPP counterpart and the influence on specificity 
was investigated in order to shed light on how engineering of correlated positions can be 
performed. 
2 RESULTS & DISCUSSION 
2.1 Coevolution network 
An accurate multiple sequence alignment (MSA) is a prerequisite to reliably detect correlated 
positions (see also Chapter 1). To that end, the 3DM software suite was employed, which uses 
structural information to guide the MSA and to improve the accuracy compared to conventional 
alignment methods. Related crystal structures are first superposed and the regions that are 
conserved among all structures, the so-called core regions, are retained. All known sequences are 
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subsequently aligned against these core regions, and parts outside the cores are discarded for the 
correlated mutation analysis (CMA). Typically structures and sequences of an entire protein family 
are used. The α-amylase family, to which SP and SPP belong, is however very large and structurally 
diverse and it would therefore be impossible to obtain relevant CMA patterns, not in the least 
because the core regions would represent only a tine fraction of the total structures. Hence, only 
the closest structural neighbours of SP and SPP were selected as input for the 3DM software 
(Figure 6.1). That way, the core regions are sufficiently large (±70% of the protein sequence) 
without limiting the sequence diversity.  
 
 
Figure 6.1 Phylogenetic tree of all subfamilies used to study the coevolution networks in 
sucrose phosphorylase and sucrose 6’-phosphate phosphorylase (subfamilies according to the 
3DM classif ication which is based on a representative crystal structure for each specif icity; 
sucrose-active enzyme subfamilies: 3CZK, 1G5A and 2GDV). 
 
In total, 1773 sequences are present, covering (at least) ten specificities from different types of 
CAZymes (hydrolases, transglycosidases and phosphorylases using different donor and acceptor 
substrates) (Figure 6.1). Twenty-one positions were found to be strongly correlated, but only at four 
a different residue was found between BaSP and TtSPP (Figure 6.2a). In addition, CMA was also 
performed on the subset of sucrose-active enzymes, consisting of the 3DM subfamilies 1G5A 
(amylosucrase), 3CZK (sucrose hydrolase) and 2GDV (sucrose phosphorylase and sucrose 6’-
phosphorylase). These enzymes all use the same donor substrate (sucrose), but very distinct 
acceptor substrates (an linear amylose-like chain, water or inorganic phosphate). Hence, this might 
help to identify those positions important for the acceptor specificity. CMA on this subset yielded 
thirty highly correlated positions that form a very complex network (Figure 6.2b). Only four 
positions from the bigger dataset appeared again, proving that the outcome of the CMA is strongly 
dependent on the input sequences. This is in a way not surprising and it is moreover not unlikely 
that the two networks represent different aspects of the enzymes. It is for instance possible that the 
! 3CZK Sucrose hydrolase EC 3.2.1.48 
1G5A 
Amylosucrase 
EC 2.4.1.4 
2GDV 
Sucrose phosphorylase
EC 2.4.1.7 
1H3G 
Cyclomaltodextrinase 
EC 3.2.1.54 
1IZJ 
Neopullulanase / a-amylase I 
EC 3.2.1.135 / 3.2.1.1 
1EA9 
Cyclomaltodextrinase 
EC 3.2.1.54 1EA9 
Maltogenic amylase / neopullulanase / pullulanase 
EC 3.2.1.133 / 3.2.1.135 / 3.2.1.41 
2WCS 
a-amylase (debranching) / pullulanase / maltodextrin glucosidase 
EC 3.2.1.133 / 3.2.1.135 / 3.2.1.41 
1BVZ 
a-amylase II, pullulanase II 
EC 3.2.1.135  
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bigger dataset reveals mechanistic aspects like hydrolase versus transglycosidase, while the smaller 
dataset pinpoints residues involved in specificity.  
 
 
Figure 6.2 Coevolving positions in (a) the closest structural neighbours of sucrose 
phosphorylase and sucrose 6’-phosphorylase and (b) the sucrose-active enzymes 
(amylosucrase, sucrose hydrolase, sucrose phosphorylase and sucrose 6’-phosphorylase) 
(green node: same residue in SP and SPP; yellow node: different residue in SP and SPP; 
correlations coloured according to strength (red strongest correlation); numbering according 
to sucrose phosphorylase from Bifidobacterium adolescentis) . 
 
The correlated positions are scattered around the protein, ranging from as close as 4 Å to over 30 
Å away from the centre of the active site. It is generally known that the closer to the active site, the 
higher the chance a mutation has an influence on specificity364. Yet, more distant mutations can 
also have a profound effect, but these are particularly difficult to detect. CMA could therefore be an 
ideal tool to reveal these hotspots. Nevertheless, to change the specificity initial focus will always 
be on the residues that are in direct contact with the substrate. Here, we are interested in changing 
(a) 
(b) 
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the acceptor specificity, but unfortunately most residues that make up the acceptor site are not 
part of the core regions. As a consequence they can never be detected by CMA, despite it was  
 
 
Figure 6.3 Residues at correlated positions that differ between BaSP and TtSPP. Positions (a) 
near the catalytic nucleophile Asp192, the ‘hydrophobic sandwich’ Phe53 and important donor 
site residues, (b) near the transition state stabil iser Asp290, (c) in the acceptor site and (d) 
near loop that potential ly influences access to the active site (yellow sticks: sucrose; white 
sticks: catalytic triad and ‘hydrophobic sandwich’; green sticks; correlated positions that are 
different between BaSP and TtSPP) (note that for clarity of the figure a different colouring 
scheme was used compared to the network) . 
(a) (b) 
(c) (d) 
Val154 
Val161 
Gln159 
Phe53 
Asp290 
Asp192 
Ala84 
Phe53 
Asp290 
Asp192 
Thr288 
Val285 
Phe53 
Asp290 
Asp192 
Leu343 Tyr344 
Tyr236 
Trp274 
Ala254 
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shown that they are highly important for controlling the specificity in SP (Chapter 2) and SPP 
(Chapter 4). Hence, although it cannot be excluded that correlated positions have a direct influence 
on specificity, it seems that they rather play a role in supporting and fine-tuning the different active 
site architectures (considered they are indeed involved in specificity). 
To have an idea if the correlated positions could be involved in specificity, a closer look was taken 
to their location in the structure (not yet taking into account the number or strength of 
correlations) and some do seem to be good candidates (Figure 6.3). Residues 343 and 344 are part 
of the acceptor site loop A and the latter residue is known to be involved in specificity in SP 
(Chapter 2) and SPP (Chapter 4). Residues 285 and 288 on the other hand are close to the 
transition state stabiliser Asp290 and they are part of the same loop. Since the side chains of 285 
and 288 point towards each other, mutation could result in a different backbone conformation and 
accordingly a slightly different position and orientation of the transition state stabiliser. A similar 
observation was made for the adjacent residues 154, 159 and 161 together with residue 84 which 
are all located close to the catalytic nucleophile Asp192, the ‘hydrophobic sandwich’ Phe53 and the 
acceptor site loops. It is thus probable that the aforementioned residues have an impact on the 
positioning of crucial residues in the active site, accordingly tweaking the interactions that take 
place. 
For other positions, no clear indications are found that they might have an impact on specificity. 
Some are however expected to be involved in other properties. Residues 95 and 418 are part of the 
protein’s surface, which could make them important for stability. Positions 236, 254 and 274 in 
contrary are found near a loop that potentially influences the accessibility to the active site. Both 
the length and composition of this loop is highly variable in the sucrose-active enzymes. It is 
therefore likely that at these correlated positions, specific residues are present to accommodate the 
different loops. 
2.2 Evolution of the coevolution network 
Correlated positions are according to the definition positions that do not evolve independently 
from one another. In the networks considered here, all positions are interconnected and mutation 
of one position would thus require mutation of all other positions. Evolution of proteins is however 
a gradual process and it is accordingly impossible that all these changes occurred at the same 
moment. The current states are just a snapshot of one point in time and therefore it would be 
helpful to know which evolutionary steps led to the divergences that are observed today. 
To trace the evolution of the coevolving positions, ancestral sequence reconstruction was applied 
(in a similar way as for the reconstruction of the last common ancestor of SP and SPP; Chapter 5). 
The 3DM alignment is ideally suited for this purpose since it is accurate and does not contain any 
gaps. Moreover, the outgroup is sufficiently large and diverse, which further contributes to the 
reliability of the ancestral reconstruction365, 366. The LG+I+G evolutionary model was found to be the 
most compatible with the input sequences (see methods and materials for details) and accordingly 
it was used for the construction of the maximum likelihood tree as well as for the actual 
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reconstruction. After the reconstruction, the evolution of the correlated positions was followed 
starting from BaSP over the last common ancestor (LCA) of SP and SPP to TtSPP (Figure 6.4). From 
BaSP to the LCA a gradual evolution through single or two simultaneous mutations was observed. 
The probabilities of the reconstructed ancestral states at each node were moreover higher than 
90%. From the LCA towards TtSPP on the other hand, several mutations occured at the same time, 
especially at the node where the SPP-like enzymes branch of from the SP enzymes. Probabilities are 
in addition also lower (60-70%). More SPP-like input sequences are probably necessary to provide 
sufficient data for the reconstruction algorithm to accurately portray this transition. Nevertheless, a 
clear distinction can be made between mutations occurring at different stages of the evolution. 
Note that the LCA shares ten residues with BaSP and only five with TtSPP. Since it is known that the 
ancestor of SP and SPP displays SP activity (Chapter 5), this might be an indication that correlated 
positions are indeed involved in specificity. A remarkable observation is furthermore that positions 
that are close to each other in the structure (e.g. 154, 159 and 161) or that are strongly correlated 
with each other and other positions (e.g. 161, 285 and 348) not necessarily evolve simultaneously. 
To change specificity by mutagenesis, it is thus unclear which positions should be mutated together 
or if they should be mutated together anyway. It could be that two mutations separately already 
have a positive effect, but that the combination is much better. In this case, protein engineers that 
want to evolve enzymes in the lab will always reach the desired mutant, regardless whether they  
 
 
 
8 
1 
8 
4 
9 
5 
1 
5 
4 
1 
5 
9 
1 
6 
1 
2 
3 
6 
2 
5 
4 
2 
7 
4 
2 
8 
5 
2 
8 
8 
2 
9 
5 
3 
4 
3 
3 
4 
4 
3 
4 
8 
4 
1 
8 
 
BaSP M A Q V Q V Y A W V T I L Y S P Present 
SPBifi  SP 
M A Q V Q V Y A W V T I L Y S P 
 
M A Q T Q V Y A W V T I L Y C P 
 M L Q T Q V Y A W V T I L Y C P 
 M L Q T Q I Y A W V T I L Y C P 
LCA M L Y T Q I H A W V T I L Y C P Past 
 M L Y C Q I H A W V T V I Y C P 
 
SP  SPP 
M L Y C E I H A W V T V I Y C P 
L L Y T E I H I Y M C I V H C P 
 L L Y T E I H I Y M C K V H C P 
 L L Y T E I Q I Y M C K V H C D 
TtSPP L L Y T E I Q I Y M C K V H C N Present 
                  
Figure 6.4 Evolutionary trace of the correlated positions in the sucrose-active enzymes from 
BaSP over the last common ancestor of SP and SPP (LCA) to TtSPP (green; residue present in 
BaSP; yellow; residue present in TtSPP; SPBifiSP: node at which Bif idobacteria-l ike SP 
enzymes branch off from the other SP enzymes; SPSPP: node at which SPP-like enzymes 
branch off from the SP enzymes; only transitions are shown where at least one mutation 
occurs, residue numbering according to BaSP) 
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mutate positions separately or together. On the other hand, it could also be that during natural 
evolution a less fit mutant persists for a while, until a compensating mutation occurs that yields the 
best possible mutant. Accordingly, if all single mutants are inferior they will never find the desired 
mutant if they use a strategy where only one position is mutated at the time.  
2.3 Introducing SPP residues in SP at correlated positions 
To investigate the impact of mutations at correlated positions, residues in BaSP were switched to 
their TtSPP counterpart. As discussed above, large parts of the acceptor site are not present in the 
core regions (and thus not taken into account for the CMA), though it has been shown that they 
are crucial for specificity (Chapter 2 and 4). Therefore, in order to allow BaSP to perform the SPP 
reaction, acceptor site loop A (residues 340-345) and loop B (residues 132-137) were first swapped 
with those from TtSPP. For loop A, the NLDLY motif was replaced by GFDVH and for loop B 
YRPRPG with FLRRT. The resulting mutant will be referred to as BaSPP and serves as a reference for 
comparing activities. BaSPP catalyses the SPP reaction at a very low rate of 0.002 U/mg, while its SP 
activity is 0.035 U/mg. BaSPP thus still performs around 20 times better its ‘old’ SP activity, than the 
newly introduced SPP activity. This shows that altering the acceptor site loops is essential, but not 
sufficient to establish a true switch in specificity.  
In an attempt to improve the activity and tilt the specificity balance in favour of SPP activity, several 
correlated positions were additionally mutated to SPP-specific residues. These were introduced as 
single mutations as well as in different combinations, but apart from two, all mutants had a 
decreased SP and SPP activity, although in most cases the impact on the latter was more severe 
(Table 6.1). Mutation V154T in contrast was neutral and the combination with V161I could double 
the SPP activity, while it did not have an effect on SP activity. As a consequence, it seems that 
introducing SPP specific residues at correlated positions can only sporadically improve the SPP 
activity in SP. 
Despite the fact that the impact on activity was negative in most cases, it does prove that the 
selected correlated positions are involved in activity. Moreover, the SP and SPP activity were 
affected to a different extent, indicating a role in specificity. As a consequence, a closer look was 
taken at the different aspects of the correlation network (strength of correlation, CMA score, 
proximity in the structure). These however strongly overlap for many positions, e.g. two positions 
are correlated and at the same time close to each other in the structure. It is therefore very difficult 
to link a particular property of the network to the impact on activity and specificity. Changing valine 
to isoleucine at position 161 for instance decreased the SPP activity fivefold (Table 6.1). 
Simultaneous mutation with V154T could however increase the SPP activity again tenfold. Both 
positions are close to each other in the structure and are connected in the network. This suggests 
that simultaneous mutation of positions that are at the same time structural and network 
neighbours, is the key to success. Yet, position 159 shares the same properties with the former two, 
but the triple mutant had again a severely impaired activity, thereby negating the proposed 
hypothesis. Furthermore, the extend to which a mutation has an influence on activity or specificity 
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seemed to be independent of CMA score, strength of correlation or stage in evolution. The same is 
in addition true for the change in size or physico-chemical properties entailed with a mutation. 
Simultaneous mutation of two structurally adjacent residues in contrast resulted in some cases in a 
higher activity or a shifted specificity compared to the individual mutations, e.g. residue pairs 
V154T-V161I and V285M-T288C, but this is not generally applicable (Table 6.1). 
 
Table 6.1 Sucrose 6'-phoshate phosphorylase (SPP) and sucrose phosphorylase (SP) activity of 
different mutants created to investigate different properties of the correlation network 
(influence of the correlated mutation analysis (CMA) score, strength of correlation between 
positions, proximity of residues in the structure and time point at which the mutation 
occurred during the evolution of SP to SPP) 
mutant high 
CMA 
score 
strong 
corre-
lation1 
close 
in 
structure2 
SP 
→
SPP 
SPP activity 
(10-3 U/mg) 
SP activity 
(10-3 U/mg) 
reference       
   BaSPP     2.17 ± 0.03 (100%) 34.9 ± 0.6 (100%) 
single mutants       
   M81L    x 0.21 ± 0.01 (9%) 20.0 ± 2.0 (57%) 
   V154T   x (b)  2.06 ± 0.21 (95%) 32.2 ± 1.4 (92%) 
   Q159E   x (b) x 0.38 ± 0.01 (18%) 16.3 ± 1.2 (47%) 
   V161I x x x (b)  0.38 ± 0.04 (17%) 19.4 ± 1.7 (56%) 
   A254I    x 0.28 ± 0.04 (13%) 16.9 ± 1.5 (48%) 
   W274Y    x 1.00 ± 0.01 (46%) 11.8 ± 0.5 (34%) 
   V285M x x x (a) x 0.05 ± 0.01 (2%) 2.4 ± 0.4 (7%) 
   T288C x  x (a) x 0.31 ± 0.09 (14%) 19.8 ± 1.3 (57%) 
   I295K    x 0.19 ± 0.03 (9%) 10.5 ± 1.0 (30%) 
   S348C x x   0.80 ± 0.03 (37%) 25.4 ± 2.2 (73%) 
combinations       
   154+161   x (b)  4.61 ± 0.67 (212%) 38.6 ± 3.7 (111%) 
   154+159+161   x (b)  0.50 ± 0.14 (23%) 27.1 ± 2.5 (77%) 
   285+288 x  x (a) x 0.82 ± 0.01 (38%) 16.2 ± 2.4 (46%) 
   161+285+348 x x   0.23 ± 0.06 (11%) 7.8 ± 0.7 (22%) 
   161+285+288+348 x x   0.14 ± 0.02 (6%) 8.6 ± 0.3 (25%) 
1 marked residues have strong correlations with each other (see also Figure S6.1); 2 two separate clusters (a) 
and (b) of residues that are close to each other in the structure (see also Figure 6.3) 
 
3 CONCLUSION 
Structural analysis of the correlated positions suggests that they might serve a supportive role for 
e.g. different active site architectures or loops. It was further shown that mutation of these positions 
indeed has an influence on activity and specificity, and that it is possible to optimise enzyme 
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properties by adjusting the correlation network. No relation was however observed between the 
extend of the effect and the strength of correlation, proximity in the structure, CMA score nor the 
stage in evolution at which the positions changed. This makes it accordingly nearly impossible to 
derive general guidelines on how to use correlated mutation data. It though seemed that structural 
context may be more important than the network itself and that some mutations need to be 
present at the same time. Nevertheless, there are still many questions surrounding the application 
of correlated positions for enzyme engineering and future research is accordingly needed.  
4 METHODS AND MATERIALS 
4.1 Correlated mutation analysis and ancestral sequence reconstruction 
The structure-guided multiple sequence alignment was generated with the 3DM package (Bio-Prodict, 
Nijmegen, The Netherlands)284, 367. In brief, 3DM superposes the structures of related proteins and generates a 
structure-based sequence alignment that contains all positions that are structurally conserved among the 
structures (called the core regions). All structures that share at least two thirds of their structural elements with 
the crystal structure of sucrose phosphorylase from Bifidobacterium adolescentis (pdb entry 2GDV) were 
selected for superposition (pdb entries 3CZK, 1G5A, 1H3G, 1IZJ, 1EA9, 1BVZ and 2WCS) and all know 
sequences were aligned against the obtained core regions. Quality is more important than quantity and 
therefore all sequences that cannot unambiguously be aligned are discarded (according to a built-in scoring 
function). Correlated mutation analysis (CMA) was subsequently performed with the comulator tool, which 
compares the abundance of certain amino acid pairs to the entire dataset (for details see Kuipers et al.230). 
CMA was also carried out for the subset of sucrose-active enzymes (3DM families 2GDV, 1G5A and 3CZK). 
For the ancestral sequence reconstruction, all 404 aligned protein sequences from the sucrose-active enzymes 
subset (core regions only) were retrieved from the 3DM database. The same workflow was followed as 
described in Chapter 5, with the difference that other software packages were used for the construction of the 
tree and the reconstruction process. ProtTest 3.2.1208 was run to select the evolutionary model that fits the 
input sequences best. According to the statistical BIC, AIC and AICc criterions, the LG+I+G substitution 
matrix217 (a recent evolutionary model that is generally applicable) was most suited and it was therefore used 
to construct a maximum likelihood tree with eight discrete rate categories (to account for among-site 
variation; some sites mutate faster than others), an estimated proportion of invariable sites (some sites are 
conserved in the input sequences), nearest-neighbour interchange tree rearrangement and optimisation of the 
tree topology, branch lengths and substitution model parameters in PhyML 3.0213. The tree was checked 
manually to assess its validity (clustering of genera, species, related organisms, ... ) and compared to a 
bootstrap consensus tree (1000 replicates) built in TreeFinder368 and visualised in iTOL369. The ancestral states 
were derived with the PAML 4.7 package210, 370, using a gamma shape parameter of 1.15 and the LG+I+G 
model.  
4.2 Mutagenesis, enzyme expression and purification 
Site-directed mutations were introduced with a modified two-stage megaprimer-based whole-plasmid PCR 
method295 (as described in Chapter 2), using the primers listed in Table S6.2 and the constitutive expression 
plasmid pCXP34his containing the gene of sucrose phosphorylase from Bifidobacterium adolescentis (same as 
described in Chapter 2 and 3). Enzymes were produced and purified as previously described123. 
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4.3 Activity measurements 
All reactions were performed with 100 mM donor (α-D-glucose 1-phosphate) and 100 mM acceptor (D-fructose 
or D-fructose 6-phosphate) in 50 mM MOPS buffer pH 7.0 at 37°C. Samples were analysed by High 
Performance Anion Exchange Chromatography (HPAEC) (Dionex ICS-3000, Thermo Scientific) with Pulsed 
Amperometric Detection (PAD). Samples treatment and analysis was performed in exact the same way as 
described in Chapter 5. 
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SUPPLEMENTARY DATA 
 
 
Figure S6.1 Coevolving positions with the highest correlation strength in the sucrose-active 
enzymes (same figure as Figure 6.2, but only strongest correlations are shown; green node: 
same residue in SP and SPP; yellow node: different residue in SP and SPP; numbering 
according to sucrose phosphorylase from Bifidobacterium adolescentis) . 
 
 
Table S6.1 Correlated mutation analysis (CMA) score and number of correlations of the 
correlated positions that have a different residue in Bif idobacterium adolescentis sucrose 
phosphorylase (BaSP) and Thermoanaerobacterium thermosaccharolyticum sucrose 6’-
phosphate phosphorylase (TtSPP) (residue numbering according to BaSP). 
position CMA score number of correlations 
285 11.26 13 
161 11.11 13 
288 8.53 10 
348 7.86 9 
343 6.67 8 
295 4.94 6 
274 4.16 5 
418 2.46 3 
81 1.70 2 
159 1.64 2 
254 0.82 1 
154 0.80 1 
236 0.80 1 
344 0.80 1 
Table S6.2 Primers used for site-directed mutagenesis 
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mutant primer 5’→3’ 
BaSPP BaSP_CO3_Fw_NLLY340GFV
H 
GGTGCGGCGGCATCGGGCTTTGATGTGCACCAAGTTAATAGTA
CC 
 BaSP_CO3_Rv_YRPRPG132FL
RRT 
GACCTGGCAGGCATTTATCTGCGTCGTCCGGG 
TCTGCCGTTTAC 
BaSPP_M81L BaSPP_CO3_Fw_M81L CCCACAACATTCTGGTGGATGCAATCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_V154T BaSPP_CO3_Fw_V154T CGCGTCTGGTCTGGACGTCTTTTACCCCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_Q159E BaSPP_CO3_Fw_Q159E CTTTTACCCCGGAGCAAGTGGACATCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_V161I BaSPP_CO3_Fw_V161I CCCGCAGCAAATCGACATCGATACG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_A254I BaSPP_CO3_Fw_A254I CGCGTTTATGACTTTATCCTGCCGCCGCTGC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_T288C BaSPP_CO3_Fw_W274Y GGTGGCCCATTACACGGATATTCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_V285M shuf pCXP 01 Fw GAATTCGGAGGAAACAAAGATGGG 
 BaSPP_CO3_Rv_V285M CATGCGTATCCAGCATGGTAACAGCATTG 
BaSPP_T288C BaSP_CO3_Fw_VT285VC GTTACCGTCCTGGATTGCCATGACGGCATCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_I295K BaSPP_CO3_Fw_I295K GACGGCATCGGCGTTAAAGATATCGGTTCAG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_S348C BaSPP_CO3_Fw_S348C GTGCACCAAGTTAATTGTACCTACTACTCCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_154_161 BaSPP_CO3_Fw_VV154TI CGCGTCTGGTCTGGACCTCTTTTACCCCGCAGCAAATTGACATC
GATACG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_154_159_161 BaSPP_CO3_Fw_VQV154TEI GCGTCTGGTCTGGACGTCTTTTACCCCGGAGCAAATTGACATCG
ATACGG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_285_288 shuf pCXP 01 Fw GAATTCGGAGGAAACAAAGATGGG 
 BaSPP_CO3_Rv_VT285MC GCCGATGCCGTCATGGCAATCCAGCATGGTAA CAGCATTGTTC 
BaSPP_161_285_348 BaSPP_CO3_Fw_V161I CCCGCAGCAAATCGACATCGATACG 
 BaSPP_CO3_Rv_V285M CATGCGTATCCAGCATGGTAACAGCATTG 
 BaSPP_CO3_Fw_S348C GTGCACCAAGTTAATTGTACCTACTACTCCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSPP_161_285_288
_348 
BaSPP_CO3_Fw_V161I CCCGCAGCAAATCGACATCGATACG 
BaSPP_CO3_Rv_VT285MC GCCGATGCCGTCATGGCAATCCAGCATGGTAA CAGCATTGTTC 
 BaSPP_CO3_Fw_S348C GTGCACCAAGTTAATTGTACCTACTACTCCG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
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ABSTRACT 
Stability is an important property of biocatalysts and in silico prediction of stabilising mutations 
could greatly reduce time, cost and effort compared to current in vitro screening procedures. Here, 
we evaluated the potential of the FoldX algorithm. All possible point mutations were introduced in 
a sucrose phosphorylase and those predicted to improve the free energy of folding or the dimer 
interaction energy were visually inspected for unreasonable mutations. Two thirds were rejected 
during this manual selection, mostly because hydrophobic residues became too solvent exposed. 
From the remaining mutants, the nine most promising were experimentally tested. Unfortunately 
none proved to be more stable: four appeared to be neutral or nearly neutral, while five were 
deleterious. Remarkably, the mutant predicted to be the most stabilising drastically impaired 
stability. To explain these findings, molecular dynamics (md) simulations were performed. Root 
mean square fluctuations (rmsf), representing local flexibility, were found to be bad predictors of 
stability. Examining if the interactions responsible for the predicted stability are maintained over a 
period of time in contrast could indeed explain the observed effects in many cases. 
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1 INTRODUCTION 
In the everlasting pursuit to make industrial enzymatic processes economically more feasible, the 
stability of the biocatalyst plays a key role135, 240, 371. Also protein engineers aiming at improving the 
catalytic properties of an enzyme benefit from a stable template. Indeed, mutations that improve 
function often decrease stability and can even lead to loss of folding and expression223, 224, 362. 
Thermostable variants are therefore highly interesting, but they are often not available from natural 
diversity. Increasing the stability of known enzymes by means of mutagenesis is accordingly the 
alternative. Depending on the amount of structural and sequence information available, methods 
like random mutagenesis, rational design, B-fit method, consensus design, ancestral method, 
truncation, circularisation and chimeric designs can be applied (among others)135, 240. Successful 
outcome for all these techniques have been reported, but at the same time they all have their 
limitations. It is for instance not straightforward to rationally predict the effect of a mutation372, 
consensus designs are highly dependent on the input sequences346 and random methods require a 
high-throughput screening method373. Hence, it is not surprising that computational design is 
currently a hot topic. A vast number of variants can be evaluated in silico, and only a few designs 
need to be assessed in vitro. That way, creation of stable enzymes could become faster, less labour-
intensive and more cost-efficient.  
One of the available algorithms is FoldX, which quickly and quantitatively estimates all relevant 
interactions that contribute to the stability of proteins and protein complexes251, 374, 375. These terms 
include van der Waals interactions, solvation, hydrogen bonds, electrostatic interactions as well as 
entropy costs, and they are used to calculate the free energy of folding ∆Gfold. The impact of a 
mutation on stability is then simply the difference in free energy of folding before and after 
mutation (∆∆Gfold). FoldX is useful for the prediction of stability changes due to point mutations. It 
has mainly been used to study protein-protein and protein-DNA interactions, and only a few 
examples are known where it is used to improve the stability of an enzyme248, 376. Here, the 
algorithm was applied to stabilise sucrose phosphorylase (SP). This enzyme naturally catalyses the 
reversible phosphorolysis of sucrose into α-D-glucose 1-phosphate, but it can also glycosylate a 
wide variety of other small organic compounds, making it attractive for the production of industrial 
fine chemicals26, 72. High-throughput is particularly difficult due to the high dependency of the 
stability on the protein concentration98, and in silico mutagenesis is therefore an attractive 
alternative. Here, SP from Bifidobacterium adolescentis was used since it is the only SP whose 
crystal structure (dimer) has been resolved (structure is required as input for FoldX). Its operational 
stability has previously been enhanced by immobilisation96, 98 and its inherent stability by 
mutagenesis332, but there is still room for improvement. Therefore, in this work the change in 
stability of all possible point mutations was calculated with FoldX and after visual inspection of the 
top fifty most stabilising, the six most promising mutants were created in vitro. Additionally, the 
dimer interface was screened for mutations that could improve the interaction between the two 
subunits, and three additional mutants were tested in vitro. Eventually, molecular dynamics (md) 
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simulations were performed to investigate whether this could be a useful step for filtering out false 
positives. 
2 RESULTS AND DISCUSSION 
2.1 Point mutations 
The change in stability was calculated for each possible point mutation at every position that was 
further than 10 Å away from the active site and that was not part of the dimer interface. These 
latter positions were treated differently (see further). The cut-off of 10 Å was handled to minimise 
the chance of disrupting the catalytic function364. For the same reason all residues closer than 7.5 Å 
were also not allowed to move during the in silico mutagenesis. In total, 424 positions were 
individually mutated into all 20 possible amino acids, and the corresponding change in total free 
energy of folding was derived (∆∆Gfold). To assure that the changes were sufficiently significant, only 
mutations that improved ∆Gfold by 1.5 kcal/mol (approximately three times the error margin) were 
retained for further analysis (Table S7.1). The models of the remaining mutants were manually 
visually inspected to identify mutations that are likely to be infeasible in reality. Out of the 55 
mutants, 37 were rejected for different reasons, but mostly because a hydrophobic residue was 
introduced at a surface exposed position or at a water-accessible cavity (77%). The others were 
rejected because they caused excessive van der Waals clashes (5%), disrupted hydrogen bonds that 
were believed to be important (5%) or introduced a proline in a helix (3%). From the remaining 18 
mutations, the six most promising mutations were selected for in vitro evaluation, i.e. T208D, 
Q376L, Q376M, N280K, A11P and V271L.  
The most stabilising mutation predicted by FoldX was T208D, which introduces a negatively 
charged residue at the N-terminal end of an α-helix and accordingly stabilises the helix by 
neutralisation of the overall dipole moment372, 377 (Figure 7.1a). An additional hydrogen bond could 
be formed as well, although this also brings along slight van der Waals clashes. Position 376 is at 
the heart of the TIM barrel and the side chain of the Gln present the wild-type enzyme is situated 
in a rather apolar environment and is only involved in one hydrogen bond. Moreover, small voids 
are found in the vicinity. Accordingly, substitution by Leu or Met could improve the packing of the 
core, which is also reflected by the improved van der Waals interaction and solvation energy term 
in the FoldX energy function (Figure 7.1b-c). The same was observed for V271L, which is situated in 
a hydrophobic pocket (Figure 7.1d). Substitution of loop residue Ala11 by a Pro was also predicted 
to be stabilising, agreeing with the general assumption that a proline in a loop reduces the local 
flexibility372, 378 (Figure 7.1e). Finally, replacement of Asn280 by Lys entailed the formation of two 
new hydrogen bonds and helix dipole neutralisation (Figure 7.1f). 
The six mutants were recombinantly expressed and purified. All of them were active and had 
specific activities (65-110 U/mg) comparable to the wild-type enzyme (~100 U/mg). Their kinetic 
stability was subsequently assayed by determining the residual activity after incubation at 70 °C for 
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15 minutes (Figure 7.2). Unfortunately, none of the variants had a higher stability than the wild-type 
enzyme. 
 
 
Figure 7.1 Potential ly stabil ising point mutations retained for in vitro analysis and ∆∆Gfold 
(kcal/mol) predicted by FoldX. (a) Asp208 at N-terminal end of α-helix neutralising the overall 
dipole moment, (b-d) Leu376, Met376 and Leu271 improving packing in hydrophobic 
environment, (e) Pro11 reducing loop flexibil ity and (f) Lys280 creating two new hydrogen 
bonds (green: mutated residue). 
(a) (b) 
(f) (e) 
(c) (d) 
T208D 
-3.8 ± 0.2 kcal/mol 
Q376L 
-2.6 ± 0.3 kcal/mol 
Q376M 
-2.5 ± 0.1 kcal/mol 
V271L 
-1.9 ± 0.1 kcal/mol 
N280K 
-2.5 ± 0.3 kcal/mol 
A11P 
-2.3 ± 0.1 kcal/mol 
CHAPTER 7  In silico prediction of stabilising mutations 
 166 
Strikingly, mutant T208D mutant did no longer show any activity at all after incubation, even 
though FoldX classified it as the most promising mutation. Maybe the increase in van der Waals 
clashes had a higher impact on stability than anticipated. In previous research, two other residues 
of the same enzyme had also been altered with the aim of improving the helix dipole, but yielded 
very unstable variants too332. For Q376M a drastic lower stability was observed as well, while the 
stability of Q376L was not significantly different from that of the wild-type enzyme. Apparently, Leu 
has the same effect as the similarly-sized Gln, whereas Met might already be too bulky and 
interfere with a decent packing of the TIM-barrel core. A more limited drop in stability was 
observed for the variant with Lys at position 280. The predictions of that mutant’s stability had a 
relatively high standard deviation, suggesting that the algorithm may have experienced trouble with 
the side chain’s degrees of freedom. Accordingly, the predicted hydrogen bonds of the side chain 
(which are the main reason for stability improvement) might in reality not be present. Variants A11P 
and V271L at last did not significantly differ from the wild-type enzyme. The suggested reduction in 
loop flexibility and better packing, respectively, could thus not improve the stability. 
 
 
Figure 7.2 Relative thermostabil ity of the single mutants after incubation at 70°C for 15 
minutes (mutants retained after the generated models of the top stabil is ing mutations 
predicted by FoldX had been manually inspected for unreasonable predictions; see text for 
details) . 
 
2.2 Dimer interface 
The sucrose phosphorylase from Bifidobacterium adolescentis (BaSP) forms a functional homodimer, 
in which inter-subunit interactions keep the two chains of the dimer together93, 103. It is known from 
literature that such interactions can significantly contribute to an enzyme’s stability327, 379, 380. This 
was also what was observed in a variant of BaSP in which position 393 was changed from Arg into 
Asn. In the wild-type enzyme, arginine was believed to suffer from electrostatic repulsion with the 
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same amino acid in the other subunits, as their side chains pointed towards each other332. 
Replacement with Asn alleviated this problem.  
 
 
Figure 7.3 Improved hydrogen bonding interactions at the dimer interface, and ∆∆Gfold 
(kcal/mol) and change in inter-subunit interaction energy ∆Eint predicted by FoldX. (a) location 
of the mutations at the dimer interface, (b) S116R, (c) T124R and (d) T149R (white: subunit A; 
yellow: subunit B; green: mutated residue).  
 
To check whether changing other dimer interactions could also improve the stability, all twenty-six 
positions at the dimer interface were saturated in silico, one by one. Each time the same mutation 
was introduced in both subunits and the change in stability was predicted. In addition, the 
interaction energy between the subunits was calculated as well. Only three mutants showed an 
increase for both parameters, namely S116R, T124R and T149R (Figure 7.3). For all three mutants, 
predicted increase in stability and interaction energy was mainly due to newly created hydrogen 
bonds between the guanidino group of the introduced Arg and the other subunit. 
In vitro evaluation of the mutants was performed as before, i.e. comparison of the residual activity 
after incubation at 70 °C for 15 minutes (Figure 7.4). Sadly, all mutants had a stability that was 
worse than the wild-type enzyme. Although for all of them a higher interaction energy as well as 
(a) (b) 
(c) (d) 
S116R 
∆∆Gfold = -3.0 ± 0.5 kcal/mol 
∆Eint = -2.2 ± 0.5 kcal/mol 
T124R 
∆∆Gfold = -0.9 ± 0.8 kcal/mol 
∆Eint = -3.9 ± 1.2 kcal/mol 
T149R 
∆∆Gfold = -1.1 ± 0.7 kcal/mol 
∆Eint = -2.4 ± 0.9 kcal/mol 
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stability was predicted, it did seem to be different in reality. Since in all cases an arginine was 
introduced, one could speculate that this amino acid’s high side chain flexibility could have caused 
issues at the interface, e.g. electrostatic repulsion or van der Waals clashes. These findings together 
with the fact that no other mutants were predicted to have better stabilities and interaction 
energies, could indicate that the two monomers perfectly fit at the dimer interface. Consequently, 
this might partly explain the exceptional stability of sucrose phosphorylase from Bifidobacterium 
adolescentis compared to other SP enzymes, which are all monomeric. 
 
 
Figure 7.4 Relative thermostabil ity of the dimer interface mutants after incubation at 70°C for 
15 minutes (mutants retained after the generated models of the top stabil is ing mutations 
predicted by FoldX had been manually inspected for unreasonable predictions; see text for 
details) . 
 
2.3 Molecular dynamics simulations 
Stabilities predicted by FoldX did not agree with those obtained from the wet lab experiments. One 
reason for this discrepancy could be that fact that FoldX performs its calculations on a rigid crystal 
structures. These are however usually obtained at low temperatures and the conformation in a 
packed crystal does not necessarily represent the physiological state. Moreover, enzymes are in 
reality flexible entities that do not a have a single fixed conformation. Hence, molecular dynamics 
(md) simulations were applied to have a more detailed view on the behaviour of the mutants and 
what the causes of the lower stability could be. 
To mimic physiological conditions, each mutant structure was put in a box of water molecules 
together with some salt ions, and simulation parameters were optimised to obtain stable 
simulations. Since water molecules are added randomly, the system first needs to be relaxed by 
energy minimisation in order to remove steric clashes or inappropriate geometry. After the 
potential energy has converged (Figure 7.5a), the solvent and ions were equilibrated around the 
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protein. First, isothermal-isochoric (NVT; constant Number of particles, Volume and Temperature) 
conditions were applied until the temperature reached a plateau at the desired value of 333K 
(Figure 7.5b). Thereafter the pressure and density were stabilised under isothermal-isobaric (NPT; 
constant Number of particles, Pressure and Temperature) conditions (Figure 7.5c and d). An 
equilibrium value of around 995-996 g/l was obtained for the density, while the average pressure 
approached the reference of 1 bar (note that fluctuations of the order of hundreds of bar are 
typical). Starting from this stable and equilibrated system, the behaviour of the enzyme was 
simulated over a timescale of one nanosecond. After 200 ps, the root-mean-square deviation (rmsd) 
of the protein stagnated around an equilibrium value of 1.5-1.7 Å, comparable to a rmsd of 1.7-2.1 
Å for the available crystal structures (1R7A, 2GDU and 2GDV).  
 
 
Figure 7.5 Different steps performed in the molecular dynamics simulations of each mutant, 
i l lustrated for the wild-type enzyme. (a) potential energy Epot during the energy minimisation 
step (typical value: minus 105-106 kJ/mol) , (b) temperature during the equil ibration of the 
solvent around the protein under NVT conditions (set point 333K), (c) pressure (set point 1 
bar) and (d) density during equil ibration under NPT conditions (expected value of 995-996 g/l 
for the density according to the water model used), and (e) root-mean-square deviation 
(rmsd) of the entire protein during a nanosecond simulation (only one repetit ion shown for 
clarity) . 
 
The mutations investigated in this research were either destabilising (T208D, N280K and Q376M) or 
neutral (A11P, V271L, Q376L). As a positive control, rationally designed stabilising mutations from 
previous work332 were included in the md simulations as well. These comprised mutations that 
aimed at decreasing the local flexibility (D445P/D446T), introducing additional salt bridges (Q331E 
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and Q460E/E485H) or promoting dimer interaction (R393N) (Figure S7.1). Decreasing local flexibility 
is generally regarded as an important factor for increasing the stability240, 248, 381. Therefore, it was 
 
Figure 7.6 Root-mean-square fluctuations (rmsf) of the alpha carbon atom and the complete 
residue (average of all atoms) of all residues within 4.5 Å of the mutated residue for (a) 
destabil is ing, (b) neutral and (c) stabil is ing mutations (average of 3 repetit ions; standard 
deviations not shown for clarity (cv <5% for low rmfs values and up to 20% for the most 
flexible residues); no rmsf statistically significantly different between wild-type and mutant). 
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investigated whether comparing the root-mean-square fluctuations (rmsf) between the wild-type 
enzyme and the mutants is a reliable parameter. According to the hypothesis, stabilising mutations 
should result in a lower and destabilising in a higher rmsf. Initially, only the mutated residue was 
taken into account, and the rmsf values of the alpha carbon atom (representing main chain 
flexibility) and the entire residue (average of all atoms) were compared between the mutant and 
the wild-type enzyme (Figure S7.3). For every mutation, the alpha carbon rmsf values were nearly 
identical before and after mutation. When the complete residues were considered, differences could 
be observed for the stabilising mutation D445P (lower rmsf) and the destabilising mutation N280K 
(higher rmsf). It is however not unlikely that this is an artefact due to the nature or size of the side 
chain (Pro side chain is fixed, and surface exposed Lys much larger than Asn). Moreover, for all 
others no significant differences were observed.  
Focussing only on the mutated residue does accordingly not seem to be reliable, and therefore the 
scope was broadened to all residues within 4.5 Å from the mutated residue (Figure 7.6). 
Unfortunately, the predictive power was again ambiguous. Mutant D445P/D446T (designed to 
reduce the local flexibility) and the highly destabilising mutation T208D showed indeed a lower and 
higher flexibility of the surrounding residues, respectively. The conclusions could for the former 
however only be drawn from the complete residues and not from the alpha carbons, while for the 
latter it was the other way around. Furthermore, mutation Q331E displayed a higher local flexibility 
both in terms of alpha carbons and complete residues, but ensures in contrast to what one would 
expect from the in silico analysis a higher stability in vitro. In addition, often a few residues within 
the 4.5 Å sphere have higher rmsf values while the remaining have lower values, making the 
interpretation of the overall local flexibility nearly impossible. It can therefore be concluded that 
rmsf values can give an indication for highly (de)stabilising mutations, but they are in general not a 
good parameter for stability predictions. 
An alternative to comparing local flexibility, is to look at particular features of the introduced 
mutations i.e. are the desired interactions present over the investigated period of time. First, the in 
vitro stabilising mutations (rationally designed mutants from previous work) will be considered. In 
the wild-type enzyme, the Arg393 side chains of each monomer are facing each other at the dimer 
interface, which could cause electrostatic repulsion (Figure S7.1). Simulations over 10 ns support this 
hypothesis, as the distance between the alpha carbons steadily increased from around 7.5 Å to over 
20 Å, driving both monomers apart at that position (Figure 7.7). For the R393N mutant in contrast, 
the distance remained below 10 Å most of the time. The asparagine side chains indeed formed 
hydrogen bonds, but not necessarily with each other. Mostly, the Asn side chain interacted with the 
main chain of the other monomer. Moreover, in the mutant the side chains from the neighbouring 
Asn396 also interacted with one another (interactions not present in the wild-type enzyme) and 
with the side chains of Asn393 (Figure S7.2). Mutation R393N thus not only provided better dimer 
interactions itself, it also enabled the naturally present Asn396 to further contribute to a better 
contact at the interphase. 
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Figure 7.7 Alpha carbon - alpha carbon distances of residues at position 393 and number of 
inter-subunit hydrogen bonds for residues at position 393 and 396 for the wild-type enzyme 
and R393N mutant (a) over time and (b) i l lustrated in the structure (sc: side chain; all : al l 
atoms; only one repetit ion shown for clarity)  
t = 0 ns 
t = 8.1 ns 
t = 0 ns 
t = 8.1 ns 
Cα - Cα = 7.5 Å 
Cα - Cα = 23.5 Å 
Cα - Cα = 7.7 Å 
Cα - Cα = 7.6 Å 
wild-type R393N 
(a) 
(b) 
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At the surface of the C-terminal domain (anti-parallel ß-sheets), the side chains of Arg445 - Gln460 
- Glu485 - Asp490 are lining each other and mutations Q460E and E485H were introduced to 
increase the number of hydrogen bonds (Figure S7.1). Simulations indeed confirm this assumption 
(Figure 7.8). The fraction of time that two hydrogen bonds are present is more than double 
compared to the wild-type enzyme, while the fraction no hydrogen bonds are present is twice as 
low. Hydrogen bonds were mostly present between Arg445 - Glu460 and His485 - Asp490, but 
between Glu460 and His485 they were observed as well. The ß-sheets are thus not only held 
together by the main chain hydrogen bonds, but also due to favourable side chain interactions.  
A last stabilising mutation is Q331E in which Gln331 was changed to Glu with the aim of 
strengthening the interaction with His323 (Figure S7.1). This time the stabilising effect was less 
clear. Side chain hydrogen bonding occurred only occasionally and was highly dependent on the 
initial side chain orientation and protonation state of His323. 
 
 
Figure 7.8 Number of hydrogen bonds between side chains in the C terminal domain (side 
chain interaction of position 455, 460, 485 and 490; wild-type: Arg-Gln-Glu-Asp; mutant; Arg-
Glu-His-Asp). 
 
For the interpretation of the mutations predicted by FoldX, a closer look will be taken at the 
individual energy terms. Mutation T208D was predicted to be stabilising through hydrogen bonding 
with the backbone nitrogens of residues 210 and 211 and accordingly neutralising the helix dipole. 
Simulation of mutant T208D however revealed the Asp208 side chain flips 180° and the initial 
hydrogen bonds get lost over time (Figure 7.9a and c). New H-bonds are formed with the 
backbone nitrogens of residues 204-206, thereby slightly displacing the backbone of all 
surrounding residues (in agreement with the above discussed rmsf analysis). The predicted 
stabilising effect is thus absent and the different backbone conformation probably introduced 
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strain. Most likely this triggered local unfolding, regarding the very poor in vitro stability of this 
mutant. 
 
 
Figure 7.9 Evolution of the number of side-chain hydrogen bonds of mutant (a) T208D and (b) 
N280K over time with their init ial hydrogen bonding partners (top) and all residues (bottom) 
and (c) snapshots of T208 at different time points (sc: side chain; all : al l atoms; only one 
repetit ion shown for clarity) 
 
Replacing Asn280 with Lys resulted according to FoldX in strong hydrogen bonds, dipole 
neutralisation and improved van der Waals interactions through the hydrophobic part of the side 
chain. The hydrogen bonds are yet only present for a few picoseconds and not replaced by any 
others (Figure 7.9b), and the van der Waals interactions got lost as well. Lacking any favourable 
interactions, the high cost for the solvent exposure of the Lys side chain gained the upper hand, 
explaining the decreased stability. In contrast to the destabilising mutations discussed above, no 
obvious cause could be indicated for the instability of mutant Q376M. It had nearly the same 
(c) 
t = 0 ns t = 0.87 ns 
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values for al individual FoldX energy terms as the neutral Q376L mutation, and surrounding 
residues did not behave differently during simulation. Similarly, for the other neutral mutations 
A11P and V271L no contradictions were observed between the FoldX predictions and the molecular 
dynamics simulations. 
2.4 Optimisation of the workflow 
The ultimate goal is to have a fully automated protocol that delivers stabilised proteins. It is 
however clear that the current workflow does not meet this demand. It requires a lot of manual 
intervention and unfortunately still yields a lot of false positives. One part that could easily be 
automated is the inspection of the top mutants predicted by FoldX. The detection of e.g. 
hydrophobic residues at the surface, prolines in helices or unsatisfied side chain hydrogen bonds 
can be readily automated in software packages like YASARA289. Lowering the number of false 
positives on the other hand will be more challenging. In that respect, md simulations can be a 
great help, as shown in this work and others240, 248, 381. They are however computationally much 
more demanding and can certainly not be performed in high-throughput. It would therefore be 
convenient if false positives could be eliminated in an earlier stage. To that end, the stability of 
point mutations predicted by other fast algorithms could be calculated in parallel to FoldX and only 
those mutations that agree in this second opinion could be considered for further investigation. 
Tough it has been shown that combining different methods could improve the prediction accuracy 
in absolute numbers, it can still be beneficial in qualitative terms. Alternatively, an ensemble of 
input structure for FoldX could be taken from an initial md simulation of the wild-type structure. 
Automated interpretation of the md simulation will probably always require manual intervention. 
Root-mean-square fluctuations appeared to be bad predictors of stability, a phenomenon also 
observed by other researchers248. Looking at particular features seems to be more promising, but 
requires an individual treatment of every mutation. Moreover, the optimal timespan of simulation is 
difficult to define. Some researchers perform simulations of only 100 ps248. Results in this work, 
however, show that the interactions predicted by FoldX are present during this pre-equilibration 
phase, but get lost once the system is equilibrated (e.g. T208D and N280K). For mutant R393N even 
a simulation time of 10 ns was required to observe specific effects. Accordingly, in silico results 
should be interpreted with caution, and a comparative study of different workflows would be of 
great interest. 
3 CONCLUSION 
Out of all possible point mutations, several were predicted to be stabilising by the FoldX algorithm. 
For a few, the calculated dimer interaction energies were in addition better as well. Despite the 
elimination of unreasonable mutations by visual inspection, none of the top predicted mutants 
were found to be stabilising in vitro. Yet, the reason for the destabilising effect as well as the 
stabilising effect of mutations from previous work could in many cases be explained by molecular 
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dynamics simulations. The downside is however that they are computationally much more intensive 
and each mutant needed to be interpreted individually, which hampers a fully automated workflow. 
Nevertheless, md simulations are a valuable and necessary addition to the FoldX stability 
calculations.  
4 METHODS AND MATERIALS 
4.1 In silico prediction of stabilising mutations with FoldX 
X-ray structures are usually acquired under non-physiological conditions and therefore the observed angles, 
distances and conformations are very likely to contain slight errors. Therefore, rotamers were first optimised, 
van der Waals clashes eliminated and neighbouring residues moved in order to obtain new energy minima 
(RepairPDB command). The resulting model served as the template for mutagenesis. All residues within 7.5 Å 
from the centre of the active site (= geometric centre of the catalytic tryad) were kept in a fixed conformation 
and only residues further than 10 Å away were mutated. For these latter, all possible point mutations were 
introduced using the BuildModel command. The default settings (for which FoldX was optimised) were used251, 
374, 375, except for the number of runs. Each model was built five times to prevent the algorithm from being 
trapped in a local minimum, which is especially important for residues with a large degree of freedom such as 
arginine. The AnalyseComplex command was used to estimate interaction energies between subunits. Visual 
inspection of the models was done in YASARA289. 
4.2 Molecular dynamics simulations 
Simulations were performed with GROMACS 4.6.5263, 382 in a cubic box of tip3p water providing a minimum 
layer of 7.5 Å of water on each side of the protein. Charge neutrality was achieved by randomly replacing 
waters with the required number of sodium ions and ion strength was brought to 0.15 mol/l. First, a steepest 
descent energy minimisation was performed until the maximum force was smaller than 1000 kJ/mol/nm, 
followed by a solute restraint relaxation of the solvent under an isothermal-isochoric (NVT; constant Number 
of particles, Volume and Temperature) ensemble. A constant temperature of 333K was controlled by a 
modified Berendsen thermostat383 (time constant 0.1 ps). Subsequently, the pressure and density were 
stabilised under isothermal-isobaric (NPT; constant Number of particles, Pressure and Temperature) conditions 
using the same thermostat and Parrinello-Rahman barostat384 (reference pressure 1 bar, time constant 2.0 ps), 
and position restraints of the complete protein. Bonds between heavy atoms and corresponding hydrogen 
atoms were restrained to their equilibrium bond lengths using the LINCS algorithm385. Short-range interactions 
were considered and long-range electrostatic interactions were calculated using particle mesh Ewald (PME) 
method386, 387 using a cut-off value of 1.0 nm for both. A grid spacing of 0.12 nm was applied for fast Fourier 
transform calculations. All simulations were performed under periodic boundary conditions to avoid edge 
effects. The timestep for the production run was 1.25 fs and the total runtime 1 or 10 ns for the mono- or 
dimers, respectively. For every simulation, the average values for temperature, pressure and density for the 
different equilibration steps were verified to match the set points, before the production run. All mutants were 
simulated in triplicate, and if outliers were observed an extra repetition was performed. To ensure conclusions 
on root-mean-square fluctuations (rmsf), hydrogen bonding, distances between atoms, … are drawn from a 
fully equilibrated system, analysis were performed over the time range of 400 to 1000 ps. 
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4.3 Site-directed mutagenesis and stability measurements 
Site-directed mutations were introduced according to the protocol reported by Sanchis et al.295 as described in 
Chapter 2, using the primers listed in Table S7.2. The stability measurement were conducted in exactly the 
same was as decribed by Cerdobbel at al.332 to enable the comparison with mutants created in previous work. 
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SUPPLEMENTARY DATA 
 
 
 
Figure S7.1 Rational mutations increasing the stabil ity of sucrose phosphorylase. (A) Q331E 
and (B) Q460E/E485H introducing salt-bridgeds, and (C) R393N promoting dimer interaction 
(gray: wild-type; yellow; mutant; mutations simulated in PyMOL) (from Cerdobbel et al . 
2011332) . 
 
 
 
 
 
Figure S7.2 Hydrogen bonds in mutant R393N (time points correspond to snapshot taken from 
the trajectory in Figure 7.7 
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Figure S7.3 Root-mean-square fluctuations (rmsf) of the alpha carbon atom and the complete 
residue (average of all atoms) for the wild-type enzyme and different mutants (destabil is ing, 
neutral , stabil is ing). 
 
 
 
Table S7.1 Top stabil is ing point mutations predicted by FoldX, based on the change in total 
free energy of folding (∆∆Gfold) 
rank mutant ∆∆Gfold 
(kcal/mol) 
remark 
1 T208D1, 2 -3.84 ± 0.13 Negative charge at N-terminal end of α-helix. High VdW clashes (0.89 
kcal/mol). 
2 T321M -3.06 ± 0.05 Hydrophobic residue at surface. 
3 Q359Y -2.96 ± 0.02 Hydrophobic residue at surface. Disrupts interaction with Asp495 which 
may destabilise C domain. 
4 T284L -2.93 ± 0.02 Hydrophobic residue near water-accessible cavity and several polar 
residues. 
5 H261W -2.82 ± 0.07 Hydrophobic residue at surface. 
6 H360W -2.79 ± 0.02 Hydrophobic residue at surface. 
7 N424L -2.76 ± 0.02 Hydrophobic residue at surface and near water-accessible cavity. 
8 R249M -2.64 ± 0.02 Hydrophobic residue at surface. 
9 Q376L1, 2 -2.61 ± 0.25 Improved solvation energy and sidechain entropy. Eliminates sidechain 
hydrogen bonds. 
10 Q376M1, 2 -2.54 ± 0.10 See Q376L. 
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rank mutant ∆∆Gfold 
(kcal/mol) 
remark 
11 T321W -2.53 ± 0.02 Hydrophobic residue at surface. 
12 N280K1, 2 -2.45 ± 0.28 Two new hydrogen bonds. Improved VdW energy and hydrophobic 
solvation. 
13 H261F -2.41 ± 0.03 Hydrophobic residue at surface and near water-accessible cavity. 
14 T284I -2.37 ± 0.01 Hydrophobic residue near water-accessible cavity and several polar 
residues. 
15 T23I -2.28 ± 0.01 Hydrophobic residue at surface. 
16 A11P1, 2 -2.26 ± 0.01 Proline in loop. Near solvent-accessible cavity. 
17 T284V -2.25 ± 0.01 Improved solvation energy, but puts hydrophobic residue in rather 
polar environment. 
18 Q6M -2.22 ± 0.07 Hydrophobic residue near water-accessible cavity. 
19 S407P -2.21 ± 0.01 Proline in α-helix. 
20 H261L -2.18 ± 0.15 Hydrophobic residue at surface. 
21 T208M -2.17 ± 0.20 Hydrophobic residue at surface. 
22 Q359W -2.16 ± 0.05 Hydrophobic residue at surface and near water-accessible cavity. 
23 N424M -2.12 ± 0.02 Hydrophobic residue at surface. 
24 Q6L -2.08 ± 0.04 Hydrophobic residue near water-accessible cavity. Removes hydrogen 
bond between ß-sheets of barrell. 
25 A146K1 -2.00 ± 0.04 Lys at surface. High entropy. Close to several other residues occupied 
by Lys. 
26 S352F -1.97 ± 0.55 Hydrophobic residue at surface. 
27 E485Y -1.95 ± 0.07 Hydrophobic residue at surface. 
28 D35P -1.95 ± 0.16 Hydrophobic residue at surface. 
29 V271L1, 2 -1.94 ± 0.02 Better VdW and hydrophobic solvation. In clearly hydrophobic 
environment. Possibly better fit in hydrophobic pocket.  
30 V241R1 -1.92 ± 0.46 Improved hydrogen bond energy.  
31 H261M -1.91 ± 0.02 Hydrophobic residue at surface. 
32 Q6F -1.91 ± 0.02 VdW clashes (1.32 kcal/mol). Hydrophobic residue in solvent-accessible 
cavity. 
33 H261Y -1.83 ± 0.01 Hydrophobic residue at surface. 
34 S187L -1.83 ± 0.03 Hydrophobic residue at surface. 
35 S187Y -1.83 ± 0.10 Hydrophobic residue at surface. 
36 H404P -1,81 ± 0,13 High VdW clashes (1.17 kcal/mol). 
37 T321L -1,79 ± 0,04 Hydrophobic residue at surface. 
38 Q359F -1,74 ± 0,02 Hydrophobic residue at surface. 
39 G222A1 -1,71 ± 0,01 Improved VdW interactions. 
40 H273M -1,69 ± 0,06 Hydrophobic residue at surface. 
41 T23M -1,68 ± 0,16 Hydrophobic residue at surface. 
42 V241L1 -1,66 ± 0,08 Improved hydrophobic interactions. 
43 H323F -1,64 ± 0,18 Hydrophobic residue at surface. 
44 V473R1 -1,57 ± 0,06 Polar residue at surface. Forms two new hydrogen bonds. 
45 A146R1 -1,57 ± 0,34 Polar residue at surface. High deviation. 
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rank mutant ∆∆Gfold 
(kcal/mol) 
remark 
46 S216L -1,56 ± 0,06 Hydrophobic residue at surface. 
47 D31R1 -1,56 ± 0,02 Improved hydrogen bonds. 
48 N280R1 -1,56 ± 0,12 Improved hydrogen bonds. 
49 V271M1 -1,55 ± 0,15 Improved VdW interactions. 
50 T203D1 -1,55 ± 0,18 Improved hydrogen bonds. 
51 S167D1 -1,55 ± 0,1 Negative charge at N-terminal end of α-helix. 
52 E483F -1,52 ± 0,04 Hydrophobic residue at surface. 
53 H273F -1,52 ± 0,01 Hydrophobic residue at surface. 
54 D316M -1,51 ± 0,01 Hydrophobic residue at surface. 
55 D35L -1,51 ± 0,08 Hydrophobic residue at surface. 
1 retained after visual inspection for unreasonable mutations; 2 stability assayed in vitro 
 
 
 
Table S7.2 Primers used for site-directed mutagenesis 
mutant primer 5’→3’ sequence 
BaSP_A11P BaSP_CO3_Fw_A11P CCAACTGATTACCTATGCGGATCGTCTGGGTGATG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_T208D BaSP_CO3_Fw_T208D ACCAGTTGCTTTATGGACCCGAAAACGTTCAAACTGATTTCCC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_V271L BaSP_CO3_Fw_V271L AGTACCGGCCACGTCGAACCGCTGGCCCATTG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_N280K BaSP_CO3_Fw_N280K ACGGATATTCGTCCGAAGAATGCTGTTACCGTCCTG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_Q376L BaSP_CO3_Fw_Q376L GCCCACGTAATAGACCAGCGGAACACCCGG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_Q376M BaSP_CO3_Fw_Q376M GCCCACGTAATAGACCATCGGAACACCCGGCAG 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_T114R BaSP_CO3_Fw_T114R TACCCGATGTTTCTGCGCATGAGCAGCGTGTTC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_S116R BaSP_CO3_Fw_S116R GATGTTTCTGACCATGCGCAGCGTGTTCC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_T124R BaSP_CO3_Fw_T124R GAACGGTGCCCGTGAAGAAGACCTGGCAGGCATTTATC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
BaSP_T146R BaSP_CO3_Fw_T149R TACAAATTCGCAGGCAAACGCCGTCTGGTC 
 shuf pCXP 01 Rv ATCCAACGCGTTGGAGCTCTC 
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1 TOWARDS A PRODUCTION PROCESS FOR KOJIBIOSE 
Very recently a new process has been developed for the production of kojibiose319. According to 
the authors, it is a novel biotechnological, cost-effective and environmentally friendly process for 
the enzymatic synthesis of kojibiose with relatively high yield (38%) and purity (65%) from readily 
available and inexpensive raw materials such as sucrose and lactose. It should accordingly be a 
much better alternative than other currently available methods. The process consists of four 
different steps: first, a kojibiose moiety-containing trisaccharide is synthesised from sucrose and 
lactose by the action of a dextransucrase (24 h), followed by a yeast treatment to remove 
monosaccharides (inhibit the enzyme in the subsequent step) (4 h). Next, the galactose moiety is 
cleaved off with a ß-galactosidase to yield kojibiose (1.5 h) and in a final step another yeast 
treatment is applied (42 h). A process using a mutant enzyme developed in this work (Chapter 3) 
could however offer several advantages over the process described above. The overall yield of the 
dextransucrase process is only 38%, mainly due to the formation of side products. Moreover, one of 
these side products is leucrose, which cannot be metabolised by the yeast. As a consequence, it is 
present in the final product (together with stress metabolites from the yeast) and the purity of the 
kojibiose is only 65%. In our process, the side product maltose is only formed in trace amounts and 
hydrolysis of the donor substrate is minimal, which would allow to obtain yields of >80%. 
Moreover, after reaction only kojibiose, glucose, fructose, remnants of sucrose and traces of 
maltose are present in the reaction mixture. All sugars expect for kojibiose are readily metabolised 
by the yeast and accordingly it should be possible to easily reach a purity of at least 95%. In 
addition, the total process time could also be shorter with our process. Indeed, the production of 
kojibiose only requires a single step, with an enzyme that has a comparable activity as the 
dextransucrase, and the purification can be completed more quickly because the remaining sugars 
can be metabolised more easily by the yeast (removal of galactose by yeast is slow and the main 
course of the lengthy yeast treatment in the dextransucrase process). That way, the amount of 
stress metabolites produced by the yeast will most likely also be much lower. Furthermore, the cost 
of glucose is only half of that of lactose and by adding glucose isomerase to the reaction, it might 
perhaps even be possible to generate (part of the) glucose in situ from the liberated fructose 
(Figure 8.1). Of course, careful optimisation of the reaction conditions is still required to obtain an 
industrially relevant process. Attention should be paid to substrate or product inhibition, formation 
of side products and reuse of the produced kojibiose upon prolonged incubation at higher 
substrate concentrations. It would also be wise to evaluate the behaviour of different improved 
variants, since this might slightly deviate from what is observed at the relatively low substrate 
concentrations (to industrial standards) used in this work. Yet, during the determination of the 
kinetic parameters only trance amounts of maltose and no other side products were observed at 
concentrations up to 1.25 M of glucose, and product inhibition was limited as well. Moreover, 
kojibiose can only be used at an extremely low rate by the mutant enzymes and it is thus a stable 
product throughout the entire reaction course. To summarise, with the developed mutant enzymes 
in this work, a cost-effective and environmentally friendly process for the production of kojibiose 
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has become available with a higher yield and final product purity than the best process currently 
known. 
 
 
Figure 8.1 Production process for kojibiose (SP variant: engineered sucrose phosphorylase 
with improved kojibiose selectivity; GI: glucose isomerase). 
 
2 NEW SPECIFICITIES 
As discussed in chapter 4, the search for a thermostable sucrose phosphorylase (SP) revealed 
sucrose 6’-posphate phosphorylase (SPP) as a novel specificity. This newly discovered enzyme 
catalyses the reversible phosphorolysis of sucrose 6’-phosphate, but it is also active on sucrose. It 
can thus be used as a ‘normal’ sucrose phosphorylase and it is highly thermostable, making it an 
attractive biocatalyst for industrial applications. Moreover, it has recently been shown that a stable 
sucrose phosphorylase can be used in biphasic solvent-water systems to glycosylate a range of 
phenolic compounds like anti-oxidants and fragrance components388. As the active site of SPP is 
slightly different from SP enzymes, it is not unlikely that it will be able to glycosylate other 
compounds and accordingly further expand the scope of available glycosides. SPP is in addition an 
ideal starting point for mutagenesis, regarding its excellent stability. 
Besides the industrial relevance, the discovery of this enzyme is also interesting from a scientific 
point of view. SPP is indeed not only a new enzyme specificity, it also entails a new pathway for 
sucrose breakdown and it might help in understanding the sucrose metabolism in some bacteria. 
Its substrate sucrose 6’-phosphate is furthermore a key intermediate in the synthesis of sucrose in 
plants, where sucrose is synthesised by the concerted action of sucrose-phosphate synthase and 
sucrose phosphatase389. Sucrose 6’-phosphate is however currently very expensive (6-12 EUR/mg) 
and commercially only available at mg scale (<250 mg). With SPP it could be produced more 
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economically from glucose 1-phosphate (or sucrose) and D-fructose 6-phosphate (30-70 EUR/g; 
<25 g) at a scale that would allow plant biochemists to use it for scientific research. 
The structure-function relationships in SPP were investigated as well in this thesis. Mutational data 
proved that differences in the active site accounted for the difference in specificity. The positions 
where residues in SPP deviated from those fully conserved in SP enzymes, were crucial for SPP 
activity. Comparison of these positions with the remaining sequences classified in the same 
subfamily revealed that several of them in turn housed other residues. Phylogenetic analysis in 
addition showed that the observed motifs were conserved within specific branches. This together 
with the importance of the active site residues suggests that next to sucrose phosphorylase and 
sucrose 6’-phosphate phosphorylase still other specificities are present in the GH13 subfamily 18. 
To investigate this hypothesis, three representatives of different clades have been cloned and 
expressed at the lab in the meantime (unpublished results). None of them displayed either SP or 
SPP activity and consequently these are indeed new specificities. Unfortunately, extensive screening 
for the actual substrate could not disclose the native activity. In case of SPP, the activity was also 
not found by simple substrate screening, but only after carefully analysing the gene landscape. The 
same approach could therefore be applied for the other enzymes, and it could in general be a 
useful strategy for the identification of new specificities. Alternatively, determination of the crystal 
structure would allow the docking of different kinds of molecules. With this virtual screening much 
more potential substrates could be analysed, including expensive or difficult to obtain compounds. 
Likewise, the same strategy could be applied to discover the specificity of the many proteins of 
unknown function that are currently present in the pdb database. Moreover, concerning the fact 
that the number of available sequences in public databases is exponentially increasing, nature 
should perhaps be the first place to look for a desired enzyme, rather than trying to engineer one. 
3 CLASSICAL PROTEIN ENGINEERING APPROACHES 
Regardless of how diversity is created or what properties one aims to improve, a prerequisite for 
finding a desired variant is a good screening or selection method. Selection for improved 
transglycosylation activity on a minimal medium is however not straightforward as the desired 
substrates are not always available, specific knockout mutants are required and one easily selects 
for improved hydrolase activity instead of transglycosidase activity. Screening is therefore preferred. 
Previously, a colorimetric high-throughput screening assay for glycoside phosphorylases has been 
established at our lab, which relies on the detection of inorganic phosphate released during the 
transfer of the glycosyl moiety from the sugar phosphate to the acceptor molecule71. Although it 
has been successfully applied for the creation of cellobiose phosphorylase variants with a 
broadened acceptor specificity70 and improved trehalose phosphorylase variants for the production 
of trehalose analogues390, the assay has a few disadvantages for engineering of specificity. The 
crude enzyme extract used during high-throughput screening always contains some contaminating 
phosphatase activity from E. coli enzymes (even in engineered strains with a decreased expression 
of phosphatases). If initial activities on new substrates are low and improvements expected to be 
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small, the desired signal will most likely get lost in the background noise. For sucrose 
phosphorylase which has a different reaction mechanism, an additional unwanted signal is 
measured from the hydrolytic side activity. Moreover, if an acceptor can be glycosylated at multiple 
positions no distinction can be made between the different products. Similarly, the BCA assay 
quantifying the release of fructose from sucrose and used to screen libraries for more stable SP 
variants332, cannot discriminate between the desired reaction and the hydrolytic or other side 
activities, and cannot be applied for acceptors that are reducing. Consequently, an alternative 
screening method for more demanding targets was desirable. 
Directing the preference of sucrose phosphorylase towards kojibiose production instead of maltose 
is such a problem that cannot be addressed with the conventional colorimetric assays described 
above. High Performance Anion Exchange Chromatography (HPAEC) on the other hand is ideally 
suited for the analysis of carbohydrates and therefore a procedure was established which allows the 
screening with crude enzyme extract (Chapter 3). To that end, lysis conditions and sample 
treatment were optimised resulting in a fairly robust workflow. Especially the ratio of different peaks 
within the same sample was found to show very little variation and accordingly resulted in few false 
positives during screening. Analysis of one sample took 12 minutes which roughly corresponds to 
one microtiter plate per day (= screening effort required for NNK randomised library of one 
position). This is of course not high-throughput, yet one should keep in mind that several products 
can be detected directly and simultaneously. In this work, nigerose and isomaltose (prebiotics) 
could also be detected next to kojibiose, but unfortunately no variants producing these compounds 
were observed. HPAEC methods for the separation of different carbohydrates are moreover very 
easy to optimise and relatively short analysis times (5-15 min) can be readily achieved (HPAEC uses 
only NaOH, NaAc and water as eluens which are in situ mixed according to the eluens profile). 
Consequently, the HPAEC screening procedure optimised here could in general be valuable for 
detecting enzyme variants that need to produce specific linkages as is e.g. required for prebiotic 
(oligo)saccharides and other glycoconjugates. 
The trade-off between quality and quantity posed the need of small libraries. Positions were 
therefore fully randomised one by one and the best mutants were combined. That way, a final 
variant was obtained with a nice selectivity of 95%. One can however always discuss whether the 
strategy followed here was the best or if another would have been able to find an even better 
variant, but like Uwe Bornscheuer wrote: ‘the best approach to a particular protein engineering 
problem is a matter of opinion and personal preference, although it is preferably the one that 
allows reaching the goal with the least effort’135. Since the goal of a selective enzyme was reached 
and the screening effort hardly could have been lower, the followed approach is at least not bad. 
Obviously, ideally not only the selectivity but also the activity was improved. Simultaneous mutation 
of different positions could perhaps have revealed mutants that meet both criteria, but one would 
quickly run against the limits of screening capacity. Indeed, full randomisation of two positions at 
the same time would already require one month of continuous screening and three positions even 
two and a half year. Using a NDT degenerate codon could lower the screening effort, but on the 
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other hand restricts the number of amino acids. It is also possible that the active site is already 
roughly compliant with the substrate and only needs some fine-tuning. Michaelis-Menten constants 
of the best variants were indeed acceptably low (certainly for industrial processes) and the low 
activity was mainly due to a low turnover number. Increasing this latter parameter is however far 
from trivial and it is not unlikely that mutation of second or even third shell residues is required to 
tweak the interactions in the active site. Regarding the still very limited knowledge on how more 
distant mutations affect what happens in the active site, random mutagenesis is probably the 
‘easiest’ solution. The utility of this latter approach was once again proven in a recent example from 
our lab in which a trehalose phosphorylase was engineered to accept galactose instead of glucose. 
Despite a wealth of structural and sequence information, site-saturation mutagenesis of active site 
residues could not yield improved variants able to handle the ‘small’ change of a single flipped 
hydroxyl group. Only random mutagenesis could do the trick by mutating residues further away 
from the active site. It thus can be expected that in the coming years random mutagenesis will still 
play a important role in enzyme engineering and in some case will even be required to obtain an 
optimal biocatalyst for a certain reaction. Nevertheless, time and effort should be invested in 
techniques like ancestral sequence reconstruction, correlated mutation analysis and in silico design 
among others, to increase our understanding of how enzymes work and how we can manipulate 
them for our own needs. 
4 ANCESTRAL SEQUENCE RECONSTRUCTION 
It is generally accepted that different enzyme specificities originate from a common ancestor185, 186. 
This ancestor thus had the potential to evolve into new specificities, which might not be the case 
for present-day enzymes because they have become too specialised. In the context of enzyme 
engineering this would mean that an ancestral enzyme is a better starting point for mutagenesis 
than a present-day enzyme. In this work, this hypothesis was investigated for the first time. To that 
end, SP and SPP were used as a case study since both activities are closely related and their 
respective determinants of specificity had been elucidated (Chapter 2 and 4). Their common 
ancestor was resurrected (SP activity) and SPP determining residues were introduced in this and 
two present-day SP enzymes. In the ancestor, no SPP activity was however detected, in contrast to 
one of its present-day counterparts. This latter enzyme has an excellent stability, suggesting that 
this is more crucial for a template than its ‘antiquity’. Moreover, the example presented here is only 
a case study in which it was exactly known where both specificities split off in the phylogenetic tree 
and consequently how far one should go back in time. In reality, mutagenesis is performed to 
obtain new specificities, and it is accordingly impossible to predict which ancestor would be most 
suited. As a consequence, it would in principle be necessary to reconstruct several ancestral 
enzymes from different nodes and preferably evaluate their properties like expression, activity, 
stability and promiscuity first. In addition, there might be ancestors that have the capacity to evolve 
to their currently known descendants, but not necessary to new specificities. The reconstruction 
process is furthermore subjected to technical limitations. Very often the input sequences do not 
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represent the full sequence space, hampering correct alignment, phylogenetic tree building and 
ancestral reconstruction, which makes it likely to yield suboptimal or even inferior protein 
structures. The most interesting ancestors i.e. ancestor of several different specificities can 
additionally not be addressed in most cases, due to the complexity of the problem. Full-length 
ancestral sequences might therefore not be very well suited for protein engineering. 
Despite the conclusion of this work that ancestral reconstruction might not be the best way to 
generate a good starting point for protein engineering, it has been shown that an appropriate 
mutational background is necessary for key function-switching mutations359. However, this often 
involves the presence of only a few essential residues. Since it is not uncommon that sequences 
with an identity as low as 40% (e.g. sucrose phosphorylase) still display the same specificity, it is not 
unlikely that these crucial mutations are somewhere present in the current natural diversity. 
Consequently, it is wise to explore the properties, especially promiscuity and stability, of enzymes 
from different parts of the phylogenetic tree and select the most interesting candidate(s). 
Alternatively, neutral drift can be applied in which the current sequence is enriched with mutations 
that are (nearly) neutral for the native activity391. At the same time promiscuous functions and 
accordingly evolvability can be promoted. The advantage is that one can be sure that the resulting 
sequences are expressed and properly folded, and in contrast to ancestral reconstruction, not only 
existing paths from the past, but also new ones can be opened. As a consequence, if an efficient 
screening or selection method is available, this might even be a convenient way to obtain 
interesting starting points. Alternatively, it could be interesting to investigate whether neutral drift 
could be simulated in silico, by generating large libraries of mutant enzymes and retaining variants 
with low energy structures (e.g. with Rosetta).  
If not for direct applications, ancestral reconstruction might be useful to investigate some more 
fundamental aspects. The four major types of CAZymes (glycosidase hydrolases, transglycosidases, 
phosphorylases and transferases; Chapter 1) are evolutionary all linked to each other. 
Transglycosidases (TG) are essentially specialised glycosidases (GH) and glycoside phosphorylases 
(GP) can be found in transferase (GT) as well as glycosidase families. Many specificities of hydrolytic 
CAZymes are available and these enzymes are typically robust to process conditions, yet they are 
not suited for synthesis reactions. Glycosyl transferases on the other hand are, and a wide range of 
specificities are known, but they unfortunately require expensive nucleotide sugars. Turning GTs or 
GHs into transglycosidases or phosphorylases would therefore enormously expand the repertoire of 
glycosidic compounds that could be readily synthesised from simple sugars or sugar phosphates. 
However, up till now neither random nor rational mutagenesis attempts have been very successful. 
There are though a few cases where different types of CAZymes are present in the same family and 
this consequently could provide information on how to make the switch. In GH65, a GP and a GH 
are found that both act on trehalose, while for this same substrate the totally different GT4 family 
holds a GT and also a GP. In GH13 even three types are present, i.e. sucrose phosphorylase (GP), 
amylosucrase (TG) and sucrose hydrolase (GH), all acting on the same substrate. Direct comparison 
of present day structures and sequences is however not straightforward because of the low 
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sequence identity and low structural similarity of crucial parts (Chapter 2). Retracing the evolution 
could however narrow the range of mutations to consider and provide clues on important 
mutational event like changes in conserved motifs or critical indels. Although closely related on 
family scale and in substrate use, sucrose phosphorylase is too distinct from amylosucrase and 
sucrose hydrolase for ancestral reconstruction. These latter two are on the other hand much more 
similar and they would therefore be interesting to study the GH/TG switch by retracing their 
evolution. Similarly, the GH/GP and GT/GP switch could be studied in the other families. 
5 CORRELATED MUTATIONS 
At first sight, coevolving positions are relatively easy to detect by statistical analysis of a large 
multiple sequence alignment (MSA). If for two positions certain residue pairs are overrepresented 
compared to what is observed for the entire dataset, than they are correlated. The pitfall is however 
that you always get a result, regardless whether the correlations are meaningful or not. The 
outcome of the correlated mutation analysis (CMA) is highly dependent on the number and 
composition of sequences, and the quality of the MSA. Moreover, the coevolution signal must be 
separated from strong background signals resulting from various correlations of non-coevolving 
residues229. Associations between sites can for instance persist over time as a natural result of a 
common evolutionary history (phylogenetic linkage)237, rather than due to structural or functional 
restraints. It is therefore important that the current algorithms are further improved, because it is 
obviously impossible to understand the role of coevolving positions if they cannot be reliably 
detected. 
Despite the fact that ‘real’ correlations are hard to detect and different CMA approaches can yield 
different positions, several studies agree that (at least some) of the correlated mutations are 
important for enzyme function or stability. They are accordingly hotspots for enzyme engineering 
and the ultimate goal would then of course be to grasp the complexity of correlated mutations and 
to derive guidelines on how to use them for engineering of stability and specificity. To that end, 
(assuming correlated positions can be revealed unequivocally) the same questions posed in Chapter 
6 need to be addressed, i.e. which residues from the network are most important, single versus 
multiple mutations, importance of strength of correlation, number of correlations, spatial proximity 
and antiquity. Research in this thesis unfortunately failed to provide clear answers to these specific 
questions, but it did show that mutations at correlated positions can alter the activity and 
specificity. Similar conclusions are found in literature examples, though some attempted to provide 
more details. The number of correlations is suggested to be important because positions with many 
coevolving partners tend to have an increased probability of being important for enzyme function 
or stability392 and they are more likely to change protein function upon mutation222. In addition, it is 
suggested that only a small fraction of strongly correlated residue pairs have a destabilising-
restoring relationship when introduced one after the other, while most are neutral or nearly neutral 
for stability393. This agrees well with our findings that strongly correlated mutations not necessarily 
evolve at the same point in time. Both observations accordingly imply that strongly correlated 
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positions do not need to be present at the same moment, at least for stability. For specificity in 
contrast, synergistic effects seem to be required to obtain the desired result230, 363, although two or 
three simultaneous mutations already seem to be enough and mutation of all interconnected 
positions thus not necessary. Moreover, only residues naturally present in the MSA were used. In 
conclusion, protein engineers aiming at improving enzyme activity and specificity should focus on 
the positions with the highest number of correlations without bothering too much about the exact 
correlations or the strength of correlation. Randomisation of two or three positions with residues 
present in natural sequences should already be enough to capture synergistic effects. These 
guidelines should however be handled with caution, since they are derived from a limited number 
of examples and because different CMA approaches are not always directly comparable. A 
comprehensive study evaluating different algorithms combined with experimental data on stability, 
activity, specificity and foldability of different enzymes would therefore be of great interest.  
It would also be worth investigating whether mutation at a correlated position has a higher 
probability of having an impact on activity and specificity than mutation at a random position 
within 10 Å from the active site. Indeed, on the one hand which positions pop out as correlated is 
highly dependent on a number of factors, confer this work where a subset of sequences yielded a 
totally different network than the complete dataset. On the other hand, it appears that correlated 
positions in all cases have a higher chance of being involved in enzyme function or stability. This is 
somehow contradictory. In addition, CMA reveals positions that might be important for the existing 
functionalities, but this is not necessarily true for new functions. A comparison between mutations 
at correlated positions or random positions near the active site would accordingly provide valuable 
information on the utility of correlated mutations. 
6 IN SILICO PREDICTION OF STABILITY 
Whether applied in an industrial process or used as a template for mutagenesis, an important 
property of a biocatalyst will always be its stability. As discussed above, a convenient and probably 
even the easiest and fastest way is to search for an enzyme variant from a thermophilic organism 
(Chapter 4). Thermostable variants for a desired reaction are however not always available from 
nature. They can of course be obtained by introducing mutations in existing enzymes, but this is 
often not very straightforward. It is for instance still hard to predict the effect of a mutation on 
stability in a rational way, despite the numerous efforts to derive general guidelines. High-
throughput screening on the other hand often suffers from an excess of false positives e.g. due to 
differences in expression level and dependency of stability on the protein concentration. Regardless 
of these problems, classical screening will always be time-consuming and costly, and it would 
therefore be highly interesting if the major part the in vitro work could be replaced with in silico 
approaches. 
In this work we used FoldX to evaluate stability changes upon point mutations, but unfortunately 
none of the most promising mutants were experimentally more stable. FoldX has however the 
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potential to predict stabilising mutations since it has previously been successfully applied to 
stabilise an enzyme248 and it moreover performed well in an independent study comparing six 
different algorithms394. It should therefore be encouraged to further evaluate the possibilities of 
FoldX, as well as other approaches like Rosetta. Molecular dynamics (md) were furthermore shown 
to be a valuable addition. Automated interpretation of the trajectories is currently not yet possible 
and still requires manual intervention, but nevertheless md simulation can address questions that 
cannot be answered with other techniques. Hence, in the future they will play a prominent role in 
engineering stability. 
7 OUTLOOK 
Many research groups from all over the world are currently gathering genetic information from 
diverse and previously unexplored habitats and a wealth of new genes is becoming publically 
available. Costs for chemical synthesis of genes have moreover dropped over the last years and 
synthetic genes will become even cheaper in the future. This opens the door to a vast number of 
novel specificities and stable biocatalysts and hence this is an opportunity we cannot leave unused.  
Creating enzymes ourselves is on the other hand invaluable as well. Not only because we then can 
address specific problems, but also because it can broaden our knowledge on the functioning of 
enzymes. Optimisation of biocatalysts will in the coming years still mainly be achieved by semi-
rational approaches, simply because our understanding of all aspects of biocatalysis is currently too 
limited. Moreover, several of these techniques are readily available and well established by now, 
and alternatives are not yet generally competitive. Methods like iterative saturation mutagenesis 
and CASTing will be the main contributors to enzymes with altered specificity and stability. It is in 
addition probable that often even completely random mutagenesis will still be required to obtain a 
fully efficient and stable biocatalyst. Nevertheless, we should keep on searching for more efficient 
ways of engineering. In that respect, bioinformatics will undeniably play a crucial role. Several tools 
are steadily becoming common practice. Homology modelling, ligand docking, multiple sequence 
alignments and phylogenetics now belong to the standard toolbox of every self-respecting protein 
engineer. These can now already aid in lowering the screening effort by limiting the number of 
positions to mutate e.g. only those in direct proximity of one part of a new substrate, or by 
restricting the set of amino acids used e.g. only hydrophobic or only naturally occurring in related 
sequences. With the increasing computing power and faster algorithms for ligand docking, a logic 
next step would be to perform the classical CASTing in silico and only screen a library of the best 
designs. Due to the limitations of the current algorithms, initially screening effort will probably still 
be considerable. On the other hand, bigger jumps in sequence space can be achieved because 
more positions can be randomised simultaneously and with the same screening effort the chance 
of finding an improved variant is much higher. Moreover if predictions of side chain and backbone 
conformations, protein-ligand interactions and stability changes will get more refined, the number 
of variants to screen will be narrowed to only a handful designs.  
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Even if we have mastered the art of shaping proper active sites, it is not unlikely that in many cases 
the finesses will be missing for truly efficient catalysis. Indeed, we cannot ignore the rest of the 
protein structure. Of course, the structure serves in the first place as a scaffold for the catalytic 
machinery and the active site, but the subtle interactions it provides to tweak the active site cannot 
be denied. Understanding how second and third shell residues contribute to catalysis will be a 
major challenge and this question will probably not be solved in the first coming years. Ancestral 
reconstruction and correlated mutation analysis could however provide insight in how nature 
exploits more distant residues to optimise activities. Moreover, even without currently knowing the 
exact role of correlated positions, they could be a worthy alternative to fully random mutagenesis.  
We should furthermore always keep in mind that enzymes are highly dynamic entities. We are used 
to look at one single, rigid structure and our view might therefore be biased. Conformational 
changes are often induced upon binding of substrates and loop movements are sometimes 
required for catalysis. In addition, the accessibility of the active site might in some cases be as 
important as the stabilisation of the transition state. Indeed, it does not make sense to screen for 
active site variants that could act on non-natural substrates, if the active site is not accessible in the 
first place. In this regard, molecular dynamics will be a helpful tool to visualise and analyse motions 
of loops and substrates, to verify if certain interactions are maintained, to simulated folding and 
unfolding and many more. Likewise, the more sophisticated quantum mechanical calculations can 
be used to simulate the actual catalytic steps. These dynamic approaches are unfortunately very 
computer intensive, but with the increasing computing power, better force fields and faster 
algorithms, the number of possibilities will grow tremendously. It is thus clear that we still need 
some technological advances and knowledge on how enzymes work, but nonetheless the ultimate 
goal of designing enzymes de novo is steadily becoming at our fingertips. 
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Glycosidic compounds are chemical structures that consist of sugars molecules or that have a sugar 
attached to another molecule. They are now already used in various industries and have the 
potential to serve an even much wider range of applications. They can be synthesised chemically, 
but with the right enzymes, production processes can often be much cleaner and more efficient. 
Glycoside phosphorylases are such enzymes that can be used to synthesise glycosides and in that 
respect sucrose phosphorylase is highly interesting. Sucrose phosphorylase is namely not restricted 
to its wild-type substrates. It can also transfer a sugar moiety to a variety of different acceptor 
molecules. In addition, it uses sucrose as a cheap, renewable and reactive donor substrate, which 
makes it an attractive biocatalyst for the production of special sugars and glucoconjugates. 
Activities on relevant components are unfortunately poor and in many cases not even exceeding 
the unwanted hydrolytic side activity. Moreover, for industrial processes increased stability is also 
desired. It is thus clear that sucrose phosphorylase offers many possibilities, but that still some 
improvements are required to fully exploit its potential. Therefore, in this thesis enzyme engineering 
was applied to alter the specificity and enhance the stability of sucrose phosphorylase. 
Knowing how specificity is controlled, would allow to optimise alternative activities in a more 
efficient way. Therefore, a map of the acceptor site of the SP from Bifidobacterium adolescentis was 
first created by substituting each residue by alanine and analysing the influence on the affinity for 
both the natural (inorganic phosphate and fructose) and alternative acceptors (D-arabitol and 
pyridoxine). All residues examined were found to contribute to the specificity for phosphate 
(Arg135, Leu343, Tyr344), fructose (Tyr132, Asp342) or both (Pro134, Tyr196, His234, Gln345). 
Alternative acceptors that are glycosylated rather efficiently e.g. d-arabitol were found to interact 
with the same residues as fructose, whereas poor acceptors like pyridoxine did not seem to make 
any specific interactions with the enzyme. Furthermore, it was shown that SP is already optimised to 
outcompete water as an acceptor substrate, meaning that it will be very difficult to lower its 
hydrolytic activity any further. Consequently, increasing the transglycosylation activity towards 
alternative acceptors seems to be the best strategy, although that would probably require a drastic 
remodelling of the acceptor site in most cases. 
Regioselectivity can most likely be engineered more easily than completely shifting specificity, but it 
can nevertheless be equally important. Kojibiose (Glc-α1,2-Glc) for instance is a very expensive and 
hardly available compound with prebiotic properties, while its regioisomer maltose (Glc-α1,4-Glc) is 
cheap and has little added value. Natural sucrose phosphorylases produce a mixture of both and a 
variant that only makes kojibiose would of course be of great interest. To that end, ten positions in 
the acceptor site were randomised individually and screened with a high performance anion 
exchange chromatography (HPAEC) based screening procedure. Several improved mutants were 
obtained from this first round of mutagenesis and the best mutant L341I displayed a selectivity of 
79%. Rational combination as well as combinations predicted by a statistical ProSAR model could 
further improve the selectivity, although the former approach yielded the best mutants. Two double 
(L341I_Q345S and L341I_Q345N) and one triple mutant (L341I_Y344A_Q345N) were obtained with 
selectivities of 93 to 95%. Activities were only slightly lower than the wild-type enzyme and 
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therefore the variants created in this work will allow the development of a cost-effective and 
scalable process for the enzymatic synthesis of kojibiose from the readily available and low-cost 
substrates sucrose and glucose.  
As discussed above, stable biocatalysts are a real benefit for industrial processes. Thermophilic 
organisms are a rich source of stable enzymes, but for sucrose phosphorylase this area has not yet 
been explored. Hence, in this study, the putative sucrose phosphorylase from the thermophile 
Thermoanaerobacterium thermosaccharolyticum was recombinantly expressed and fully 
characterised. The enzyme showed significant activity on sucrose (optimum at 55°C), and with a 
melting temperature of 79°C and a half-life of 60 hours at the industrially relevant temperature of 
60°C, it is far more stable than known sucrose phosphorylases. Substrate screening and detailed 
kinetic characterisation revealed however a preference for sucrose 6’-phosphate over sucrose. The 
enzyme can thus be considered as a sucrose 6’-phosphate phosphorylase, a specificity not yet 
reported to date. Homology modelling and mutagenesis pointed out particular residues (Arg134 
and His344) accounting for the difference in specificity. Moreover, phylogenetic and sequence 
analysis suggest that glycoside hydrolase 13 subfamily 18 might harbour even more specificities. In 
addition, the second gene residing in the same operon as sucrose 6’-phosphate phosphorylase was 
identified as well, and found to be a phosphofructokinase. The concerted action of these both 
enzymes implies a new pathway for the breakdown of sucrose, in which the reaction products end 
up at different stages of the glycolysis. 
In addition to the development of applications, techniques like ancestral reconstruction, correlated 
mutation analysis and in silico prediction of stability were evaluated for their general utility in 
protein engineering. Present-day enzymes have evolved from a common ancestor that is believed 
to be promiscuous and to have an appropriate mutational background to evolve. Ancestral 
enzymes would accordingly be ideally suited to create new (related) specificities by directed 
evolution. To investigate whether an ancestral enzyme could be a good starting point for 
mutagenesis and what the role of promiscuity is, a full-length ancestor of sucrose phosphorylase 
(SP) and sucrose 6’-phosphate phosphorylase (SPP) enzymes was reconstructed. The ancestor 
behaved like a sucrose phosphorylase, but its activity was one to three orders of magnitude lower 
than present-day SP’s. This was mainly due to a low kcat (<1 s-1) and a high KM for sucrose and 
fructose (>200 mM). In addition, promiscuity was very similar in qualitative terms, but activities were 
in general lower. Swapping SP specific residues with their SPP counterpart could furthermore not 
introduce SPP activity in the ancestor. However, the same mutations could enable a specificity 
switch in a thermostable present-day SP, showing that for directed evolution a stable template 
might be more appropriate than a reconstructed ancestor. 
Another aspect of evolution that could be useful for enzyme engineering, is coevolution of specific 
positions in related enzymes. Statistical analysis of large multiple sequence alignments can reveal 
such correlated positions, i.e. positions that house specific combinations of residues more prevalent 
than expected from random distribution. They often form complex networks and are likely to be 
involved in activity, specificity and stability. Their exact role is however currently still obscure. 
Summary 
 222 
Therefore, in this work we compared correlated mutations in two related specificities (sucrose and 
sucrose 6’-phosphate phosphorylase) and experimentally evaluated hypotheses on different aspects 
of the correlation network. Distribution across the structure suggests that correlated positions 
might be involved in supporting the different active site topologies, rather than directly being 
involved in substrate contact. Retracing the evolution showed that correlated positions that are 
close to each other in the structure or that are strongly correlated often not evolve simultaneously. 
Introduction of the active site of sucrose 6’-phosphate phosphorylase in sucrose phosphorylase 
enable this latter enzyme to catalyse the former reactions. The activity was however very low en 
therefore correlated positions were mutated as well. This caused a decrease in activity (up to fifty-
fold) in most cases, but in one double mutant the activity could selectively be increased by a factor 
of two. Mutation of correlated positions can thus alter the specificity, but general guidelines on 
which positions to mutate and which residues to introduce, could unfortunately not be derived and 
will need further research. 
Stable enzymes are important as already discussed previously. They can be obtained from natural 
diversity, but not every specificity is available and therefore stable variants need to be created by 
engineering existing enzymes. In that respect, in silico prediction of stabilising mutations could 
greatly reduce time, cost and effort compared to current in vitro screening procedures. Here, we 
evaluated the potential of the FoldX algorithm. All possible point mutations were introduced in a 
sucrose phosphorylase and those predicted to improve the free energy of folding or the dimer 
interaction energy were visually inspected for unreasonable mutations. Two thirds were rejected 
during this manual selection, mostly because hydrophobic residues became too solvent exposed. 
From the remaining mutants, the nine most promising were experimentally tested. Unfortunately 
none proved to be more stable: four appeared to be neutral or nearly neutral, while five were 
deleterious. Remarkably, the mutant predicted to be the most stabilising drastically impaired 
stability. To explain these findings, molecular dynamics (md) simulations were performed. Root 
mean square fluctuations (rmsf), representing local flexibility, were found to be bad predictors of 
stability. Examining if the interactions responsible for the predicted stability are maintained over a 
period of time in contrast could indeed explain the observed effects in many cases. 
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Glycosidische verbindingen zijn chemische structuren die bestaan uit suikermoleculen of die 
gekoppeld zijn aan suikermoleculen. Deze verbindingen worden nu reeds gebruikt in uiteenlopende 
industrieën en bieden potentieel aan een nog veel bredere waaier aan toepassingen. Ze kunnen 
chemisch worden gesynthetiseerd, maar met gepaste enzymen kunnen schonere en efficiëntere 
productieprocessen bekomen worden. Glycoside fosforylases zijn een klasse van enzymen die 
gebruikt kunnen worden voor de synthese van deze glycosidische verbindingen en binnen deze 
groep is sucrose fosforylase uiterst interessant. Sucrose fosforylase is namelijk niet gelimiteerd tot 
zijn wildtype substraat. Het kan ook een suiker transfereren naar diverse andere acceptor 
moleculen. Daarnaast gebruikt het sucrose als een goedkoop, hernieuwbaar en reactief donor 
substraat, wat het een aantrekkelijke biokatalysator maakt voor de productie van speciale suikers en 
glycoconjugaten. Activiteit op relevante componenten is jammer genoeg maar pover en in veel 
gevallen overheerst zelfs de ongewenste hydrolytische nevenactiviteit. Bovendien is voor industriële 
processen een verhoogde stabiliteit wenselijk. Het is duidelijk dat sucrose fosforylase veel 
mogelijkheden biedt, maar een aantal verbeteringen zijn echter nog nodig om het potentieel 
volledig te benutten. In deze thesis werd daarom geprobeerd via enzyme engineering de 
specificiteit van sucrose fosforyalse aan te passen en de stabiliteit te verhogen. 
Weten hoe de specificiteit wordt gecontroleerd, zou toelaten om alternatieve activiteiten efficiënter 
te optimaliseren. De interacties in de acceptorsite van het Bifidobacterium adolescentis sucrose 
phosphorylase werden daarom eerst in kaart gebracht, door alle residuen te vervangen door een 
alanine en vervolgens de affiniteit voor de natuurlijke (anorganisch fosfaat en fructose) en 
alternatieve acceptoren (arabitol en pyridoxine) na te gaan. Er werd vastgesteld dat alle 
onderzochte residuen bijdragen tot de specificiteit voor fosfaat (Arg135, Leu343 en Tyr344), 
fructose (Tyr132 en Asp342) of beide (Pro134, Tyr196, His234 en Gln345). Alternatieve acceptoren 
die efficiënt kunnen worden geglycosyleerd (zoals arabitol bijvoorbeeld) interageren met dezelfde 
residuen als fructose, terwijl slechte acceptoren zoals pyridoxine geen specifieke interacties lijken te 
maken met het enzym. Daarnaast werd ook aangetoond dat sucrose fosforylase geoptimaliseerd is 
om water te beconcurreren als acceptor. Dit betekent dat het uiterst moeilijk wordt om de 
hydrolytische nevenactiviteit verder terug te dringen. Het verhogen van de transglycosylatie 
activiteit op alternatieve acceptoren lijkt bijgevolg de beste strategie, hoewel dit in de meeste 
gevallen waarschijnlijk een drastische aanpassing van de acceptorsite zal vereisen. 
In tegenstelling tot het volledig veranderen van de specificiteit, is het aanpassen van de 
regioselectiviteit van het enzym waarschijnlijk eenvoudiger. Nochtans kunnen beide nochtans even 
belangrijk zijn. Kojibiose (Glc-α1,2-Glc) is bijvoorbeeld een zeer dure en moeilijk te verkrijgen 
component, terwijl het regio-isomeer maltose (Glc-α1,4-Glc) goedkoop is en weinig toegevoegde 
waarde biedt. Natuurlijke sucrose fosforylases produceren een mengsel van beide. Een variant die 
enkel kojibiose maakt zou natuurlijk zeer interessant zijn en om dit doel te bereiken werd een 
bestaand enzym gemuteerd. Tien posities in the acceptorsite werden eerst elk afzonderlijk volledig 
gerandomiseerd en gescreend met een high performance anion exchange chromatography (HPAEC) 
gebaseerde screeningsmethode. Deze eerste ronde bracht verschillende verbeterde mutanten voort, 
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waarvan de beste (L431I) naast een selectiviteit van 79% eveneens betere kinetische parameters 
had. Zowel het rationeel combineren als combinaties voorspeld door een statistisch model konden 
de selectiviteit verder doen toenemen, maar de eerstgenoemde aanpak leverde de beste mutanten 
op. Twee dubbele (L341I_Q345S en L341I_Q345N) en één driedubbele mutant (L341I_Y344A_Q345N) 
werden bekomen met een selectiviteit tussen 93% en 95%. Hun activiteiten zijn bovendien slecht 
iets lager in vergelijking met het wildtype enzym en bijgevolg maken deze mutanten het mogelijk 
om een rendabel en schaalbaal proces te ontwikkelen voor de enzymatische synthese van kojibiose, 
startende van de goedkope en gemakkelijk beschikbare substraten sucrose en glucose. 
Zoals reeds eerder werd aangehaald, zijn stabiele biokatalysatoren een groot voordeel voor 
industriële processen. Thermofiele organismen zijn een rijke bron van stabiele enzymen, maar in het 
geval van sucrose fosforylase werd deze mogelijkheid nog niet verkend. Vandaar dat een enzym uit 
Thermoanaerobacterium thermosaccharolyticum, dat mogelijk een sucrose fosforylase is, in dit werk 
recombinant tot expressie werd gebracht en volledig gekarakteriseerd. Het enzym vertoont 
duidelijke activiteit op sucrose (optimaal bij 55°C) en met een smelttemperatuur van 79°C en een 
halfwaardetijd van 60 uur bij de industrieel relevante temperatuur van 60°C, is het veel stabieler 
dan alle tot nu gekende sucrose fosforylases. Evaluatie van verschillende andere substraten en 
gedetailleerde karakterisering brachten echter een voorkeur voor sucrose 6’-fosfaat aan het licht. 
Het enzym kan dus beschouwd worden als een sucrose 6’-fosfaat fosforylase, een tot nu toe 
ongekende specificiteit. Vervolgens toonde analyse van een homologie model in combinatie met 
mutagenese aan dat specifieke residuen (Arg134 en His344) verantwoordelijk zijn voor het verschil 
in specificiteit. Het bestuderen van de fylogenie en verwante sequenties suggereert bovendien dat 
er mogelijks nog meer nieuwe specificiteiten te vinden zijn in glycoside hydrolase 13 subfamilie 18. 
Daarnaast werd aangetoond dat het tweede gen uit hetzelfde operon als sucrose 6’-fosfaat 
fosforylase een fosfofructokinase is en de gezamenlijke werking van beide enzymen impliceert een 
nieuwe afbraakroute voor sucrose. 
Naast het ontwikkelen van concrete toepassingen werd ook nagegaan of een aantal technieken 
zoals ancestral reconstruction, analyse van gecorreleerde mutaties en in silico voorspelling van 
stabiliteit, algemeen kunnen worden gebruikt voor protein engineering. Hedendaagse enzymen zijn 
geëvolueerd uit een gemeenschappelijke voorouder die verondersteld wordt promiscue te zijn en 
een geschikte genetische achtergrond te hebben om te evolueren naar nieuwe specificiteiten. Deze 
ancestor enzymen zouden dus in principe ook ideaal moeten zijn om in het labo te evolueren tot 
nieuwe (gerelateerde) specificiteiten. Om na te gaan of ancestor enzymen inderdaad een goed 
startpunt zijn voor mutagenese en wat de rol van promiscuïteit hierbij is, werd de 
gemeenschappelijke voorouder van de sucrose en sucrose 6-fosfaat fosforylases volledig 
gereconstrueerd. Het ancestor enzym gedroeg zich als een sucrose fosforylase, maar de activiteit 
was één tot drie grootteordes lager dan hedendaagse sucrose fosforylases. Dit was voornamelijk 
toe te schrijven aan een zeer lage kcat (<1 s-1) en een hoge KM voor sucrose en fructose (>200 mM). 
De promiscuïteit was bovendien kwalitatief niet verschillend, maar de activiteiten waren over het 
algemeen wel beduidend lager. Het introduceren van residuen die belangrijk zijn voor sucrose 
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sucrose 6-fosfaat fosforylase activiteit, konden niet voor een switch in specificiteit zorgen. Deze 
zelfde mutaties konden dit echter wel in een thermostabiel hedendaags sucrose fosforylase. Dit 
toont aan dat een stabiele template meer geschikt is voor mutagenese, dan een gereconstrueerd 
ancestor enzym. 
Een ander aspect van evolutie dat nuttig zou kunnen zijn voor enzyme engineering, is co-evolutie 
van specifieke posities in gerelateerde enzymen. Statistische analyse van aligneringen van een groot 
aantal sequenties kan dergelijke correlaties blootleggen. Vaak vormen deze correlaties complexe 
netwerken en er wordt aangenomen dat de kans groot is dat ze op één of andere manier 
betrokken zijn bij activiteit, specificiteit en stabiliteit. Over hun exacte rol is momenteel echter 
weinig gekend. Om hieraan tegemoet te komen, werden in deze thesis de gecorreleerde mutaties 
van twee verwante specificiteiten (sucrose en sucrose 6’-fosfaat fosforylase) vergeleken en 
hypothesen over verschillende aspecten van het correlatienetwerk experimenteel geëvalueerd. De 
verspreiding over de structuur suggereert dat gecorreleerde posities waarschijnlijk een 
ondersteuning bieden van de verschillende active sites, eerder dan direct betrokken te zijn bij 
contact met substraten. Het volgen van het evolutionair pad van deze posities bij de overgang van 
de ene specificiteit naar de andere toonde aan dat posities die dicht bij elkaar liggen in de 
structuur of die sterk met elkaar gecorreleerd zijn, niet noodzakelijk samen evolueren. Introductie 
van de active site van sucrose 6’-fosfaat fosforylase in sucrose fosforylase stelde deze laatste in 
staat om de sucrose 6’-fosfaat fosforylase reactie te katalyseren. De activiteit was echter zeer laag 
en om deze op te krikken, werden ook de gecorreleerde posities gemuteerd. Dit resulteerde in de 
meeste gevallen in een verlaging van de activiteit (tot een factor 50), maar in één dubbele mutant 
kon de sucrose 6’-fosfaat fosforylase activiteit selectief worden verhoogd met een factor 2. Er kan 
dus geconcludeerd worden dat mutatie van gecorreleerde posities de activiteit en specificiteit kan 
beïnvloeden, maar algemene richtlijnen over welke posities hiervoor het belangrijkst zijn of welke 
specifieke mutaties moeten worden geïntroduceerd, kon onmogelijk worden afgeleid. Verder 
onderzoek is dus vereist.  
Het belang van stabiele enzymen werd reeds eerder aangehaald. Een aantal zijn te vinden binnen 
de natuurlijke diversiteit, maar niet alle specificiteiten zijn beschikbaar en bijgevolg moeten stabiele 
varianten bekomen worden door engineering van bestaande enzymen. In silico voorspelling van 
stabiliserende mutaties zou hierbij een enorme hulp kunnen zijn, omdat op deze manier de kosten, 
tijd en moeite sterk kunnen worden teruggebracht in vergelijking met in vitro screening procedures. 
In dit werk werd nagegaan of het FoldX algoritme een bijdrage kan leveren tot deze doelstelling. 
Daartoe werd voor een sucrose fosforyalse de free energy of folding en de dimeer interactie-
energie voor alle mogelijke puntmutaties in silico voorspeld en verbeterde mutanten werden 
vervolgens visueel geïnspecteerd. Twee derde overleefde deze manuele selectie niet, vaak omdat 
hydrofobe residuen te sterk werden blootgesteld aan solvent. Van de overblijvende werden de 
negen meest belovende experimenteel getest. Helaas was geen enkele mutatie stabiliserend: vier 
bleken neutraal of bijna neutraal te zijn, terwijl de overige nefast waren voor stabiliteit. Opmerkelijk 
is dat de mutatie voorspeld door FoldX als de beste, in werkelijkheid de stabiliteit zeer sterk 
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aantastte. Om een verklaring te bieden voor deze bevindingen, werd beroep gedaan op molecular 
dynamics simulaties. Resultaten toonden aan dat kwadratisch gemiddelde schommelingen, die een 
maat zijn voor lokale flexibiliteit, slechte predictoren zijn voor stabiliteit. De waargenomen effecten 
konden daarentegen in veel gevallen wel verklaard worden door na te gaan of de interacties 
verantwoordelijk voor de voorspelde stabiliteit, behouden bleven over een bepaalde tijdspanne. 
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